Escolar Documentos
Profissional Documentos
Cultura Documentos
India Strategy
FY19
earnings Political flux
growth
25%
Monsoon
boost
Trade war / oil
price shocks
Improving
Industrial macros
capex revival
FY18 earnings
growth Rebound of
11% corporate
lenders
April 2018 2
India Strategy | Earnings recovery imminent
India Strategy
BSE Sensex: 33,371 S&P CNX: 10,245
Global Cyclicals drive earnings; Autos and Technology show good recovery
As we step into FY19, the clamor for an earnings recovery has become louder. This is
particularly because the last three years were characterized by a muted earnings
performance due to macro disruptions and several policy changes pertaining to
asset quality in the banking sector. Although we expect Nifty earnings to grow by a
decent 11% in FY18, it is much below our FY18-beginning estimate of +17% – this
can be mainly attributed to the drag from corporate banks (ICICI Bank, Axis Bank
and SBI, which together accounted for 62% of the cut in Nifty PAT estimate in a span
of a year).
However, we believe the worst of the NPA cycle is behind, and with resolution in
several key NCLT assets, the earnings picture for BFSI could turn much brighter in
FY19. Our consumption recovery theme is also gaining strength – also because the
government is expected to be supportive of consumption demand in an election-
busy year. Projection of a normal monsoon in CY18 adds to the cheer. Also, on the
investment side, industrial capex is showing signs of recovery.
Overall, we expect FY19 to kick-start earnings recovery for India, although the
market is likely to be distracted by several macro factors along the way, such as the
ongoing global trade conflict, the US Fed rate increase cycle, domestic equity flows
and, last but not the least, the domestic political developments in an election-heavy
year. Although the path to earning revival is more like a game of snakes-and-ladders
than a straight line, we expect more encouraging ladders than slippery snakes in
FY19. Also, after the recent correction in the markets and the softening of bond
yields, we believe valuations offer enough bottom-up stock-picking opportunities.
April 2018 3
India Strategy | Earnings recovery imminent
We expect Nifty Sales, EBITDA and PAT to growth 14%, 11% and 14%,
respectively. PAT growth of 14%, if delivered, will be highest in 15 quarters.
We have revised our Nifty EPS estimates downwards by 2% and 3% for FY18E
and FY19E to INR462 and INR 577 vs. INR471 and INR595 earlier, respectively.
We are now building in Nifty EPS growth of 11%/25%/21% for FY18/19/20.
April 2018 4
India Strategy | Earnings recovery imminent
Telecom universe will report loss. Idea’s loss is expected to remain elevated
while Bharti is expected to post 80% YoY decline in profits.
April 2018 5
India Strategy | Earnings recovery imminent
April 2018 6
India Strategy | Earnings recovery imminent
3. Bajaj Finance: Bajaj Finance is expected to continue its strong growth trajectory
and post a solid 43% earnings growth. Growth will be driven by consumer and
rural segments. This will be its 12th consecutive quarter of 30%+ profit growth.
4. Coal India: EBITDA is expected to grow 39% YoY due to 5% volume growth, 7%
reduction in cost of production due operating leverage, and 23% increase in E-
auction prices. PAT growth is expected to be even higher due to volatility in tax
rates.
5. RIL: Led by stronger petchem margins, petchem volumes & sustained strong
refining margins, we expect EBITDA to grow 32% YoY & 9% QoQ in the quarter.
6. Titan: Gains from healthy sales growth of around 17% in 4QFY18 will be further
boosted at the EBITDA and PAT level by unusually low EBITDA margin in base
quarter 4QFY17.
7. Tech Mahindra: EBITDA margin bottomed out in 4QFY17 at 12%, ensuing its
recovery thereafter. It should exit FY18 with a strong 17.3% EBITDA margin,
+530bp YoY. This is driving the bulk of the profit growth in the company. Dollar
revenue growth is estimated to be 10%.
WEAK PERFORMANCE
1. SBI: SBI is expected to post a loss of INR16.5b, compared to a loss of INR24b in
the previous quarter, led by elevated provisions as slippages are expected to
remain high.
2. ICICI Bank: ICICI Bank is expected to report 32% YoY decline in PAT to INR13.8b,
led by elevated credit costs towards meeting PCR for NCLT accounts, as well as
high slippages from other stressed accounts
3. Bharti Airtel: Bharti is expected to post a sharp 12% EBITDA decline and 80%
drop in PAT. This is on the back of continued ARPU decline in India resulting in
17% fall in India wireless EBITDA.
April 2018 7
India Strategy | Earnings recovery imminent
March 2018, in line with our forecast of 4%. It also cut its inflation forecasts for
1HFY19/2HFY19 to 4.7%-5.1%/4.4% from 5.1%-5.6%/4.5% earlier.
Also, our proprietary Economic Activity Index (EAI) points toward a continued
recovery, albeit with monthly volatility. After growing reasonably by ~7% YoY in
January 2018, India’s economic activity index (EAI) grew at the four-month
slowest pace of 6.3% YoY in February 2018. Nonetheless, it implies average
growth of 6.6% in the first two months of 2018, similar to the growth witnessed
in 3QFY18. An extremely favorable base is expected to support EAI growth in
March 2018. Accordingly, we continue expecting real GDP growth to improve
slightly from 7.2% in 3QFY18 to 7.3% in 4QFY18.
Another concern – the sharp rise in bond yields – has also been addressed. Bond
yields had shot up by more than 100bp from 6.7% to7.8% in 6 months, led by
global bond moves and heightened concerns about domestic inflation and fiscal
slippage. However, yields have come off 60-70bp over the past month due to
the combination of policy moves. The Indian government’s 1HFY19 borrowing
calendar has provided some succor. It has planned to borrow only 47.6% of its
full-year borrowing target in 1HFY19, much lower than the average 1H
borrowing of 60-62% of the full-year borrowing target over the past many years.
Furthermore, the borrowing composition, as desired, has tilted toward short-
end securities, which is likely to flatten the yield curve. This announcement
resulted in a correction of bond yields by 30bp in a day. With the RBI revising its
FY19 inflation forecast downward, it added another catalyst for bond yields to
cool off.
April 2018 8
India Strategy | Earnings recovery imminent
3. Earnings recovery has been extremely narrow in FY17 and FY18; expected to
get broader in FY19 and FY20; Financials to make a comeback in FY19
Earnings growth in FY17 and FY18 has been very narrow. It was led by a few
sectors. For example, after growing 14% in FY17, the MOSL Universe earnings
are expected to grow at 8% in FY18. Three sectors – PSU Banks, Metals and Oil &
Gas – accounted for 17%, 18% and 43% of the earnings delta in FY17, i.e. ~80%
of growth was driven by these three cyclicals.
Similarly, in FY18, Metals, Oil & Gas, NBFC and Autos will contribute 46%, 17%,
19% and 20%, respectively, of the earnings delta for the MOSL Universe, i.e.
>100%% of growth coming from just four sectors.
Financials’ contribution in earnings growth has come off significantly (from 46%
in FY15 to 23% in FY17) owing to a drag in PSU Banks and private corporate
lenders. It is expected to decline further to 11% in FY18. FY17 and FY18 have
seen a significant increase in gross NPAs and a consequent rise in provisioning
requirement for PSU Banks and Private Corporate lenders, resulting in a sharp
drop in overall contribution of Financials to earnings growth.
Going forward, we expect financials to make a comeback as asset quality issues
bottom out and provisioning pressure fades off. We expect Financials’
contribution in earnings growth to go back to ~40% in FY19 and sustain even in
FY20 (largely in line with its weight in Nifty). This will largely be driven by PSU
Banks, given the low base of earnings and expected normalization of
provisioning costs.
On the contrary, we expect contribution of global cyclicals like Metals and
Cyclicals in incremental earnings to moderate. From 49% of incremental
earnings in FY18E, we expect Metals’ contribution to drop to 12% in FY19 and
3% in FY20.
For Oil & Gas, we expect the sector’s contribution in MOSL universe earnings
growth to come off from 17% to 6% in FY19 and then move up to 12% in FY20.
April 2018 9
India Strategy | Earnings recovery imminent
April 2018 10
India Strategy | Earnings recovery imminent
earnings growth, MOSL Universe ex PSU Banks and Metals is expected to post
11.5% YoY earnings growth.
For 4QFY18, we expect MOSL Universe revenue to grow 14% YoY (revenue was
up 15% YoY in the base quarter), among the highest in 22 quarters.
MOSL Universe EBITDA growth is estimated at 11% YoY (on a base of 13%
growth), with flat underlying operating margin for MOSL Universe (ex-Financials
and OMCs). MOSL Universe PAT is likely to grow 11% YoY (24% PAT growth in
4QFY17) driven by Global Cyclicals like Metals, Oil & Gas & Coal India.
Global Cyclicals will drive 72% of the incremental PAT delta for MOSL Universe
PAT, with a strong 21% YoY PAT growth.
Defensives are expected to post PAT growth of 3% after 5 consecutive quarters
of PAT decline. This will be aided by improvement in earnings growth of
Technology universe which is expected to post a double digit profit growth after
eight quarters.
Domestic Cyclicals is expected to post muted 7% YoY PAT growth, dragged by
Banks. Nifty earnings are expected to grow 14% YoY, while Nifty ex-OMCs,
Metals and PSU Banks is expected to post 12% YoY profit growth.
April 2018 11
India Strategy | Earnings recovery imminent
Another concern – the sharp rise in bond yields – has also been addressed by
the recent policy moves of the RBI, and bond yields have cooled off ~60bp from
their recent peak.
3. Earnings recovery has been extremely narrow in FY17 and FY18; expected to
get broader in FY19 and FY20; Financials to make a comeback in FY19
Earnings growth in FY17 and FY18 has been very narrow. It was led by a few
sectors. For example, after growing 14% in FY17, the MOSL Universe earnings
are expected to grow at 8% in FY18. Three sectors – PSU Banks, Metals and Oil &
Gas – accounted for 17%, 18% and 43%, respectively, of the earnings delta in
FY17, i.e. ~80% of growth was driven by these three cyclicals.
Similarly, in FY18, Metals, Oil & Gas, NBFC and Autos will contribute 46%, 17%,
19% and 20%, respectively, of the earnings delta for the MOSL Universe, i.e.
>100%% of growth coming from just four sectors.
Financials’ contribution in earnings growth has come off significantly (from 46%
in FY15 to 23% in FY17) owing to a drag in PSU Banks and private corporate
lenders. It is expected to decline further to 11% in FY18.
Going forward, we expect financials to make a comeback as asset quality issues
bottom out and provisioning pressure fades off. We expect Financials’
contribution in earnings growth to go back to ~40% in FY19 and sustain even in
FY20 (largely in line with its weight in Nifty). This will largely be driven by PSU
Banks, given the low base of earnings and expected normalization of
provisioning costs.
On the contrary, we expect contribution of global cyclicals like Metals and
Cyclicals in incremental earnings to moderate. From 46% of incremental
earnings in FY18E, we expect Metals’ contribution to drop to 12% in FY19 and
3% in FY20.
April 2018 12
India Strategy | Earnings recovery imminent
For Oil & Gas, we expect the sector’s contribution in MOSL universe earnings
growth to come off from 17% to 6% in FY19 and then move up to 12% in FY20.
April 2018 13
India Strategy | Earnings recovery imminent
April 2018 14
June-12 18.6 Jun-12-35.4 Jun-12 16.5
Sep-12 18.3 Sep-12 65.4 18.8
April 2018
Dec-12 18.0 Dec-12 -3.2 Dec-12 10.3
Mar-13 18.9 Mar-13 3.9 7.7
on high base
June-13 18.1 Jun-13 88.3 Jun-13 7.2 PAT decline
Sep-13 18.4 Sep-13 -9.7 12.6
Dec-13 18.6 Dec-13 5.2 Dec-13 12.0
Mar-14 18.5 Mar-14 -0.9 11.5
June-14 18.8 Jun-14 32.2 Jun-14 14.2
MOSL Universe
Sep-14 18.3 Sep-14 5.6 4.6
growth for MOSL Universe
Sep-15 18.6 Sep-15 0.2 -5.6
Dec-15 18.9 Dec-15 1.1 Dec-15 -4.9
Mar-16 20.2 Mar-16 -16.5 2.6
June-16 21.2 Jun-16 0.8 Jun-16 -1.6
Sep-16 19.9 Sep-16 8.1 3.7
Dec-16 20.0 Dec-16 18.9 Dec-16 8.5
Mar-17 19.9 Mar-17 24.2 14.8
Source: MOSL
Source: MOSL
Source: MOSL
Dec-15 9.3
Mar-16 10.8 Dec-16 -0.8 Dec-16 4.2
June-16 10.5 Mar-17 -4.1 Mar-17 1.0
Sep-16 10.1
Dec-16 9.4 June-17-13.6 June-17 -0.9
Mar-17 10.3 Sep-17 -5.3 Sep-17 1.3
June-17 9.4
Sep-17 9.9 Dec-17 -1.6 Dec-17 2.8
Exhibit 5: After 5 consecutive quarter of YoY PAT decline,
Exhibit 3: Sales growth of Defensives inching up gradually
Gas and Coal India. This will result in share of global cyclicals in MOSL earnings
Share of global cyclicals in MOSL universe earnings pool at 26 quarter high
Earnings growth in 4QFY18 is singularly led by global cyclicals like Metals, Oil &
Exhibit 7: 4QFY18 PAT margin for MOSL Universe (ex OMCs
Mar-18 10.3
15
Source: MOSL
Source: MOSL
Source: MOSL
MOSL Universe: Double digit Sales and PAT growth, defensives PAT to grow at 3% after five quarters of
India Strategy | Earnings recovery imminent
India Strategy | Earnings recovery imminent
Auto universe PAT for the quarter at INR 134b will be at all-time high.
Technology sector will also post all-time high absolute profits in 4QFY18.
Exhibit 8: Sectoral quarterly PAT trend (INR b)
Sector FY14 FY15 FY16 FY17 FY18
Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec MarE
Auto 56 77 86 84 95 80 80 65 102 72 88 124 92 94 59 110 64 110 82 134
Capital Goods 16 22 24 54 19 20 21 47 14 16 7 46 16 25 25 54 21 32 31 59
Cement 19 11 11 18 18 14 10 16 14 16 16 24 27 22 16 22 28 20 18 22
Consumer 47 49 54 50 53 56 59 56 57 58 64 60 65 65 65 67 65 72 75 74
Financials 194 169 175 208 212 197 194 216 208 201 116 -10 153 166 183 125 195 185 124 119
Private Banks 70 72 80 85 82 85 95 100 91 98 106 83 94 94 97 102 102 98 104 105
PSU Banks 92 62 61 81 93 75 61 70 76 59 -37 -146 11 16 32 -37 34 19 -52 -63
NBFC 33 34 34 42 37 37 38 46 39 43 44 50 46 54 53 57 56 65 70 75
Healthcare 32 42 87 45 47 51 35 39 56 57 54 54 60 62 56 48 32 49 47 47
Infrastructure 2 2 2 3 2 2 2 3 3 3 3 2 3 3 3 4 4 3 4 5
Logistics 3 3 3 3 4 3 4 4 3 3 3 4 3 2 3 5 3 3 2 3
Media 6 6 6 5 5 6 8 6 8 8 9 9 8 8 9 8 8 10 9 7
Metals 68 72 77 85 88 91 78 41 48 57 -13 30 34 38 54 99 68 78 113 130
Oil & Gas 63 170 109 316 160 131 58 242 233 119 185 204 271 200 226 236 198 245 303 263
Oil & Gas Ex OMCs 107 140 147 135 122 126 82 129 135 120 132 149 140 148 146 163 155 167 183 184
Retail 2 2 2 2 2 3 2 2 2 2 3 2 2 2 3 2 3 3 3 4
Technology 106 121 129 134 132 137 144 141 141 152 153 158 153 157 164 155 152 163 162 171
Telecom 15 13 15 24 23 27 28 29 23 26 26 28 28 24 8 11 3 0 -2 -7
Utilities 84 78 88 92 85 66 76 98 89 87 88 93 87 72 81 83 85 73 86 113
Others 10 7 8 9 12 8 9 11 13 7 11 9 16 10 12 15 15 11 14 17
MOSL Univ 723 842 876 1,133 957 890 810 1,016 1,012 881 809 835 1,015 948 964 1,043 941 1,054 1,070 1,158
MOSL Univ Ex Metals,
501 538 630 652 615 593 612 662 655 646 674 747 700 694 651 745 641 713 707 829
Oil & PSU Banks
Exhibit 9: Sectoral quarterly PAT growth trend (%)
Sector FY14 FY15 FY16 FY17 FY18
Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec MarE
Auto -9 45 67 3 70 4 -7 -23 8 -10 10 91 -10 31 -33 -11 -31 16 39 22
Capital Goods -43 -24 -19 -14 19 -10 -12 -14 -28 -20 -69 0 20 51 274 16 26 31 24 10
Cement -31 -48 -35 -15 -6 28 -11 -12 -21 13 68 49 93 39 1 -5 3 -9 11 -2
Consumer 13 15 15 13 12 14 10 13 9 4 7 6 13 13 2 11 0 10 16 11
Financials 8 -4 -7 4 9 17 11 4 -2 2 -40 PL -26 -17 58 LP 28 11 -32 -5
Private Banks 29 26 20 20 18 19 19 17 10 14 12 -16 3 -3 -9 22 9 4 8 3
PSU Banks -6 -30 -31 -9 2 21 0 -13 -18 -21 PL PL -86 -73 LP Loss 218 15 PL Loss
NBFC 17 11 3 6 13 7 13 10 5 17 16 8 20 24 19 15 21 22 33 30
Health Care 43 40 133 48 45 20 -59 -12 20 11 53 38 7 9 4 -12 -46 -20 -15 -2
Infrastructure -1 2 4 52 19 5 10 -6 16 60 27 -14 10 -8 27 70 45 10 34 19
Logistics -6 -1 9 22 13 -2 32 20 -8 4 -32 0 -20 -26 -13 26 23 27 -7 -45
Media 23 14 17 2 -2 2 26 8 42 38 6 57 -1 2 1 -5 2 29 1 -14
Metals -34 6 28 -7 30 26 2 -51 -45 -38 PL -28 -29 -32 LP 236 99 104 108 31
Oil & Gas LP -47 -41 -16 154 -23 -47 -23 45 -9 219 -16 16 68 22 16 -27 22 34 11
Oil & Gas Ex OMCs -8 -6 9 25 14 -10 -44 -4 11 -5 61 15 4 24 10 9 10 12 26 13
Retail 15 3 -12 12 -5 22 7 1 -13 -37 13 -13 33 13 -1 1 15 71 38 68
Technology 17 31 33 38 25 13 11 6 7 11 7 12 8 4 7 -2 0 3 -1 11
Telecom 44 41 128 105 48 105 86 17 2 -5 -9 -2 20 -6 -68 -59 -90 PL PL PL
Utilities -7 6 -6 -13 1 -15 -14 6 5 31 16 -5 -2 -17 -8 -11 -3 2 6 37
Others 26 -3 3 3 15 16 10 19 11 -6 21 -12 21 42 11 65 -3 6 20 12
MOSL Univ 88 -10 5 -1 32 6 -8 -10 6 -1 0 -18 0 8 19 25 -7 11 11 11
MOSL Univ Ex Metals, 6 18 26 11 23 10 -3 2 6 9 10 13 7 7 -3 0 -8 3 9 11
Source: MOSL
Note: Comparable Universe, excludes Alkem Labs, Interglobe Aviation, CG Consumer Electricals, Equitas Holding, IDFC Bank, RBL Bank, L&T
Infotech, Manpasand, SH Kelkar, Endurance Tech, Gujarat Gas, Music Broadcast, Avenue Supermarts, Quess Corp, Teamlease Service, HDFC
Standarad Life, Mahanagar Gas, PC Jeweller, Mas Financials and Laurus Labs.
April 2018 16
India Strategy | Earnings recovery imminent
April 2018 17
India Strategy | Earnings recovery imminent
Nestle, Pidilite, Colgate and United Breweries are expected to post strong set of
numbers, posting PAT growth in excess of 17%, whereas Emami and Jyothy Lab
will post PAT de-growth.
Utilities are expected to report 37% growth in PAT, led by strong performance
from Coal India (89% YoY PAT growth) and Power Grid (19.2% YoY PAT growth).
Coal India alone will contribute roughly 80% to the PAT delta. Utilities ex Coal
India are still expected to post a robust 11% PAT growth in 4QFY18.
Technology is expected to report its first double digit PAT growth (10.9%) after
eight quarters, with Persistent systems (-16.4%) being the only IT company
expected to report PAT de-growth. In 4Q, YoY revenue trajectory is likely to
continue to inch up. We expect such acceleration in INFO, TCS and TECHM, and
also organically for WPRO - across our top-tier universe
Telecom universe will report loss. Idea’s loss is expected to remain elevated
while Bharti is expected to post 80% YoY decline in profits.
Oil & Gas is expected to report 11% YoY PAT growth on a base of 15% growth in
the quarter ended Mar’17, driven by RIL( contributing 57% to PAT delta), ONGC
and IOC. Among OMCs, only IOC is expected to post strong performance, led by
Paradip ramp-up. HPCL and BPCL would post YoY PAT decline due to lower
marketing margins.
Exhibit 11: 4QFY18 sectoral PAT growth YoY (%) Exhibit 12: 4QFY18 sectoral PAT growth QoQ (%)
61 93
37 31 30 63
22 19 13
11 11 11 11 10 4 3
32 23 21
17 15 15 8 8 6
6 4 2
-1 -2
-13
-1 -1
-45 -13-18
PL Loss
Loss Loss
MOSL Univ
Utilities
Banks - PSU
Metals
NBFC
Health Care
Telecom
Sensex
Auto
Consumer
Logistics
Technology
Cap. Goods
Banks - Pvt
Cement
Media
Life Ins
Retail
Infra
MOSL Univ
Utilities
Banks - PSU
Telecom
Metals
NBFC
Health Care
Sensex
Logistics
Cap. Goods
Auto
Cement
Banks - Pvt
Consumer
Technology
Media
Life Ins
Infra
Retail
Exhibit 13: 25% of the companies likely to report PAT decline; lowest since March 2011
Earnings Gr. >30% >15-30% >0-15% <0% Ex OMCs (%)
26 -8 -15 23 26 24 4 11 18 1
15 13 6 -3 12 17 -7 -3 -11 -4 8
24 20 -15 -11 42 22 9 9 0 8 9 7 -13 1 20 10 12
% of MOSL Universe companies
11 18 -9 -3
21 24 23 26 42 41 27
32 35 31 30 27 25 24 31 34 31 38 39 26 35
38 46 36 40 37 34 31 35 44 45 33 30
25
42 40 42 40 37 38 45 36
14 9 10
19 24
26 14 14 9 13 20 18 18 27 15 20
21 11 24 19 13 27 17 16 19 22 25 17 16 18 20 22 22
17 16 24 16
18 22 18 22 10 22
21
18 23 17 22 25
20
22 21 20 25 19
18 22 17 19 18 20 20 20 14 12 19
10 14 24 25 18 17 16 18 14 20 22 20 23 16 12 26 13
44 45 35 51 18
41 43 38 32 39 35
30 26 27 32 31 35
21 21 24 25 25 28 26 24 19 26 24 19 20 26 18 21 21 21 25 26 28 29 29 23 17 26
Dec 07
June 08
June 09
June 10
June 11
June 12
June 13
June 14
June 15
June 16
June 17
Mar 08
Sep 08
Dec 08
Mar 09
Sep 09
Dec 09
Mar 10
Sep 10
Dec 10
Mar 11
Sep 11
Dec 11
Mar 12
Sep 12
Dec 12
Mar 13
Sep 13
Dec 13
Mar 14
Sep 14
Dec 14
Mar 15
Sep 15
Dec 15
Mar 16
Sep 16
Dec 16
Mar 17
Sep 17
Dec 17
Mar 18E
April 2018 18
India Strategy | Earnings recovery imminent
THREE KEY TRENDS Three key macro trends as we step into FY19
However, with the impact of demonetization now behind and GST-related issues
gradually settling down, the macros appear to have bottomed out, in our view.
Better-than-expected GDP data for 3QFY18, IIP trends, auto monthly sales numbers
and fuel consumption data are all pointing toward a gradual demand pick-up.
Broadly speaking, while GDP growth has bottomed out, inflation too has moderated.
Exhibit 14: Real GDP growth has bottomed out (%) Exhibit 15: IIP growth also showing higher prints
Real GDP 10 IIP growth
10 % YoY
7.5
9 8
8
7 5
6
5 3
(% YoY)
4
3 0
Jul-16
Jul-17
Jun-16
Jun-17
Nov-16
Nov-17
Apr-16
May-16
Apr-17
May-17
Aug-16
Dec-16
Aug-17
Dec-17
Jan-16
Feb-16
Mar-16
Sep-16
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Oct-16
Oct-17
2
Q3 FY14 Q3 FY15 Q3 FY16 Q3 FY17 Q3 FY18
0.0
-25.0
-50.0
Jul-16
Jul-17
Nov-16
Nov-17
May-16
May-17
Mar-16
Sep-16
Jan-17
Mar-17
Sep-17
Jan-18
Mar-18
Jul-16
Jul-17
Nov-16
Nov-17
May-16
May-17
Mar-16
Sep-16
Jan-17
Mar-17
Sep-17
Jan-18
Mar-18
April 2018 19
India Strategy | Earnings recovery imminent
6.1
9.4
Jun-16
Jun-17
Apr-16
Feb-16
Aug-16
Apr-17
Dec-16
Feb-17
Aug-17
Dec-17
Feb-18
Oct-16
Oct-17
Jun-16
Jun-17
Apr-16
Feb-16
Aug-16
Apr-17
Dec-16
Feb-17
Aug-17
Dec-17
Feb-18
Oct-16
Oct-17
Exhibit 20: Real rural wage growth has been steady Exhibit 21: Construction activity has made a strong rebound
Real rural wages (% YoY) Construction 18.0
2.0
(% YoY)
Jun-16
Jun-17
Apr-16
Feb-16
Aug-16
Apr-17
Dec-16
Feb-17
Aug-17
Dec-17
Feb-18
Oct-16
Oct-17
Jun-16
Jun-17
Apr-16
Feb-16
Aug-16
Apr-17
Dec-16
Feb-17
Aug-17
Dec-17
Feb-18
Oct-16
Oct-17
In fact, our growth and inflation outlooks have turned more favorable. Following
better-than-expected 3QFY18 data and revisions in the previous quarters’ data, our
economist, Nikhil Gupta, has revised up our real GVA/GDP growth forecasts for FY18
to 6.4%/6.7% from 6%/6.3% earlier. Furthermore, real GDP is expected to grow
6.9% in FY19, slightly better than 6.8% expected previously. With CPI consistently
coming in below our expectations, we have revised down our FY19 forecast from
5.1% to 4.4%.
Exhibit 22: Revision in key Economic Indicators; GDP growth revised-up; CPI revised downward
Actual data Revised Apr’18 forecasts Previous Jan’18 forecasts
Macro indicators Unit FY16 FY17 FY18F FY19F FY20F FY18F FY19F FY20F
Nominal GDPMP % YoY 10.4 10.8 11.3 11.6 12.3 10 11.4 11.9
Real GDPMP % YoY 8.2 7.1 6.7 6.9 7.2 6.3 6.8 7.4
Real GVABP % YoY 8.1 7.1 6.4 6.7 7 6 6.4 7
Consumer price index (CPI) % YoY 4.9 4.5 3.6 4.4 4.5 3.8 5.1 4.7
Policy repo rate (year-end) % pa 6.75 6.25 6 6 6 6 6 6
INRUSD (average) unit 65.5 67.1 64.4 66 67.7 64.6 65.5 65.7
Current account balance % of GDP -1.1 -0.7 -1.7 -1.7 -1.7 -1.4 -1.5 -1.8
Fiscal balance % of GDP -3.9 -3.5 -3.5 -3.3 -3.1 -3.5 -3.2 -3
The RBI, in its recent monetary policy meeting, revised down its 4QFY18 inflation
projection to 4.5% from 5.1% earlier, implying inflation of 3.9%-4% in March 2018,
in line with our forecast of 4%. It also cut its inflation forecasts for 1HFY19/2HFY19
to 4.7%-5.1%/4.4% from 5.1%-5.6%/4.5% earlier.
April 2018 20
India Strategy | Earnings recovery imminent
Exhibit 23: RBI expects inflation to remain contained in Exhibit 24: …and expects GDP growth to pick up from 6.6%
FY19… in FY18 to 7.4% next year
Our proprietary Economic Activity Index (EAI) points toward a continued recovery,
albeit with monthly volatility. After growing reasonably by ~7% YoY in January 2018,
India’s economic activity index (EAI) grew at the four-month slowest pace of 6.3%
YoY in February 2018. Nonetheless, it implies average growth of 6.6% in the first two
months of 2018, similar to the growth witnessed in 3QFY18. An extremely favorable
base is expected to support EAI growth in March 2018. Accordingly, we continue
expecting real GDP growth to improve slightly from 7.2% in 3QFY18 to 7.3% in
4QFY18.
Exhibit 25: MOSL’s proprietary EAI posts healthy growth for Exhibit 26: …on account of a surge in investment activity
the fourth consecutive month in February 2018… (percentage point)
% YoY 3-mma Economic Activity Index Consumption Investment Net exports EAI
12
(pp)
9
3.9 5.3
6 4.2 3.4
5.2 4.1 4.1
3
(1.2) (1.1) (2.6)
0 (0.6) (1.2)
-3
Feb-17
Dec-17
Jan-18
Feb-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Oct-17
Please refer to our earlier report for details Contribution of different components to EAI’s growth
Another concern – the sharp rise in bond yields – has also been addressed. Bond
yields had shot up by more than 100bp from 6.7% to7.8% in 6 months, led by global
bond moves and heightened concerns about domestic inflation and fiscal slippage.
However, yields have come off 60-70bp over the past month due to the
combination of policy moves. The Indian government’s 1HFY19 borrowing calendar
April 2018 21
India Strategy | Earnings recovery imminent
has provided some succor. It has planned to borrow only 47.6% of its full-year
borrowing target in 1HFY19, much lower than the average 1H borrowing of 60-62%
of the full-year borrowing target over the past many years. Furthermore, the
borrowing composition, as desired, has tilted toward short-end securities, which is
likely to flatten the yield curve. This announcement resulted in a correction of bond
yields by 30bp in a day. With the RBI revising its FY19 inflation forecast downward, it
added another catalyst for bond yields to cool off.
Exhibit 27: 10-year G-Sec yield has softened ~70bps from the recent peak
8.0
7.5
7.0
6.5
6.0
Jul-17
Jun-17
Nov-16
Nov-17
Apr-17
May-17
Apr-18
Dec-16
Aug-17
Dec-17
Sep-16
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-16
Oct-17
2. Industrial capex – on a recovery path
Industrial capex in India has been subdued over the past 5-6 years, as reflected in
weak capex spends by Indian companies, corroborated by weak orders for
equipment suppliers and muted industrial credit growth. However, capex by
consumer-oriented sectors like Autos, Telecom, Media, FMCG, Food & Beverages
and Consumer Durables/Electronics has remained largely uninterrupted. Capex
spend by the private sector has been an Achilles’ heel, impacting investments in the
economy. Leveraged balance sheets, low capacity utilization and several macro
disruptions in the economy impacted the private investment cycle. Therefore, the
burden of investment growth was falling on the government’s shoulders.
Government spending on infrastructure, especially on roads and railways, has
indeed gone up. However, private capex recovery is the key for sustainable pick-up
in investments in the economy.
Exhibit 28: Government’s share of gross projects has increased sharply from FY11
70,000
46% 42% 38%
56% 53% 49% 60,000
59% 60% 59%
50,000
40,000
54% 58% 62%
44% 47% 51%
41% 40% 41% 30,000
20,000
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Jan-18
April 2018 22
India Strategy | Earnings recovery imminent
After many years, we are seeing some early signs of pick-up in industrial capex. Post
the cyclical downturn in the core sectors, we are starting to see green shoots of
recovery in sectors like Oil & Gas (O&G), Steel, Cement and Fertilizers, with the
situation expected to get even better. Private sector capex in the Power sector will
be toward renewables; a revival is unlikely in coal-fired plants in the medium term.
Oil & Gas: Capex is being driven by BS-VI emission norm-related upgrades, along
with brownfield/greenfield expansions by state oil marketing companies.
Additionally, five fertilizer plants are being set up, providing further capex
opportunities. We estimate total O&G capex over 2017-21E at INR2.2t (8%
CAGR)
Cement sector: Region-wise, utilization has already crossed 80% in north and
east India, and is at ~75% in west India and ~55% in south India. Capacity
addition is primarily being planned by companies in east India due to strong
demand (growing at ~12% YoY). Among the listed companies, UltraTech, Dalmia
Bharat and Shree Cement are adding capacities. JSW Cement, an unlisted player,
is looking to add ~8MTPA of capacity. Most cement players are evaluating
WHRGs to reduce electricity consumption. We estimate cement capex to grow
at a CAGR of 9% over FY17-21.
Steel capex: With rising commodity prices and protection of import tariffs,
metal companies are announcing capacity addition (FY17-21E capex CAGR of
7%). Tata Steel and JSW Steel have already started work on their respective
plants. However, many steel players like Bhushan Steel, Monnet Ispat, Essar
Steel and Electrosteel remain under stress, and their assets are in the process of
being sold by their lenders under the Insolvency and Bankruptcy (IBC) code.
Power sector capex: Capex in the power sector has largely shifted toward
renewables at the cost of coal-fired plants. This is especially true for private
sector capex in power. We do not expect any revival in coal-fired capex in the
medium term (FY17-21E: -8% CAGR), and see a continued rise in the share of
renewables.
Consumer-oriented sectors: Sectors like Autos, FMCG, Consumer
durables/electronics and F&B continue to add capacity, given strong end-market
demand. However, pharma capex is expected to remain muted over FY17-21
owing to deterioration in the business environment for the sector.
Exhibit 29: Refining sector capacity addition and utilization Exhibit 30: Steel sector capacity addition and utilization
Incremental capacity (Mn ton) Utilisation(%) Capacity Addittion m tons Capacity Utilisation(%)
102
107
106
104
103
103
103
102
102
102
101
100
94
92
91
98
90
96
96
88
94
94
86
92
92
91
84
84
89
82
82
88
81
81
81
87
80
80
76
75
74
73
72
72
70
74
68
43
17
29
20
16
13
2
0
4
9
7
8
9
7
1
0
0
2
1
1
4
4
8
6
3
6
9
3
6
5
7
2
7
7
5
3
5
FY99
FY01
FY03
FY05
FY07
FY09
FY11
FY13
FY15
FY17
FY19E
FY21E
FY98
FY99
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
FY21E
April 2018 23
India Strategy | Earnings recovery imminent
Exhibit 31: Cement sector capacity addition and utilization Exhibit 32: Industrial credit growth starting to pick up
Capacity Addittion (m tons) Utilisation (%) 50%
94
94
35%
90
88
86
35%
84
83
82
81
81
81
81
79
78
76
76
66
74
63
65
71
69
69
68
20%
68
5%
2.1%
29
25
27
41
36
12
36
21
17
18
15
16
14
20
15
8
8
8
4
5
5
7
1
6
-
-10% -5%
Dec-06
Dec-07
Dec-08
Dec-09
Dec-10
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
Dec-17
FY97
FY98
FY99
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
FY21E
Source: MOSL, Company Source: MOSL, Company
April 2018 24
India Strategy | Earnings recovery imminent
Exhibit 33: Metals contribution to incremental MOSL Exhibit 34: Oil & Gas contribution to incremental MOSL
Universe PAT growth expected to moderate Universe PAT growth expected to moderate too
46%
43%
18% 17%
12% 12%
6%
3%
Exhibit 35: Autos contribution to incremental MOSL Universe Exhibit 36: Financials contribution to incremental MOSL
PAT growth has been on the higher side in FY18 Universe PAT growth will see a sharp rebound
20% 44%
39%
14%
8%
23%
10%
-6%
FY17 FY18 FY19 FY20 FY17 FY18 FY19 FY20
Exhibit 37: Sectoral PAT and PAT delta contribution to MOSL Universe
Sector PAT (INR B) Sector-wise PAT Delta (INR B) Sector-wise PAT Delta (%)
FY16 FY17 FY18E FY19E FY20E FY16 FY17 FY18 FY19 FY20 FY16 FY17 FY18 FY19 FY20
Auto (17) 375 343 407 591 692 52 -32 64 184 101 -32% -6% 20% 14% 8%
Capital Goods (17) 88 128 151 182 215 -22 40 23 31 33 14% 8% 7% 2% 3%
Cement (13) 88 103 92 150 195 15 14 -10 58 45 -9% 3% -3% 4% 4%
Consumer (18) 243 261 287 338 397 20 18 26 51 59 -13% 4% 8% 4% 5%
Financials (38) 551 667 699 1,220 1,772 -302 116 32 521 552 187% 23% 10% 39% 44%
Private Banks (13) 409 406 456 631 852 24 -3 50 175 221 -15% -1% 16% 13% 17%
PSU Banks (7) -40 45 -34 251 504 -346 85 -79 284 254 214% 17% -25% 21% 20%
Life Insurance (1) 8 9 9 10 13 0 1 0 1 3 0% 0% 0% 0% 0%
NBFC (17) 174 208 268 328 402 20 34 60 60 74 -13% 7% 19% 4% 6%
Healthcare (22) 210 232 187 251 316 33 22 -45 64 64 -20% 4% -14% 5% 5%
Infrastructure (4) 9 11 14 15 15 1 1 3 1 0 -1% 0% 1% 0% 0%
Logistics (3) 13 12 13 16 19 -1 -1 1 3 2 1% 0% 0% 0% 0%
Media (13) 32 33 35 51 65 6 2 2 16 14 -4% 0% 1% 1% 1%
Metals (10) 135 228 375 534 574 -168 93 147 159 40 104% 18% 46% 12% 3%
Oil & Gas (14) 773 992 1,047 1,134 1,289 187 219 55 87 156 -116% 43% 17% 6% 12%
Excl. OMCs (11) 636 730 788 914 1,022 110 94 58 126 108 -68% 19% 18% 9% 9%
Retail (3) 12 13 19 24 31 -1 1 6 5 6 1% 0% 2% 0% 0%
Technology (15) 597 644 679 712 790 14 47 35 33 78 -8% 9% 11% 2% 6%
Telecom (4) 97 71 -7 -17 14 -14 -26 -77 -11 31 8% -5% -24% -1% 2%
Utilities (7) 351 325 362 466 517 30 -26 37 104 51 -19% -5% 12% 8% 4%
Others (25) 89 111 132 177 213 -12 22 21 45 36 7% 4% 6% 3% 3%
MOSL (223) 3,663 4,174 4,494 5,844 7,112 -162 511 320 1,350 1,269 100% 100% 100% 100% 100%
April 2018 25
India Strategy | Earnings recovery imminent
172 Contribution to 1HFY18 PAT growth (%) Contribution to 2HFY18 PAT growth (%)
45
38
20 15
60 51 15
30 28 22 15 8 7 5 5 4
14 6 6 4 3 2 2 1 1 0
0 -1 -4
-2 -3 -12
-30
-64
-97
-115 -48
Capital Goods
Metals
Banks-PSU
NBFC
Others
Utilities
Healthcare
Infrastructure
Telecom
Consumer
Banks-Pvt
Technology
Logistics
Media
Cement
Life Insurance
Automobiles
Retail
Utilities
Capital Goods
Healthcare
Metals
NBFC
Others
Infrastructure
Telecom
Banks-PSU
Consumer
Logistics
Technology
Cement
Automobiles
Banks-Pvt
Media
Life Insurance
Oil & Gas
Retail
Exhibit 39: Cyclicals growth expected to significantly exceed MOSL Universe average growth in FY18, with likely recovery in
Automobiles and Oil & Gas in 2HFY18
Utilities
Capital Goods
Telecom
Utilities
Metals
Banks-PSU
Capital Goods
Telecom
Banks-PSU
Metals
NBFC
Infrastructure
Others
Infrastructure
Others
NBFC
Consumer
Logistics
Consumer
Cement
Logistics
Banks-Pvt
Technology
Media
Media
Cement
Automobiles
Life Insurance
Automobiles
Life Insurance
Banks-Pvt
Technology
Retail
MOSL
Oil & Gas
Retail
MOSL
April 2018 26
India Strategy | Earnings recovery imminent
17 7 6 4 2 2 1 0
27 24 17
30 30 0 -1 -2
-1 -19 -26
1063
1,208 1,182
Private Banks
Healthcare
PSU Banks
Utilities
NBFC
Others
Metals
Infrastructure
Telecom
Consumer
Logistics
Auto
Technology
Cement
MOSL 4QFY17
Cap Goods
Media
Life Insurance
MOSL 4QFY18E
Retail
Oil & Gas
PAT (INRb)
PAT (INRb)
Source: MOSL
Share of Defensives to come off further; Global Cyclicals contribution to see sequential pick-up
Exhibit 41: PAT share of Global Cyclicals will see 4pp increase in 4QFY18
100%
Defensives
33 27 25 28 32
35 40 40 42 39 35 34 36 35
75%
Global cyclicals 25 34
25 32 40 41 37 33 33 25 27 27
50% 24 35 38
26 23
34 36 3632
25%
43
Domestic cyclicals
37 35 34 37 37 34 39 36 38 37
30 30
0%
June-09
June-10
June-11
June-12
June-13
June-14
June-15
June-16
June-17
Mar-09
Sep-09
Dec-09
Mar-10
Sep-10
Dec-10
Mar-11
Sep-11
Dec-11
Mar-12
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18E
April 2018 27
India Strategy | Earnings recovery imminent
0
-1 -3
-4 -4 -5
-8 -8
-12
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18
Exhibit 43: 4QFY18 Nifty PAT to post 14% growth, led by Metals, Auto & Oil and Gas
65
38 36 34
27 29 24 LPA: 10%
22 19 21 19 24 19
16 13 12 16 12 14
11 11 9 14 13
4
10 6 5 2 8 5 1 7 7
0 0
-6 -1
-2 -3 -3 -8
-8 -5 -12 -7
-15
-20
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18
April 2018 28
India Strategy | Earnings recovery imminent
47
35 37
29 31
25 26
20 21
17 16 15 18 20 18 15
13 12 13 11 14 13 17 LPA: 12% 16
10 13 10
4 5 6 5 1 5 8 11 8 8 11 11
6 3 2 2
-2
-5 -8 -10 -5
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18
Healthcare
Utilities
Telecom
NBFC
Nifty
Banks-PSU
Metals
Auto
Consumer
Agro Chem
Technology
Cement
Banks-Pvt
Cap Goods
Media
Retail
Infra
April 2018 29
India Strategy | Earnings recovery imminent
April 2018 30
India Strategy | Earnings recovery imminent
BHARTI: -80,
Telecom PL BHIN: 12
TCOM: -90,IDEA: Loss
TRP: -12,GRAN: -14,AJP: -
FORH: LP,CIPLA:
CDH: 29,ALPM: GNP: 14,GLXO: 11,ARBP: 17,LAURUS: -29,SUNP: -
Health Care -1 113,IPCA: 99,JUBILANT:
22,DRRD: 20 9,DIVI: 2 30,SLPA: -38,BIOS: -39,
48,SANL: 44,ALKEM: 31
STR: -41,LPC: -45
SRCM: 8, DBEL: -3,UTCEM &
GRASIM: 59,
Cement -2 ACEM: 20 TRCL: 3, ICEM: -30,
SNGI: 52
ACC: 1 BCORP: Loss
RADIOCIT: 170,
ENIL: -2,JAGP: -10,Z: -
Media -13 HTML: 62, SUNTV: 23 DBCL: 8
58,DITV: Loss
PRIF IN: 60,PVRL: LP
April 2018 31
India Strategy | Earnings recovery imminent
EARNINGS FY18-20 FY18 marks bottoming out of earnings; All eyes on FY19
Financial to lead the earnings recovery
FY18 earnings growth to come in at 11%: We expect FY18 revenue growth for
our MOSL Universe to come in at 13% (v/s 0% CAGR in FY14-17). This will be the
first year of double-digit revenue growth after three years of flattish sales
performance. The topline performance is led by Metals, Oil & Gas, Cement and
Autos. Overall, we expect EBITDA margin for MOSL Universe (ex-OMCs,
Financials) to stay flat at 20% in FY18. For MOSL Universe, we expect profits to
grow 8% YoY. Metals alone account for 46% of the incremental profits followed
by Autos (20% of delta), and Oil & Gas (17% of delta). PSU Banks, Healthcare and
Cement are key laggards with earnings decline of P to L, 14% and 3%
respectively.
Corporate lenders to drive Nifty earnings growth of 25% in FY19: Nifty sales are
expected to continue the momentum and deliver healthy 14% YoY growth in
FY19. Nifty EBITDA and PAT are expected to grow 19% and 26% in FY19 and
record 16% and 23% CAGR over FY18-20, respectively. The strong earnings
growth of FY19 is expected to be led by corporate lenders like SBI, ICICI and Axis
Bank. Excluding these corporate lenders, Nifty earnings growth for FY19E is
expected at 19%. Apart from the corporate lenders, Tata Motors, ONGC and
Coal India are other key contributors for FY19 Nifty earnings growth.
Exhibit 47: Recovery in Cyclicals to drive robust 19% PAT CAGR (FY17-20E)
EBITDA
Sales Gr. / EBIDTA EBIDTA PAT Gr. / PAT delta
Sector margin
CAGR (%) Margin (%) CAGR (%) CAGR (%) Share (%)
change (bp)
(No of Companies) (FY17-20) FY18E (FY17-20) FY17-20 FY18E FY19E FY20E (FY17-20) FY17-20
High PAT CAGR (>20%) 12 29.5 16 356 17 56 29 33 70
Financials (38) 17 85.8 16 -207 5 74 45 38 38
PSU Banks (7) 12 79.3 11 -332 -176 -841 101 124 16
Private Banks (13) 19 86.8 19 -130 12 38 35 28 15
Life Insurance (1) 24 125.3 18 -1919 3 14 26 14 0
NBFC (17) 21 83.5 22 145 29 23 23 25 7
Metals (10) 7 19.8 16 500 65 42 7 36 12
Retail (3) 21 10.4 29 194 49 27 26 34 1
Auto (17) 13 13.6 18 196 19 45 17 26 12
Media (13) 11 29.0 16 413 6 44 27 25 1
Others (25) 17 18.9 21 193 19 34 20 24 3
Cement (13) 8 18.3 13 281 -10 63 30 24 3
Medium PAT CAGR (10-20%) 11 21.8 15 279 5 25 17 15 17
Capital Goods (17) 12 10.5 19 195 18 20 18 19 3
Utilities (7) 9 31.7 17 732 11 29 11 17 7
Consumer (18) 12 23.6 14 123 10 18 17 15 5
Logistics (3) 13 13.7 12 -30 8 22 15 15 0
Infrastructure (4) 12 31.6 5 -560 33 4 -1 11 0
Healthcare (22) 10 20.2 12 111 -19 34 26 11 3
Low PAT CAGR (up to 10%) 12 16.1 10 -82 1 6 15 7 13
Oil & Gas (14) 14 13.1 14 -8 6 8 14 9 10
Excl. OMCs (11) 15 17.2 17 92 8 16 12 12 10
Technology (15) 8 22.9 8 -17 5 5 11 7 5
Telecom (4) 0 30.9 -1 -21 PL LP -179 -42 -2
MOSL (223) 12 22.3 14.3 155 8 30 22 19 100
MOSL Excl. OMCs (220) 12 24.6 14.7 215 8 33 22 21 NA
Sensex (30) 11 27.0 14.2 262 11 29 21 20 NA
Nifty (50) 11 22.8 13.7 193 11 26 20 19 NA
April 2018 32
India Strategy | Earnings recovery imminent
FY18 earnings recovery led by three sectors – Metals, Auto and Oil & Gas
For MOSL Universe, we estimate FY18 PAT growth at 8% (after 14% growth in
FY17), led by strong performance in Metals, Oil & Gas, Auto and NBFC. Metals,
Oil & Gas and Autos contribute 83% of the earnings delta for our universe in
FY18E.
Pharma and Telecom are expected to post muted performance, led by sector-
specific headwinds.
Exhibit 48: Nifty EPS – expect 19% CAGR over FY17-20E (v/s 5% CAGR over FY12-17)
FY17-20E:
18.5% CAGR 20%
25% 695
FY08-17:
11%
4.5% CAGR 577
6%
FY01-08: 462
407 413 394 417
21% CAGR 347 369
315
281 251 247
236
169 184
131
73 78 92
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
Nifty EPS estimates revised downwards by 2%/3% for FY18/19
We have downgraded our estimates for Nifty EPS: -2% for FY18 to INR462 v/s
INR471 earlier, -3% for FY19 to INR577 v/s INR595 earlier, and -.2% for FY20 to
INR695 v/s INR696 earlier.
We are now building in earnings growth of 11%/25%/21% for the Nifty EPS for
FY18/19/20.
For FY18, major earnings upgrades are in Grasim Industries (+34%) and HPCL
(+14%) while the major earnings downgrades are in Axis Bank (-13%), SBI (-11%),
ICICI Bank (-11%), and Ultratech Cement (-13%).
For FY19, the major earnings upgrades are in M&M (+7%) while the major
downgrades are Bharti Airtel (-53%), Vedanta (-20%), and Axis Bank (-20%).
Exhibit 49: Top Nifty companies’ EPS upgrades/downgrades since 3QFY18 review (%)
Companies FY18 Companies FY19
Grasim Industries 34 ICICI Bank 10
HPCL 14 Mahindra & Mahindra 7
UPL 6 State Bank 4
BPCL 6 Tech Mahindra 3
GAIL 6 HCL Technologies 3
Dr Reddy’ s Labs -10 IOC -11
State Bank -11 Grasim Industries -18
ICICI Bank -11 Vedanta -20
Ultratech Cement -13 Axis Bank -20
Axis Bank -13 Bharti Airtel -53
April 2018 33
India Strategy | Earnings recovery imminent
April 2018 34
NIFTY FY18E NIFTY FY17
3510
3226
April 2018
SBI 145 Reliance Ind. 63
Tata Motors 106 Tata Steel 33
ONGC 64 HDFC Bank 30
Coal India 53 Vedanta 29
ICICI Bank 45 Hindalco 24
HDFC Bank 45 SBI 22
Vedanta 39 Tata Motors 19
Reliance Ind. 39 Infosys 18
Axis Bank 32 Coal India 18
TCS 24 Power Grid 16
Grasim Inds 23 M&M 15
Maruti 22 KMB 13
Sun Pharma 20 Indiabulls HSG 9
Power Grid 20 HUL 9
NTPC 18 L&T 9
KMB 17 GAIL 9
Hindalco 15 Yes Bank 3561.631528 8
ITC 15 Maruti 8
Tata Steel 13 Tech Mah. 8
Ultratech 13 HDFC 8
HDFC 12 IndusInd Bk 7
Yes Bank 12 Bajaj Fin 7
L&T 12 ITC 7
IndusInd Bk 10 Bajaj Finserv 6
Bajaj Fin 10 Eicher Mot. 5
HUL 9 NTPC 5
M&M 8 ONGC 5
Dr Reddy’s 8 Cipla 5
Bajaj Finserv 8 HCL Tech. 4
Eicher Mot. 6 Wipro 3
Indiabulls HSG 6 Hero Moto 3
Titan Co 3
Bajaj Auto 6
Bajaj Auto 2
Adani Ports 5
UPL 2
Zee Ent. 4
Asian Paints 0
Wipro 4
Zee Ent. 0
GAIL 4 Dr Reddy’s 1
Lupin 4 Adani Ports 2
Asian Paints 4 HPCL 2
Cipla 4 Bharti Infratel 2
HCL Tech. 3 IOC 2
Hero Moto 3 Ultratech 5
Titan Co 3 TCS
Bharti Infratel 3 5
Axis Bank 5
BPCL 2 Grasim Inds 9
Tech Mah. 2 Lupin 12
UPL 2 BPCL 16
Bharti Airtel 7 ICICI Bank 27
Infosys 8 Bharti Airtel 30
HPCL 11
3,510
Sun Pharma 31
IOC 29 NIFTY FY18E
NIFTY FY19E 4,379
35
India Strategy | Earnings recovery imminent
India Strategy | Earnings recovery imminent
April 2018 36
India Strategy | Earnings recovery imminent
April 2018 37
India Strategy | Earnings recovery imminent
Private Banks We expect value migration from private 11.9 24.7 3.9 HDFCB, IIB and RBL amongst private
to PSU banks to continue, with former banks.
being better positioned to capture
growth with better capitalization. We
expect private banks to record
3.9%/1.9% QoQ/YoY PAT growth due to
two of the large P banks, ICICI and Axis
Bank, recording a significant PAT
decline, while HDFC Bank is expected to
report 21% YoY PAT growth. Mid-sized
private banks are expected to report
20% - 25% PAT growth.
PSU Banks On a sequential basis, we expect profit -1.7 -22.4 Loss We prefer SBIN and BOB among PSU
growth to remain muted for state- banks.
owned banks, with elevated provisions
toward NCLT exposures and fraud
accounts in many banks. We expect all
PSU banks, with the exception of Indian
Bank and BoB, to report losses led by
elevated provisions in a muted revenue
growth environment. Even as bond
yields have increased post 3QFY18
levels, MTM provisioning impact is
expected to be softer in 4Q, with RBI
allowing banks to spread their losses
over four quarters.
NBFC Core housing growth has stabilized post 20.0 18.6 29.8 LICHF and PNBHF are key stocks to look
RERA implementation, and tier II and III out for with regards margins, given the
locations are the key growth drivers. sharp rise in GSec yields over the past
For housing finance corporations six months.
(HFCs), we expect the share of non- Vehicle financiers, especially CV
retail loans in the overall portfolio to financiers, are likely to witness a very
inch higher. strong quarter on the growth front.
Growth rates will remain healthy for Repco may disappoint on growth as
segments like consumer durables, two- state-specific issues in Tamil Nadu have
wheelers and vehicle finance. M&HCV not yet been completely resolved.
demand has been strong in the quarter
– GoI’s infra push being the key driving
factor.
We expect a gradual improvement for
microfinance institutions (the most
impacted segment post
demonetization) in terms of both
growth and asset quality. Our
interaction with gold financiers
suggests that growth is slowly coming
back.
Elevated GSec yields could play a
spoilsport over the medium term from
a spreads perspective. Yields have
hardened 100bp+ from their lows six
months back. If they sustain at these
levels, HFCs would be most impacted.
Vehicle financiers have pricing power to
maintain margins.
April 2018 38
India Strategy | Earnings recovery imminent
April 2018 39
India Strategy | Earnings recovery imminent
Oil & Gas Singapore complex GRM stood at 21.9 18.0 11.3 -0.4 IOCL is expected to report adjusted
USD7.0/bbl in 4QFY18 v/s EBITDA of INR75b (-10% YoY, +8% QoQ)
USD7.3/bbl in 3QFY18 and in 4QFY18. Expect GRM of USD5.6/bbl
USD6.4/bbl in 4QFY17. We expect and refinery throughput at 17.1mmt
marginal inventory gain/loss during for 4QFY18.
the quarter. HPCL is expected to report adjusted
Average Brent crude price was up EBITDA of INR22.4b (-21% YoY, +33%
24% YoY and 9% QoQ to USD67/bbl. QoQ) in 4QFY18. Expect GRM of
We expect higher realizations to USD4.6/bbl and refinery throughput at
benefit the upstream companies. 4.6mmt for 4QFY18.
ONGC and Oil India should see a YoY BPCL is expected to report adjusted
increase in EBITDA. EBITDA of INR32.1b (+45% YoY, flat
RIL is expected to clock GRM of QoQ) in 4QFY18. Expect GRM of
USD11.4/bbl, led by strong USD5.3/bbl and refinery throughput at
benchmark (premium of 7.3mmt for 4QFY18.
USD4.4/bbl). The Petchem segment
is expected to do better, led by
healthy petchem deltas and strong
volume growth.
Excl. OMCs Crude oil prices continued their 23.5 30.5 13.1 1.1 Continue to like OMCs: Strong
upward trend in 4QFY18 as well. benchmark GRMs and sequentially
Average Brent crude price was up better marketing margins are expected
24% YoY (9% QoQ) at USD67/bbl. to benefit OMCs’ (IOCL/BPCL/HPCL)
OMCs are likely to post marginal profitability during the quarter. We
refining inventory gains for the expect OMCs’ core earnings to improve
quarter. sequentially in 4QFY18. Among the
Domestic oil & gas production has OMCs, we have a higher preference for
improved, which would be beneficial IOCL due to its (a) highest
for the upstream companies. Rise in diversification, (b) strong free cash flow
crude oil price and revived generation and (c) inexpensive
production volume growth for oil valuations.
and gas would benefit ONGC/OINL. Prefer IGL among CGDs: We expect
We expect volume growth to volume growth to continue for CGD
continue for CGD players. We might players. Spot as well as crude-linked
see margin compression (YoY/QoQ) LNG prices have inched up in 4QFY18.
in the industrial segment due to However, Gujarat Gas had already
competition from alternative fuels. taken a price hike of INR2.5/scm in Dec
2017 which would take care of the
increased cost. We prefer IGL among
CGD players due to (a) higher longevity
of volume growth compared to MGL
and (b) higher share of CNG v/s PNG,
supporting stable EBITDA/SCM.
PLNG – a long-term buy: Visibility on
PLNG’s medium/long-term earnings is
high, given (a) the huge gas demand-
supply gap in India, (b) volume growth,
driven by gradual capacity addition,
and (c) earnings growth boosted by
April 2018 40
India Strategy | Earnings recovery imminent
Telecom Expect 4QFY18 to witness revenue -10.1 -16.1 PL -2.1 BHARTI’s India wireless EBITDA is
and EBITDA drop, primarily on expected to witness steep 17% QoQ
account of ARPU downtrading. decline, pulling down consol. EBITDA
Further, a cut in international IUC by 8% QoQ. Bharti’s Africa EBITDA to
and Jio Phone re-launch (with new grow 1% QoQ led by cost efficiencies.
price plan of INR49) are only IDEA’s consol. EBITDA likely to
expected to magnify the impact. We decline 15% QoQ.
expect consol. revenue dip of ~4% BHIN’s consol. EBITDA to decline 2%
QoQ for Bharti/Idea. QoQ.
Consolidation in the telecom sector, TCOM to see 1% QoQ overall EBITDA
led by shutdown/acquisition of growth on the back of 3% data
smaller players, should continue to EBITDA growth, partly offset by a 9%
pull down net tenancies. Bharti decline in voice EBITDA.
Infratel is likely to witness 2% QoQ
decline in net tenancies due to the
exit from smaller operators, pulling
down consol. revenue by 2% QoQ.
Tata Comm.’s revenue is expected to
grow marginally by 1% QoQ as
growth in data revenue is expected
to offset the impact of decline in
voice segment.
April 2018 41
India Strategy | Earnings recovery imminent
April 2018 42
India Strategy | Earnings recovery imminent
0
-1
-2 -3
10,114
-4 -4
4,735
3,021
5,249
5,834
5,296
5,683
6,704
8,491
7,738
9,174
-5
-5
Jun-14
Jun-15
Jun-16
Jun-17
June-13
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18
FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18
Annual Return in INR (%) Annual Return in USD (%)
April 2018 43
India Strategy | Earnings recovery imminent
Exhibit 55: World equity indices (FY18) – local currency Exhibit 56: World equity indices (FY18) – USD (%)
Brazil 31 Brazil 24
MSCI EM 22 MSCI EM 22
Japan 13 Japan 19
UK -4 Russia MICEX 0
Exhibit 57: Trend in India's contribution to world market cap Exhibit 58: Market cap change in FY18 (%)
India's Contribution to World Mcap (%) 0.6
1.8 1.0 6.4 1.3 2.2 7.7 29.4 3.7 0.5
3.5
3.3 Mkt cap chg 12M (%) Curr Mcap (USD Tr)
26 25
3.0
Average of 2.5% 20
2.7 17 17
2.5
12 11 11 10 8
2.0
1.6
1.5
Indonesia
Brazil
Korea
India
China
Russia
Japan
Taiwan
US
UK
Mar-08
Sep-08
Mar-09
Sep-09
Mar-10
Sep-10
Mar-11
Sep-11
Mar-12
Sep-12
Mar-13
Sep-13
Mar-14
Sep-14
Mar-15
Sep-15
Mar-16
Sep-16
Mar-17
Sep-17
Mar-18
April 2018 44
India Strategy | Earnings recovery imminent
11
11
11
10
10
10
11
9
8
5
4
4
3
2
1
0
-1
-1
-2
-2
-2
-2
-3
-4
-8
-9
-9
SBI -15
Dr Reddy's -21
Sun Pharma -28
Tata Motors -30
Lupin-49
Reliance Ind.
Hero Moto
Wipro
Axis Bank
BPCL
Coal India
Bajaj Fin.
L&T
TCS
IOC
Tata Steel
Kotak Mah.Bk
GAIL
Nifty
Hindalco
Asian Paints
NTPC
Maruti
Bharti Airtel
HCL Tech
Zee Ent
Vedanta
Cipla
HUL
IndusInd Bk
Eicher Motors
ICICI Bank
Adani Ports
UPL
Power Grid
Infosys
UltraTech
Titan Co
Grasim Ind
Yes Bank
HDFC Bank
Bajaj Finserv
M&M
Bharti Infratel
Tech Mah.
Indiabulls Hsg
HDFC
HPCL
Bajaj Auto
ONGC
ITC
April 2018 45
India Strategy | Earnings recovery imminent
22.0 7.3
-0.2 -1.0-0.6-0.8
-2.3 -1.4 -1.3
-4.4 -4.2 -3.6
Jun-13
Jun-14
Jun-15
June-16
June-17
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
Exhibit 63: Yearly FII flows in equities (USD b) Exhibit 64: Quarterly FII flows in equities (USD b)
-10.4
Jun-13
Jun-14
Jun-15
June-16
June-17
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
Exhibit 65: Yearly DII ex-MF flows in equity (USD b) Exhibit 66: Quarterly DII ex-MF flows in equity (USD b)
13.7 1.3
11.6 0.5
0.3 0.5
7.4
-0.2 -0.1 -0.5
-0.3 -0.6 -0.8
2.0 -0.9
0.3 -1.5 -1.5 -1.5
-2.0 -2.2
-0.7 -2.4
-2.8-3.0
-3.9 -3.9
-5.3 -4.3
-4.9
-8.5 -10.3
Jun-13
Jun-14
Jun-15
June-16
June-17
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
April 2018 46
India Strategy | Earnings recovery imminent
10 Year 3.0
21 10 Year
Avg: 17.0x
Avg: 2.5x 2.6
17 17.4 2.5
13 2.0
9 1.5
Apr-08
Apr-09
Apr-10
Apr-11
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
Apr-08
Apr-09
Apr-10
Apr-11
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
Exhibit 69: 12-month forward Nifty RoE (%) Exhibit 70: India’s market cap to GDP (%)
18.1
103 Average of 78% for
95 the period
16.7 88 86
10 Year Avg: 83 80
81
15.1% 71 69
15.3 64 66
15.3
55
13.9
12.5
Apr-08
Apr-09
Apr-10
Apr-11
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18E
Midcaps underperform large-caps; still command premium v/s large caps
Midcaps have struggled over the last few months, resulting in its
underperformance versus large-caps. In FY18, midcaps have delivered 9%
returns, as against 10% by Nifty.
Midcaps now trade at a 19% premium to the Nifty on a P/E basis.
120
110
110
109
100
90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
April 2018 47
India Strategy | Earnings recovery imminent
Exhibit 72: Midcaps v/s Nifty P/E (x) – 12-month forward Exhibit 73: Midcaps trading at 19% premium to Nifty
Midcap PE (x) Nifty PE (x) Midcap Vs Nifty PE Prem/(Disc) (%)
36.0 85
Nifty Avg: 18.6x
Midcap Avg: 19.4x
29.0 55
Average: 4%
22.0 20.8 25
19
15.0
17.4 -5
8.0 -35
Apr-13
Aug-13
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Apr-17
Dec-16
Aug-17
Apr-18
Dec-17
Apr-13
Aug-13
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Apr-17
Dec-16
Aug-17
Apr-18
Dec-17
April 2018 48
India Strategy | Earnings recovery imminent
WEIGHT
MOSL model SECTOR WEIGHT / PORTFOLIO
PICKS
BSE
100
MOST
WEIGHT
RELATIVE TO
EFFECTIVE SECTOR
STANCE
BSE100
portfolio Financials 33.4 34.0 0.6 Neutral
Private 20.3 20.0 -0.3 Underweight
HDFC Bank 8.2 8.0 -0.2 Buy
ICICI Bank 3.7 4.0 0.3 Buy
Yes Bank 1.2 3.0 1.8 Buy
IndusInd Bank 2.0 3.0 1.0 Buy
RBL 0.0 2.0 2.0 Buy
PSU 2.5 3.0 0.5 Neutral
SBI 2.0 3.0 1.0 Buy
NBFCs 10.6 11.0 0.4 Neutral
HDFC 6.4 5.0 -1.4 Buy
Bajaj Finance 0.8 3.0 2.2 Buy
Shriram Transport Finance 0.5 3.0 2.5 Buy
Auto 10.8 12.0 1.2 Overweight
M&M 1.5 4.0 2.5 Buy
Maruti 2.5 4.0 1.5 Buy
Motherson Sumi 0.5 2.0 1.5 Buy
Tata Motors 1.4 2.0 0.6 Buy
Consumption / Retail 12.1 11.0 -1.1 Underweight
Titan 0.8 4.0 3.2 Buy
Pidilite Inds. 0.3 3.0 2.7 Buy
Emami 0.0 2.0 2.0 Buy
United Spirits 0.0 2.0 2.0 Neutral
Energy 10.1 11.0 0.9 Neutral
Reliance Inds 6.1 5.0 -1.1 Buy
ONGC 1.1 2.0 0.9 Buy
IOC 0.8 2.0 1.2 Buy
Petronet LNG 0.4 2.0 1.6 Buy
Cap Goods, Infra & Cement 8.5 9.0 0.5 Neutral
Larsen & Toubro 3.4 5.0 1.6 Buy
Shree Cement 0.3 2.0 1.7 Buy
Thermax 0.0 2.0 2.0 Buy
Technology / Media 12.3 6.0 -6.3 Underweight
Infosys 4.6 4.0 -0.6 Buy
Sun TV 0.0 2.0 2.0 Buy
Healthcare 4.4 4.0 -0.4 Neutral
Sun Pharma 1.2 2.0 0.8 Buy
Cipla 0.6 2.0 1.4 Neutral
Utilities / Metals 6.7 4.0 -2.7 Underweight
Hindalco 0.6 2.0 1.4 Buy
Power Grid Corp. 0.9 2.0 1.1 Buy
Midcaps 1.8 9.0 7.2 Overweight
Team Lease 0.0 1.0 1.0 Buy
Sadbhav Engg 0.0 1.0 1.0 Buy
Future Consumer 0.0 1.0 1.0 Buy
Oberoi Realty 0.0 1.0 1.0 Buy
Aegis Logistics 0.0 1.0 1.0 Buy
UPL 0.6 1.0 0.4 Buy
Exide Inds. 0.2 1.0 0.8 Buy
Tata Chemicals 0.3 1.0 0.7 Buy
Repco Home Fin 0.0 1.0 1.0 Buy
Cash 0.0 0.0 0.00
TOTAL 100.0 100.0
April 2018 49
India Strategy | Earnings recovery imminent
MOSL Universe:
4QFY18 Highlights
&
Ready Reckoner
Note: In our quarterly performance tables, our four-quarter numbers may not always add up to the full-year
numbers. This is because of differences in classification of account heads in the company’s quarterly and annual
results or because of differences in the way we classify account heads as opposed to the company.
All stock prices and indices as on 3 April 2018, unless otherwise stated.
April 2018 50
India Strategy | Earnings recovery imminent
15.2% 11.8%
14.2% 11.4% 11.2%
11.9%
11.0%
-6.9%
Sectoral sales growth - quarter ended Mar-18 (%) Sectoral net profit growth - quarter ended Mar-18 (%)
22 21 61
19 17
16 15 14 37 31
10 10 10 8 8 7 6
22 19
11 11 11 11 10
5
-1 -2 -4
-13
-45
-10 PL
MOSL Univ
Utilities
Metals
Health Care
Telecom
Auto
Consumer
Logistics
Technology
Cement
Cap Goods
Media
Retail
Infra
Oil & Gas
Financials
MOSL Univ
Utilities
Metals
Health Care
Telecom
Auto
Logistics
Cement
Consumer
Cap Goods
Media
Technology
Oil & Gas
Retail
Infra
Financials
April 2018 51
India Strategy | Earnings recovery imminent
April 2018 52
India Strategy | Earnings recovery imminent
April 2018 53
India Strategy | Earnings recovery imminent
April 2018 54
India Strategy | Earnings recovery imminent
April 2018 55
India Strategy | Earnings recovery imminent
April 2018 56
India Strategy | Earnings recovery imminent
April 2018 57
India Strategy | Earnings recovery imminent
April 2018 58
India Strategy | Earnings recovery imminent
April 2018 59
India Strategy | Earnings recovery imminent
April 2018 60
India Strategy | Earnings recovery imminent
April 2018 61
India Strategy | Earnings recovery imminent
April 2018 62
India Strategy | Earnings recovery imminent
MOSL Universe:
4QFY18 Highlights
&
Ready Reckoner
Note: In our quarterly performance tables, our four-quarter numbers may not always add up to the full-year
numbers. This is because of differences in classification of account heads in the company’s quarterly and annual
results or because of differences in the way we classify account heads as opposed to the company.
All stock prices and indices as on 3 April 2018, unless otherwise stated.
April 2018 63
India Strategy | Earnings recovery imminent
April 2018 64
March 2018 Results Preview | April 2018
Automobiles
Company name Volume recovery continues
Amara Raja Batteries Price increases, operating leverage to drive margin expansion
Ashok Leyland
Bajaj Auto Volume recovery continued in 4QFY18 as well, with strong volume momentum in 2Ws
Bharat Forge (+29% YoY), 3Ws (+95%), UVs (+25%) and CVs (+32%).
BOSCH EBITDA margin for our auto OEM (ex-JLR) universe is likely to expand (+230bp YoY or
CEAT +20bp QoQ to 14.2%) for the third consecutive quarter, with high commodity costs
Eicher Motors offset by price increases and operating leverage.
Endurance technologies
We have lowered our FY19 EPS estimates for BJAUT (-4%), MSIL (-6%), TVSL (-11%) and
Escort
TTMT (-6.2%), but increased for AL (+16%), MM (+7%) and ESC (+9%).
Our top picks are MSIL, EIM and MSS among large caps, and AL and EXID among mid-
Exide Industries
caps. We also believe that MM is the best play on a rural market recovery.
Hero MotoCorp
Mahindra & Mahindra Volume recovery continues across segments
Maruti Suzuki A low base of last year in 2Ws, a strong recovery in rural areas, and a revival in
Tata Motors construction/mining activities drove a sustained recovery in volumes. Our channel
TVS Motor Company checks indicate continued above-average volume growth in rural markets. This has
resulted in strong 2W demand, which is estimated to have grown at ~29% YoY. On
the other hand, CV volumes are driven by the ban on overloading in key states, the
revival in construction/ mining activities, and the cyclical recovery in LCVs. CV
volumes are estimated to increase ~32% YoY, with LCV growth of ~44% and M&HCV
growth of 18.5%. PV demand increased at ~7%, with modest growth of ~4% in cars
and ~25% growth in UVs.
Price increase, operating leverage boost margins despite RM cost inflation
EBITDA margin for the auto OEM (ex-JLR) universe is likely to expand (+230bp YoY or
+20bp QoQ to 14.2%) for the third consecutive quarter, boosted by price increases
and operating leverage, despite commodity price inflation. We expect highest
margin expansion for TTMT S/A (+540bp), HMCL (+290bp), TVS (+240bp) and AL
(+210bp). While we do not expect any company to report YoY contraction in
margins, MM’s margins are estimated to contract ~130bp on a QoQ basis due to
seasonality.
Demand outlook positive across segments, competitive intensity key
Demand outlook for FY19 is positive across segments, driven by a continued rural
recovery, initial estimate of normal monsoon, and a pick-up in economic activity.
We estimate 10-12% growth for 2Ws, 8-10% for 4Ws, 10-12% for M&HCVs, 12-15%
for LCVS and 8-10% for tractors. Key threats to demand are posed by inflationary
fuel prices and higher interest rates. While we expect the margins to improve,
competitive intensity and commodity inflation could also have their effects.
Valuation and view
We have lowered our FY19 EPS estimates for BJAUT (-4%), MSIL (-6%), TVSL (-11%)
and TTMT (-6.2%), but increased for AL (+16%), MM (+7%) and ESC (+9%). The
demand environment and the changing competitive landscape would be the key
determinants of the stock performance. Our top picks are MSIL, EIM and MSS
among large caps, and AL and EXID among mid-caps. We also believe that MM is the
best play on a rural market recovery.
Jinesh Gandhi – Research Analyst (Jinesh@MotilalOswal.com); +91 22 6129 1524
Research Analyst: Deep Shah (deep.shah@MotilalOswal.com); +91 22 6129 1533; Suneeta Kamath (deep.shah@MotilalOswal.com); +91 22 6129 1534
April 2018 65
March 2018 Results Preview | Sector: Automobiles
Exhibit 3: Trend in segment-wise EBITDA margins (%) Exhibit 4: Commodity prices remain at higher levels
4QFY17 1QFY18 3QFY18 2QFY18 4QFY18 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
16.3 16.6
15.4 15.8 15.4 15.0
13.814.5 13.513.2
10.6
9.3
7.9
6.4
2.3
112
122
113
119
124
130
138
126
135
145
107
100
111
121
110
118
117
123
130
97
April 2018 66
March 2018 Results Preview | Sector: Automobiles
Exhibit 5: Trend in key currencies v/s INR Exhibit 6: QoQ margin (ex-JLR) expands since 1QFY18
USD GBP JPY Aggregate (excld JLR) Aggregate (incl JLR)
120
17
14
100
11
80 8
Jun-15
Jun-16
Jun-17
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Sep-17
Dec-17
Mar-18
4QFY12
2QFY13
4QFY13
2QFY14
4QFY14
2QFY15
4QFY15
2QFY16
4QFY16
2QFY17
4QFY17
2QFY18
4QFY18
Source: Bloomberg, MOSL Source: Company, MOSL
April 2018 67
March 2018 Results Preview | Sector: Automobiles
Exhibit 9: Relative performance – Three months (%) Exhibit 10: Relative performance – One year (%)
105 125
100 115
95 105
90 95
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
April 2018 68
March 2018 Results Preview | Sector: Automobiles
Quarterly Performance
Y/E March (INR m) FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Sales 13,081 13,331 13,269 13,445 14,975 14,275 15,535 15,109 53,172 59,893
YoY Change (%) 15.0 15.8 9.5 17.4 14.5 7.1 17.1 12.4 15.1 12.6
RM Cost (% of sales) 65.7 63.9 65.0 68.0 70.0 66.0 66.9 66.7 65.6 67.4
Staff Cost (% of sales) 5.0 5.2 5.5 5.2 5.4 5.2 4.9 5.1 4.7 4.2
Other Exp (% of sales) 11.9 13.7 14.1 13.0 11.7 12.1 12.0 12.8 13.9 11.6
EBITDA 2,273 2,297 2,040 1,844 1,929 2,381 2,416 2,327 8,499 9,052
Margins (%) 17.4 17.2 15.4 13.7 12.9 16.7 15.6 15.4 16.0 15.1
Depreciation 441 457 469 499 544 584 587 656 1,912 2,371
Interest 14 15 14 15 14 13 11 14 58 51
Other Income 90 120 133 151 137 122 168 148 492 575
PBT 1,908 1,945 1,689 1,480 1,508 1,907 1,985 1,806 7,022 7,205
Rate (%) 31.5 29.9 33.5 33.0 33.7 33.3 32.3 32.9 31.9 33.0
Adj PAT 1,307 1,363 1,123 992 999 1,272 1,345 1,212 4,785 4,828
YoY Change (%) 8.0 10.4 -17.9 -9.1 -23.6 -6.7 19.7 22.2 -2.7 0.9
E: MOSL Estimates
April 2018 69
March 2018 Results Preview | Sector: Automobiles
Ashok Leyland
Bloomberg AL IN CMP: INR148 TP: INR179 (+21 %) Buy
Equity Shares (m) 2926.5
In 4QFY18, volumes increased 23% YoY (+26% QoQ), as M&HCV
M. Cap. (INR b)/(USD b) 432 / 7
and LCV sales increased 15% YoY and 59% YoY, respectively, led
52-Week Range (INR) 152 / 81
by continued strong demand supported by overloading ban.
1,6,12 Rel Perf. (%) 7 / 15 / 64
We expect realization to increase by 5.9% YoY (-3.6% QoQ), led by
BS-4 related price hikes, lower discounts on QoQ basis and mix
Financial Snapshot (INR b) impact.
Y/E March 2017 2018E 2019E 2020E Net revenue is likely to grow 30.6% YoY (+21.5% QoQ) to
Sales 200.2 260.4 308.0 360.6 INR86.4b, led by volume and realization growth.
EBITDA 22.0 28.4 35.6 42.8 EBITDA margin is likely to expand 210bp YoY (+200bp QoQ) to
NP 12.4 15.9 21.2 26.9 13.1% led by operating leverage.
Adj. EPS (INR) 4.2 5.4 7.2 9.2 EBITDA should increase 55% YoY (44% QoQ) to INR11.3b.
EPS Gr. (%) 0.2 28.8 33.1 27.1 PAT should increase 62.7% YoY (+54.8% QoQ) to INR7.0b.
BV/Sh. (INR) 20.9 23.9 28.5 34.7 We revised EPS estimates of FY19/FY20 by 16.4%/19.4% to factor
RoE (%) 21.4 24.3 27.6 29.2 for higher volumes (6%/9% in FY19/FY20) and better operating
RoCE (%) 21.8 20.3 23.3 25.2 performance. The stock trades at EV/EBITDA of 11.2x FY19E and
Valuations 8.8x FY20E EBITDA. Maintain Buy.
P/E (x) 35.0 27.2 20.4 16.0
Key issues to watch
P/BV (x) 7.1 6.2 5.2 4.3
Update on CV demand and discount trends.
EV/EBITDA (x) 19.4 14.7 11.2 8.8
Div. Yield (%) 1.1 1.4 1.5 1.7
Update on LCVs, exports and defence business.
RM cost guidance and price hikes to mitigate the same.
Capex and investment guidance for FY19.
Quarterly Performance
FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Total Volumes (nos) 31,165 33,441 32,838 47,622 28,484 40,985 46,627 58,735 145,066 174,831
Growth % 10.7 -10.5 6.2 8.5 -8.6 22.6 42.0 23.3 3.4 20.5
Realizations (INR '000) 1,367 1,382 1,470 1,390 1,488 1,475 1,526 1,471 1,380 1,489
% change -0.9 4.0 10.5 2.1 8.9 6.7 3.8 5.9 2.3 7.9
Net operating revenues 42,588 46,224 48,283 66,179 42,378 60,469 71,132 86,412 200,187 260,390
Change (%) 9.7 -6.9 17.4 10.8 -0.5 30.8 47.3 30.6 5.7 30.1
RM/sales % 68.7 67.8 65.1 71.9 69.4 71.3 71.4 70.6 69.7 70.8
Staff/sales % 8.4 8.0 8.2 6.2 10.3 8.1 6.9 5.9 7.6 7.4
Other exp/sales % 11.6 12.6 10.8 10.8 13.0 10.4 10.6 10.3 11.6 10.8
EBITDA 4,820 5,365 4,541 7,299 3,061 6,118 7,884 11,329 22,025 28,392
EBITDA Margin (%) 11.3 11.6 9.4 11.0 7.2 10.1 11.1 13.1 11.0 10.9
Other Income 385 316 258 404 384 557 380 380 1,363 1,700
Interest 338 339 453 423 366 410 335 356 1,554 1,467
PBT before EO Item 4,154 4,146 2,395 6,114 1,730 4,826 6,576 9,948 16,809 23,081
EO Exp/(Inc) 0 0 0 3,508 126 0 0 0 3,508 126
PBT 4,154 4,146 2,395 2,605 1,605 4,826 6,576 9,948 13,301 22,955
Effective Tax Rate (%) 30.0 29.0 32.5 - 30.7 30.7 31.6 31.2 8.0 31.2
Adj. PAT 2,908 2,944 1,617 4,279 1,199 3,342 4,497 6,963 12,360 15,880
Change (%) 130.0 14.5 -25.6 -16.5 -58.7 13.5 178.1 62.7 2.6 28.5
E: MOSL Estimates
April 2018 70
March 2018 Results Preview | Sector: Automobiles
Bajaj Auto
Bloomberg BJAUT IN CMP: INR2,791 TP: INR3,550 (+27%) Buy
Equity Shares (m) 289.4
Overall volume increased by 32.7% YoY (-4.4% QoQ) to ~1,045k
M. Cap. (INR b)/(USD b) 808 / 12
units due to ~34% YoY increase in domestic volume, while export
52-Week Range (INR) 3473 / 2695
volumes increased by ~31% YoY. Volume growth was led by 3Ws,
1,6,12 Rel Perf. (%) -6 / -18 / -11
as domestic 3Wvolumes increased by 144% YoY, while 3W
exports grew by 83% YoY.
Financial Snapshot (INR b) We expect realization to grow by 2.5% YoY (flat QoQ) led by
Y/E MAR 2017 2018E 2019E 2020E improvement in product mix and price hikes. Consequently, net
Sales 218 251 275 310 revenues are expected to increase by 36% YoY (5% QoQ).
EBITDA 44.2 47.4 53.2 62.9 We expect EBITDA margin to expand by ~60bp YoY (-20bp QoQ)
NP 40.8 42.8 48.6 57.1 to 19.1%, as margin was impacted by BS-IV related provisioning in
Adj. EPS (INR) 141 148 168 197 4QFY17.
EPS Gr. (%) -1.7 4.8 13.5 17.5 We expect PAT to grow by 22% YoY (2.7% QoQ) to INR9.8b.
BV/Sh. (INR) 589 649 717 802 We have cut our EBITDA margin estimate by 80bp/30bp in
RoE (%) 26.9 23.9 24.6 26.0 FY19/FY20, resulting in EPS declining by 4.2%/2.8% for
RoCE (%) 24.6 21.6 22.5 33.0 FY19E/FY20E.
Payout (%) 46.9 52.8 53.7 51.8 The stock trades at 16.6x FY19E and 14.2x FY20E EPS; maintain Buy.
Valuations
P/E (x) 19.8 18.9 16.6 14.2 Key issues to watch
P/BV (x) 4.7 4.3 3.9 3.5 Update on demand of new launches.
EV/EBITDA (x) 14.9 13.8 12.0 9.8 Export demand outlook and pricing in key currency market.
Div. Yield (%) 2.0 2.3 2.7 3.0 Comments on 3W demand recovery in domestic market.
Update on EV strategy.
April 2018 71
March 2018 Results Preview | Sector: Automobiles
Bharat Forge
Bloomberg BHFC IN CMP: INR717 TP: INR869 (+21%) Buy
Equity Shares (m) 465.7
BHFC’s shipment tonnage is expected to increase by 21.7% YoY
M. Cap. (INR b)/(USD b) 334 / 5
(+3.3% QoQ) to 67,169 tons, as demand for class 8 trucks as well
52-Week Range (INR) 800 / 511
1,6,12 Rel Perf. (%) -6 / 10 / 22
as domestic CV was strong, along with strong recovery in oil & gas
and industrial segments.
Net realization is expected to increase 4.6% YoY (flat QoQ) to
Financial Snapshot (INR b)
Y/E Mar 2017 2018E 2019E 2020E
~INR213.3k/ton.
Sales 64.0 82.1 94.2 108.7
As a result, net revenue would increase 27.3% YoY (+3.0% QoQ) to
EBITDA 12.5 17.9 22.1 26.8 ~INR14.3b.
EPS (INR) 13.1 20.0 26.4 34.8 EBITDA margin is likely to expand 180bp YoY (+30bp QoQ) to
EPS Gr. (%) -7.2 52.8 32.1 31.7 30.2%.
BV/Sh. (INR) 88.4 103.3 123.4 150.6 PAT is expected to increase by 31.7% YoY (+3.9% QoQ) to INR2.4b.
RoE (%) 16.2 20.9 23.3 25.4 We maintain our FY19 and FY20E EPS estimates.
RoCE (%) 9.5 13.2 15.8 18.5 The stock trades at 27.2x FY19E and 20.6x FY20E EPS; Maintain
Valuations Buy.
P/E (x) 54.8 35.9 27.2 20.6
Key issues to watch
P/BV (x) 8.1 6.9 5.8 4.8
Update on FY19 outlook for Class 8 trucks & India M&HCV.
EV/EBITDA(x) 29.0 19.6 15.7 12.5
Outlook for oil & gas and mining segments, primarily with
EV/Sales (x) 5.7 4.3 3.7 3.1
regard to price recovery.
Consolidated
Comment on industry-wide supply constraint in domestic CV.
Update on new order wins and ramp-up of past order wins
under commercial vehicles, PVs, aerospace and rail.
Update on capex plans and any capacity addition plans.
Quarterly performance (INR m)
FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Tonnage 49,098 46,203 47,083 55,189 55,100 58,659 65,050 67,169 197,573 245,978
Change (%) -5.6 -15.3 -7.2 5.3 12.2 27.0 38.2 21.7 -5.8 24.5
Realization (INR '000/ton) 184.2 192.8 200.4 204.0 217.9 214.5 213.8 213.3 195.6 214.7
Change (%) -15.9 -6.4 -4.0 5.7 18.3 11.2 6.7 4.6 -4.7 9.8
Net operating income 9,044 8,909 9,437 11,257 12,008 12,580 13,906 14,328 38,647 52,822
Change (%) -20.6 -20.7 -11.0 11.3 32.8 41.2 47.4 27.3 -10.2 36.7
RM/Sales (%) 34.4 34.4 32.6 35.1 35.0 35.0 35.6 35.2 34.2 35.3
Staff Cost (% of Sales) 10.1 10.1 9.6 9.2 8.9 8.5 8.0 8.1 9.7 8.3
Other Exp. (% of Sales) 28.5 27.6 30.2 27.3 28.3 27.1 26.4 26.5 28.3 27.0
EBITDA 2,444 2,477 2,606 3,200 3,333 3,694 4,163 4,327 10,726 15,518
EBITDA Margins (%) 27.0 27.8 27.6 28.4 27.8 29.4 29.9 30.2 27.8 29.4
Non-Operating Income 256 309 208 222 259 366 219 229 995 1,074
Interest 170 189 183 185 185 217 143 185 728 730
Depreciation 740 726 739 744 774 781 807 806 2949 3,168
EO Exp / (Inc) 0 0 0 -380 0 0 0 0 -380 0
PBT after EO items 1,791 1,870 1,892 2,872 2,633 3,063 3,432 3,565 8,425 12,693
Eff. Tax Rate (%) 31.8 32.2 32.0 27.8 33.5 33.5 33.5 33.5 30.6 33.5
Adj. PAT 1,221 1,269 1,286 1,801 1,751 2,037 2,282 2,371 5,587 8,441
Change (%) -37.7 -26.3 -22.8 8.7 43.4 60.5 77.4 31.7 -16.9 51.1
E: MOSL Estimates
April 2018 72
March 2018 Results Preview | Sector: Automobiles
Bosch
Bloomberg BOS IN CMP: INR19,116 TP: INR19,096 (0%) Neutral
Equity Shares (m) 31.4
Net revenue is expected to grow 16% YoY (-2.6% QoQ) to
M. Cap. (INR b)/(USD b) 600 / 9
INR29.9b, led by strong growth in CVs and Tractors.
52-Week Range (INR) 25245 / 16990
1,6,12 Rel Perf. (%) 4 / -12 / -27
EBITDA margin is expected to decline by 290bp YoY (+990bp QoQ)
to 24.4%, impacted by higher import content for BS6 products.
EBITDA is projected to grow 4% YoY (+64% QoQ) to INR7.3b.
Financial Snapshot (INR b)
Y/E Mar FY17 FY18E FY19E FY20E
Adjusted PAT is likely to increase 5% YoY to INR4.6b.
Sales 104.4 115.2 132.2 150.8
We cut FY19 EPS by 3.6% and FY20 EPS by 5% to factor in
EBITDA 19.6 21.3 27.2 31.9 potentially lower margins on BS6 than original estimate.
NP 14.4 14.0 17.8 21.2 The stock trades at 32.8x FY19E and 27.5x FY20E EPS; Maintain
EPS (INR) 473.1 459.1 582.9 694.4 Neutral.
EPS Gr. (%) -1.8 -3.0 27.0 19.1
BV/Sh. (INR) 2,883.1 3,155 3,501 3,912
RoE (%) 15.8 15.2 17.5 18.7
RoCE (%) 23.1 23.0 26.3 27.9
Key issues to watch
Valuations
Implementation of BS-VI norms for 2-wheelers and underlying
P/E (x) 40.4 41.6 32.8 27.5
opportunity for Bosch.
P/BV (x) 6.6 6.1 5.5 4.9
EV/EBITDA(x) 28.9 25.0 19.3 16.2
Advancement of BS-VI implementation and its impact on Bosch.
EV/Sales (x) 5.4 4.6 4.0 3.4 Capex plans for BS VI norms.
Further details on EV strategy & competitive positioning in EVs.
April 2018 73
March 2018 Results Preview | Sector: Automobiles
CEAT
Bloomberg CEAT IN CMP: INR1,599 TP: INR1,787 (12%) Buy
Equity Shares (m) 40.5
We expect revenue to increase 12% YoY (+5% QoQ) to INR16.5b
M. Cap. (INR b)/(USD b) 65 / 1
in 4QFY18.
52-Week Range (INR) 2030 / 1324
1,6,12 Rel Perf. (%) 3 / -12 / 8
RM cost is expected to increase by 330bp QoQ (-140bp YoY) to
61.5% in 4QFY18.
We estimate 90bp QoQ (+200bp YoY) contraction in EBITDA
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
margin to 11%. EBITDA is likely to grow 37% YoY (-3% QoQ) to
Sales 64.4 63.4 70,1 83,3
INR1.8b.
EBITDA 10.2 9.0 11.0 12.2 We expect adjusted PAT to increase 21% YoY to INR964m.
NP 3.8 2.5 3.4 4.5 The stock trades at ~18.9x FY19E and 14.3x FY20E EPS. Maintain
EPS (Rs) 93.3 61.1 84.7 111.7 Buy.
EPS Gr. (%) -16.9 -34.6 38.6 31.9
BV/Share 597.0 648.7 722.1 819.0
RoE (%) 16.9 9.8 12.4 14.5
Key things to watch for
RoCE (%) 13.5 8.5 10.0 11.1
Movement in raw materials prices.
Valuations
P/E (x) 17.1 26.2 18.9 14.3
Growth in replacement market.
P/BV (x) 2.7 2.5 2.2 2.0 Update on capex plans and timeline for capacity additions.
EV/EBITDA (x) 11.2 12.6 10.7 8.1
EV/Sales (x) 1.1 1.1 1.2 1.0
April 2018 74
March 2018 Results Preview | Sector: Automobiles
Eicher Motors
Bloomberg EIM IN CMP: INR28,052 TP: INR34,529 (+23%) Buy
Equity Shares (m) 27.2
Royal Enfield’s volumes grew by 27.4% YoY (+9.9% QoQ) to
M. Cap. (INR b)/(USD b) 763 / 12
227,041 units, aided by additional capacity amid healthy demand.
52-Week Range (INR) 33484 / 25316
1,6,12 Rel Perf. (%) 3 / -16 / -2
Net realization is expected to improve by 4.3% YoY (+0.6% QoQ),
supported by price hikes and mix. We expect EBITDA margin to
expand ~60bp YoY to 32% (+30bp QoQ).
Financial Snapshot (INR b)
VECV’s volume increased by ~33.2% YoY (+42.3% QoQ). We
Y/E Dec FY17 FY18E FY19E FY20E
Net Income 70.3 89.3 107.7 129.4 expect net realization to increase by 6.5% YoY (-1.7% QoQ).
EBITDA 21.7 28.4 35.1 43.9 Margin is expected to be at 9.9%, up by ~170bp YoY (+110bp
Net Profit 16.8 22.2 28.4 36.4 QoQ).
Adj. EPS (INR) 616.7 814.4 1,045.3 1,337.1 Consolidated revenue would increase ~32.1% YoY (+9.9% QoQ) to
EPS Gr. (%) 56.5 32.1 28.4 27.9 INR24.9b. Consolidated margin is likely to be 33.2%. Consolidated
BV/Sh. (INR) 1,964 2,525 3,369 4,477 Adj. PAT is estimated to grow ~59% YoY (+40% QoQ) at INR7.3b.
RoE (%) 37.3 36.3 35.5 34.1 We are providing INR2.9b for write-off of investment in Polaris JV.
RoCE (%) 33.5 33.5 31.2 31.0 The stock trades at 26.8x FY19E and 21x FY20E EPS. Maintain Buy.
Payout (%) 0.4 0.5 0.6 0.7 Key issues to watch
Valuations
Outlook on RE demand and order book.
P/E (x) 45.5 34.4 26.8 21.0
Update on time-line for new launches.
P/BV (x) 14.3 11.1 8.3 6.3
Update on current demand trends for commercial vehicles and
EV/EBITDA (x) 28.5 21.4 16.7 12.9
discount levels.
Div. Yield (%) 0.4 0.5 0.6 0.7
Update on capacity addition for RE & VECV.
April 2018 75
March 2018 Results Preview | Sector: Automobiles
Endurance Technologies
Bloomberg ENDU IN CMP: INR1,263 TP: INR1,531(+21%) Buy
Equity Shares (m) 140.7
We expect 21.2% YoY growth (5.8% QoQ) in consolidated revenue
M. Cap. (INR b)/(USD b) 178 / 3
to INR16.7b, led by strong performance in domestic as well as
52-Week Range (INR) 1422 / 767
1,6,12 Rel. Perf. (%) -4 / 23 / 52
exports segments.
Consolidated EBITDA is expected to grow 21.6% YoY (3.6% QoQ),
led by healthy growth in the operating performance of both
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
Indian and European operations.
Sales 55.9 64.2 73.3 86.0
EBITDA margin is likely to remain flat YoY (-30bp QoQ) at 13.8%
EBITDA 7.6 9.0 11.1 13.8 mainly due to RM cost inflation.
NP 3.3 3.9 5.4 7.2 We expect PAT to grow 20% YoY (+4.7% QoQ) to INR1b.
Adj EPS (INR) 23.5 27.9 38.2 51.0 The stock trades at 33x FY19E EPS and 24.8x FY20 EPS. Maintain
EPS Gr. (%) 9.9 18.8 37.0 33.5 Buy.
BV/Sh. (INR) 122.9 145.7 175.7 211.3
RoE (%) 20.8 20.8 23.8 26.4 Key issues to watch for
RoCE (%) 15.6 17.4 21.1 24.5 Update on supplies to HMSI and Hero MotoCorp.
Valuations Update on new products in India.
P/E (x) 53.8 45.3 33.0 24.8 EU business: Level of ramp-up at new plant in Germany.
P/BV (x) 10.3 8.7 7.2 6.0
EV/EBITDA (x) 23.9 20.2 16.1 12.7
April 2018 76
March 2018 Results Preview | Sector: Automobiles
Escorts
Bloomberg ESC IN CMP: INR884 TP: INR826 (-6%) Sell
Equity Shares (m) 122.6
Tractor volumes grew ~57% YoY to 23,568 units. Realizations are
M. Cap. (INR b)/(USD b) 108 / 2
estimated to decline ~2% QoQ due to weaker mix.
52-Week Range (INR) 922 / 519
1,6,12 Rel Perf. (%) 2 / 28 / 53 We expect revenue to grow 42% YoY to INR14.5b in 4QFY18,
driven strong tractor volumes.
Financial Snapshot (INR Billion)
We expect EBITDA margin to expand 430bp to 11.6%.
Y/E March 2017 2018E 2019E 2020E
Consequently, EBITDA should grow 126% YoY to INR1,681m.
Sales 41.5 51.8 58.1 64.2
EBITDA 3.1 5.7 6.8 8.0 PAT should grow by 126% to INR1.1b, restricted by higher tax
NP 1.6 3.5 4.4 5.2 rate.
EPS (INR) 19.2 39.1 49.5 59.0
We have upgraded our EPS estimates for FY19/20E by 9%/7% to
EPS Growth (%) 70.5 103.5 26.5 19.3
factor in the strong outlook for tractors.
BV/Sh (INR) 190.1 244.3 285.5 336.2
RoE (%) 10.6 18.3 18.7 19.0 The stock trades at 17.9x/15x FY19/20E EPS. Maintain Sell.
RoCE (%) 10.2 18.1 18.7 28.3
Payout (%) 16.9 12.7 16.8 14.1
Key things to watch for
Valuations
Market share movement and new launches.
P/E (x) 46.0 22.6 17.9 15.0
P/BV (x) 4.7 3.6 3.1 2.6
Visibility of order book execution in railways division.
EV/EBITDA (x) 24.3 12.9 10.2 8.0
EV/Sales(x) 1.8 1.4 1.2 1.0
April 2018 77
March 2018 Results Preview | Sector: Automobiles
Exide Industries
Bloomberg EXID IN CMP: INR233 TP: INR286 (+23%) Buy
Equity Shares (m) 850.0
We expect revenues to grow 21% YoY to INR23.8b, led by strong
M. Cap. (INR b)/(USD b) 198 / 3
OEM and replacement demand, as well as ramp-up in telecom
52-Week Range (INR) 250 / 193
1,6,12 Rel Perf. (%) 13 / 6 / -10
segment for EXID.
Spot LME lead prices increased marginally by 0.5% QoQ, but 6%
YoY in 4QFY17.
Financial Snapshot (INR b)
EBITDA margin is likely to shrink 10bp YoY (+60bp QoQ) to 13%.
Y/E MARCH 2017 2018E 2019E 2020E
Net Sales 76.2 91.3 105.0 121.1 PAT is likely to grow by 6% YoY (+13% QoQ) to INR1.75b.
EBITDA 10.9 12.1 14.5 17.1 The stock trades at 23.6x FY19E and 19.2x FY20E EPS. Maintain
Adj. PAT 6.9 6.8 8.4 10.3 Buy.
Adj. EPS (INR) 8.1 8.0 9.9 12.1 Key issues to watch
EPS Gr. (%) 10.6 -1.3 23.3 22.6 Update on demand environment for OEMs, auto replacement
BV/Sh. (INR) 58.4 63.5 70.8 79.2 and industrial battery segments post demonetization.
RoE (%) 13.9 12.6 14.0 15.3 Market share in autos and non-autos.
RoCE (%) 14.2 12.8 14.4 15.8 Outlook for raw material cost trend, recent pricing action and
Valuations 29.5 27.4 22.3 26.4 currency hedges, if any.
P/E (x) Update on technical alliance with China-based Chaowei group
P/BV (x) 28.7 29.0 23.6 19.2
for lithium ion battery.
EV/EBITDA (x) 4.0 3.7 3.3 2.9
Div. Yield (%) 15.8 14.0 11.3 9.2
April 2018 78
March 2018 Results Preview | Sector: Automobiles
Hero MotoCorp
Bloomberg HMCL IN CMP: INR3,640 TP:INR3,922 (+8%) Neutral
Equity Shares (m) 199.7
Volume increased by ~23% YoY (17% QoQ) to 2m units, led by
M. Cap. (INR b)/(USD b) 727 / 11
healthy rural sentiment.
52-Week Range (INR) 4200 / 3180
Realization would be flat YoY and QoQ at INR42,834/unit.
1,6,12 Rel Perf. (%) 4 / -10 / 2
Net revenue should increase by 24% YoY (17% QoQ) to INR85.7b.
EBITDA margin is expected to expand by ~290bp YoY (+90bp QoQ)
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
to 16.7%, over lower base of previous year due to provisioning
Sales 284.7 322.1 361.3 395.7
related to BS-IV transition.
EBITDA 46.3 53.4 58.2 63.4 EBITDA is likely to grow 49.7% YoY (+23.8% QoQ) to ~INR14.3b.
NP 33.8 37.2 40.3 44.3 We expect PAT to grow 37.4% YoY (+22.4% QoQ) to INR9.9b.
Adj. EPS (INR) 169.1 186.1 202.0 221.3 The stock trades at 18x FY19E and 16.4 FY20E EPS; maintain
EPS Gr. (%) 6.9 10.0 8.5 9.6 Neutral.
BV/Sh. (INR) 506.3 584.0 671.5 764.6 Key issues to watch
RoE (%) 35.7 34.1 32.2 30.9 Update on rural demand.
RoCE (%) 34.5 32.9 31.2 30.0 Update on discounts given.
Payout (%) 57.8 55.6 54.1 54.6 Update on demand of new launches.
Valuations Outlook on exports.
P/E (x) 21.5 19.6 18.0 16.4
P/BV (x) 7.2 6.2 5.4 4.8
EV/EBITDA (x) 14.4 12.1 11.0 9.9
Div. Yield (%) 2.3 2.5 2.6 2.9
April 2018 79
March 2018 Results Preview | Sector: Automobiles
Mahindra CIE
Bloomberg MACA IN CMP: INR221 TP: INR272 (+23%) Buy
Equity Shares (m) 378.4
MACA’s standalone revenue is expected to increase by 24% YoY
M. Cap. (INR b)/(USD b) 84 / 1
(+2.5% QoQ), led by strong growth for key customers and merger
52-Week Range (INR) 270 / 199
1,6,12 Rel Perf. (%) -5 / -12 / -14
of Gears India.
Standalone EBITDA margin is expected to expand ~190bp YoY
(+90bp QoQ) to 11.2% due to favourable mix and operating
Financial Snapshot (INR b)
Y/E Dec 2017 2018E 2019E 2020E
leverage.
As a result, standalone PAT is expected to grow 67.5% YoY
Sales 65.2 68.8 74.2 78.8
EBITDA 8.2 9.4 11.1 12.2 (+53.7% QoQ).
EPS (Rs) 9.6 12.1 15.1 16.8 Consolidated revenue is expected to grow by ~5% YoY (-3% QoQ)
EPS Growth (%) 107.8 26.3 24.8 11.3 to INR16.6b.
BV/Share (Rs) 98.3 110.4 125.5 142.4 Consolidated EBITDA margin is expected to expand ~170bp YoY
RoE (%) 10.4 11.6 12.8 12.6 (+30bp QoQ) to 13.7% mainly attributable to improved
RoCE (%) 8.7 10.1 11.5 11.5 performance in standalone business. As a result, consol. PBT is
Valuations expected to grow ~22% YoY (+7% QoQ) to INR1.4b.
P/E (x) 23.0 18.2 14.6 13.1 The stock trades at 14.6x FY19E and 13.1x FY20E EPS; maintain
P/BV (x) 2.2 2.0 1.8 1.6 Buy.
EV/EBITDA(x) 11.5 9.7 7.8 6.7 Key issues to watch
EV/Sales (x) 1.5 1.3 1.2 1.0 Outlook for CY18.
Consolidated Update on new products/customer addition.
Update on new order wins and ramp-up of past orders.
Quarterly performance
Consolidated (INR m) CY17 CY18E CY17 CY18E
Consolidated 1Q 2Q 3Q 4Q 1QE 2QE 3QE 4QE
Net Sales 15,781 15,849 16,494 17,077 16,570 16,721 17,401 18,099 65,200 68,791
YoY Change (%) 18.9 15 32 25.2 5.0 6 6 6.0
EBITDA 1,889 1,995 2,052 2,285 2,270 2,307 2,367 2,500 8,221 59,347
Margins (%) 12.0 12.6 12.4 13.4 13.7 13.8 13.6 13.8
PBT before EO exp 1,170 1,233 1,334 1,330 1,423 1,462 1,530 1,678 5,136 6,093
YoY Change (%) 49.0 58.3 98.5 250.0 21.6 18.6 14.7 25.8 89.8 18.6
E: MOSL Estimates
Standalone (INR m)
Y/E December CY17 CY18E CY17 CY18E
1Q 2Q 3Q 4Q 1QE 2QE 3QE 4QE
Net Sales 4,641 4,495 4,847 5,615 5,754 5,169 5,525 6,468 19,607 22,916
YoY Change (%) 14.8 11.2 21.0 39.6 24.0 15.0 14.0 15.2 21.7 16.9
EBITDA 431 427 488 583 647 594 681 828 1,948 2,750
Margins (%) 9.3 9.5 10.1 10.4 11.2 11.5 12.3 12.8 9.9 12.0
Depreciation 171 182 178 228 230 235 235 244 759 944
Interest 26 18 13 33 30 25 25 21 98 101
Other Income 29 43 27 38 35 38 35 42 127 150
PBT before EO expense 264 269 325 360 422 372 456 604 1,217 1,855
Extra-Ord expense 0 0 0 69 0 0 0 0 69 0
PBT 264 269 325 291 422 372 456 604 1,148 1,855
Tax 97 93 121 144 144 127 155 205 455 631
Rate (%) 36.9 34.4 37.3 49.6 34.0 34.0 34.0 34.0 39.6 34.0
Reported PAT 166 176 204 146 279 246 301 399 693 1,224
Adj PAT 166 176 204 181 279 246 301 399 735 1,224
YoY Change (%) -2.1 25.1 86.2 65.7 67.5 39.2 47.8 95.8 28.0 66.6
E: MOSL Estimates
April 2018 80
March 2018 Results Preview | Sector: Automobiles
April 2018 81
March 2018 Results Preview | Sector: Automobiles
Maruti Suzuki
Bloomberg MSIL IN
CMP: INR9,024 TP: INR10,685 (+18%) Buy
Equity Shares (m) 302.1
Volume grew by 11.4% YoY (+7.1% QoQ) to 461.7k units, led by
M. Cap. (INR b)/(USD b) 2726 / 42
52-Week Range (INR) 10000 / 6024
Baleno, Brezza, newly launched Swift Dzire, and recovery in small
1,6,12 Rel Perf. (%) 4 / 8 / 37 cars.
Net realization is likely to improve 2.2% YoY (+1.1% QoQ) to
April 2018 82
March 2018 Results Preview | Sector: Automobiles
Motherson Sumi
Bloomberg MSS IN CMP: INR333 TP: INR437 (+31%) Buy
Equity Shares (m) 2105.3
We estimate consolidated revenues to grow ~43% YoY, driven by
M. Cap. (INR b)/(USD b) 700 / 11
consolidation of PKC, strong growth in S/A business (+18%), PKC
52-Week Range (INR) 395 / 247
1,6,12 Rel Perf. (%) 6 / -8 / 21
(+31%) and SMP (+19.5%). However, we estimate SMR revenues
to decline 1%.
Consolidated PAT is expected to decline ~4% YoY to ~INR5.2b,
Financial Snapshot (INR b)
Y/E Mar 2017 2018E 2019E 2020E
impacted by margin decline in S/A and start-up costs in SMRPBV.
Sales 424.9 571.2 683.2 825.6
Standalone EBITDA margin is expected to decline ~190bp YoY
EBITDA 42.8 51.7 74.7 100.1 (+130bp QoQ) to 18.7% due to impact of copper price inflation.
EPS (Rs) 7.7 8.1 12.5 17.5 For SMR, we estimate EBITDA margins to improve ~20bp to
EPS Growth (%) 18.2 5.0 54.7 39.6 ~11.4% due to operating leverage.
BV/Share (Rs) 39.3 44.8 53.7 65.7 For SMP, we estimate EBITDA margins to improve ~20bp to ~5.9%
RoE (%) 25.6 19.2 25.4 29.3 due to operating leverage.
RoCE (%) 14.7 11.8 17.4 21.5 For PKC, we estimate EBITDA margins to improve ~150bp to 7.8%
Payout (%) 23.6 26.8 29.1 31.5 due to partial easing up of supply side constraints.
Valuations The stock trades at 26.6x FY19E and 19x FY20E EPS; Maintain Buy.
P/E (x) 43.2 41.1 26.6 19.0
Key issues to watch
P/BV (x) 8.5 7.4 6.2 5.1
Update on order book of SMRPBV and PKC.
EV/EBITDA(x) 12.1 14.3 9.7 6.9
Update on new plants of SMRPBV.
EV/Sales (x) 1.2 1.3 1.1 0.8
Update on trends in key businesses.
April 2018 83
March 2018 Results Preview | Sector: Automobiles
Tata Motors
Bloomberg TTMT IN CMP: INR343 TP:INR528 (+54%) Buy
Equity Shares (m) 3396.6
Consolidated revenues are estimated to grow 15.5% YoY, with
M. Cap. (INR b)/(USD b) 1166 / 18
EBITDA margin expanding 70bp YoY to 14.7%. As a result, adj. PAT
52-Week Range (INR) 487 / 325
is estimated to grow 11% YoY to ~INR48.1b.
1,6,12 Rel Perf. (%) -5 / -23 / -39
We expect JLR’s (incl. JV) volume to be up by 2.6% YoY (+13%
QoQ), impacted by weak demand environment in key markets.
Financial Snapshot (INR b) Net realization is expected to increase by 3% YoY (-0.2% QoQ), led
Y/E March 2017 2018E 2019E 2020E by better mix. EBITDA margin would expand 20bp YoY (+380bp
Net Sales 2,697 2,925 3,336 3,586 QoQ) to 14.7%, led by a better mix and lower Fx hedge losses.
EBITDA 369.1 367.1 524.1 556.4 Higher depreciation would lead to adj. PAT decline of 11% YoY to
NP 67.3 86.7 192.3 199.4 GBP482m.
Adj. EPS (INR) 19.8 25.5 56.6 58.7 S/A volume increased 38% YoY (+19% QoQ), led by 46% growth in
EPS Gr. (%) -48.4 28.8 121.8 3.7 LCVs, 18% YoY growth in M&HCV. EBITDA margin is likely to
BV/Sh. (INR) 171.0 206.6 264.5 324.5 expand 540bp YoY to 9.5%. We expect standalone operations to
RoE (%) 9.8 13.5 24.0 19.9 be PAT positive at INR5.5b (2nd consecutive quarter of positive
RoCE (%) 9.2 7.8 12.8 11.1 PAT).
Payout (%) 0.0 1.3 0.6 0.6 The stock trades at 6.1x FY19E and 5.8x FY20E EPS. Buy.
Valuations Key issues to watch
P/E (x) 17.3 13.4 6.1 5.8 Current demand trends for JLR and outlook for key markets.
P/BV (x) 2.0 1.7 1.3 1.1 Update on new launches.
EV/EBITDA (x) 3.6 3.9 2.7 2.4 Impact of forex hedge loss.
Div. Yield (%) 0.0 0.1 0.1 0.1 Update on Chery JV operations and CV business outlook.
Quarterly Performance
Y/E March FY17 FY18E FY17 FY18E
(Consolidated) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
JLR vols. (incl JV) 134,334 139,227 152,245 175,000 138,476 153,210 159,067 179,593 600,806 630,346
JLR Realizations (GBP/unit) 44,338 45,642 46,200 45,746 47,483 48,137 47,181 47,081 45,515 47,449
JLR EBITDA (%) 12.5 10.9 10.1 14.5 7.9 11.8 10.9 14.7 12.1 11.6
S/A vol. (units) 126,839 134,397 132,553 148,533 109,692 153,321 171,388 204,356 542,322 638,757
S/A Realizations (INR/unit) 811,243 765,059 769,912 914,725 829,080 905,798 939,482 940,480 818,038 912,757
S/A EBITDA (%) 6.5 3.3 1.4 4.1 0.0 7.0 8.5 9.5 3.8 7.2
S/A PAT (INR m) 258 -5,793 -10,452 -5,369 -4,671 -2,953 1,880 5,535 -21,341 -181
Net Op Income 650,047 635,376 639,330 772,172 584,934 706,907 741,561 892,009 2,696,925 2,925,410
Growth (%) 7.6 3.3 -9.4 -2.9 -10.0 11.3 16.0 15.5 -1.2 8.5
EBITDA 90,275 74,298 62,403 108,012 49,648 89,383 85,435 130,740 295,887 355,206
EBITDA Margins (%) 13.9 11.7 9.8 14.0 8.5 12.6 11.5 14.7 11.0 12.1
PBT before EO Exp 34,718 21,304 13,071 52,011 -5,145 30,099 19,070 57,661 82,002 101,686
EO Exp/(Inc) 9,204 11,311 7,085 356 -42,515 -715 -1,220 0 27,955 -44,449
PBT after EO Exp 25,514 9,993 5,986 51,655 37,370 30,814 20,290 57,661 54,047 146,135
Tax rate (%) 28.2 42.5 144.8 24.0 32.3 35.4 52.6 23.7 60.2 32.4
Adj PAT 28,970 14,788 -2,239 43,229 3,045 24,366 11,408 48,123 46,581 86,696
Growth (%) (39.0) 61.1 (107.2) (25.0) (89.5) 64.8 (609.6) 11.3 -64.3 86.1
E: MOSL Estimates
April 2018 84
March 2018 Results Preview | Sector: Automobiles
EPS (INR) 11.7 14.1 22.4 32.4 (+30bp QoQ), as margin was dented in 4QFY17 due to provision
EPS Gr. (%) 14.1 20.4 58.8 44.1 related to BS IV transition.
BV/Sh (INR) 50.7 61.2 78.9 105.2 We expect PAT to increase ~38% YoY (+13% QoQ) to INR1.7b.
RoE (%) 25.6 25.3 32.0 35.2 We have cut our FY19E/20E margin by 50bp/10bp. We have
RoCE (%) 22.8 25.6 34.6 41.4 revised downward our FY19E/20E EPS estimate by 11%/5% to
Payout (%) 25.6 25.5 21.4 18.6 factor in lower EBITDA margin and lower other income.
Valuations The stock trades at 28.9x FY19E and 20.1x FY20E EPS; Maintain
P/E (x) 55.3 45.9 28.9 20.1 Neutral.
P/BV (x) 12.8 10.6 8.2 6.2 Key issues to watch
EV/EBITDA (x) 37.3 27.2 17.4 12.4 Update on demand for new launches Apache RR310 and NTorq.
Div. Yield (%) 0.4 0.5 0.6 0.8 Update on future product actions, including EVs.
Impact on spare parts business post GST.
Update on outlook for exports.
S/A Quarterly Performance
Y/E March (INR m) FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE FY17 FY18E
Motorcycles 282,441 332,070 247,635 213,642 330,050 365,277 313,892 346,357 1,072,503 1,355,576
Scooters 196,314 229,455 221,088 223,242 257,572 328,333 268,947 280,066 870,863 1,134,918
Mopeds 218,872 233,636 233,758 221,253 197,449 229,726 216,478 233,279 910,519 876,932
Three-wheelers 17,337 20,401 16,081 15,435 17,037 25,248 26,968 29,431 69,254 98,684
Volumes (units) 714,964 815,562 718,562 673,572 802,108 948,584 826,285 889,133 2,923,139 3,466,111
Growth (%) 12.1 20.2 2.4 2.0 12.2 16.3 15.0 32.0 9.1 18.6
Realization (INR/unit) 40,305 42,014 41,519 42,230 42,382 42,721 44,597 44,981 41,515 43,669
Growth (%) (0.1) 0.5 0.7 (0.3) 5.2 1.7 7.4 6.5 0.1 5.2
Net Sales 28,817 34,265 29,834 28,445 33,995 40,524 36,850 39,994 121,353 151,363
Growth (%) 11.9 20.8 3.0 1.7 18.0 18.3 23.5 40.6 9.3 24.7
RM (% of sales) 72.5 72.3 72.0 75.1 74.6 73.4 72.7 72.9 73.0 73.4
Emp cost ( % of sales) 6.3 5.8 6.4 6.1 6.1 5.4 5.7 5.6 6.1 5.7
Other exp (% of sales) 14.2 13.8 14.2 13.1 13.1 12.6 13.8 13.4 13.8 13.2
TOTAL EXPENDITURE 26,806 31,498 27,649 26,830 31,881 37,021 33,982 36,749 112,782 139,632
EBITDA 2,011 2,767 2,185 1,615 2,114 3,503 2,868 3,245 8,571 11,731
EBITDA Margin(%) 7.0 8.1 7.3 5.7 6.2 8.6 7.8 8.1 7.1 7.8
Interest 98 94 115 132 107 155 122 137 440 521
Depreciation 660 724 720 775 783 836 824 840 2,878 3,284
Other Income 362 392 348 632 571 456 182 144 1,734 1,352
PBT before EO Exp 1,616 2,340 1,698 1,340 1,794 2,968 2,104 2,412 6,987 9,278
Tax rate (%) 24.5 24.2 21.9 5.4 27.8 28.2 26.6 27.6 20.1 27.6
Adjusted PAT 1,220 1,774 1,327 1,268 1,295 2,132 1,543 1,747 5,581 6,717
Growth (%) 21.9 33.4 10.4 (6.8) 6.1 20.2 16.3 37.8 14.1 20.4
E: MOSL Estimates
April 2018 85
March 2015
2016 March
Results2018
Preview
Results
| Sector:
Preview
Capital
| April
Goods
2018
Technology
Capital Goods
Business activity showing signs of stabilization post GST
Company name
Capex activity remains weak, though green shoots seen in select pockets
ABB
Bharat Electronics Domestic capex cycle weak; exports hamstrung by subdued global demand
BHEL The domestic capex cycle appears to have remained weak. New project
announcements stood at INR6.6t in FY18, a dip of 52% YoY and the lowest since
Blue Star
FY05. Private sector projects fell to their lowest since FY04 to INR3.7t (down 51%
CG Power YoY) and accounted for 56% of total new projects. Though the near-term outlook
Crompton Greaves Consumer remains subdued, we note that policy initiatives and efforts are underway to (i)
Cummins India expedite regulatory approvals, and (ii) establish monetary conditions conducive to
industrial revival over the medium term.
Engineers India
GE T&D We believe investment revival would be triggered by: (i) a sustained recovery in
consumption demand, and thus, capacity utilization, and (ii) investment push by
Havells India
the public sector, leading to a virtuous cycle of cash flow generation.
Larsen & Toubro Simultaneously, sustained progress in reviving stalled projects is imperative to
Siemens attract new investments and stimulate aggregate demand. Currently, stalled
Thermax
projects stand at 11.6t, 11.4% of the projects under implementation.
By initiating the GST, labor and energy sector reforms, the Indian government
Voltas
has partly addressed concerns about the pace and extent of reforms.
Implementation of substantive reforms is essential for structured investment
growth.
Indian machinery exports have decelerated due to weak global demand,
geopolitical concerns, and currency volatility across markets, among others.
Also, volatile crude prices have had an adverse impact on global trade, and thus,
investment demand. Project awards in the Middle-East have been muted.
In our view, the successful implementation of this initiative should benefit Capital
Goods players. Increased imports over the past 5-6 years, particularly from
China/South Korea, have been a key concern across several product segments, even
where domestic manufacturing capabilities and competitiveness exist. Key
beneficiaries include BHEL/Siemens (railways, solar cells, power T&D, defense, etc),
L&T/Bharat Electronics (defense), ABB/Alstom/CG Power/Siemens (power T&D, etc)
and Thermax (industrial products/power BTG).
2.8
16.0
15.5
14.5
14.0
13.5
12.3
12.1
12.0
12.0
12.0
11.6
17.9
11.3
15.3 11.0
10.6
10.2
16.6 10.0
10.0
9.9
9.7
9.2
16.1
16.0
8.7
8.7
8.5
8.4
8.3
8.7 7.8
15.5
2.7 7.2
9.6 6.6
14.5
14.0
4.3
13.5
12.3
26.3
12.1
12.0
12.0
12.0
11.7
11.6
19.6
1.3
3.1
1.2
28.8
16.8
15.6
11.3
21.7
18.2
20.9
5.3
11.0
6.6
2.4
2.9
22.0
3.5
12.8
16.4
10.6
10.2
10.0
10.0
9.9
9.7
9.2
8.7
8.7
8.5
8.4
8.3
-5.2
1QFY14 -3.5
7.8
7.2
4.3
6.6
3QFY15 -1.0
-0.8
1QFY16 -1.4
1QFY11
3QFY11
1QFY12
3QFY12
1QFY13
3QFY13
3QFY14
1QFY15
3QFY16
1QFY17
3QFY17
1QFY18
3QFY18
1QFY11
3QFY11
1QFY12
3QFY12
1QFY13
3QFY13
1QFY14
3QFY14
1QFY15
3QFY15
1QFY16
3QFY16
1QFY17
3QFY17
1QFY18
3QFY18
April 2018 87
December 2018 Results Preview | Sector: Capital Goods
58
56
55
52
3.0
2,686
2.9
2.9
2.8
31
2.6
2.5
2.5
22
2.4
2.4
2.4
2.4
2.4
2.3
2.3
2.3
2.3
18
2.3
2.3
17
20
15
15
2.2
14
2.1
-9
1.7
2
2,964
2,893
2,958
2,989
3,028
2,943
3,230
3,482
3,594
3,605
3,813
3,717
3,934
3,847
3,868
3,797
3,970
3,955
3,871
4,062
-1
-2
-5
-13
-17
-22
3QFY17 -24
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
3QFY13
1QFY14
3QFY14
1QFY15
3QFY15
1QFY16
3QFY16
1QFY17
1QFY18
3QFY18
Source: MOSL, Company Source: MOSL, Company
Exhibit 6: Relative performance – three-month (%) Exhibit 7: Relative performance – one-year (%)
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
April 2018 88
March 2018 Results Preview | Sector: Capital Goods
ABB
Bloomberg ABB IN
CMP: INR1,283 TP: INR1,240 (-3%) Sell
Equity Shares (m) 211.9
M. Cap. (INR b)/(USD b) 272 / 4
During the quarter, ABB has opened its power distribution factory
52-Week Range (INR) 1744 / 1175 in Nashik, and facility for electrical safety and energy efficiency
1,6,12 Rel Perf. (%) -14 / -14 / -14 products in Bangalore.
We expect ABB to register 19% YoY growth in revenue, led by 21%
Financial Snapshot (INR b)
growth in the power grid segment, as we anticipate the execution
Y/E Dec 2017 2018E 2019E 2020E of HVDC order to contribute to revenue.
Net Sales 90.9 115.9 123.2 122.0 We expect EBITDA margin to improve 170bp to 9.6%, led by better
EBITDA 7.4 11.2 12.9 15.0 operating leverage.
Adj. PAT 4.2 6.4 7.4 9.2 Net profit growth is expected to remain robust at 56% YoY to
Adj. EPS (INR) 19.8 30.1 35.0 35.5 INR1.4b. Maintain Sell.
EPS Gr (%) 12.1 52.0 16.2 1.5
BV/Sh (INR) 170.2 195.2 221.0 247.3
RoE (%) 11.6 15.4 15.8 14.4
RoCE (%) 16.2 22.9 23.7 21.7
Payout (%) 22.5 14.7 22.5 22.5
Valuations Key issues to watch
P/E (x) 64.7 42.6 36.7 36.1 Management commentary suggests cautious optimism.
P/BV (x) 7.5 6.6 5.8 5.2 Continued focus on exports and services to be an important driver
EV/EBITDA (x) 21.9 16.6 12.4 9.1 of projected strong double-digit revenue and profit growth.
Div. Yield (%) 0.3 0.3 0.6 0.6 Continued preference for cash generation vis-à-vis profits.
Quarterly Performance
Y/E December CY17 CY18 CY17 CY18E
1Q 2Q 3Q 4Q 1QE 2QE 3QE 4QE
Sales 21,689 22,237 19,234 27,794 25,780 29,180 27,820 33,129 89,614 114,498
Change (%) 8.3 6.2 (6.4) 10.8 18.9 31.2 44.6 19.2 5.3 27.8
EBITDA 1,715 1,473 1,342 2,937 2,480 2,780 2,570 3,376 7,361 11,206
Change (%) -5.2 29.7 13.4 1.4 44.6 88.7 91.6 14.9 6.0 52.2
As % of Sales 7.9 6.6 7.0 10.6 9.6 9.5 9.2 10.2 8.2 9.8
Depreciation 376 383 389 432 400 350 350 419 1580 1519
Interest 212 231 152 178 200 200 200 193 773 793
Other Income 186 326 378 188 200 200 200 278 1210 878
PBT 1,312 1,185 1,178 2,515 2,080 2,430 2,220 3,041 6,218 9,771
Tax 428 435 344 800 700 800 780 1,108 2,018 3,388
Effective Tax Rate (%) 32.6 36.7 29.2 31.8 33.7 32.9 35.1 36.5 32.5 34.7
Repoted PAT 884 751 1,134 1,715 1,380 1,630 1,740 1,933 4,200 6,383
Adj. PAT 884 751 834 1,715 1,380 1,630 1,440 1,933 4,200 6,383
Change (%) -5.3 34.9 18.2 5.4 56.1 117.2 72.7 12.7 12.1 52.0
April 2018 89
March 2018 Results Preview | Sector: Capital Goods
Bharat Electronics
Bloomberg BHE IN CMP: INR147 TP: INR210 (+41%) Buy
Equity Shares (m) 2457.0
For FY18, BHE plans to pursue business opportunities in solar
M. Cap. (INR b)/(USD b) 360 / 6
energy, homeland security, smart cities, smart cards and telecom.
52-Week Range (INR) 193 / 138
For FY18, BHE’s growth would be driven by radar/missile systems,
1,6,12 Rel Perf. (%) -2 / -16 / -11
communication and network-centric systems, tank electronics, gun
upgrades, electro-optic systems, and electronic warfare systems.
Financial Snapshot (INR b)
BHE has planned capacity enhancement and creation of new test
Y/E March 2017 2018E 2019E 2020E
facilities for the defense business.
Net Sales 86.1 112.4 124.8 133.9
We expect BHE to register revenue growth of 14% YoY, supported
EBITDA 15.5 17.4 19.1 20.4
by execution of Akash missile system, IACCS, and ship-borne EW
NP 6.3 7.1 7.8 8.3
systems.
EPS (INR) 27.2 12.1 10.0 6.8
We expect EBITDA margin of 26.2% v/s 24.6% in 4QFY17 on better
EPS Gr. (%) 30.6 39.6 44.1 49.0
operating leverage. EBITDA is likely to grow 21% YoY to INR11.8b.
BV/Sh (INR) 20.6 17.8 17.6 16.9
PAT is expected to grow 13% YoY to INR8.9b. Maintain Buy.
RoE (%) 18.8 20.1 18.6 17.8
RoCE (%) 86.1 112.4 124.8 133.9
Valuations
P/E (x) 25.4 20.8 18.9 17.7
Key issues to watch
P/BV (x) 5.2 3.7 3.3 3.0
Revenue growth: Key orders (Akash missile, intake of INR67b in
EV/EBITDA (x) 20.2 12.7 12.1 11.2
FY11-12) are currently under execution for Army and Air Force.
Operating at 60% capacity utilization; possibility of strong operating
leverage.
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18
1QE 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales 8,714 17,031 20,421 39,877 17,248 24,762 25,128 45,228 86,119 112,367
Change (%) -20.8 15.9 34.3 23.7 97.9 45.4 23.1 13.4 17.5 30.5
EBITDA (467) 3,384 4,828 9,797 1,633 5,950 4,452 11,837 17,617 23,872
Change (%) -699 87 74 8 -450 76 -8 21 28 36
As of % Sales -5.4 19.9 23.6 24.6 9.5 24.0 17.7 26.2 20.5 21.2
Depreciation 435 455 455 571 561 590 594 422 1,915 2,166
Interest 0 3 106 9 3 0 0 0 118 3
Other Income 1,387 1,714 776 909 723 510 492 675 4,710 2,400
PBT 486 4,641 5,043 10,125 1,793 5,870 4,350 12,090 20,294 24,103
Tax 125 1178 1307 2208 540 1746 1322 3141 4818 6749
Effective Tax Rate (%) 25.7 25.4 25.9 21.8 30.1 29.7 30.4 26.0 23.7 28.0
Reported PAT 361 3,463 3,735 7,918 1,253 4,124 3,028 8,949 15,476 17,354
Change (%) -52.9 68.2 33.3 6.3 247.2 19.1 -18.9 13.0 18.4 12.1
Adj PAT 361 3,463 3,735 7,918 1,253 4,124 3,028 8,949 15,476 17,354
Change (%) -52.9 68.2 33.3 6.3 247.2 19.1 -18.9 13.0 18.4 12.1
April 2018 90
March 2018 Results Preview | Sector: Capital Goods
BHEL
Bloomberg BHEL IN CMP: INR85 TP: INR80 (-6%) Sell
Equity Shares (m) 3671.4
We expect muted revenue growth of 10% YoY, led by lower
M. Cap. (INR b)/(USD b) 314 / 5
52-Week Range (INR) 122 / 80
availability of orders for execution.
1,6,12 Rel Perf. (%) -4 / -3 / -35
We expect gross margin to decline 375bp YoY to 41.5%, led by
adverse revenue mix.
Despite gross margin compression, operating profit is likely to
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E register strong growth of 89% YoY to INR12.3b, as 4QFY17 had
Net Sales 282.2 291.0 319.4 361.9 provision of INR9.6b related to employee expenses.
EBITDA 8.3 13.4 18.5 24.0 We estimate net profit at INR8.1b, as against profit of INR2.2b in
PAT 4.9 11.6 13.2 15.8 4QFY17.
EPS (INR) 1.3 3.2 3.6 4.3 During the quarter, BHEL has secured orders worth INR7.4b for
EPS Gr. (%) -169.3 135.9 14.2 14.2 nuclear steam generators.
BV/Sh. INR 88.0 89.0 90.1 91.5 It has also bagged an order for setting up a 2,400MW supercritical
RoE (%) 1.5 3.6 4.0 4.7 thermal power project in Jharkhand worth INR117b.
RoCE (%) 0.7 2.6 3.0 3.9 BHEL is L1 in 5.2GW of orders. Maintain Sell.
Payout (%) 59.8 59.8 59.8 59.8
Valuations
P/E (x) 63.8 27.1 23.7 19.8 Key issues to watch
P/BV (x) 1.0 1.0 0.9 0.9 Continued constraints on execution due to operational issues.
EV/EBITDA (x) 25.4 14.8 12.1 10.2 Trends in provisions, particularly for liquidated damages on
Div Yield (%) 0.9 2.2 2.5 3.0 project completion.
* Consolidated
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales (Net) 56,118 66,645 63,210 96,882 55,056 62,971 66,264 106,712 282,222 291,002
Change (%) 28.7 12.2 18.7 -2.9 -1.9 -5.5 4.8 10.1 10.8 3.1
EBITDA 710 1,551 2,239 6,509 -883 -954 2,954 12,290 8,270 13,407
Change (%) -133.9 -135.4 -113.9 -24.9 -224.3 -161.5 32.0 88.8 -160.5 62.1
As a % Sales 1.3 2.3 3.5 6.7 -1.6 -1.5 4.5 11.5 2.9 4.6
Interest 57 50 263 3,136 657 552 610 1,180 3,506 3,000
Depreciation 2,182 2,080 2,088 2,139 2,001 1,872 1,820 1,858 8,488 7,552
Other Income 2,493 1,961 1,358 1,452 4,622 4,850 1,375 1,760 3,189 5,262
PBT 965 1,382 1,246 2,686 1,080 1,473 1,898 44,496 6,237 15,462
Tax 188 292 310 530 272 318 367 2,909 1,320 3,866
Effective Tax Rate (%) 19.4 21.1 24.9 19.7 25.2 21.6 19.3 6.5 21.2 25.0
Reported PAT 778 1,090 935 2,156 808 1,154 1,532 8,102 4,917 11,597
Change (%) 129.5 -160.3 -108.6 -57.4 3.9 5.9 63.8 275.9 -169.3 135.9
Adj. PAT 778 1,090 935 2,156 808 1,154 1,532 8,102 4,917 11,597
Change (%) 129.5 -160.3 -108.6 -57.4 3.9 5.9 63.8 275.9 -169.3 135.9
April 2018 91
March 2018 Results Preview | Sector: Capital Goods
Blue Star
Bloomberg BLSTR IN CMP: INR795 TP: INR780 (-2%) Neutral
Equity Shares (m) 95.6
Unitary cooling division (UCP) is likely to report revenue growth of
M. Cap. (INR b)/(USD b) 76 / 1
3% YoY; however, on a like-to-like basis, we expect growth of
52-Week Range (INR) 845 / 587
1,6,12 Rel Perf. (%) 7 / -3 / 1
18%, given pickup in summer and price hike taken by the
company post implementation of new norms.
We expect revenue growth of 13% YoY in the MEP segment, given
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
pickup in execution of orders in hand post contract renegotiation,
Net Sales 44.0 47.8 57.5 65.4 which happened on account of GST implementation.
EBITDA 2.4 3.0 3.9 4.8 Operating margin is expected to expand 160bp YoY to 7.1%, led
Adj. PAT 1.2 1.6 2.3 3.0 by better margins in the MEP segment (+90bp YoY). Operating
EPS(INR) -6.0 36.0 48.2 26.9 profit is expected to grow 41% YoY.
EPS Gr. (%) 79.2 83.6 90.0 98.2 Volatile crude prices have raised apprehensions over the pace of
BV/Sh. (INR) 14.8 18.5 26.5 32.1 order awards and execution in the Middle East. Even in the
RoE (%) 61.5 61.5 61.5 61.5 domestic market, new project awards remain constrained.
RoCE (%) 44.0 47.8 57.5 65.4 Maintain Neutral.
Payout (%) 2.4 3.0 3.9 4.8
Valuations Key issues to watch
P/E (x) 62.3 47.9 32.3 25.5
Impact of implementation of new efficiency norms on Blue
P/BV (x) 9.6 9.5 8.8 8.1
Star’s market share and sales.
EV/EBITDA (x) 31.3 25.3 19.1 15.6
Sustainability of profitability and capital employed in MEP
Div Yield (%) 1.0 1.3 1.9 2.4
business.
*Consolidated
April 2018 92
March 2018 Results Preview | Sector: Capital Goods
April 2018 93
March 2018 Results Preview | Sector: Capital Goods
Crompton
Bloomberg CROMPTON IN CMP: INR231 TP: INR305 (+32%) Buy
Equity Shares (m) 626.8
We expect sales to register growth of 8% YoY, driven by 16%
M. Cap. (INR b)/(USD b) 145 / 2
growth in the lighting segment.
52-Week Range (INR) 295 / 200
1,6,12 Rel Perf. (%) 1 / 0 / -9
We expect operating profit of INR1.6b in 3QFY18, an improvement
of 16% YoY, and 90bp expansion in EBITDA margin to 13.8%.
Net profit is expected to be INR1b in 4QFY18 as against INR885m in
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
4QFY17, implying a growth of 20.7%. Maintain Buy.
Net Sales 39.8 41.4 46.6 52.6
EBITDA 4.9 5.3 6.4 7.3
Adj. PAT 2.9 3.2 4.1 4.8
EPS (INR) 4.7 5.1 6.5 7.7
EPS Gr. (%) 146.1 8.9 27.1 18.4 Key issues to watch
BV/Sh. (INR) 8.6 11.7 14.3 17.3 Details of segmental sales, as CROMPTON intends to improve
RoE (%) 76.4 50.2 49.9 48.5
sales of its premium category products.
RoCE (%) 32.5 28.4 30.8 34.5
Ad spends incurred by the company during the quarter, as
Payout (%) 32.7 33.0 50.0 50.0
CROMPTON intends to position itself as an electrical consumer
Valuations
durables brand as against its current positioning as a fans brand.
P/E (x) 49.6 45.5 35.8 30.3
P/BV (x) 27.0 19.9 16.3 13.4
EV/EBITDA (x) 30.8 28.3 23.0 20.0
Div Yield (%) 0.7 0.7 1.4 1.7
* Consolidated
April 2018 94
March 2018 Results Preview | Sector: Capital Goods
Cummins India
Bloomberg KKC IN CMP: INR740 TP: INR1,040 (+41%) Buy
Equity Shares (m) 277.2
We expect revenue to increase 3% YoY, supported by growth in the
M. Cap. (INR b)/(USD b) 205 / 3
power generation (9% YoY) and distribution & spares (10% YoY)
52-Week Range (INR) 1096 / 671
1,6,12 Rel Perf. (%) -6 / -26 / -35
segments. The industrial segment is expected to register 13% YoY
growth, led by pick-up in demand from infrastructure side.
Pickup in the domestic demand environment and various pricing
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
actions taken by KKC would help strengthen its market leadership
Net Sales 50.8 50.5 59.6 68.8 position in the MHP and HHP segments.
EBITDA 8.0 7.3 10.0 12.0 Domestic revenue should grow 7% YoY in 4QFY18.
Adj. PAT 7.3 6.4 8.6 10.2 We expect export revenue to register 2% growth on YoY basis to
EPS (INR) 26.5 23.0 31.0 36.8 INR3b in 4QFY18, given weak demand in the export market.
EPS Gr. (%) -2.6 -13.2 34.7 18.6 EBITDA margin is expected to improve 100bp YoY to 15.4%; net
BV/Sh. (INR) 135.0 143.9 155.8 170.0 profit is expected to register growth of 6% YoY to INR1.7b.
RoE (%) 21.2 16.5 20.7 22.6 Maintain Buy.
RoCE (%) 20.0 15.8 19.8 21.7
Payout (%) 52.8 52.8 52.8 52.8
Valuations
Key issues to watch
P/E (x) 27.9 32.2 23.9 20.1 Performance of the exports segment, considering poor demand
P/BV (x) 5.5 5.1 4.7 4.4 conditions in LatAm, Europe and China.
EV/EBITDA (x) 25.7 28.1 20.4 16.8
Div Yield (%) 1.9 1.6 2.2 2.6
April 2018 95
March 2018 Results Preview | Sector: Capital Goods
Engineers India
Bloomberg ENGR IN CMP: INR164 TP: INR200 (+22%) Buy
Equity Shares (m) 673.9
We expect revenue to increase 18% YoY, supported by growth in
M. Cap. (INR b)/(USD b) 110 / 2
turnkey segment execution (24% YoY) and expect consultancy and
52-Week Range (INR) 206 / 141
1,6,12 Rel Perf. (%) -3 / 5 / 2
engineering projects to register 16% growth.
Despite strong revenue growth, we expect operating profit to
decline 26% YoY, as consultancy and engineering projects segment
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
as well as turnkey project segment included provision write-back of
Net Sales 14.5 18.0 23.8 28.3 INR570m in 4QFY17, leading to margin expansion in both
EBITDA 3.0 4.6 5.0 6.1 segments. We expect margins to normalize in 4QFY18.
Adj. PAT 2.9 4.0 4.3 5.2 We expect net profit to decline 43% YoY to INR890m, led by
EPS (INR) 4.3 6.3 6.9 8.2 normalized tax rate assumed for 4QFY18 (34% as against 19% in
EPS Gr. (%) 3.8 48.1 9.2 19.8 4QFY17). Maintain Buy.
BV/Sh. (INR) 41.2 44.0 47.5 51.7
RoE (%) 10.4 13.9 14.1 15.6
RoCE (%) 10.4 13.9 14.1 15.6
Payout (%) 46.4 46.4 46.4 46.4
Valuations
Key issues to watch
P/E (x) 37.6 25.4 23.3 19.4 Performance of the turnkey project segment, which has seen
P/BV (x) 3.9 3.6 3.4 3.1 margin volatility in the recent past.
EV/EBITDA (x) 28.0 16.4 14.7 11.5
Div Yield (%) 0.9 1.6 1.7 2.1
April 2018 96
March 2018 Results Preview | Sector: Capital Goods
GE T&D
Bloomberg GETD IN CMP: INR400 TP: INR430 (8%) Neutral
Equity Shares (m) 256.1
We expect GETD to register revenue growth of 11% YoY to
M. Cap. (INR b)/(USD b) 102 / 2
INR13.3b in 4QFY18. Revenue growth would be driven by
52-Week Range (INR) 473 / 318
1,6,12 Rel Perf. (%) -2 / -2 / 6
execution of the Champa-Kurukshetra pole 3/4 project, which is
expected to be commissioned by FY18.
We expect operating profit of INR1b in 4QFY18, as against
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
INR722m in 4QFY17. Gross margin is likely to improve 90bp to
Net Sales 40.5 48.5 49.5 52.5 28.3% from 27.4% in 4QFY17.
EBITDA 2.2 4.2 4.8 5.2 GETD is expected to book net profit of INR534m as against
Adj. PAT 1.5 2.6 2.9 3.3 INR443m in 4QFY17. Maintain Neutral.
EPS (INR) 5.7 10.3 11.3 12.9
EPS Gr. (%) 325.3 79.8 9.7 14.2
BV/Sh. (INR) 40.3 47.2 54.2 62.3
RoE (%) 12.4 23.5 22.3 22.1
RoCE (%) 15.7 28.6 29.2 30.1
Payout (%) 31.4 31.4 31.4 31.4
Valuations
Key issues to watch
P/E (x) 70.3 39.1 35.7 31.2
Progress in the Champa-Kurukshetra project.
P/BV (x) 10.0 8.5 7.4 6.5
EV/EBITDA (x) 48.3 24.3 20.8 18.7
EV/ Sales (x) 2.7 2.1 2.0 1.9
Div Yield (%) 0.4 0.9 0.9 1.0
Quarterly Performance
FY17 FY18E FY17 FY18
Y/E March 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales 8,546 8,350 11,652 11,963 12,093 8,700 14,386 13,275 40,521 48,453
Change (%) 11.6 -4.3 63.2 26.9 41.5 4.2 23.5 11.0 22.7 19.6
EBITDA 21 349 751 1,097 1,055 805 728 1,599 2,230 4,187
Change (%) -70.3 -48.7 -241.2 81.7 4,875.9 130.6 -3.0 45.7 -9.0 -9.0
As of % Sales 0.2 4.2 6.4 9.2 8.7 9.3 5.1 12.0 5.5 8.6
Depreciation 217 220 221 224 224 228 218 172 873 873
Interest 226 240 343 344 278 225 238 240 589 589
Other Income 326 425 493 177 421 344 630 362 427 427
PBT -2,425 314 679 705 974 695 1,099 1,550 1,195 3,152
Tax -455 109 236 244 358 220 381 525 508 508
Effective Tax Rate (%) 18.8 34.7 34.7 34.6 36.8 31.6 34.7 33.8 42.5 16.1
Reported PAT -1,970 205 443 461 616 475 718 1,026 687 2,644
Change (%) -2,041.0 -43.2 -215.4 70.9 -131.3 131.6 62.0 122.4 0.0 0.0
Adj PAT 360 205 443 461 616 475 521 1,026 687 2,644
Change (%) 254.6 -43.2 -215.4 70.9 71.1 131.6 17.6 122.4 2.0 2.0
April 2018 97
March 2018 Results Preview | Sector: Capital Goods
Havells India
Bloomberg HAVL IN CMP: INR509 TP: INR630 (+24%) Buy
Equity Shares (m) 625.0
Standalone revenue is expected to register growth of 45% YoY,
M. Cap. (INR b)/(USD b) 318 / 5
driven by revenue contribution from recently-acquired Lloyd
52-Week Range (INR) 593 / 434
1,6,12 Rel Perf. (%)
(INR5.7b). We expect the cables segment to register 7% YoY
2 / -3 / -3
growth, led by an improvement in the prices of copper. Lighting
segment is expected to register 13% growth, whereas electrical
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
consumer durables segment is expected to register 8% growth.
Net Sales We expect operating margin to decline 90bp YoY to 12.5% on
61.4 80.8 97.6 113.5
EBITDA 8.2 10.3 13.1 16.0
account of increased contribution from low-margin Lloyd business.
Adj. PAT 6.0 7.0 8.5 10.6
Net profit is expected to register 20% growth YoY to INR2.1b.
Adj. EPS (INR) 9.6 11.1 13.7 17.0 Maintain Buy.
EPS Gr. (%) 17.1 16.5 22.8 24.1
BV/Sh(INR) 52.4 58.8 66.6 76.3
RoE (%) 18.2 18.9 20.5 22.2
RoCE (%) 18.2 19.1 21.1 23.2
Payout (%) 42.8 42.8 42.8 42.8
Valuations
Key issues to watch
P/E (x) Commentary on progress of integration of the consumer durables
53.1 45.6 37.1 29.9
P/BV (x) arm of Lloyd Electric with itself.
9.7 8.6 7.6 6.7
EV/EBITDA (x) 35.9 30.1 23.2 18.6
Commentary on demand scenario across product categories.
Div Yield (%) 0.7 0.8 1.0 1.2
April 2018 98
March 2018 Results Preview | Sector: Capital Goods
April 2018 99
March 2018 Results Preview | Sector: Capital Goods
Siemens
Bloomberg SIEM IN CMP: INR1,124 TP: INR1,285 (+14%) Neutral
Equity Shares (m) 356.1
We expect SIEM to register 28% YoY revenue growth during the
M. Cap. (INR b)/(USD b) 400 / 6
quarter to INR37.4b, led by strong performance by the power & gas
52-Week Range (INR) 1470 / 1065
1,6,12 Rel Perf. (%) -1 / -12 / -25
and energy management segments.
Operating margin is expected to improve by 130bp YoY to 10.8%,
and operating profit is expected to register 45% YoY growth.
Financial Snapshot (INR b)
Y/E September 2017 2018E 2019E 2020E
Net profit is expected to register 60% growth YoY to INR2.9b, led
Net Sales 110.1 138.4 143.2 159.7 by higher other income. Maintain Neutral.
EBITDA 10.5 15.1 17.1 18.8
Adj. PAT 7.0 10.8 12.3 13.8
Adj. EPS (INR) 19.8 30.4 34.6 38.8
EPS Gr (%) 10.9 53.8 13.8 12.3
BV/Sh. (INR) 216.4 235.8 257.9 282.7
RoE (%) 9.1 12.9 13.4 13.7
RoCE (%) 14.0 19.1 19.9 14.4
Payout (%) 40.9 44.0 30.0 30.0
Key issues to watch
Valuations
Raw material imports account for 55% of raw material cost;
P/E (x) 56.9 37.0 32.5 29.0
Siemens AG’s network comprises 82% of imports; INR
P/BV (x) 5.2 4.8 4.4 4.0
depreciation of 11% YoY v/s EUR could have a negative impact on
EV/EBITDA (x) 34.2 23.4 20.3 18.1
the margin profile.
Div. Yield (%) 0.8 0.8 0.9 1.0
Thermax
Bloomberg TMX IN CMP: INR1,136 TP: INR1,350 (+19%) Buy
Equity Shares (m) 112.6
During the quarter, Thermax bagged an INR5b order from a
M. Cap. (INR b)/(USD b) 128 / 2
fertilizer company for three natural gas-based co-generation
52-Week Range (INR) 1375 / 835
1,6,12 Rel Perf. (%) -4 / 16 / 5
plants of 20MW each.
Revenue is likely to grow 24% YoY, supported by execution pick-
up in the energy segment (+30% YoY) and an improvement in
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
orders available for execution. Operating margin is expected to
Net Sales 44.8 49.6 57.2 71.0 improve by 50bp to 12%.
EBITDA 4.3 4.8 6.1 7.7 Ordering activity remains muted in a weak macro environment.
Adj. PAT 3.1 3.2 4.0 4.9 We believe ordering activity has remained at the base level, with
EPS (INR) 27.2 28.0 35.1 43.5 Thermax announcing a single project worth INR5b. Maintain Buy.
EPS Gr. (%) 8.5 3.1 25.3 23.9
BV/Sh. (INR) 225.4 245.7 272.3 306.5
RoE (%) 12.6 11.9 13.6 15.0
RoCE (%) 11.3 12.1 13.5 14.8
Payout (%) 30.3 23.5 20.7 18.3
Valuations Key issues to watch
P/E (X) 41.8 40.5 32.3 26.1 Demand environment in domestic and overseas markets.
P/BV (X) 5.0 4.6 4.2 3.7
Sustainability of margins in the chemical (17.3%) and
EV/EBITDA (X) 29.3 26.3 20.4 16.1
environment (8.1%) segments.
Div Yield (%) 0.5 0.6 0.6 0.7
Thermax Consolidated
FY17 FY18E FY17 FY18E
Y/E March 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales 9,791 10,703 9,440 14,905 8,718 10,331 11,170 18,412 44,831 49,641
Change (%) -20.4 -15.4 -22.6 -0.2 -11.0 -3.5 18.3 23.5 -18.5
EBITDA 804 919 875 1,732 721 952 955 2,220 4,330 4,848
Change (%) -21.2 -16.8 3.6 30.9 -10.3 3.6 9.1 28.2 -3.4 12.0
As of % Sales 8.2 8.6 9.3 11.6 8.3 9.2 8.5 12.1 9.7 9.8
Depreciation 194 199 197 229 189 189 208 194 819 779
Interest 32 24 17 25 16 51 25 8 97 100
Other Income 231 361 252 297 241 236 238 361 1,141 1,076
PBT 809 1,057 913 1,775 757 947 961 2,379 4,554 5,044
Tax 277 350 335 598 284 370 378 784 1,560 1,816
Effective Tax Rate (%) 34.3 33.1 36.7 33.7 37.5 39.0 39.3 33.0 34.3 36.0
Reported PAT 532 708 578 1,177 473 578 583 1,594 2,230 3,158
Change (%) (26.4) (4.8) (5.5) 1.9 (11.1) (18.3) 0.9 35.5 (20.6) 41.6
Adj PAT 490 783 536 615 406 568 586 1,598 3,063 3,158
Change (%) (10.4) 32.4 (1.2) (46.2) (17.0) (27.4) 9.3 159.8 8.5 3.1
Voltas
Bloomberg VOLT IN CMP: INR648 TP: INR665 (+2%) Neutral
Equity Shares (m) 330.8
Unitary cooling division (UCP) is likely to report revenue growth of
M. Cap. (INR b)/(USD b) 214 / 3
15% YoY, led by pickup in summer and price hike taken by the
52-Week Range (INR) 675 / 401
1,6,12 Rel Perf. (%) 7 / 18 / 45
company post implementation of new energy efficiency norms.
We expect revenue growth of 12% YoY in the MEP segment,
supported by favorable base in 4QFY17. The key monitorable
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
would be sustainability of margins in the segment. VOLT had
Net Sales 60.3 67.1 78.1 89.5 booked EBIT margin of 7.1% in 3QFY18 on execution of better
EBITDA 5.8 7.1 8.4 9.6 margin orders and pickup in execution of domestic orders.
Adj. PAT 5.1 6.0 7.1 8.0 Volatile crude prices have raised apprehensions over the pace of
EPS(INR) 15.5 18.0 21.3 24.3 order awards and also execution in the Middle East. Even in the
EPS Gr. (%) 100.0 113.2 129.0 146.9 domestic market, new project awards remain constrained.
BV/Sh. (INR) 18.0 16.9 17.6 17.6 Maintain Neutral.
RoE (%) 16.5 16.2 16.9 17.0
RoCE (%) 26.2 26.2 26.2 26.2
Payout (%) 60.3 67.1 78.1 89.5 Key issues to watch
Valuations Impact of implementation of new energy norms on VOLT’s
P/E (x) 42.0 36.0 30.4 26.7 market share and sales.
P/BV (x) 6.5 5.7 5.0 4.4 Sustainability of profitability in MEP segment and also execution
EV/EBITDA (x) 36.7 29.4 24.4 21.0 of international orders (50% of orders are from Qatar).
Div Yield (%) 0.5 0.6 0.7 0.8
*Consolidated
Technology
Cement
Affordable housing, infrastructure to drive healthy demand
Company name
Margins under pressure due to cost push
ACC
Ambuja Cements Volume growth led by affordable housing and infrastructure segments
Birla Corporation We expect companies under our coverage to report volume growth of ~8% YoY in
Dalmia Cement
4QFY18, adjusting for the acquisition impact on UltraTech. All India demand
continues to be healthy, led by pickup in infrastructure, affordable housing, and
Grasim Industries
rural housing in select regions. On a YoY basis, demand is picking up in South,
India Cements Central and East India.
Sanghi Industries
Shree Cement Demand growth in the South is strong, led by Andhra Pradesh and Telangana.
Ramco Cement
Demand growth in the East remains healthy, led by housing and infrastructure
segments. Central India has also seen strong demand improvement, led by revival of
UltraTech Cement
sand mining. Demand in the North is moderate due to the impact of sand mining
ban in Rajasthan. However, players have benefitted due to ramp-down of Binani’s
assets to less than 50% utilization. Demand growth in the West has been healthy
due to pick up in infrastructure projects and favorable base.
We expect the MOSL Cement universe to record volume growth of ~8% YoY in
4QFY18, adjusted for the acquisition impact on UltraTech. We expect (a) pan-India
players to report volume growth of 7% YoY, (b) North based players like SRCM to
report 8%YoY increase in volumes, and (c) South-based (DBEL, TRCL and ICEM)
companies to post 9-14% volume growth.
have increased 13% YoY and ~3% QoQ, which should translate into higher freight
cost. EBITDA/ton is likely to be lower by INR22 QoQ for our coverage companies, as
the impact of weaker realizations and cost push has been offset by the impact of
positive operating leverage.
Top picks: Shree Cement, Ramco Cement, Birla Corp and Dalmia Cement
Shree Cement’s superior execution capabilities would enable it to achieve RoIC of
over 50% (FY19E), while its gross block to capacity has been structurally trending
downward. Ramco Cement is likely to generate strong operating cash flow, which
would be used to raise grinding capacity by ~16% over FY17-20. We estimate 8%
EBITDA CAGR and 11% PBT CAGR over FY17-20. Birla Corp is likely to be profitable
due to the strong performance of the acquired subsidiary, Reliance Cement. With a
23% market share in the Satna cluster and Reliance Cement’s mineral concession, it
has the potential to expand to multiple states. We believe Dalmia Cement’s
deleveraging play and superior volume growth make it attractive for re-rating.
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
278
291
281
278
283
287
291
277
274
275
321
323
304
299
292
305
313
304
301
311
297
304
290
287
288
North Average Prices East Average Prices West Average Prices South Average Prices Central Average Prices National Average
Prices
Source: Company, MOSL
Exhibit 2: Diesel prices up 13%YoY in 4QFY18 Exhibit 3: Petcoke prices increased 31% YoY in 4QFY18
Diesel price (INR/ltr) YoY growth in Diesel prices Retail petcoke prices (INR/tonne)
29% 67%
44% 51%
20%
13% 25% 31%
12%
8% 11% 11% 17%
4% 3%
-21%
49.3
47.1
46.0
45.6
51.5
52.8
55.0
58.8
55.9
58.8
61.4
66.3
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Source: Company, MOSL Source: Company, MOSL
Exhibit 4: MOSL coverage realization declined ~1%QoQ in Exhibit 5: Profitability to decrease 3%QoQ, led by lower
4QFY18 realizations
1,009
783
820
790
490
567
738
783
694
584
854
712
717
714
840
971
880
781
774
877
753
731
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Exhibit 6: Relative performance—3 months (%) Exhibit 7: Relative performance—1 year (%)
Sensex Index MOSL Cement Index Sensex Index MOSL Cement Index
143
109
103 131
97 119
91 107
85 95
Dec-17
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
ACC
Bloomberg ACC IN CMP: INR1,551 TP: INR1,710 (10%) Neutral
Equity Shares (m) 188.0
We expect dispatches to grow 7% YoY to 7.06mt in 1QCY18, led by
M. Cap. (INR b)/(USD b) 291 / 4
52-Week Range (INR)
capacity ramp-up of eastern units. Average realizations are
1869 / 1450 1,450
1,6,12 Rel Perf. (%)
expected to decline by ~1% QoQ to INR4,452/ton due to pricing
-3 / -12 / -5
drop in underlying markets.
Revenues are expected to increase ~12% YoY to INR34.6b. EBITDA
Financial Snapshot (INR Billion)
Y/E Dec 2016 2017 2018E 2019E
margin is expected to be 9.7%, flat QoQ (-1.3pp YoY).
Sales 108 129 144 162 EBITDA/ton is estimated at INR476 (-INR42 YoY, flat QoQ) due to
EBITDA 13 15 18 21 6% YoY increase in cost partially offset by 4% YoY increase in
NP 7 9 12 14 realization. PAT is likely to increase marginally by 1.5% YoY to
Adj. EPS (INR) 36 47 64 74 INR2.1b.
EPS Gr. (%) -4 31 35 16 The stock trades at a P/E of 24x (CY18E) and 21x (CY19E),
BV/Sh (INR) 461 479 507 497 EV/EBITDA of 14x (CY18E) and 11x (CY19E), and EV/ton of USD110
RoE (%) 8 10 13 15 (CY18E) and USD107 (CY19E). Maintain Neutral.
RoCE (%) 8 10 13 14
Payout (%) 88 62 57 114
Valuations
Key issues to watch out for
P/E (x) 43 33 24 21 Cement pricing recovery.
P/BV (x) 3 3 3 3 Volume growth and demand revival.
EV/EBITDA (x) 21 17 14 11 Ramp-up of new plant in the East.
EV/Ton (x) 121 117 110 107
Ambuja Cements
Bloomberg ACEM IN CMP: INR241 TP: INR264 (+10%) Neutral
Equity Shares (m) 1985.7
We expect dispatches to grow 5% YoY to 6.3mt in 1QCY18, led by
M. Cap. (INR b)/(USD b) 478 / 7
volume growth in underlying markets. Average realizations are
52-Week Range (INR) 291 / 224
1,6,12 Rel Perf. (%)
expected to decline 1% QoQ to INR4,525/ton due to sequentially
-3 / -16 / -10
weak pricing in underlying markets. Revenue is likely to grow 13%
YoY (and 7% QoQ) to INR28.6b.
Financial Snapshot (INR Billion)
Y/E DEC 2016 2017 2018E 2019E
EBITDA margin is expected to be 18% (-0.9pp QoQ, +3.67pp YoY).
Sales 91.6 104.5 119.0 137.9
EBITDA/ton is estimated at INR818 (-INR46 QoQ, +INR212 YoY).
EBITDA 15.8 19.0 24.3 34.1
Adjusted PAT is estimated to increase 19.5% YoY to INR2.9b.
NP 9.7 12.0 16.1 25.2
The stock trades at a P/E of 20x (CY18E) and 12.8x (CY19E),
Adj. EPS (INR) 4.9 6.0 8.1 12.7
EV/EBITDA of 11.6x (CY18E) and 7.6x (CY19E), and EV/ton of
EPS Gr. (%) -10.6 29.5 34.2 56.8 USD142 (CY18E) and USD131 (CY19E). Maintain Buy.
BV/Sh. (INR) 96.4 101.1 106.8 119.0
RoE (%) 5.1 6.1 7.8 11.2
RoCE (%) 6.9 6.5 8.3 11.5
Payout (%) 29.6 26.0 28.9 3.5 Key issues to watch out for
Valuations Volume growth recovery and outlook.
P/E (x) 34.8 26.9 20.0 12.8 Cement pricing outlook and sustainability.
P/BV (x) 1.7 1.6 1.5 1.4 Cost curve trend in CY18.
EV/EBITDA (x) 18.0 15.3 11.6 7.6
EV/Ton (USD) 154 147 142 131
Birla Corporation
Bloomberg BCORP IN CMP: INR 764 TP: INR1,004 (+31%) Buy
Equity Shares (m) 77.0
4QFY18 consolidated cement volumes are estimated to increase
M. Cap. (INR b)/(USD m) 59 / 1
6% YoY to 3.5mt, led by ramp-up of reliance assets. Realizations
52-Week Range (INR) 1290 / 685
1,6,12 Rel Perf. (%)
are estimated to increase by 1% QoQ to INR4,631/ton, led by
-14 / -22 / -9
better prices in the central region.
We estimate consolidated cement EBITDA/ton at INR457 (flat
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
QoQ). EBITDA margin is expected to decline by 5.8pp YoY (flat
Sales 43.5 56.0 63.4 68.3
QoQ) to 10.5%.
EBITDA 6.2 7.4 10.4 11.6
Consolidated EBITDA is likely to increase 15% QoQ (but decline
NP 2.2 0.6 3.3 3.9
32% YoY) to INR1.6b. We expect the company to report a loss of
Adj. EPS (INR) 28.5 7.4 42.3 50.5
INR38m in 4QFY18 as against a profit of INR1b in 4QFY17.
EPS Gr. (%) 27.9 -74.0 470.3 19.2 The stock trades at a P/E of 18.1x (FY19E) and 15.1x (FY20E),
BV/Share (INR) 429 426 457 496 EV/EBITDA of 8.4x (FY19E) and 6.9x (FY20E), and EV/ton of USD83
RoE (%) 7.1 1.7 9.6 10.6 (FY19E) and USD77 (FY20E). Maintain Buy.
RoCE (%) 8.0 5.2 7.6 7.8
Payout (%) 40.8 160.0 27.4 23.0
Key issues to watch out for
Valuation
Volume growth recovery and outlook.
P/E (x) 26.8 103.0 18.1 15.1
Cement pricing outlook and sustainability.
P/BV (x) 1.8 1.8 1.7 1.5
Update on profitability of acquired subsidiary of Reliance.
EV/EBITDA (x) 14.9 12.8 8.4 6.9
EV/Ton (USD) 89 90 83 77
Dalmia Cement
Bloomberg DBEL IN CMP: INR2,867 TP: INR3,300(+15%) Buy
Equity Shares (m) 88.8
4QFY18 cement volumes are estimated to increase ~14% YoY to
M. Cap. (INR b)/(USD b) 255 / 4
5.17mt, led by growth in the South and the East. Realizations are
52-Week Range (INR) 3349 / 1965
1,6,12 Rel Perf. (%)
estimated to decline ~2.6% QoQ to INR4,907/ton, led by weaker
7 / 0 / 34
prices in the South, partially offset by healthy prices in the East.
Financial Snapshot (INR Billion)
We estimate cement EBITDA/ton at INR989 (-INR106/ton QoQ)
Y/E March 2017 2018E 2019E 2020E due to decline in realization. EBITDA margin is expected to decline
Sales 74.0 85.1 96.7 109.4 5.1pp YoY and 1.6pp QoQ to 20.2%.
EBITDA 19.0 19.6 22.2 25.7 EBITDA is estimated to decrease 7% YoY to INR5.12b, translating
NP 3.4 4.6 6.5 9.1 into adjusted PAT decline of 3% YoY to INR1.7b.
Adj. EPS(INR) 38.8 52.0 72.9 102.2 The stock trades at a P/E of 39.3x (FY19E) and 28.1x (FY20E),
EPS Gr. (%) 81.2 34.0 40.3 40.1 EV/EBITDA of 13.9x (FY19E) and 11.6x (FY20E), and EV/ton of
BV/Sh (INR) 558 608 677 775 USD180 (FY19E) and USD174 (FY20E). Maintain Buy.
RoE (%) 7.2 8.9 11.3 14.1
RoCE (%) 7.3 8.0 9.4 11.0
Payout (%) 6.0 4.5 4.8 4.5
Valuation Key issues to watch out for
P/E (x) 74.0 55.2 39.3 28.1 Volume growth recovery and outlook.
P/BV (x) 5.1 4.7 4.2 3.7 Cement pricing outlook and sustainability.
EV/EBITDA (x) 17.5 16.1 13.8 11.6 Update on restructuring timelines.
EV/Ton (USD) 176 184 180 174
Grasim Industries
Bloomberg GRASIM IN CMP: INR1,086 TP: INR1,187(+9%) Neutral
Equity Shares (m) 657.3
VSF margins are likely to be stable, led by firm VSF prices globally.
M. Cap. (INR b)/(USD b) 714 / 11
52-Week Range (INR) 1300 / 872
Margins for the chemical business are likely to be stable due to
1,6,12 Rel Perf. (%) -5 / -12 / 12 shutdown of capacities globally.
Standalone EBITDA should remain stable at INR8.7b.
Financial Snapshot (INR Billion) We estimate adjusted PAT at INR5.02b (+7% QoQ). Maintain
Y/E March 2017 2018E 2019E 2020E Neutral.
Sales 360.7 461.5 566.3 653.2
EBITDA 73.9 71.3 121.9 145.7
Adj. PAT 31.7 14.4 53.6 65.4
Adj. EPS (INR) 67.8 30.8 114.8 140.0
EPS Gr. (%) 28.3 -54.6 272.6 22.0
BV/Sh. (INR) 672.3 698.1 807.9 942.9
RoE (%) 10.8 4.5 15.2 16.0
RoCE (%) 12.2 6.2 13.0 14.4
Payout (%) 7.8 16.2 4.4 3.6
Key issues to watch out for
Pick-up in cement demand and pricing.
Outlook on VSF business, and strategy to utilize upcoming
capacities globally.
Outlook on chemical business.
India Cements
Bloomberg ICEM IN CMP: INR153 TP: INR148 (-3%) Neutral
Equity Shares (m) 308.2
M. Cap. (INR b)/(USD b) 47 / 1
India Cements’ volumes are expected increase by 9% YoY to 3.16mt
52-Week Range (INR) 226 / 136 in 4QFY18 due to healthy demand from the southern region. We
1,6,12 Rel Perf. (%) 0 / -22 / -18 expect realizations to decrease by 2% QoQ to INR4,365/ton due to
weak prices in the underlying markets of the South. We estimate
Financial Snapshot (INR Billion) revenue at INR13.7b (+3% YoY).
Y/E March 2017 2018E 2019E 2020E EBITDA is estimated at INR1.8b. EBITDA margin is likely to contract
Sales 50.8 51.5 57.8 65.5 1.3pp YoY and 0.9pp QoQ to 12.8%, translating into blended
EBITDA 8.6 7.1 8.9 10.3 EBITDA/ton of INR560 (-INR53 QoQ and –INR 95YoY) led by
NP 1.7 0.9 2.0 2.9 decrease in realization. PAT is expected to be INR238m in
Adj. EPS (INR) 5.6 2.9 6.6 9.4 4QFY18(v/s INR343m in 4QFY17).
EPS Gr. (%) 31.3 -48.5 129.3 41.8 The stock trades at a P/E of 23x (FY19E) and 16.3x (FY20E),
BV/Sh (INR) 165.8 167.6 173.0 181.3 EV/EBITDA of 8.5x (FY19E) and 7.1x (FY20E), and EV/ton of USD71
RoE (%) 3.4 1.7 3.9 5.3 (FY19E) and USD69 (FY20E). Maintain Neutral.
RoCE (%) 5.1 4.4 5.5 6.6
Payout (%) 20.7 40.1 17.5 12.3
Valuations Key issues to watch out for
P/E (x) 27.2 52.9 23.0 16.3 Visibility on demand recovery in the South.
P/BV (x) 0.9 0.9 0.9 0.8 Demand, especially in Tamil Nadu, after resolution of sand mining
EV/EBITDA(x) 8.9 10.8 8.5 7.1 ban.
EV/Ton (USD) 72 72 71 69 Pricing outlook in South India.
Ramco Cements
Bloomberg TRCL IN CMP: INR756 TP: INR877 (+16%) Buy
Equity Shares (m) 235.6
4QFY18 volumes are estimated to grow 14% YoY to 2.6mt, with
M. Cap. (INR b)/(USD b) 178 / 3
52-Week Range (INR)
growth from underlying markets of the South and East. Average
840 / 649
1,6,12 Rel Perf. (%) realizations are expected to decline by 1.5% QoQ to 4,539/ton due
4/3/0
to weaker prices in the South offset by healthy prices in the East.
EBITDA margin is likely to contract 1.9pp YoY (flat QoQ) to 22%.
Financial Snapshot (INR Billion)
EBITDA/ton (ex-windmill) is estimated at INR1020 ( -INR55YoY,
Y/E MARCH 2017 2018E 2019E 2020E
+INR24 QoQ) due to YoY increase in cost.
Sales 39.3 43.2 48.2 56.6 PAT is estimated to increase 3% YoY to INR1.4b.
EBITDA 11.6 10.6 12.0 14.7 The stock trades at a P/E of 25.5x (FY19E) and 20x (FY20E),
NP 6.5 5.7 7.0 8.9
EV/EBITDA of 14.6x (FY19E) and 11.8x (FY20E), and EV/ton of
Adj. EPS (INR) 27.3 24.0 29.7 37.8
USD165 (FY19E) and USD144 (FY20E). Maintain Buy.
EPS Gr. (%) 24.0 -11.9 23.4
27.6
BV/Sh. (INR) 157.1 178.2 203.2 236.3
RoE (%) 19.0 14.3 15.6 17.2
RoCE (%) 14.0 11.6 13.3 15.6
Payout (%) 12.8 19.3 15.7 12.4
Valuations
Key issues to watch out for
P/E (x) 25.8 31.5 25.5 20.0 Volume growth recovery and outlook.
P/BV (x) 4.5 4.2 3.7 3.2
Cement pricing outlook and demand sustainability in the South
EV/EBITDA (x) 15.1 17.1 14.6 11.8
(AP and Tamil Nadu).
EV/Ton (USD) 162 170 165 144
Sanghi Industries
Bloomberg SNGI IN CMP: INR122 TP: INR157 (+29%) Buy
Equity Shares (m) 251.0
We expect 4QFY18 cement volumes to decline by 4% YoY to 0.74mt
M. Cap. (INR b)/(USD b) 31 / 0
due to lower clinker sale. Realizations are expected to increase 4%
52-Week Range (INR) 144 / 68
1,6,12 Rel Perf. (%)
QoQ to INR4,002/ton due to strong pricing in Gujarat.
6 / 9 / 61
Revenue is estimated at INR2.9b (+21% YoY; +6% QoQ) and EBITDA
at INR714mn (+69%YoY; +16%QoQ), translating into margin of 24%
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
(+7pp YoY; +2pp QoQ), led by realization improvement. Adjusted
Sales 10.0 10.7 13.4 15.5
PAT is likely to be INR400m (+52% YoY; +24% QoQ).
EBITDA 2.0 2.5 3.4 4.1
The stock trades at a P/E of 14.3x (FY19E) and 10.8x (FY20E),
NP 0.6 1.1 2.1 2.8
EV/EBITDA of 8.6x (FY19E) and 6.4x (FY20E), and EV/ton of USD109
Adj. EPS (INR) 2.9 4.6 8.5 11.3
(FY19E) and USD76 (FY20E). Maintain Buy.
EPS Gr. (%) -15.7 59.3 86.0 32.5
BV/Share (INR) 50.6 57.3 67.0 79.8
RoE (%) 5.8 9.7 15.6 17.5
RoCE (%) 7.7 10.4 13.4 13.0
Valuation
Key issues to watch out for
P/E (x) 42.5 26.7 14.3 10.8
Volume and pricing recovery for western region.
P/BV (x) 2.4 2.1 1.8 1.5
Update on expansion projects.
EV/EBITDA (x) 15.6 12.4 8.6 6.4
EV/Ton (USD) 116.8 115.7 109.4 76.6
Shree Cement
Bloomberg SRCM IN CMP: INR16,623 TP: INR19,116(+15%) Buy
Equity Shares (m) 34.8
We expect 4QFY18 cement volumes to grow 8% YoY to 6.4mt, led
M. Cap. (INR b)/(USD b) 579 / 9
52-Week Range (INR)
by healthy growth in eastern markets. Realizations are expected to
20560 / 15600
1,6,12 Rel Perf. (%) 2 / -16 / -14
decline 1.5% QoQ to INR4,058/ton due to weak pricing in the
North.
Financial Snapshot (INR Billion)
Revenue is estimated at INR25.9b (+9% YoY) and EBITDA at INR6b,
Y/E March 2017 2018E 2019E 2020E translating into margin of 23.2% (+1.8pp YoY; flat QoQ) due to YoY
Sales 84.3 96.0 119.5 155.1 increase in realization.
EBITDA 23.7 24.1 29.9 40.2 Merchant power sales are expected to be meaningfully lower due
NP 13.4 12.7 16.5 23.7 to a sharp decline in merchant power rates. We expect power
Adj. EPS (INR) 384.4 365.7 473.5 679.2 EBITDA to be around INR86m.
EPS Gr. (%) 5.4 -4.9 29.5 43.5 SRCM should report an EBITDA/ton of INR931 (-INR73 QoQ), led by
BV/Share (INR) 2,210 2,527 2,952 3,584 weaker QoQ realization and cost push. Adjusted PAT is likely to be
RoE (%) 18.4 15.4 17.3 20.8 INR3.3b (+8% YoY).
RoCE (%) 17.5 14.3 16.4 19.7 The stock trades at a P/E of 35.1x (FY19E) and 24.5x (FY20E),
Payout (%) 43.8 13.2 10.2 7.1 EV/EBITDA of 17.9x (FY19E) and 13.5x (FY20E), and EV/ton of
Valuation USD203 (FY19E) and USD179 (FY20E). Maintain Buy.
P/E (x) 48.7 45.5 35.1 24.5
Key issues to watch out for
P/BV (x) 8.5 6.6 5.6 4.6 Volume and pricing recovery for North India.
EV/EBITDA (x) 26.3 22.7 17.9 13.5 Update on various expansion projects.
EV/Ton (USD) 312 224 203 179 New expansion plans.
UltraTech Cement
Bloomberg UTCEM IN CMP: INR3,949 TP: INR4,799 (+22%) Buy
Equity Shares (m) 274.4
M. Cap. (INR b)/(USD b)
4QFY18 grey cement volumes are estimated at 17.8mt, including
1084 / 17
52-Week Range (INR) JPA’s volumes. While JPA is expected to operate at 70%
4594 / 3774
1,6,12 Rel Perf. (%) -3 / -5 / -13
utilization, standalone UTCEM volumes are expected to grow by
9% YoY. Realizations are estimated to remain flat QoQ at
Financial Snapshot (INR Billion)
INR4,795/ton, as pricing improvement in Central and East India
Y/E March 2017 2018E 2019E 2020E will be offset by weaker pricing in North and South India.
Sales 238.9 295.2 371.0 429.0 We estimate EBITDA/ton at INR791 (-INR10QoQ) due to flat
EBITDA 49.7 56.2 76.5 94.1 realization and cost structure remaining flat QoQ. EBITDA margin
NP 26.4 21.3 34.0 45.3 is expected to remain stable at 16.5%.
Adj. EPS (INR) 96.1 77.5 123.7 165.0 EBITDA is estimated to increase 13% QoQ to INR14.4b, while PAT
EPS Gr. (%) 11.3 -19.3 59.5 33.4 is estimated to decline 30% YoY to INR4.9b due to higher interest
BV/Share (INR) 872 944 1,037 1,152 cost and depreciation related to JPA’s acquisition.
RoE (%) 11.6 8.5 12.5 15.1 The stock trades at a P/E of 32x (FY19E) and 24x (FY20E),
RoCE (%) 9.7 7.3 8.8 10.5 EV/EBITDA of 15x (FY19E) and 12x (FY20E), and EV/ton of USD188
Payout (%) 12.1 22.5 18.8 17.6 (FY19E) and USD184 (FY20E). Maintain Buy.
Valuation
Key issues to watch out for
P/E (x) 41.1 50.9 31.9 23.9
Volume growth recovery and outlook.
P/BV (x) 4.5 4.2 3.8 3.4
Cement pricing outlook and sustainability.
EV/EBITDA (x) 21.4 21.1 15.0 11.9
Update on JPA’s operations.
EV/Ton (USD) 247 213 188 184
Consumer
Company name Volume growth recovering, ITC to drag overall numbers
Asian Paints Rural sales likely to outpace urban sales for the third consecutive quarter
Britannia Industries
Colgate Strong performance likely from BRIT, Page, UB and Colgate
Dabur For our Consumer Universe, we expect aggregate revenue to grow 8.2% YoY and
Emami aggregate PAT to grow 11% YoY in 4QFY18. Flat sales expected from ITC, as a result
Future Consumer of unusually high base quarter, net sales growth of 21% in cigarettes (due to
Godrej Consumer extremely low excise duty in 4QFY17), are likely to drag down overall sector sales
GSK Consumer growth, which otherwise would have been in double digits. With all three
Hindustan Unilever components of sales –volumes, realization and premiumization – now firing in
ITC
tandem, overall sales growth, barring ITC, is on a recovery path. Aggregate EBITDA is
Jyothy Labs
likely to grow 10.9% YoY, with sales growth revival leading to better absorption of
costs. EBITDA margin is likely to be 60bp higher YoY.
Marico
Nestle India
We expect ITC’s sales to come in flat YoY (with flat cigarette volumes). Cigarette
Page Industries
gross sales were up 6% in the base quarter, while net sales were up 21% due to very
Pidilite Industries
low excise. Consequently, we expect an 8% YoY decline in cigarette net sales in
P&GHH
4QFY18. Adj. PAT for the company is expected to grow 6.9% YoY. HUVR’s volume
United Breweries
growth is likely to be the second highest in 10 quarters at 7%, as rural continues to
United Spirits
do well and both CSD/wholesale seem to have normalized for them (sales growth is
likely to be at 9.4%). EBITDA margin should expand 110bp YoY. Britannia, Colgate,
Page Industries, United Breweries, P&G Hygiene, Asian Paints and Nestle are all
likely to report double-digit sales, EBITDA and PAT growth. Best YoY growth in PAT in
4QFY18 is likely to come from Britannia, Page Industries, Pidilite, Colgate, P&G
Hygiene and Healthcare and Nestle, all of which are likely to report 15% PAT growth.
It is likely to be another subdued quarter on earnings growth for Dabur, Emami,
Marico and GCPL.
105 120
100 110
95 100
90 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Exhibit 5: PFAD prices down 15% YoY and 2% QoQ Exhibit 6: Palm oil prices down 21% YoY and 5% QoQ
Palm Fatty Acid price (INR/MT) Palm Oil (Malaysian Ringgit Per Metric Tonne)
39,027
2,394
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Exhibit 7: Mentha prices up 46% YoY; down 5% QoQ Exhibit 8: TiO2 prices up 3% YoY and 2% QoQ
250
1,430
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Asian Paints
Bloomberg APNT IN CMP: INR1,153 TP: INR1,250 (+8%) Neutral
Equity Shares (m) 959.2
We expect revenue to grow 14% YoY to INR45.1b in 4QFY18, with
M. Cap. (INR b)/(USD b) 1106 / 17
8% volume growth in the domestic decorative business.
52-Week Range (INR) 1261 / 1032
1,6,12 Rel Perf. (%) 5 / -5 / -6 We note that crude prices are up 24% YoY and 9% QoQ in
4QFY18. The magnitude of price movement in crude derivatives is
Financial Snapshot (INR b) lower vis-à-vis crude prices.
Y/E March 2017 2018E 2019E 2020E
Sales 152.9 168.5 200.3 235.5 Gross margins are therefore expected to be down 60bp YoY to
EBITDA 30.2 31.4 37.7 44.8 43.3%.
Adj. PAT 20.2 20.6 24.3 29.3 Operating margin is likely to contract by 60bp to 17.4%, with
Adj. EPS (INR) 21.0 21.5 25.4 30.5 EBITDA growing 10.1% YoY in 4QFY18.
EPS Gr. (%) 8.7 2.1 18.2 20.2
BV/Sh.(INR) 79.3 81.2 91.3 102.0
We estimate 10% adj. PAT growth for 4QFY18.
RoE (%) 28.5 26.8 29.4 31.6 The stock trades at 45.4x/37.8x FY19E/20E EPS of
RoCE (%) 24.2 22.7 25.5 27.7 INR25.4/INR30.5; maintain Neutral.
Payout (%) 37.8 46.6 51.2 55.7
Valuations
Key issues to watch for
P/E (x) 54.8 53.7 45.4 37.8
Volume growth trends and demand scenario in urban and rural
P/BV (x) 14.5 14.2 12.6 11.3 geographies.
EV/EBITDA (x) 35.6 34.5 28.6 23.9 Demand outlook for industrial paints.
Div. Yield (%) 0.8 1.0 1.3 1.7 Outlook for raw materials/pricing actions.
Quarterly market share trend.
Britannia Industries
Bloomberg BRIT IN
CMP: INR5,093 TP: INR6,180 (+21%) Buy
Equity Shares (m) 120.0
We expect Britannia’s (BRIT) sales to grow 14.9% YoY to INR25.8b,
M. Cap. (INR b)/(USD b) 611 / 9
with base business volumes growing 12% on a favorable base of
52-Week Range (INR) 5121 / 3320
1,6,12 Rel Perf. (%) 5 / 11 / 39
2% volume growth.
Wheat and sugar are down YoY. Gross margins are likely to
Financial Snapshot (INR b) expand 60bp YoY to 38.6% in 4QFY18.
Y/E March 2017 2018E 2019E 2020E
Sales 89.6 99.0 118.6 142.6 We expect 170bp YoY expansion in operating margin to 15.4%.
EBITDA 11.9 14.5 18.1 22.6 Estimate 29.3% EBITDA growth and 28.3% adj. PAT growth for the
Adj. PAT 8.8 10.1 12.6 15.8 quarter.
Adj. EPS (INR) 73.7 84.2 105.1 131.5 The stock trades at 48.5x/38.7x FY19E/20E EPS of
EPS Gr. (%) 7.3 14.3 24.8 25.1 INR105.1/INR131.5; maintain Buy. Britannia is one of our top
BV/Sh.(INR) 224.7 271.7 315.8 340.3
picks in the tier-II consumer space.
RoE (%) 36.9 33.9 35.8 40.1
RoCE (%) 31.1 28.9 30.9 35.0
Payout (%) 32.7 35.0 50.0 70.0
Valuations
Key issues to watch for
P/E (x) 69.1 60.5 48.5 38.7
Pace of rural recovery.
P/BV (x) 22.7 18.7 16.1 15.0
Outlook for raw materials.
EV/EBITDA (x) 51.1 41.5 33.3 26.5
Update on dairy business.
Div. Yield (%) 0.5 0.6 1.0 1.8
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Base business volume growth (%) 10.0 10.0 2.0 2.0 2.0 5.0 11.0 12.0 6.0 7.5
Net Sales 21,063 23,612 22,648 22,444 22,248 25,365 25,583 25,799 89,623 98,996
YoY Change (%) 8.5 11.0 5.6 5.2 5.6 7.4 13.0 14.9 7.4 10.5
COGS 12,879 14,902 14,190 13,915 13,873 15,840 15,745 15,849 55,887 61,307
Gross Profit 8,184 8,709 8,458 8,528 8,375 9,525 9,838 9,950 33,736 37,689
Margins (%) 38.9 36.9 37.3 38.0 37.6 37.6 38.5 38.6 37.6 38.1
Other Operating Exp 5,367 5,578 5,487 5,448 5,479 5,836 5,946 5,967 21,872 23,228
% of Sales 25.5 23.6 24.2 24.3 24.6 23.0 23.2 23.1 24.4 23.5
Total Exp 18,246 20,481 19,678 19,363 19,352 21,676 21,691 21,816 77,759 84,535
EBITDA 2,817 3,131 2,970 3,081 2,896 3,689 3,892 3,983 11,864 14,461
Margins (%) 13.4 13.3 13.1 13.7 13.0 14.5 15.2 15.4 13.2 14.6
YoY Growth (%) 3.5 2.0 0.9 6.1 2.8 17.8 31.0 29.3 -5.1 21.9
Depreciation 279 289 303 322 332 336 329 402 1,193 1,399
Interest 15 15 11 13 13 14 26 2 55 55
Other Income 739 670 544 335 741 596 451 518 2,424 2,306
PBT 3,263 3,496 3,201 3,081 3,293 3,934 3,989 4,097 13,040 15,313
Tax 1,071 1,156 997 973 1,133 1,326 1,354 1,394 4,197 5,206
Rate (%) 32.8 33.1 31.1 31.6 34.4 33.7 33.9 34.0 32.2 34.0
Adjusted PAT 2,192 2,340 2,204 2,108 2,160 2,609 2,635 2,703 8,843 10,107
YoY Change (%) 13.2 5.8 4.6 5.9 -1.5 11.5 19.6 28.3 7.3 14.3
E: MOSL Estimates
Colgate
Bloomberg CLGT IN
CMP: INR1,084 TP: INR1,420 (+31%) Buy
Equity Shares (m) 272.0
We expect Colgate’s (CLGT) sales to grow 10.3% YoY to INR11.4b,
M. Cap. (INR b)/(USD b) 295 / 5
with 6% toothpaste volume growth.
52-Week Range (INR) 1176 / 970
1,6,12 Rel Perf. (%) 4 / -4 / -4 Gross margins are expected to expand by 40bp YoY to 63.0%.
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Toothpaste Volume Gr % 5.0 4.0 -12.0 -3.0 -5.0 -0.9 12.0 6.0 -1.5 3.0
Net Sales 10,131 10,566 8,746 10,375 9,781 10,849 10,333 11,439 39,818 42,402
YoY Change (%) 8.8 9.5 -8.6 2.2 -3.5 2.7 18.2 10.3 2.9 6.5
COGS 3,822 3,910 3,159 3,877 3,584 3,970 3,598 4,228 14,768 15,379
Gross Profit 6,309 6,656 5,587 6,498 6,197 6,879 6,735 7,211 25,050 27,023
Gross Margin (%) 62.3 63.0 63.9 62.6 63.4 63.4 65.2 63.0 62.9 63.7
Other operating Expenses 4,197 3,909 3,446 4,055 3,979 3,873 3,911 4,377 15,606 16,140
% to sales 41.4 37.0 39.4 39.1 40.7 35.7 37.9 38.3 39.2 38.1
EBITDA 2,113 2,748 2,141 2,443 2,218 3,006 2,824 2,834 9,444 10,882
Margins (%) 20.9 26.0 24.5 23.5 22.7 27.7 27.3 24.8 23.7 25.7
YoY Growth (%) 3.7 8.1 -10.3 1.2 5.0 9.4 31.9 16.0 0.7 15.2
Depreciation 316 333 342 341 373 392 396 405 1,332 1,565
Financial other Income 101 113 109 80 125 89 90 110 403 413
PBT 1,897 2,527 1,908 2,182 1,970 2,703 2,519 2,539 8,514 9,730
Tax 640 714 630 756 606 927 812 865 2,740 3,211
Rate (%) 33.7 28.3 33.0 34.6 30.8 34.3 32.3 34.1 32.2 33.0
Adj PAT 1,257 1,813 1,278 1,426 1,364 1,776 1,707 1,673 5,774 6,519
YoY Change (%) 1.3 15.6 -12.8 -0.5 8.5 -2.1 33.5 17.4 1.2 12.9
E: MOSL Estimates
Dabur
Bloomberg DABUR IN
CMP: INR337 TP: INR430 (+28%) Buy
Equity Shares (m) 1761.5
We expect sales to grow 7.5% YoY to INR20.6b, led by 8.5%
M. Cap. (INR b)/(USD b) 594 / 9
domestic organic volume growth.
52-Week Range (INR) 368 / 265
1,6,12 Rel Perf. (%) 6/2/9 We expect EBITDA margin to contract 30bp YoY to 21.5% in
4QFY18, with EBITDA growth of 6.0% YoY.
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E Adjusted PAT is expected to grow 8.2% YoY in the quarter.
Sales 77.0 77.7 91.0 103.9 The stock trades at 37.3x/32.1x FY19E/20E EPS of INR9.0/INR10.5;
EBITDA 15.1 15.7 18.7 21.6 maintain Buy.
Adj. PAT 12.8 13.3 15.9 18.5
Adj. EPS (INR) 7.2 7.6 9.0 10.5
EPS Gr. (%) 1.9 4.5 19.2 16.2
BV/Sh.(INR) 27.5 32.0 35.7 37.6
RoE (%) 28.4 25.4 26.7 28.6
Key issues to watch for
RoCE (%) 24.6 22.2 23.6 25.6
Domestic volume growth and outlook for rural demand.
Payout (%) 35.0 35.0 50.0 70.0
Pick-up in science-based Ayurveda product launch.
Valuation
P/E (x) 46.5 44.5 37.3 32.1
Recovery in wholesale channel.
P/BV (x) 12.2 10.5 9.4 9.0
Margin performance in international business.
EV/EBITDA (x) 37.6 35.7 29.5 25.3 Competitive intensity, especially from Patanjali.
Div. Yield (%) 0.8 0.8 1.3 2.2
Emami
Bloomberg HMN IN
CMP: INR1,099 TP: INR1,475 (+34%) Buy
Equity Shares (m) 227.0
We project Emami’s (HMN) sales to grow ~9% YoY to INR6.3b,
M. Cap. (INR b)/(USD b) 249 / 4
with ~8% domestic volume growth on a base of negative volume
52-Week Range (INR) 1428 / 1000
1,6,12 Rel Perf. (%) 4 / -5 / -7
growth.
Gross margin is likely to remain flattish at 62.2% in 4QFY18.
Financial Snapshot (INR b) Mentha prices are up sharply by 48% YoY and down 5% QoQ in
Y/E March 2017 2018E 2019E 2020E
the quarter.
Sales 24.9 25.5 30.3 34.8
EBITDA 7.6 7.3 9.2 10.7
We expect EBITDA margin to contract 80bp to 30%. EBITDA is
NP 6.0 5.7 7.0 8.4 likely to grow ~6% YoY to INR1.9b.
EPS (INR) 26.5 25.0 31.0 36.9 PAT before amortization is expected to decline 3.4% YoY to
EPS Gr. (%) 4.5 -5.7 23.8 19.1 INR1.4b due to a high tax rate of 15.4% (full-year tax rate taken at
BV/Sh. (INR) 77.3 89.1 101.2 102.9 MAT) compared to 6.9% in the base quarter 4QFY17.
RoE (%) 35.8 30.1 32.6 36.2
RoCE (%) 31.0 29.3 37.3 42.9
The stock trades at 35.5x/29.8x FY19E/20E EPS of
Payout (%) 33.0 35.2 29.0 24.9 INR31.0/INR36.9; maintain Buy.
Valuations
P/E (x) 41.4 43.9 35.5 29.8 Key issues to watch for
P/BV (x) 14.2 12.3 10.9 10.7 Volume growth and broad consumer demand across categories.
EV/EBITDA (x) 33.3 34.0 27.0 23.1 Recovery in wholesale channel.
Div. Yld (%) 0.8 0.8 0.8 0.8
Outlook for mentha oil prices.
Competitive intensity, especially from Patanjali.
Quaterly performance
Y/E MARCH FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Domestic volume Growth (%) 18.0 11.0 0.2 -1.5 -18.0 10.0 6.0 8.0 6.9 1.5
Net Sales 6,454 5,728 7,138 5,777 5,411 6,281 7,566 6,291 25,097 25,550
YoY Change (%) 20.1 8.0 -1.5 -4.4 -16.2 9.7 6.0 8.9 4.7 1.8
COGS 2,287 1,848 2,227 2,184 1,967 2,053 2,334 2,376 8,546 8,729
Gross Profit 4,167 3,880 4,911 3,594 3,444 4,228 5,233 3,916 16,552 16,821
Gross margin (%) 64.6 67.7 68.8 62.2 63.6 67.3 69.2 62.2 65.9 65.8
Other Expenditure 2,695 2,128 2,325 1,812 2,642 2,215 2,586 2,029 8,960 9,472
% to sales 41.8 37.1 32.6 31.4 48.8 35.3 34.2 32.3 35.7 37.1
EBITDA 1,473 1,752 2,585 1,781 802 2,013 2,647 1,886 7,591 7,348
Margins (%) 22.8 30.6 36.2 30.8 14.8 32.1 35.0 30.0 30.2 28.8
YoY Change 49.2 15.1 3.7 -4.7 -45.6 14.9 2.4 5.9 10.5 -3.2
Depreciation 106 111 112 140 153 146 195 194 469 687
Interest 125 160 127 168 79 104 92 86 580 362
Other Income 51 87 82 92 65 53 55 57 311 230
PBT 1,292 1,568 2,428 1,565 635 1,817 2,414 1,663 6,853 6,529
Tax 117 230 381 108 28 227 338 256 836 849
Rate (%) 9.1 14.7 15.7 6.9 4.4 12.5 14.0 15.4 12.2 13.0
PAT before Amortization 1,175 1,336 2,047 1,456 605 1,590 2,077 1,407 6,014 5,680
YoY Change (%) 18.0 9.6 4.8 -6.6 -48.5 19.0 1.4 -3.4 5.0 -5.6
Amortization 609 680 705 623 598 604 604 593 2,617 2,400
Reported PAT 567 661 1,342 833 10 987 1,471 814 3,403 3,280
E: MOSL Estimates
Future Consumer
Bloomberg FCON IN
CMP: INR 55 TP: INR 76 (+39%) Buy
Equity Shares (m) 1834.7
We expect Future Consumer’s (FCON) sales to grow 45% YoY to
M. Cap. (INR b)/(USD b) 101 / 2
INR7.7b.
52-Week Range (INR) 79 / 29
1,6,12 Rel Perf. (%) -6 / -15 / 69 Gross margins are expected to expand by 30bp YoY to 14.1%.
Godrej Consumer
Bloomberg GCPL IN
CMP: INR1,106 TP: INR1,140 (+3%) Neutral
Equity Shares (m) 681.0
We expect Godrej Consumer’s revenue to rise 6.8% YoY to
M. Cap. (INR b)/(USD b) 753 / 12
52-Week Range (INR) 1125 / 817
INR25.4b. Soaps volumes are likely to grow 5% YoY in 4QFY18.
1,6,12 Rel Perf. (%) 5 / 9 / 19 We estimate operating margin to expand 90bp YoY to 23.6%.
Financial Snapshot (INR b) Thus, we have modeled 10.9% EBITDA growth, and expect adj.
Y/E March 2017 2018E 2019E 2020E PAT to increase by 8.2% YoY to INR4.1b YoY.
Sales 92.4 98.1 112.5 127.1 The stock trades at 45.4x/39.8x FY19E/20E EPS of
EBITDA 18.9 20.5 23.5 26.8 INR24.4/INR27.8. We have a Neutral rating on the stock.
Adj. PAT 12.9 14.5 16.6 18.9
Adj. EPS (INR) 18.9 21.3 24.4 27.8
EPS Gr. (%) 12.4 12.7 14.4 14.1
BV/Sh.(INR) 77.8 99.8 114.2 130.5
RoE (%) 24.6 24.0 22.8 22.7
RoCE (%) 16.8 16.5 16.3 16.8 Key issues to watch for
Payout (%) 31.2 35.2 41.0 45.0 Competitive intensity across categories.
Valuations Outlook for international business— demand outlook in
P/E (x) 58.5 51.9 45.4 39.8 Indonesia and margin guidance for LatAm.
P/BV (x) 14.2 11.1 9.7 8.5 Currency guidance.
EV/EBITDA (x) 41.0 37.8 32.8 28.7
Div. Yield (%) 0.5 0.7 0.9 1.1
GSK Consumer
Bloomberg SKB IN
CMP: INR6,000 TP: INR6,230 (+4%) Neutral
Equity Shares (m) 42.1
We expect GSK Consumer to report net sales of INR11.8b, up
M. Cap. (INR b)/(USD b) 252 / 4
7.3% YoY, led by 6% volume growth in HFD. We note that the
52-Week Range (INR) 6888 / 4856
1,6,12 Rel Perf. (%) -10 / 13 / 4
base is favorable for this quarter, with 1% YoY volume decline in
HFD (2.3% YoY growth in sales).
Financial Snapshot (INR b) We estimate EBITDA margin to expand 110bp YoY to 20.8%.
Y/E December 2017 2018E 2019E 2020E
Sales 40.1 43.2 48.5 54.8 Thus, EBITDA and adj. PAT are expected to grow 13.5% and 7.5%
EBITDA 8.6 8.8 10.2 12.1 YoY, respectively.
Adj. PAT 6.6 6.8 7.7 9.1
The stock trades at 32.7x/27.8x FY19E/20E EPS of
Adj. EPS (INR) 156.1 161.0 183.8 215.7
INR183.8/INR215.7. We have a Neutral rating on the stock.
EPS Gr. (%) -4.5 3.1 14.1 17.4
BV/Sh.(INR) 742.5 812.2 891.8 985.2
RoE (%) 22.2 20.7 21.6 23.0
RoCE (%) 22.2 20.8 21.6 23.0 Key issues to watch for
Payout (%) 44.9 45.0 45.0 45.0 HFD volume outlook.
Valuation Outlook for category growth and raw materials.
P/E (x) 38.4 37.3 32.7 27.8 Market share trend.
P/BV (x) 8.1 7.4 6.7 6.1
Guidance on price increases.
EV/EBITDA (x) 25.7 25.7 21.8 18.2
Div. Yield (%) 1.2 1.2 1.4 1.6
Quarterly Performance
Y/E Mar FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
HFD Volume Growth (%) -6.0 -3.0 -17.0 -1.0 0.0 2.5 15.0 6.0 -6.8 5.5
Net Sales 9,439 10,803 8,604 11,019 9,853 11,153 10,347 11,819 39,864 43,173
YoY Change (%) -5.2 -1.1 -11.5 2.3 4.4 3.2 20.3 7.3 -3.6 8.3
Total Exp 7,404 8,351 6,927 8,848 8,190 8,540 8,307 9,355 31,530 34,391
EBITDA 2,035 2,452 1,677 2,171 1,664 2,614 2,040 2,464 8,335 8,781
Margins (%) 21.6 22.7 19.5 19.7 16.9 23.4 19.7 20.8 20.9 20.3
YoY Change (%) -0.6 3.0 -9.5 1.5 -18.3 6.6 21.7 13.5 -1.0 5.4
Depreciation 147 148 171 177 170 177 151 188 642 686
Interest 6 6 6 9 5 6 2 8 28 20
Other Income 592 578 559 710 557 550 642 591 2,439 2,340
PBT 2,474 2,876 2,059 2,695 2,045 2,981 2,529 2,860 10,104 10,415
Tax 868 1,039 695 936 723 1,057 892 970 3,537 3,642
Rate (%) 35.1 36.1 33.8 34.7 35.3 35.5 35.3 33.9 35.0 35.0
Adj PAT 1,606 1,837 1,364 1,759 1,322 1,924 1,637 1,890 6,566 6,773
YoY Change (%) 2.9 -0.1 -8.3 8.4 -17.7 4.7 20.0 7.5 -4.5 3.1
E: MOSL Estimates
Hindustan Unilever
Bloomberg HUVR IN
CMP: INR1,348 TP: INR1,530 (+13%) Buy
Equity Shares (m) 2163.9
We expect Hindustan Unilever’s revenue to grow 9.4% YoY, with
M. Cap. (INR b)/(USD b) 2918 / 45
underlying domestic volume growth of 7% in 4QFY18.
52-Week Range (INR) 1415 / 899
1,6,12 Rel Perf. (%) 4 / 8 / 35 PFAD prices are down 15% YoY (down 2% QoQ) and LAB prices
are up 6.7% YoY (up 4% QoQ).
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E Gross margins are likely to expand 160bp YoY to 52.6%.
Sales 313.0 337.6 387.3 439.7 We expect operating margin to expand by 110bp YoY to 21.2% in
EBITDA 60.5 71.4 85.8 100.8 4QFY18, leading to EBITDA growth of 15.6% YoY.
Adj. PAT 42.5 51.9 61.2 72.0
Adj. EPS (INR) Adj. PAT is likely to grow 16.6% YoY to INR13b in the quarter.
19.6 24.0 28.3 33.3
EPS Gr. (%) 1.9 22.1 17.9 17.8
The stock trades at 47.7x/40.5x FY19E/20E EPS of
BV/Sh.(INR) 30.0 31.3 31.8 32.1 INR28.3/INR33.3; maintain Buy.
RoE (%) 66.5 78.2 89.6 104.1
RoCE (%) 88.5 100.7 118.6 138.7
Payout (%) 84.0 81.4 83.9 84.7 Key issues to watch for
Valuations Comments on volume growth and consumer demand
P/E (x) 68.7 56.3 47.7 40.5 environment.
P/BV (x) 45.0 43.1 42.4 42.0 Prospects of rural recovery.
EV/EBITDA (x) 47.9 40.7 33.7 28.7 Performance of Lever Ayush.
Div. Yield (%) 1.2 1.4 1.8 2.1
Quarterly performance
Y/E March FY17 FY18 Ind AS Ind AS
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE FY17 FY18
Domestic volume growth (%) 4.0 -1.0 -4.0 4.0 0.0 4.0 11.0 7.0 0.8 5.5
Net Sales 81,270 78,427 77,060 82,130 85,290 83,090 85,900 89,864 318,887 344,144
YoY Change (%) 3.6 1.4 -0.7 6.4 4.9 5.9 11.5 9.4 2.7 7.9
COGS 39,555 39,620 37,440 40,220 40,840 39,290 39,050 42,556 156,835 161,736
Gross Profit 41,715 38,807 39,620 41,910 44,450 43,800 46,850 47,308 162,052 182,408
Margin % 51.3 49.5 51.4 51.0 52.1 52.7 54.5 52.6 50.8 53.0
Operating Exp 25,368 24,760 26,060 25,400 25,790 26,980 30,050 28,218 101,588 111,038
% to sales 31.2 31.6 33.8 30.9 30.2 32.5 35.0 31.4 31.9 32.3
EBITDA 16,347 14,046 13,560 16,510 18,660 16,820 16,800 19,090 60,463 71,370
YoY Change (%) 8.1 5.1 -5.2 12.2 14.1 19.7 23.9 15.6 5.1 18.0
Margins (%) 20.1 17.9 17.6 20.1 21.9 20.2 19.6 21.2 19.0 20.7
Depreciation 933 945 1,000 1,080 1,140 1,150 1,210 1,111 3,958 4,611
Interest 60 49 50 60 60 60 50 96 219 266
Other Income 1,076 2,528 820 830 1,130 2,040 1,520 850 5,254 5,540
PBT 16,431 15,580 13,330 16,200 18,590 17,650 17,060 18,732 61,541 72,032
Tax 5,411 4,807 4,480 4,360 5,630 5,250 3,590 5,699 19,058 20,169
Rate (%) 32.9 30.9 33.6 26.9 30.3 29.7 21.0 30.4 31.0 28.0
Adjusted PAT 11,277 10,818 9,199 11,180 12,920 12,360 11,980 13,033 42,474 51,863
YoY Change (%) 6.1 9.3 -10.2 7.6 14.6 14.2 30.2 16.6 3.2 22.1
Reported Profit 11,727 10,956 10,380 11,830 12,830 12,760 13,260 13,033 44,893 51,863
E: MOSL Estimates
ITC
Bloomberg ITC IN
CMP: INR258 TP: INR275 (+6%) Neutral
Equity Shares (m) 12147.4
We expect net sales to be flattish YoY at INR111.5b, with cigarette
M. Cap. (INR b)/(USD b) 3139 / 48
volume being flat (base quarter also saw flat volume growth).
52-Week Range (INR) 353 / 250
1,6,12 Rel Perf. (%) 0 / -7 / -20 We expect cigarette EBIT to grow 2.6% YoY.
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Cigarette Vol Gr (%) 3.0 4.0 -1.0 0.0 1.0 -6.0 -2.0 0.0 1.5 -1.8
Net Sales 100,540 96,607 92,484 111,255 99,547 97,639 99,522 111,528 400,887 408,236
YoY Change (%) 9.8 9.8 4.3 14.0 -1.0 1.1 7.6 0.2 9.6 1.8
Total Exp 65,278 60,307 57,020 72,502 62,083 60,024 60,477 70,821 255,106 253,404
EBITDA 35,262 36,300 35,464 38,754 37,464 37,615 39,045 40,707 145,780 154,831
Growth (%) 8.4 7.3 2.1 7.5 6.2 3.6 10.1 5.0 6.3 6.2
Margins (%) 35.1 37.6 38.3 34.8 37.6 38.5 39.2 36.5 36.4 37.9
Depreciation 2,613 2,684 2,665 2,418 2,682 2,824 2,908 3,293 10,380 11,707
Interest 101 107 136 -115 104 290 240 190 230 824
Other Income 4,205 4,754 6,879 4,021 4,768 4,942 6,269 4,028 19,859 20,007
PBT 36,754 38,262 39,542 40,471 39,446 39,443 42,167 41,252 155,030 162,307
Tax 12,907 13,262 13,075 13,777 13,841 13,045 13,969 12,707 53,021 53,561
Rate (%) 35.1 34.7 33.1 34.0 35.1 33.1 33.1 30.8 34.2 33.0
Adj PAT 23,847 25,000 26,467 26,695 25,605 26,398 28,198 28,545 102,009 108,746
YoY Change (%) 10.1 10.5 5.7 12.1 7.4 5.6 6.5 6.9 9.5 6.6
E: MOSL Estimates
Jyothy Labs
Bloomberg JYL IN
CMP: INR389 TP: INR405 (+4%) Neutral
Equity Shares (m) 181.0
We expect Jyothy Labs’ net sales to grow 14.4% to ~INR5.1b on a
M. Cap. (INR b)/(USD b) 70 / 1
52-Week Range (INR) 441 / 325
base of 4.1% sales growth.
1,6,12 Rel Perf. (%) 15 / -8 / 2 Gross margin is likely to expand 40bp YoY to 44.4%.
Financial Snapshot (INR b) We expect EBITDA margin to grow by ~200bp YoY to 15.5%.
Y/E March 2017 2018E 2019E 2020E We have thus factored in EBITDA growth of 30.4% YoY to
Net Sales 16.8 17.3 20.5 23.9 INR791m.
EBITDA 2.5 2.6 3.2 3.8
Adj PAT 2.0 1.5 2.0 2.5 However, adj. PAT in 4QFY18 is likely to decline 50% YoY to
Adj PAT for NCD 1.5 1.1 1.5 2.0 INR543m, as there was a net tax write-back in base quarter
Adj.EPS (INR) 11.2 8.5 10.9 13.6 4QFY17.
EPS Gr. (%) 175.7 -24.8 29.3 24.0
The stock trades at 22.9x/19.3x FY19E/20E EV/EBITDA. We
BV/Sh (INR) 59.9 58.1 59.9 64.3
maintain Neutral.
RoE (%) 21.1 14.3 18.5 21.8
RoCE (%) 17.3 11.4 14.3 16.7
Valuations
Key issues to watch for
P/E (x) 34.6 46.0 35.6 28.7
Update on new launches and innovations.
P/BV (x) 6.5 6.7 6.5 6.1
Pick-up in Henkel brands’ performance.
EV/EBITDA 29.5 27.7 22.9 19.3
Dividend Yield 1.5 1.8 2.1 2.1
(%)
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Sales 4,244 4,121 3,839 4,457 3,559 4,299 4,312 5,097 16,662 17,267
YoY Change (%) 5.1 5.9 3.4 4.1 -16.1 4.3 12.3 14.4 4.6 3.6
Total Sales 4,248 4,121 3,839 4,462 3,567 4,299 4,312 5,109 16,671 17,287
COGS 2,199 2,101 2,089 2,502 1,728 2,229 2,230 2,842 8,891 9,029
Gross Profit 2,049 2,020 1,750 1,960 1,840 2,070 2,083 2,266 7,779 8,258
Margins (%) 48.2 49.0 45.6 43.9 51.6 48.1 48.3 44.4 46.7 47.8
Total Exp 1,243 1,383 1,243 1,354 1,403 1,361 1,390 1,476 5,223 5,629
EBITDA 807 637 507 606 437 709 693 791 2,557 2,629
EBITDA Growth % 38.8 28.0 -1.3 -3.5 -45.9 11.3 36.8 30.4 15.1 2.8
Margins (%) 19.0 15.5 13.2 13.6 12.2 16.5 16.1 15.5 15.3 15.2
Depreciation 133 73 73 83 141 74 78 92 363 384
Interest 143 164 144 99 86 119 120 98 551 424
Other Income 25 31 26 21 18 39 23 43 103 123
PBT 555 430 314 446 228 555 517 644 1,746 1,944
Tax 120 119 108 -629 22 98 188 100 -281 408
Rate (%) 21.6 27.7 34.3 -141.1 9.5 17.7 36.4 15.6 -16.1 21.0
Adjusted PAT after NCI 445 320 215 1,087 206 476 347 543 2,067 1,536
YoY Change (%) 72.6 61.2 6.6 778.6 -53.6 48.5 61.5 -50.0 164.4 -25.7
E: MOSL Estimates
Marico
Bloomberg MRCO IN
CMP: INR325 TP: INR350 (+8%) Neutral
Equity Shares (m) 1289.6
We expect sales to grow 11.1% YoY to INR14.6b, with 5% growth
M. Cap. (INR b)/(USD b) 419 / 6
in domestic volumes.
52-Week Range (INR) 348 / 284
1,6,12 Rel Perf. (%) 6 / 0 / -2 In our opinion, Parachute, VAHO and Saffola should post 3%, 5%
and 6% volume growth, respectively.
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E We observe that copra prices are up 69% YoY (data available till
Sales 59.2 63.0 74.0 85.4 Feb’18), while kardi oil prices are up 28% YoY. We are modeling
EBITDA 11.4 11.6 13.7 16.2 gross margin contraction of 420bp YoY to 47.4%.
Adj. PAT 8.1 8.2 9.7 11.6 EBITDA is expected to grow at 9.8% YoY, with margin contraction
Adj. EPS (INR) 6.3 6.4 7.5 9.0
of 20bp YoY to 19% in 4QFY18. Adj. PAT is projected to grow by
EPS Gr. (%) 12.1 1.7 18.0 18.8
5.8% YoY to INR1.8b.
BV/Sh.(INR) 18.0 20.6 21.6 24.0
RoE (%) 36.7 33.1 35.8 39.3 We like MRCO’s franchise, portfolio strength, management
RoCE (%) 31.5 28.3 30.7 33.6 quality and multiple growth drivers. Valuations remain fair. The
Payout (%) 47.7 50.1 72.9 61.4 stock trades at 43.1x/36.3x FY19E/20E EPS of INR7.5/INR9.0;
Valuations maintain Neutral.
P/E (x) 51.7 50.8 43.1 36.3
Key issues to watch for
P/BV (x) 18.0 15.8 15.1 13.5
EV/EBITDA (x)
Comments on volume growth trends across key categories.
36.4 35.3 30.1 25.4
Div. Yield (%) 0.9 1.0 1.7 1.7
Outlook for raw materials.
Margin expansion and guidance for the international business.
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Domestic volume growth (%) 8.0 3.4 -4.0 10.0 -9.0 8.0 9.4 5.0 3.6 3.5
Net Sales 17,523 14,395 14,114 13,152 16,815 15,363 16,243 14,612 59,180 63,033
YoY Change (%) 0.2 -0.8 -7.7 2.2 -4.0 6.7 15.1 11.1 -3.3 6.5
COGS 8,400 6,815 6,785 6,365 8,782 8,144 8,688 7,580 28,491 33,194
Gross Profit 9,123 7,581 7,328 6,787 8,033 7,219 7,556 7,033 30,690 29,840
Gross margin (%) 52.1 52.7 51.9 51.6 47.8 47.0 46.5 48.1 51.9 47.3
Other Expenditure 5,384 5,050 4,600 4,262 4,790 4,628 4,535 4,261 19,276 18,213
% to Sales 30.7 35.1 32.6 32.4 28.5 30.1 27.9 29.2 32.6 28.9
EBITDA 3,740 2,530 2,729 2,525 3,243 2,591 3,021 2,772 11,414 11,627
Margins (%) 21.3 17.6 19.3 19.2 19.3 16.9 18.6 19.0 19.3 18.4
YoY Change (%) 18.2 11.4 -5.3 20.1 -13.3 2.4 10.7 9.8 8.1 1.9
Depreciation 208 209 218 273 211 235 213 277 903 937
Interest 54 21 44 47 35 35 39 83 166 192
Other Income 275 247 233 293 229 214 174 199 1,152 816
PBT 3,753 2,548 2,700 2,497 3,226 2,535 2,943 2,611 11,497 11,315
Tax 1,072 740 781 784 866 679 709 802 3,377 3,055
Rate (%) 28.6 29.1 28.9 31.4 26.8 26.8 24.1 30.7 29.4 27.0
Minority Interest 2 2 2 4 1 6 1 2 10 10
Adjusted PAT 2,679 1,806 1,916 1,709 2,359 1,850 2,233 1,807 8,110 8,250
YoY Change (%) 17.2 18.0 -6.8 25.5 -11.9 2.5 16.5 5.8 14.4 1.7
E: MOSL Estimates
Nestle India
Bloomberg NEST IN
CMP: INR8,361 TP: INR8,275 (-1%) Neutral
Equity Shares (m) 96.4
We expect Nestle India’s net sales to grow 12.0% YoY to
M. Cap. (INR b)/(USD b) 806 / 12
~INR27.7b in 1QCY18.
52-Week Range (INR) 8374 / 6262
1,6,12 Rel Perf. (%) 8 / 8 / 16 Gross margins are likely to expand 50bp YoY to 56.3%.
Quarterly performance
Y/E December CY17 CY18 CY17 CY18E
1Q 2Q 3Q 4Q 1QE 2QE 3QE 4QE
Net Sales 24,757 23,865 25,007 25,896 27,728 27,445 28,758 27,744 99,525 111,674
YoY Change (%) 8.7 6.9 7.5 15.6 12.0 15.0 15.0 7.1 9.7 12.2
COGS 10,939 10,791 10,847 10,693 12,113 12,409 12,474 11,778 43,262 48,773
Gross Profit 13,818 13,075 14,160 15,204 15,615 15,036 16,284 15,966 56,264 62,901
Margin (%) 55.8 54.8 56.6 58.7 56.3 54.8 56.6 57.5 56.5 56.3
Operating Exp 8,708 8,645 8,388 8,873 9,753 9,668 9,790 9,404 34,620 38,614
EBITDA 5,110 4,430 5,773 6,331 5,862 5,368 6,495 6,562 21,644 24,287
Margins (%) 20.6 18.6 23.1 24.4 21.1 19.6 22.6 23.7 21.7 21.7
YoY Growth (%) -7.5 -6.1 19.2 38.7 14.7 21.2 12.5 3.6 10.1 12.2
Depreciation 867 854 864 838 936 923 933 919 3,423 3,711
Interest 228 229 229 234 207 208 208 227 930 850
Other income 578 569 564 629 693 683 677 781 2,350 2,834
PBT 4,593 3,915 5,244 5,889 5,412 4,920 6,031 6,196 19,640 22,559
Tax 1,468 1,408 1,746 1,656 1,732 1,574 1,930 1,983 6,139 7,219
Rate (%) 32.0 36.0 33.3 28.1 32.0 32.0 32.0 32.0 31.3 32.0
Adjusted PAT 3,126 2,507 3,498 4,233 3,680 3,346 4,101 4,214 13,500 15,340
YoY Change (%) 1.8 -11.8 17.8 50.2 17.7 33.5 17.2 -0.5 13.2 13.6
E: MOSL Estimate; Quarterly adjusted for Ind AS
Page Industries
Bloomberg PAG IN
CMP: INR22,288 TP: INR27,490 (+23%) Buy
Equity Shares (m) 11.2
We expect Page to report net sales of INR5.9b, up 19.7% YoY, led
M. Cap. (INR b)/(USD b) 249 / 4
by double digit volume growth. We note that volume growth in
52-Week Range (INR) 25779 / 13650
1,6,12 Rel Perf. (%) 4 / 16 / 41
men’s innerwear has a high base of 10.5%.
We expect EBITDA margin to grow by 140bp YoY to 20.9%. Thus,
Financial Snapshot (INR b) EBITDA should grow by 28.3% YoY to INR1.2b.
Y/E March 2017 2018E 2019E 2020E
Sales 21.3 25.4 32.3 41.1 Adj. PAT is likely to post 17.7% YoY growth to INR786m.
EBITDA 4.1 5.2 7.1 9.3 The stock trades at 53.6x/40.5x FY19E/20E EPS of
Adj. PAT 2.7 3.3 4.6 6.1
INR415.7/INR549.8; maintain Buy.
Adj. EPS (INR) 238.7 297.1 415.7 549.8
EPS Gr. % 15.0 24.5 39.9 32.2
FCF to PAT 0.7 1.0 0.5 0.8
BV/Sh.INR 596.9 745.5 932.5 1152.5
RoE (%) 40.0 39.9 44.6 47.7
RoCE (%) 40.4 41.4 47.5 51.7
Key issues to watch for
Payout (%) 43.7 50.0 55.0 60.0
Performance of kidswear.
Valuations
Competitive intensity.
P/E (x) 93.4 75.0 53.6 40.5
Minimum wage hike in Karnataka for textile industry.
EV/EBITDA (x) 60.2 47.6 34.7 26.5
P&G Hygiene
Bloomberg PG IN
CMP: INR9,465 TP: INR9,672 (+2%) Neutral
Equity Shares (m) 32.5
We expect PGHH to report net sales of INR6.4b, up 12% YoY.
M. Cap. (INR b)/(USD b) 307 / 5
52-Week Range (INR) 9900 / 6902 We estimate EBITDA margin to expand 160bp YoY to 28.4% in
1,6,12 Rel Perf. (%) 3 / 7 / 22 3QFY18 (June ending).
Pidilite Industries
Bloomberg PIDI IN
CMP: INR963 TP: INR1,115 (+16%) Buy
Equity Shares (m) 512.7
We expect Pidilite’s (PIDI) revenue to grow by 9% YoY, led by 16%
M. Cap. (INR b)/(USD b) 494 / 8
volume growth in Consumer and Bazaar segment. Sales growth is
52-Week Range (INR) 972 / 696
1,6,12 Rel Perf. (%) 10 / 16 / 26
likely to be much lower than volume growth because GST
reductions have been passed on in all key segments.
Financial Snapshot (INR b) EBITDA margin is expected to contract 30bp YoY to 19.6% mainly
Y/E March 2017 2018E 2019E 2020E
due to increase in VAM costs.
Sales 56.2 60.1 71.3 82.2
EBITDA 12.6 13.4 15.4 17.7 We expect EBITDA and PAT to grow by 7.1% and 22.1% YoY to
Adj. PAT 8.6 9.0 10.6 12.1 INR2.7b and INR1.9b, respectively. Tax rate was unusually high at
Adj. EPS (INR) 16.7 17.6 20.6 23.7 38.5% in 4QFY17.
EPS Gr. (%) 6.7 5.4 17.0 14.9
The stock trades at 46.7x/40.6x FY19E/20E EPS of
BV/Sh.(INR) 67.7 78.2 90.0 102.0
INR20.6/INR23.7. Maintain Buy.
RoE (%) 28.1 24.2 24.5 24.7
RoCE (%) 26.2 22.5 23.1 23.4
Key issues to watch for
Payout (%) 24.9 25.5 36.4 42.2
Volume growth in Fevicol.
Valuations
Outlook for VAM prices.
P/E (x) 57.5 54.6 46.7 40.6
P/BV (x) 14.2 12.3 10.7 9.4
Outlook for industrial and construction chemical segments.
EV/EBITDA (x) 38.0 35.4 30.5 26.3
Div. Yield (%) 0.4 0.5 0.8 1.0
United Breweries
Bloomberg UBBL IN
CMP: INR977 TP: INR1,450 (+48%) Buy
Equity Shares (m) 264.4
We expect United Breweries’ revenue to grow by 23.5% YoY to
M. Cap. (INR b)/(USD b) 258 / 4
INR13.7b.
52-Week Range (INR) 1243 / 716
1,6,12 Rel Perf. (%) -5 / 11 / 16 We build in EBITDA margin expansion of 400bp YoY to 13.1%, and
77.6% EBITDA growth YoY to INR1.8b.
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E We estimate 930.3% adj. PAT growth in 4QFY18.
Net Sales 47.6 55.2 63.5 73.0 The stock trades at 25.3x FY19E EV/EBITDA. Maintain Buy.
EBITDA 6.7 8.7 10.5 13.0
NP 2.3 3.7 4.6 6.0
EPS (INR) 8.7 14.1 17.4 22.9
EPS Growth (%) -23.0 62.0 23.9 31.2
BV/Sh. (INR) 88.3 100.3 115.4 135.2
RoE (%) 10.2 14.9 16.2 18.3
RoCE (%) 9.1 13.1 14.5 16.3
Valuations Key issues to watch for
P/E (x) 112.5 69.4 56.1 42.7 Trends in volume and margins.
P/BV (x) 11.1 9.7 8.5 7.2 Price trend and outlook for raw materials.
EV/EBITDA (x) 39.2 30.2 25.3 20.4 Traction on premium range of beers.
EV/Sales (x) 5.5 4.8 4.2 3.6
United Spirits
Bloomberg UNSP IN
CMP: INR3,250 TP: INR3,510 (+8%) Neutral
Equity Shares (m) 145.3
We expect United Spirits (UNSP) to post flattish revenue of
M. Cap. (INR b)/(USD b) 472 / 7
52-Week Range (INR) 4003 / 1831
INR20.1b, with a 9% decline in volumes.
1,6,12 Rel Perf. (%) 2 / 26 / 47 We note that molasses prices are down sharply YoY. However,
route to market changes are expected to restrict margin
Financial Snapshot (INR b)
expansion for the second consecutive quarter.
Y/E March 2017 2018E 2019E 2020E
Sales 85.5 80.1 95.7 112.3 We expect EBITDA margin expansion of 30bp YoY to 13.4% and
EBITDA 9.8 9.7 14.4 18.5 EBITDA to grow 2.2% YoY to INR2.7b.
PAT 3.9 4.7 8.3 11.4
We estimate adj. PAT of INR1.2b in 4QFY18, up 13.3% YoY.
EPS (INR) 26.7 32.6 56.9 78.5
EPS Gr. (%) 87.1 22.1 74.3 38.1 Maintain Neutral.
BV/Sh.(INR) 133.4 189.9 254.7 350.6
RoE (%) 21.3 17.2 22.3 22.4
RoCE (%) 11.8 11.9 16.7 18.9
Payout (%) 0.0 0.0 0.0 0.0
Valuations Key issues to watch for
P/E (x) 121.6 99.6 57.1 41.4 Trends in volume growth, premiumization and margins.
P/BV (x) 24.4 17.1 12.8 9.3 Price trend and outlook for ENA/molasses.
EV/EBITDA (x) 46.8 45.8 30.9 23.4
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18
(Standalone) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Volume Growth % -0.2 1.0 -5.0 -8.2 -18.9 -15.9 -14.2 -9.0 -3.1 -14.4
Total Revenues 20,405 20,268 24,553 20,250 17,818 19,513 22,633 20,138 85,476 80,102
YoY Change (%) 10.4 7.1 1.9 -0.6 -12.7 -3.7 -7.8 -0.6 4.4 -6.3
Total Exp 18,271 17,967 21,607 17,599 16,244 16,786 19,910 17,430 75,650 70,370
EBITDA 2,134 2,301 2,946 2,651 1,574 2,727 2,723 2,708 9,826 9,732
Margins (%) 10.5 11.4 12.0 13.1 8.8 14.0 12.0 13.4 11.5 12.2
EBITDA growth (%) 24.5 -20.7 15.6 142.3 -26.2 18.5 -7.6 2.2 18.8 -1.0
Depreciation 261 332 313 418 321 326 337 458 1,323 1,442
Interest 1,030 885 922 853 703 659 658 600 3,690 2,620
PBT From operations 843 1,084 1,711 1,380 550 1,742 1,728 1,650 4,813 5,670
Other income 241 339 346 253 309 305 236 254 995 1,104
PBT 1,084 1,423 2,057 1,633 859 2,047 1,964 1,905 5,808 6,775
Tax 253 445 580 515 222 681 491 638 1,923 2,032
Rate (%) 23.3 31.3 28.2 31.5 25.8 33.3 25.0 33.5 33.1 30.0
Adj. PAT 831 978 1,477 1,118 637 1,366 1,473 1,267 3,885 4,742
YoY Change (%) 616.1 -4.2 86.1 237.8 -23.4 39.6 -0.3 13.3 87.1 22.1
E: MOSL Estimates
Technology
Financials - Banks
Company name Higher provisioning to remain a drag on earnings
Private Banks RBI’s revised asset quality framework adds another layer of uncertainty
Axis Bank
DCB Bank The key factors expected to impact earnings for the quarter are: (a) tepid
Equitas Holdings corporate loan growth, (b) rising bond yields impacting treasury income, (c)
Federal Bank progress on stressed asset resolution under Insolvency and Bankruptcy Code
HDFC Bank (IBC), (d) stressed asset recognition / provisioning as per RBI’s revised asset
ICICI Bank quality framework, and, (e) incremental provisioning required for frauds
Kotak Mahindra Bank uncovered at many banks. Cost of funds is expected to start increasing hereon
RBL Bank for many banks, with deposit rates hardening. We expect trading gains to
Yes Bank
remain minimal, given increase in bond yields even though the revised
Public Sector Banks
government borrowing program has provided some comfort to bond yields.
Bank of Baroda
On a sequential basis, we expect profit growth to remain muted for state-owned
Bank of India
banks, with elevated provisions towards NCLT exposures and fraud accounts in
Canara Bank
many banks. Even as bond yields have increased post 3QFY18 levels, MTM
Indian Bank
provisioning impact is expected to be softer during 4Q, with RBI allowing banks
Punjab National Bank
to spread their losses over four quarters. We expect incremental stress addition
State Bank of India
Union Bank of India
for corporate banks to remain elevated, with high credit costs weighing down
Life Insurance
on profitability. Mid-sized private banks would continue to outshine peers due
HDFC Standard Life Insurance to continued market share gains (loan growth of 4-5x system), stable asset
quality, and stable-to-improving margins (sharp fall in bulk deposits). We expect
PAT growth of ~25% YoY for IIB, YES and KMB, and over 40% YoY for RBL.
We remain upbeat on the value migration from state-owned banks to private
sector banks. Within private sector banks, emerging private banks are likely to
be the major beneficiaries. Within state-owned banks, we like SBIN and BOB.
Among private sector banks, our key picks are HDFCB, IIB, ICICIBC and RBL.
Key things to watch for: (a) Banks’ commentary on admission status of the
second NCLT list and any color on eventual provisions needed for the same, (b)
progress in resolution of key accounts under NCLT’s first list and possible change
in expected haircut with recent developments related to their resolution, (c)
stake sale in non-core assets and capital raising plans, (d) any comments on
pickup in corporate capex, (e) commentary by banks on frauds unfolding in the
banking sector and the way ahead from here, and (f) commentary on stressed
asset reporting and outlook under RBI’s revised stressed assets framework. In
our view, excluding power, most of the highly-levered sector stress exposures
are well communicated/recognized by banks. However, RBI’s revised stressed
asset guidelines place an additional layer of difficulty for banks in terms of
implementation, as large stressed standard assets may be classified as NPA
subject to impairment tests
Great start to bids for key NCLT assets, legal challenges notwithstanding
Among the bigger NCLT first list accounts, Bhushan Steel, Bhushan Power and
Steel, and Essar Steel have received active interest from bidders with some of
the reported bids entailing significantly lower haircuts than street expectations.
Research Analyst: Nitin Aggarwal (Nitin.Aggarwal@MotilalOswal.com); +91 22 6129 1542 | Anirvan Sarkar (Anirvan.Sarkar@MotilalOswal.com); +91 22 6129 1544
Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 6129 1526 | Parth Gutka (Parth.Gutka@motilaloswal.com); +91 22 6129 1567
April 2018 138
March 2018 Results Preview | Sector: Financials
While this is an encouraging start, some of the cases have seen disqualification
of bidders due to legal reasons and second bids have been invited for the same.
While legal hiccups are expected in a first-time phenomenon such as NCLT
resolutions, the interest shown by companies in bidding for referred assets
augurs well for future resolutions; however, we remain cognizant of the fact
that the interest shown by bidders is a function of the quality of the underlying
assets, and extrapolating the success of a few good quality asset resolutions to
the larger universe of NCLT assets may be erroneous.
Loan growth picking up slowly; corporate credit pickup still some time away
Loan growth at the system level has picked up to 10%+ after several quarters of
mid-single-digit growth. However, corporate credit growth may not happen
immediately. While utilization levels are expected to pick up for core sectors,
companies are expected to bid for stressed asset sales under NCLT before
making greenfield investments.
We expect retail growth to continue showing strong traction for private banks
and expect mid-sized private banks to grow at 4-5x system during the quarter.
After a prolonged period of liquidity following demonetization, systemic deposit
growth has finally started stabilizing, as indicated by systemic credit-deposit
ratio at ~75%, the highest in seven quarters. With many banks starting to raise
deposit rates, cost of funds may have bottomed out. Mid-sized state-owned
banks would continue losing market share due to capitalization and asset quality
issues. We expect retail-focused banks like HDFCB and KMB to also report
strong growth in the corporate segment.
Cost of funds may have bottomed out – yields should follow suit
We expect NII to be flattish QoQ (rising cost of funds combined with interest
reversals) for state-owned banks. For private banks, we expect NII to grow 11%
YoY (and 4% QoQ); mid-sized private banks are expected to report ~23% YoY
growth. Weak loan growth would be the key reason for moderate revenue
growth at the sector level.
An increase in CD-ratio for most coverage banks as well as for the system over
the last two quarters indicates that liquidity in the system has slowed from the
highs witnessed post demonetization.
Many banks have raised deposit rates as an attempt to attract more deposits,
indicating a possible start of reversal of cost of funds, which has been benign so
far. However, most banks have also increased MCLR in February/March; so, NIM
is not likely to be impacted meaningfully.
Asset quality stress to stay elevated, RBI’s revised framework adds a level
of uncertainty
Factors likely to continue weighing on performance include (a) accelerated
resolution under the NCLT route, which would increase credit costs in the near
term, (b) banks’ clean-up exercise (expect largely from restructured loans and
watch list), (c) further possible slippages from RBI’s impairment test (announced
under revised stressed assets framework) for existing standard stressed assets,
which may be deemed non-performing.
Performance of SME and agriculture portfolios would be the key thing to watch
for, considering the lagged impact of demonetization and loan waivers/drought
in some large states. Farm loan waivers in key states such as UP, Maharashtra,
Karnataka and Punjab have affected asset quality in the agri segment in the
previous quarters, and we await commentary on the subsequent trend in
repayments.
While RBI’s revised stressed assets framework is expected to address
recognition and resolution irregularities and is a positive step in the longer term,
in the near term, we expect uncertainty over existing stressed standard assets
failing the impairment test and coming under the revised framework.
Exhibit 1: State-owned banks—one-year forward P/BV Exhibit 2: Private sector banks—one-year forward P/BV
P/B (x) Avg (x) Max (x) P/B (x) Avg (x) Max (x)
Min (x) +1SD -1SD Min (x) +1SD -1SD
3.5
2.3
3.0
1.7 2.8 2.6
1.8 2.2 2.6
1.3 1.2 2.0 1.8
0.9
0.8 1.3
0.9
0.7 0.7
0.3 0.5 0.5
Jun-09
Jun-14
Mar-08
Sep-10
Dec-11
Mar-13
Sep-15
Dec-16
Mar-18
Jun-09
Jun-14
Mar-08
Sep-10
Dec-11
Mar-13
Sep-15
Dec-16
Mar-18
90
95
100
105
110
2QFY15 62.7 11.0
April 2018
Sep-16
3QFY15 63.2 10.1
Oct-16
Nov-16 4QFY15 65.4 9.0
Dec-17
Dec-16 1QFY16 66.6 9.9
Jan-17
2QFY16 68.1 9.1
Feb-17
Mar-17 3QFY16 69.9 10.6
Sensex Index
Jan-18 Apr-17 10.9
4QFY16 72.5
Loans (INR t)
May-17
Jun-17 1QFY17 72.3 9.0
Jul-17 2QFY17 75.7 11.2
Aug-17
Exhibit 5: Loan growth picked up in 4Q
Dec-17
Mar-18
4QFY18 83.8 10.7
Apr-18
Sensex Index
3QFY16 4QFY16 93.3 9.3
PSU
Aug-17 4QFY16
Deposits (INR t)
4QFY17
Dec-17 1QFY18 106.1 11.1
1QFY18
Chg YoY (%)
2QFY18
Feb-18 3QFY18 108.9 3.5
3QFY18
4QFY18 111.6 5.9
Exhibit 6: Deposit growth also has shown modest recovery
Mar-18
2.3 2.4 2.5 2.3
3.9 4.1 4.1 4.0 4.1 4.0 4.0 4.0 4.0 3.9 3.9 4.1 4.0 3.9 3.83.7
4QFY18
142
Source: Bloomberg, MOSL
March 2018 Results Preview | Sector: Financials
March 2018 Results Preview | Sector: Financials
Axis Bank
Bloomberg AXSB IN CMP: INR503 TP: INR650 (+29%) Buy
Equity Shares (m) 2570.3
We expect AXSB to report ~19% loan growth, driven by continued
M. Cap. (INR b)/(USD b) 1294 / 20
strong growth in the retail and SME segments. Overall deposit
52-Week Range (INR) 628 / 448
growth is likely to be ~12%, increasing the CD ratio, which should
1,6,12 Rel Perf. (%) -2 / -7 / -11
remain elevated at ~96%.
Financial Snapshot (INR B) Margins are expected to decline slightly QoQ to ~3.3%, as cost of
Y/E March 2017 2018E 2019E 2020E
funds has started reversing.
NII 180.9 187.3 244.9 304.8
Current BB and below rated book stands at INR161b (~3.8% of
OP 175.8 159.0 211.5 267.6
loans) and is expected to be mostly recognized by FY19. We
NP 36.8 31.7 64.0 115.1
NIM (%) 3.6 3.1 3.4 3.6
expect slippages to remain at elevated levels (~5.5% annualized
EPS (INR) 15.4 12.8 24.7 44.0 slippage ratio), as the bank proceeds to clean up its balance
EPS Gr. (%) -55.5 -17.0 93.7 78.2 sheet, leading to high credit costs.
BV/Sh. (INR) 226.5 262.4 287.3 326.7 We estimate PAT at INR7b (down 43% YoY on a high base) v/s
ABV/Sh. (INR) 203.1 229.4 265.2 301.3 INR7.3b in 3QFY18, weighed down by provisions.
RoE (%) 6.9 5.1 9.0 14.3 AXSB trades at 1.8x FY19E BV and 20.4x FY19E EPS. Buy.
RoA (%) 0.6 0.5 0.8 1.3
Payout (%) 32.5 25.2 15.8 10.5
Valuations
P/E(X) 32.6 39.4 20.4 11.4 Key issues to watch for
P/BV (X) 2.2 1.9 1.8 1.5 Quantum of corporate slippages from BB and below list, and any
P/ABV (X) 2.5 2.2 1.9 1.7 revision in the size of the same.
Div. Yield (%) 1.0 0.6 0.8 0.9
Bank of Baroda
Bloomberg BOB IN CMP: INR145 TP: INR185 (+28%) Buy
Equity Shares (m) 2646.4
After an uptick in loan growth in 3Q, 4QFY18 should register ~11%
M. Cap. (INR b)/(USD b) 384 / 6
YoY loan growth (+6% QoQ). Balance sheet recalibration will
52-Week Range (INR) 207 / 128
continue, led by focus on granular retail loans. We expect drill-
1,6,12 Rel Perf. (%) 7 / 0 / -27
down in the international book to continue. We expect deposits
Financial Snapshot (INR B) to decline ~2% YoY (but grow 2% QoQ).
Y/E March 2017 2018E 2019E 2020E
We expect margins to improve to ~2.9%, as interest income
NII 135.1 161.7 175.8 195.3
reversals continue to moderate.
OP 109.8 129.5 141.5 161.3
NP 13.8 8.4 23.6 41.4 We expect slippages to remain elevated (6.7% annualized). We
NIM (%) 2.2 2.4 2.5 2.5 expect absolute GNPAs to increase 6% QoQ to ~INR514b.
EPS (INR) 6.0 3.4 8.9 15.7 Fee income growth is expected to pick up, but non-interest
EPS Gr. (%) NA -43.1 161.5 75.6 income is expected to decline 27% YoY, as the base period had
BV/Sh. (INR) 151.6 161.2 167.3 180.2 one-off treasury gains from demonetization-related inflows.
ABV/Sh. (INR) 111.9 113.0 124.2 143.4
PAT is expected to be at INR1.7b v/s INR1.1b in 3QFY18, with
RoE (%) 4.0 2.0 5.0 8.4
RoA (%) 0.2 0.1 0.3 0.5
increase in credit costs. Return ratios would still remain sub-
Div. Payout (%) 27.9 31.9 31.2 17.8 optimal. The stock trades at 0.9x FY19E BV and 16.3x FY19E EPS.
Valuations Buy.
P/E(X) 24.2 42.5 16.3 9.3 Key issues to watch for
P/BV (X) 1.0 0.9 0.9 0.8 Stress addition, mainly from the international book.
P/ABV (X) 1.3 1.3 1.2 1.0
Guidance on loan growth, margins and operating expenses.
Div. Yield (%) 1.0 0.7 1.9 1.9
Bank of India
Bloomberg BOI IN CMP: INR108 TP: INR112 (+4%) Neutral
Equity Shares (m) 2006.0
Continued asset quality strain and capital conservation efforts
M. Cap. (INR b)/(USD b) 216 / 3
have led to multiple quarters of muted loan growth. We expect
52-Week Range (INR) 217 / 91
4QFY18 loan growth at ~2% YoY (+6.5% QoQ). We believe deposit
1,6,12 Rel Perf. (%) -3 / -28 / -34
growth will stabilize and expect deposits to stay largely flat (up
Financial Snapshot (INR B) ~1% YoY).
Y/E March 2017 2018E 2019E 2020E We expect NIM to pick up sequentially to 1.9%, with moderation
NII 118.3 107.8 145.8 165.0 in interest income reversals. NII is expected to decline by 18% YoY
OP 97.3 76.3 109.1 121.7 due to sluggish loan book growth and YoY decline in NIM.
NP -15.6 -28.8 12.7 24.3 Non-interest income is likely to be largely flat sequentially (+1.7%
NIM (%) 2.1 1.8 2.2 2.3 QoQ) and decline sharply YoY, given that the base quarter had
EPS (INR) -14.8 -18.8 6.3 12.1 high treasury gains. Fee income is expected to pick up marginally.
EPS Gr. (%) NM 27.4 -133.5 91.8
We expect stress additions to moderate sequentially, as the
ROE (%) -6.7 -7.7 3.0 5.5
previous quarter had divergence-related slippages; recoveries
ROA (%) -0.3 -0.4 0.2 0.3
should pick up sharply, as a bulk of the divergence-related
BV/Sh. (INR) 224 183 186 195
ABV/Sh. (INR) 68 95 132 174
amount has been recovered by the bank.
Div. Payout (%) 0.0 NM 47.9 25.0 We expect operating profit to decline sharply by 47% YoY, led by
Valuations decline in other income absent treasury gains. BOI trades at 0.6x
P/E(X) NM NM 17.1 8.9 FY19E BV and 17.1x FY19E EPS. Neutral.
P/BV (X) 0.48 0.59 0.58 0.55 Key issues to watch for
P/ABV (X) 1.60 1.14 0.82 0.62
Stress addition trends and outlook for FY18.
Upgrade/recovery trends.
Outlook on balance sheet growth and further capital infusion.
Canara Bank
Bloomberg CBK IN CMP: INR269 TP: INR280 (+4%) Neutral
Equity Shares (m) 727.0
We expect slippages to remain elevated. Continued fresh
M. Cap. (INR b)/(USD b) 196 / 3
slippages and ageing of NPLs are expected to keep credit costs
52-Week Range (INR) 463 / 225
high (we factor in ~3.1% credit costs in 4QFY18).
1,6,12 Rel Perf. (%) -5 / -19 / -23
We expect loan growth to pick up to 11% YoY (+2% QoQ) v/s 13%
Financial Snapshot (INR B) YoY (+4% QoQ) in 3QFY18. Deposit growth is expected to be ~2%
Y/E March 2017 2018E 2019E 2020E
QoQ.
NII 98.7 119.7 139.1 161.3
We expect NIM to decline ~80bp QoQ to 2.1% (3QFY18 NIM had a
OP 89.1 98.1 117.0 139.6
NP 11.2 (1.6) 15.9 44.6 55bp contribution from interest on IT refund). Overall NII should
NIM (%) 1.9 2.1 2.2 2.3 grow ~3% YoY due to sluggish advances growth (1.7% YoY).
EPS (INR) 18.8 (2.4) 21.9 61.3 Non-interest income is expected to decline sharply YoY, as the
EPS Gr. (%) NM NM NM NM base quarter had high treasury gains post demonetization.
BV/Sh. (INR) 471 448.7 464.6 519.8 We expect a loss of ~INR8.90, (v/s profit of INR1.3b in 3QFY18,
ABV/Sh. (INR) 234 269.2 314.4 403.2
which included INR7b of interest income on IT refund). The bank
RoE (%) 4.2 (0.4) 4.1 10.8
RoA (%) 0.2 (0.0) 0.2 0.6
trades at 0.6x FY19E BV and 12.3x FY19E EPS. Maintain Neutral.
Div. Payout (%) 6.4 NM 27.5 9.8
Valuations
Key issues to watch for
P/E (x) 14.3 NM 12.3 4.4
P/BV (x) 0.6 0.6 0.6 0.5 Quantum of loans rescheduled under 5:25, SDR and S4A.
P/ABV (x) 1.15 1.0 0.9 0.7 Outlook on balance sheet growth.
Div. Yield (%) 0.4 2.0 2.2 2.2
DCB Bank
Bloomberg DCBB IN CMP: INR168 TP: INR175 (+4%) Neutral
Equity Shares (m) 307.1
Loan growth (23% YoY) and deposit growth (21% YoY) are
M. Cap. (INR b)/(USD b) 52 / 1
expected to be significantly above industry average. Growth will
52-Week Range (INR) 213 / 155
be driven by retail; management intends to curb corporate
1,6,12 Rel Perf. (%) 6 / -14 / -13
growth below 20%.
Financial Snapshot (INR B) Non-interest income is expected to grow ~15% YoY. While fee
Y/E MARCH 2017 2018E 2019E 2020E income is expected to remain healthy, trading gains should
NII 8.0 9.8 11.6 13.4
moderate, as 4QFY17 had one-off treasury gains from
OP 4.2 5.1 6.2 7.2
NP 2.0 2.4 2.9 3.3
demonetization-related liquidity.
EPS (INR) 7.0 7.8 9.4 10.9 Overall, we expect PPP growth to increase ~9% YoY. We model
EPS Gr. (%) 2.3 10.9 21.4 15.2 opex growth of 19% YoY, lower than previous quarters, as the
BV/Sh. (INR) 68.2 83.1 92.0 102.4 pace of branch addition will slow down. Credit costs may be
RoE (%) 10.8 10.6 10.8 11.2 elevated owing to potential stress in the SME and LAP segments
RoA (%) 0.9 0.9 0.9 0.9
(we factor in 1.3% slippage ratio). We expect PBT growth to
Valuations
increase 6% YoY.
P/E (x) 24.0 21.7 17.9 15.5
P/BV (x) 2.5 2.0 1.8 1.6 DCBB trades at 1.8x FY19E BV and 17.9x FY19E EPS. Expensive
valuations leave room for limited upside. Maintain Neutral.
Key issues to watch for
Management commentary on slippages in SME segment.
Update and commentary on balance sheet growth strategy.
CASA ratio and NIM performance.
Quarterly Performance (INR m)
FY17 FY18E FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Interest Income 1,770 1,903 2,095 2,203 2,332 2,481 2,505 2,524 7,971 9,841
% Change (Y-o-Y) 26.1 26.9 30.5 30.6 31.7 30.4 19.6 14.6 28.7 23.5
Other Income 601 616 641 636 858 653 749 734 2,495 2,993
Total Income 2,372 2,519 2,736 2,839 3,189 3,134 3,254 3,258 10,465 12,835
Operating Expenses 1,444 1,511 1,643 1,685 1,825 1,890 2,029 1,996 6,283 7,740
Operating Profit 927 1,009 1,093 1,153 1,364 1,244 1,225 1,261 4,182 5,095
% Change (Y-o-Y) 3.4 29.2 29.7 18.9 47.1 23.4 12.2 9.4 19.8 21.8
Core Operating Profit 755 893 968 1,112 1,364 1,244 1,225 1,261 3,630 4,439
Provisions 205 265 305 339 355 302 343 397 1,115 1,397
Profit before Tax 722 744 787 814 1,009 942 883 864 3,067 3,698
Tax Provisions 252 259 274 286 357 353 313 292 1,070 1,315
Net Profit 470 485 513 529 652 589 570 572 1,997 2,383
% Change (Y-o-Y) 0.3 31.3 24.5 -24.0 38.7 21.5 11.1 8.2 2.6 19.4
Operating Parameters
Deposit (INR b) 156.8 176.8 188.4 192.9 191.5 205.7 213.0 233.4 192.9 233.4
Loan (INR b) 133.4 144.4 145.8 158.2 162.7 174.0 186.0 194.6 158.2 194.6
Deposit Growth (%) 18.2 30.4 33.8 29.2 22.2 16.3 13.0 21.0 29.2 21.0
Loan Growth (%) 27.9 29.1 24.3 22.4 22.0 20.5 27.5 23.0 22.4 23.0
Asset Quality
Gross NPA (INRb) 2.3 2.6 2.3 2.5 2.9 3.2 3.5 3.7 2.5 3.7
Gross NPA (%) 1.7 1.8 1.6 1.6 1.7 1.8 1.9 1.9 1.6 1.9
Net NPA (INRb) 1.2 1.2 1.1 1.2 1.5 1.6 1.6 1.8 1.2 1.8
Net NPA (%) 0.9 0.8 0.7 0.8 0.9 0.9 0.9 0.9 0.8 0.9
PCR (%) 50.0 52.7 52.6 51.1 47.7 50.3 54.4 51.0 51.1 51.0
E: MOSL Estimates
Equitas Holdings
Bloomberg EQUITAS IN CMP: INR148 TP: 185 (+25%) Buy
Equity Shares (m) 337.8
We expect NII growth of 35% YoY due to (a) pickup in loan
M. Cap. (INR b)/(USD b) 50 / 1
growth, as MFI book reduction targets have been largely met, and
52-Week Range (INR) 184 / 130
(b) recalibration in the liability side (sufficient availability of
1,6,12 Rel Perf. (%) 4 / -8 / -25
funds). AUM growth is expected to be ~10% YoY, as securitized
Financial Snapshot (INR B) portfolio continues to be run down.
Y/E March 2017 2018E 2019E 2020E
NIM is expected to expand ~100bp QoQ, with quick-paced
NII 8.7 10.4 12.7 15.4
deposit accretion.
OP 3.7 2.4 4.6 6.8
NP 1.7 0.4 2.4 3.6 Opex is expected to grow by ~23% YoY (v/s 36% YoY growth in
EPS (INR) 5.6 1.1 7.0 10.7 total income), with moderation in employee and other expenses,
EPS Gr. (%) -9.5 -79.9 526.1 51.2 as employee additions related to bank transition have largely
BV/Sh. (INR) 66 67 74 83 been made.
RoE (%) 9.6 1.7 10.0 13.6 Asset quality of UCV and MSME portfolios remains a key
RoA (%) 2.2 0.4 1.7 1.9
monitorable. We factor in provisions of INR273m during the
Valuations
P/E(X) 26.4 131.4 21.0 13.9
quarter, a sharp decline from INR860m in the last quarter, as the
P/BV (X) 2.2 2.2 2.0 1.8 company has completely provided on MFI NPAs.
The stock trades at 2x FY19E BV. Maintain Buy.
Key issues to watch for
Update on the transition progress.
Commentary on growth and asset quality in MFI.
Federal Bank
Bloomberg FB IN CMP: INR92 TP: INR124 (+35%) Buy
Equity Shares (m) 1938.6
We expect FB to report ~22% YoY (5% QoQ) loan growth, aided by
M. Cap. (INR b)/(USD b) 177 / 3
renewed focus on corporate growth. Traction in SME and retail
52-Week Range (INR) 128 / 88
loans would be maintained. We expect NIM to stay flat QoQ, as
1,6,12 Rel Perf. (%) -1 / -25 / -10
any pressure in yields should be supported by benign cost of
Financial Snapshot (INR B) funds.
Y/E Mar 2017 2018E 2019E 2020E
Other income is likely to grow at 4% YoY, with moderation in
NII 30.5 36.3 43.9 52.6
treasury gains partly offset by healthy fee income.
OP 19.2 23.5 29.0 35.1
NP 8.3 10.2 13.1 16.5 Overall PPoP growth is expected to be ~19% YoY, led by strong
NIM (%) 3.3 3.2 3.2 3.2 revenue growth and controlled opex (+8% YoY).
EPS (INR) 4.8 5.6 6.8 8.5 We expect slippages to moderate during the quarter as the
EPS Gr. (%) 74.1 15.3 22.0 25.9 previous quarter had education loan waiver-related slippages of
BV/Sh. (INR) 50.8 63.5 69.4 77.1
INR710m. GNPA is expected to decline marginally to 2.4%.
ABV/Sh. (INR) 47.2 56.8 62.4 69.3
We expect PAT of INR2.8b v/s INR2.6b in 4QFY17 and ~INR2.6b in
ROE (%) 9.9 9.6 10.2 11.7
ROA (%) 0.8 0.8 0.9 0.9 3QFY18. FB trades at 1.3x FY19E BV and 13.6x FY19E EPS. Buy.
Payout (%) 26.1 14.3 12.4 9.9
Valuations Key issues to watch for
P/E(X) 19.1 16.6 13.6 10.8 Outlook on asset quality.
P/BV (X) 1.8 1.4 1.3 1.2
Strategy on balance sheet growth, particularly corporate
P/ABV (X) 1.9 1.6 1.5 1.3
growth.
Div. Yield (%) 1.2 0.9 0.9 0.9
HDFC Bank
Bloomberg HDFCB IN CMP: INR1,916 TP: INR2,400 (+25%) Buy
Equity Shares (m) 2685.6
Loan growth would be strong at 22% YoY. Deposit growth would
M. Cap. (INR b)/(USD b) 5146 / 79
trail loan growth at ~16% YoY, led by CASA inflows.
52-Week Range (INR) 2014 / 1425
CoF decline would help to negate the impact of declining yields
1,6,12 Rel Perf. (%) 4 / 0 / 22
environment, and we expect HDFCB to report flattish margins at
Financial Snapshot (INR B) 4.3% (calculated). NII is expected to grow at 18% YoY.
Y/E MARCH 2017 2018E 2019E 2020E
Other income growth is expected to moderate to ~9% YoY,
NII 331.4 401.6 484.7 588.8 factoring in lower trading gains. Fee income should remain healthy.
OP 257.3 325.0 400.7 496.1 Tie-up with new banca partners would drive fee income growth.
NP 145.5 175.3 219.8 274.8
Opex growth would be lower than total income growth at ~11%
NIM (%) 4.6 4.5 4.5 4.5
YoY, aided by the bank’s strong digital initiatives and focus on
EPS (INR) 56.8 66.8 81.8 102.3
cutting excess flab.
EPS Gr. (%) 16.7 17.7 22.5 25.0
Healthy PPoP growth would lead to 20% YoY PAT growth, in line
BV/Sh. (INR) 335.9 473.6 539.2 623.5
with 20% growth trend exhibited by the bank in the last few
ABV/Sh. (INR) 330.8 449.2 512.8 594.0
years. Asset quality is expected to remain stable, with GNPA at
RoE (%) 17.9 16.2 16.2 17.6
~1.3%.
RoA (%) 1.8 1.8 1.9 2.0
HDFCB trades at 3.6x FY19E BV and 23.4x FY19E EPS. Comfort on
Payout (%) 23.2 21.1 19.9 17.6
Valuations
earnings (~24% CAGR over FY17-20) remains high. Maintain Buy.
P/E(X) 33.7 28.7 23.4 18.7 Key issues to watch for
P/BV (X) 5.7 4.0 3.6 3.1 Performance in retail loan/agri portfolio, especially in CV/CE.
P/ABV (X) 5.8 4.3 3.7 3.2 Trends in digital banking/payments and various initiatives;
Div. Yield (%) 0.6 0.7 0.8 0.9 overall B/S growth outlook and economic recovery.
ICICI Bank
Bloomberg ICICIBC IN CMP: INR270 TP: INR370 (+37%) Buy
Equity Shares (m) 6414.0
We expect loan growth to pick up to ~11% YoY (+2% QoQ).
M. Cap. (INR b)/(USD b) 1729 / 27
Corporate loan growth would be moderate and international loan
52-Week Range (INR) 366 / 241
exposure would continue to decline. Retail loans should continue
1,6,12 Rel Perf. (%) -10 / -9 / -8
to exhibit healthy growth.
Financial Snapshot (INR B) NIM is expected to stay largely flat QoQ at ~3.1% (-40bp YoY), as
Y/E March 2017 2018E 2019E 2020E cost of funds remains favorable. NII is expected to decrease ~2%
NII 217.4 228.7 254.9 292.5 YoY.
OP 264.9 257.8 285.5 331.3 Total other income should increase sharply, led by gains from
NP 98.0 71.3 116.4 163.8 stake sale in ICICI Securities.
NIM (%) 3.3 3.1 3.1 3.1
Gross slippages are expected to increase from 3QFY18 levels and
EPS (INR) 15.3 11.1 18.1 25.5
remain high (8.2% slippage ratio).
EPS Gr (%) 0.6 -27.2 63.0 40.8
We expect PAT of INR13.8b v/s INR20.2b in 4QFY17 and INR16.5b
BV/Sh (INR)* 135.4 136.6 151.1 171.7
in 3QFY18. ICICIBC trades at 1x FY19E core BV and 8.2x FY19E EPS.
ABV/Sh (INR)* 107.9 120.7 135.6 157.1
Buy.
RoE (%) 10.2 7.2 11.1 14.3
RoA (%) 1.3 0.9 1.3 1.6
Key issues to watch for
Valuations
AP/E (x) 13.1 13.3 8.2 5.8
Movement of watch-list accounts.
AP/BV (x) 1.1 1.1 1.0 0.9 Plans on monetization of stakes in various ventures.
AP/ABV (x) 1.4 1.2 1.1 0.9 Outlook on asset quality and trend on further relapse from RL.
* BV ADJ FOR INVT IN SUBSIDIARIES
Indian Bank
Bloomberg INBK IN CMP: INR307 TP: INR371 (+21%) Buy
Equity Shares (m) 480.3
Loan growth is expected to pick up further to ~20% YoY (+3%
M. Cap. (INR b)/(USD b) 147 / 2
QoQ), led by balance sheet recalibration. Deposit growth is
52-Week Range (INR) 428 / 252
expected be 17% YoY (3% QoQ).
1,6,12 Rel Perf. (%) -1 / 11 / -2
Calculated NIM is expected to be flattish at 3%. NII will grow
Financial Snapshot (INR b) ~21% YoY on a low base.
Y/E March 2017 2018E 2019E 2020E Overall non-interest income is expected to decline 16% YoY, led
NII 51.5 63.0 70.6 82.2 by healthy traction in fee income.
OP 40.0 50.8 53.1 58.1 We expect slippage ratio to remain elevated at 2.3% and credit
NP 14.1 14.6 20.0 22.9 costs to elevate to 2.1% (1.2% in 3QFY18).
EPS (INR) 29.3 30.3 41.6 47.7 INBK trades at 0.9x FY19E BV and 7.4x FY19E EPS. Maintain Buy.
EPS Gr. (%) 97.6 3.7 37.2 14.5
BV/Sh. (INR) 301 324 356 392 Key issues to watch for
ABV/Sh. (INR) 247 281 314 351 Outlook on business growth and asset quality remain the key
RoE (%) 10.1 9.7 12.3 12.7 factors to monitor.
RoA (%) 0.7 0.6 0.7 0.7 Quantum of loans rescheduled under the 5/25 scheme.
Payout (%) 23.9 26.1 22.8 22.7 View on margins with an improvement in liquidity and lower
Valuations interest rates.
P/E(X) 10.5 10.1 7.4 6.4
P/BV (X) 1.0 0.9 0.9 0.8
P/ABV (X) 1.25 1.09 0.98 0.87
Div. Yield (%) 2.3 2.6 3.1 3.5
IndusInd Bank
Bloomberg IIB IN
CMP: INR1,830 TP: INR2,250 (+23%) Buy
Equity Shares (m) 598.2
We expect strong loan growth of ~26% YoY in 4QFY18,
M. Cap. (INR b)/(USD b) 1,095 / 17
significantly ahead of system loan growth. Deposit growth should
52-Week Range (INR) 1,841 / 1,375
10 / 2 / 19
be strong at 27% YoY. Continued market share gains in VF would
1,6,12 Rel Perf. (%)
remain a key factor to monitor. NIM is likely to stay flattish at
FINANCIAL SNAPSHOT (INR BILLION) ~4.1%. The quantum of CASA retained would be a key factor.
Y/E MARCH 2017 2018E 2019E 2020E We expect non-interest income to grow ~2%, supported by
NII 60.6 75.1 94.8 120.1 healthy fee income growth. Stronger contribution of third-party
OP 54.5 66.4 84.4 108.4 distribution fees owing to increased inflows into MFs and
NP 28.7 36.1 46.6 59.9 insurance industry should continue to support higher third-party
NIM (%) 4.2 4.2 4.2 4.2
distribution fees.
EPS (INR) 48.1 60.4 78.0 100.2
Opex growth would remain high at ~15%+ YoY v/s 13% growth in
EPS Gr. (%) 18.2 25.7 29.0 28.4
total income. Healthy PPP growth (+12% YoY) and controlled
BV/Sh. (INR) 345 397 463.3 548.8
credit costs would keep earnings growth strong at 28%+ YoY.
ABV/Sh. (INR) 331 380 446.0 530.3
IIB trades at 3.9x FY19E BV and 23.5x FY19E EPS, with best-in-
RoE (%) 15.3 16.6 18.4 20.0
class RoA of ~1.9% and RoE of 17-19%. Buy.
RoA (%) 1.8 1.8 1.9 1.9
Valuations
P/E (X) 38.1 30.3 23.5 18.3 Key issues to watch for
P/BV (X) 5.3 4.6 3.9 3.3 Continued CV/CE growth would be the key for CFD growth.
P/ABV (X) 5.5 4.8 4.1 3.5 Corporate asset quality a key monitorable.
Traction in the non-vehicle consumer lending portfolio.
RBL Bank
Bloomberg RBK IN CMP: INR483 TP: INR628 (+30%) Buy
Equity Shares (m) 415.6
Loan growth (+35% YoY) and deposit growth (+23% YoY) would be
M. Cap. (INR b)/(USD b) 201 / 3
significantly above industry average.
52-Week Range (INR) 600 / 443
We expect NII to grow 48% YoY, led by strong loan growth and
1,6,12 Rel Perf. (%) 2 / -11 / -16
favorable NIM, helped by strong CASA inflows and fall in bulk
Financial Snapshot (INR B) deposit rates.
Y/E March 2017 2018E 2019E 2020E
Overall non-interest income is expected to grow ~15% YoY, led by
NII 12.2 17.9 23.0 30.2
strong growth in fee income and digital initiatives. We expect
OP 9.2 13.2 17.6 23.2
NP 4.5 6.4 9.0 12.2 opex growth of 36%, led by continued capacity expansion.
NIM (%) 3.0 3.4 3.4 3.4 However, opex is expected to trail total income growth of 35%,
EPS (INR) 11.9 15.4 21.8 29.3 driving 34% YoY increase in PPoP.
EPS Gr. (%) 29.3 41.5 34.7 Asset quality is expected to remain largely stable in 4QFY18; MFI
BV/Sh. (INR) 113.4 155.5 173.4 197.6 and agri segment stress is expected to stabilize. Credit costs
ABV/Sh. (INR) 109.8 151.5 169.1 192.7
would largely be under control.
RoE (%) 12.3 11.9 13.2 15.8
We expect PAT growth of 10% QoQ and 40% YoY. RBK trades at
RoA (%) 1.0 1.2 1.3 1.3
Valuations 2.8x FY19E BV and 22.2x FY19E EPS. We await management
P/E(X) 40.6 31.4 22.2 16.5 commentary on asset quality and growth outlook, and maintain
P/BV (X) 4.3 3.1 2.8 2.4 our Buy rating.
P/ABV (X) 4.4 3.2 2.9 2.5 Key issues to watch for
Div. Yield (%) 0.4 0.5 0.7 0.9
Management commentary on slippages in SME segment.
Update and commentary on balance sheet growth strategy.
CASA ratio and traction on NIMs.
Yes Bank
Bloomberg YES IN CMP: INR313 TP: INR382 (+22%) Buy
Equity Shares (m) 2282.4
We expect loan growth to be significantly ahead of system
M. Cap. (INR b)/(USD b) 714 / 11
average at 39% YoY on the back of refinancing opportunities and
52-Week Range (INR) 383 / 275
1,6,12 Rel Perf. (%)
strong growth in retail banking.
-1 / -17 / -10
We expect NIM to improve YoY, helped by lower cost of funds on
Financial Snapshot (INR B) account of CASA inflows and re-pricing of bulk deposits.
Y/E March 2017 2018E 2019E 2020E
Consequently, NII growth is expected to be healthy at 26% YoY,
NII 58.0 76.5 99.3 125.1
one of the best among peers.
OP 58.4 77.2 100.9 128.2
NP 33.3 41.6 53.4 68.9 Non-interest income growth is likely to be ~18% YoY, led by
NIM (%) 3.4 3.4 3.5 3.5 strong growth from third-party distribution and processing fees.
EPS (INR) 14.6 18.2 23.4 30.2 We expect opex growth to be 19%, as the bank invests in
EPS Gr. (%) 20.8 25.0 28.4 28.9 technology to leverage retail base.
BV/Sh. (INR) 93.7 112.8 132.4 158.2 Asset quality performance so far has been significantly better
ABV/Sh. (INR) 78.5 107.6 127.6 153.1
than industry; we expect this trend to continue. YES trades at 2.4x
RoE (%) 18.9 17.4 19.1 20.8
RoA (%) 1.8 1.7 1.7 1.7
FY19E BV and 13.4x FY19E EPS. Return ratios also remain strong
Valuations (RoA of 1.7% and RoE of 19.1%). Maintain Buy.
P/E(X) 21.5 17.2 13.4 10.4 Key issues to watch for
P/BV (X) 3.3 2.8 2.4 2.0 Implementation of retail strategy on assets and liabilities sides.
P/ABV (X) 4.0 2.9 2.5 2.0 Performance on asset quality and quantum of loans rescheduled
Div. Yield (%) 0.8 0.6 1.2 1.4
under 5:25 scheme/sale to ARCs.
Financials - NBFCs
Company name Vehicle financiers lead the pack
Bajaj Finance Vehicle financiers could surprise on the upside
Capital First Core housing growth has stabilized post RERA implementation, and tier II and III
Chola. Inv & Fin. locations are the key growth drivers. For housing finance corporations (HFCs), we
expect the share of non-retail loans in the overall portfolio to inch higher.
Dewan Housing
Growth rates will remain healthy for segments like consumer durables, two-wheelers
GRUH Finance and vehicle finance. M&HCV demand has been strong in the quarter – GoI’s infra push
HDFC being the key driving factor.
Farm loan waivers and normal monsoon have lifted sentiment in the rural economy.
Indiabulls Housing
The focus on collections has also helped companies ensure strong recoveries. Vehicle
L&T Finance financiers are expected to report healthy asset quality and growth.
LIC Housing Fin We expect a gradual improvement for microfinance institutions (the most impacted
segment post demonetization) in terms of both growth and asset quality. Our
M & M Financial
interactions with gold financiers suggest that growth is slowly coming back.
MAS Financial Elevated G-Sec yields could play a spoilsport over the medium term from a spreads
Muthoot Finance perspective. Yields have hardened 100bp+ from their lows six months ago. If they
sustain at these levels, HFCs would be most impacted. Vehicle financiers have pricing
PNB Housing
power to maintain margins.
Repco Home Fin BAF, CAFL, MASFIN, CIFC and PNBHF are likely to post earnings growth of 25%+ YoY,
Shriram City Union which is commendable, in our view. Our top picks in this space are HDFC, SHTF, BAF
Shriram Transport Fin.
and CIFC.
HFCs – G-Sec yields key monitorable: HFCs under our coverage are likely to post
AUM growth in line with past trends. Repco may witness another muted quarter, as
state-specific issues in Tamil Nadu are yet to be resolved. We expect the shift
toward LAP for LICHF and toward corporate loans (opportunistic in LRD segment) for
HDFC to continue. Core retail housing yields are expected to remain under pressure
due to intense competition. The benefit of cost of funds is likely to recede, given
100bp+ increase in G-Sec yields over the last six months. G-Sec yield is a key
monitorable.
Gold financiers – recovery taking root: Over the past year, AUM of most gold
financiers has been stable. Our interactions with companies suggest that they have
witnessed some green shoots of recovery in the past quarter.
Research Analyst: Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 6129 1526 | Piran Engineer (Piran.Engineer@MotilalOswal.com); +91 22 6129 1539
Nitin Aggarwal (Nitin.Aggarwal@MotilalOswal.com); +91 22 6129 1542 | Shubhranshu Mishra (Shubhranshu.Mishra@MotilalOswal.com); +91 22 6129 1540
April 2018 160
March 2018 Results Preview | Sector: Financials
Exhibit 2: Relative performance—3 months (%) Exhibit 3: Relative performance—1 year (%)
Sensex Index MOSL Financials Index Sensex Index MOSL Financials Index
115 146
110 132
105 118
100 104
95 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Bajaj Finance
Bloomberg BAF IN
CMP: INR1,832 TP: INR2,330 (+27%) Buy
Equity Shares (m) 573.5
M. Cap. (INR b)/(USD b) 1051 / 16 We expect AUM growth of 35% YoY, driven by consumer durables
52-Week Range (INR) 1989 / 1153 financing, in which the company continues to increase its market
1,6,12 Rel Perf. (%) 12 / -8 / 43 share. Rural business too should register strong growth, albeit off a
low base.
Financial Snapshot (INR b) Calculated margins are expected to remain largely stable on YoY
Y/E Mar 2017 2018E 2019E 2020E basis at 11.5%.
NII 54.7 75.5 101.7 132.2 With investments in upgradation of systems, C/I ratio is expected to
PPP 36.4 50.2 70.5 94.0 remain largely stable YoY at 43%.
PAT 18.4 25.7 35.4 47.5 Asset quality is likely to remain stable. We expect provisions of
EPS (INR) 32.0 44.8 61.7 82.8 INR2.6b as against INR2.5b in 3QFY18 and INR2.9b in 4QFY17.
EPS Gr. % 43.6 39.8 37.8 34.2 Net profit is likely to grow 43% YoY to INR6.4b.
BV/Sh. INR 167 284 337 407 The stock trades at 5.4x FY19E and 4.5x FY20E BV. Maintain Buy.
RoA (%) 3.3 3.4 3.6 3.7
RoE (%) 21.6 19.8 19.9 22.3
Key issues to watch for
Payout (%) 14.0 12.5 12.5 12.5
Architecture of Bajaj Housing Finance.
Valuations
P/E (x) 57.2 40.9 29.7 22.1 Incremental customer acquisition.
P/BV (x) 10.9 6.4 5.4 4.5 Asset quality trends, especially in LAP and 2W/3W businesses.
Div. Yld.% 0.2 0.3 0.4 0.6 Traction in cross-sell franchise.
Capital First
Bloomberg CAFL IN
CMP: INR643 TP: INR960 (+49%) Buy
Equity Shares (m) 97.4
M. Cap. (INR b)/(USD b) 63 / 1 The company is likely to maintain its strong growth trajectory. AUM
52-Week Range (INR) 902 / 610 is likely to grow 5% QoQ and 31% YoY, driven by low base of post-
1,6,12 Rel Perf. (%) -2 / -18 / -28 demonetization 4QFY17, and market share gains in the 2W
segment.
Financial Snapshot (INR m) With margin expansion of 100bp YoY, NII is likely to grow 49% YoY
Y/E Mar 2017 2018E 2019E 2020E to INR5.6b.
NII 12.3 18.7 24.2 30.4 Cost-to-income ratio is expected to remain largely stable annually at
PPP 8.1 11.6 15.5 19.8 51%.
PAT 2.4 3.3 4.3 5.5
Asset quality is likely to remain stable. We factor in provisions of
EPS (INR) 24.6 34.2 44.6 56.8
EPS Gr. % 34.2 38.9 30.2 27.5
INR1.9b as against INR1.7b in 3QFY18 and INR1.3b in 4QFY17.
BV/Sh.INR 234.4 264.9 305.2 357.3 Net profit is likely to grow 40% YoY to INR1b.
RoA on AUM.% 1.6 1.7 1.8 1.8 The stock trades at 2.1x FY19E and 1.8x FY20E BV. Maintain Buy.
RoE (%) 12.0 13.7 15.6 17.2
Payout.% 10.6 9.0 8.0 7.0
Key issues to watch for
Valuations
P/E (x) 26.1 18.8 14.4 11.3
Management commentary on growth trends/demand for loans.
P/BV (x) 2.7 2.4 2.1 1.8 Trend in write-offs and overall credit costs.
Div. Yld.% 0.4 0.5 0.6 0.6 Guidance on C/I ratio.
Movement in borrowing costs and margins.
Gruh Finance
Bloomberg GRHF IN
CMP: INR594 TP: INR550 (-7%) Neutral
Equity Shares (m) 364.6
M. Cap. (INR b)/(USD b) 217 / 3 We expect loan growth to be largely in line with trend at 5% QoQ
52-Week Range (INR) 714 / 368 and 18% YoY.
1,6,12 Rel Perf. (%) 13 / 12 / 38 Calculated margins are likely to be largely stable YoY at 5.7%.
As a result, NII is likely to grow 16% YoY to INR2.2b.
Financial Snapshot (INR b) Operating expense growth is expected to be 16%, resulting in 17%
Y/E March 2017 2018E 2019E 2020E YoY growth in PPoP.
NII 5.2 6.7 7.8 9.4 We expect collections to be high. We expect provisions of INR26m
PPP 4.7 6.2 7.2 8.8 for the quarter.
PAT 3.0 3.6 4.2 5.2 Net profit is likely to grow 18% YoY to INR1.3b.
EPS (INR) 8.1 9.9 11.6 14.4 The stock trades at 14.8x FY19E and 12.2x FY20E BV. Maintain
EPS Gr. % 21.5 21.3 17.7 23.8 Neutral.
BV/Sh.INR 27.2 33.1 40.1 48.8
ABV/Sh.INR 27.2 33.1 40.1 48.8
Key issues to watch for
RoA (%) 2.4 2.4 2.4 2.4
32.5 32.7 31.7 32.4
Disbursement growth v/s loan growth.
RoE (%)
Payout (%) 34.0 34.0 34.0 34.0 Outlook on margins.
Valuations Management’s plan for geographic expansion.
P/E (x) 73.0 60.2 51.1 41.3 Guidance on opex.
P/BV (x) 21.9 17.9 14.8 12.2
Div. Yld. % 0.5 0.6 0.7 0.8
HDFC
Bloomberg HDFC IN
CMP: INR1,830 TP: INR2,225 (22%) Buy
Equity Shares (m) 1663.4
We estimate AUM growth of 19% YoY, in line with the trend in
M. Cap. (INR b)/(USD b) 3044 / 47
the prior quarters. We expect the pick-up in corporate loan
52-Week Range (INR) 1982 / 1461
growth to sustain.
1,6,12 Rel Perf. (%) 3 / -2 / 8
NII is expected to grow 14% YoY, with calculated margins
declining by 25bp YoY.
Financial Snapshot (INR b) Operating expenses will grow 10% YoY to INR2.1b.
Y/E Mar 2017 2018E 2019E 2020E Asset quality has remained healthy over past several quarters,
NII 99.5 113.7 131.8 153.4 and the trend is likely to continue. Asset quality in the corporate
PAT 74.4 116.6 96.3 112.5 loan book would be a key monitorable.
Adj. EPS.INR 35.7 39.9 47.7 56.3 We estimate provisions at INR1b v/s INR1.5b in 4QFY17.
EPS Gr. (%) 9.6 12.0 19.5 18.0
We expect reported PAT of INR23.4b in the quarter, manifesting a
BV/Sh. INR 253.0 372.4 429.1 470.4
growth of 14% YoY.
The stock trades at 2.9x FY19E AP/ABV and 2.1x FY20E AP/ABV
ABV/Sh. INR 201.2 244.9 304.3 345.5
(price adjusted for value of other businesses and book value
RoAA (%) 2.0 1.9 1.9 1.9
adjusted for investments made in those businesses). Buy.
Core RoE.% 18.9 18.3 17.5 17.3
Payout (%) 37.1 34.5 42.9 38.9
Key issues to watch for
Valuation
Loan growth and uptick in corporate loans.
AP/E (x) 33.2 25.7 18.7 12.7
Loan growth in affordable housing segment.
P/BV (x) 7.2 4.9 4.3 3.9
Movement in spreads and margins (on individual loans), and
AP/ABV (x) 5.9 4.2 2.9 2.1
asset quality trends.
Div. Yld (%) 1.0 0.7 1.0 1.0
Indiabulls Housing
Bloomberg IHFL IN
CMP: INR1,292 TP: INR1,630 (+26%) Buy
Equity Shares (m) 421.3
M. Cap. (INR b)/(USD b) 545 / 8 AUM growth is expected to remain robust at 9% QoQ and 28% YoY.
52-Week Range (INR) 1439 / 922 Total income (including investment income) should grow 24% YoY
1,6,12 Rel Perf. (%) 5 / -1 / 18 to INR18.5b.
Expenses (including provisions) are likely to decrease 11% YoY to
Financial Snapshot (INR b) INR4.6b (off a high base of post-demonetization 4QFY17).
Y/E Mar 2017 2018E 2019E 2020E
Asset quality is expected to remain stable.
Net Fin inc 35.3 49.7 60.8 75.8
PPP 45.5 60.6 69.0 84.8 PAT is likely to grow 25% YoY to INR10.5b during the quarter.
EPS INR 68.6 90.9 104.6 127.4 The stock trades at 3.5x FY19E and 3.1x FY20E BV. Maintain Buy.
EPS Gr. % 23.2 32.6 15.0 21.8
BV/Sh. INR 286.0 324.0 367.0 420.0
Key issues to watch for
RoA on AUM (%) 3.4 3.4 3.0 2.8
AUM growth trend and guidance.
RoE (%) 25.5 29.8 30.3 32.4
Payout (%) 39.3 50.0 50.0 50.0
Movement in incremental spreads and margins, especially given
Valuations the sharp home loan rate cuts.
P/E (x) 18.8 14.2 12.4 10.1 Asset quality trends in the corporate and LAP segments.
P/BV (x) 4.5 4.0 3.5 3.1
P/ABV (x) 4.5 4.0 3.5 3.1
Div. Yld % 2.1 3.5 4.0 4.9
L&T Finance
Bloomberg LTFH IN
CMP: INR162 TP: INR240 (+48%) Buy
Equity Shares (m) 1817.2
M. Cap. (INR b)/(USD b) 295 / 5
The company is likely to report strong numbers in the rural and
52-Week Range (INR) 214 / 119 housing finance segment. Performance in the wholesale finance
1,6,12 Rel Perf. (%) 2 / -23 / 20 segment is a key monitorable.
We expect 22% YoY growth in the focus segments, driven by
33%/47%/11% YoY growth in the rural/housing/wholesale
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
segments. AUM (including de-focused book) is likely to cross
NII 31.4 37.2 43.6 50.0
INR790b.
PPP 26.7 36.1 43.5 51.4 Total income is likely to grow 33% YoY, driven by loan mix (rural
PAT 9.2 13.3 17.8 22.5 and housing have higher margins than wholesale finance) and
EPS (INR) 5.2 6.7 9.0 11.3 increased contribution from non-fund-based businesses.
BV/Sh. INR 44.3 61.7 69.3 79.0 Asset quality is likely to remain stable. We model provisions of
RoAA (%) 1.3 1.7 1.9 2.1 INR5.4b, as against INR4.9b in 3QFY18 and INR6.9b in 4QFY17.
RoE (%) 12.4 13.3 13.7 15.3 The stock trades at 2.3x FY19E and 2.1x FY20E BV. Maintain Buy.
Payout (%) 19.8 15.2 14.9 14.7
Valuation Key issues to watch for
P/E (x) 30.9 24.1 18.1 14.3
Commentary on outlook for rural and housing finance segment.
P/BV (x) 3.7 2.6 2.3 2.1
Competition in the wholesale finance segment, especially
Div. Yld (%) 0.6 0.5 0.7 0.9
renewables.
Asset quality outlook in the builder financing segment.
RoE target post capital infusion.
MAS Financial
Bloomberg MASFIN IN
CMP: INR607 TP: INR750 (+24%) Buy
Equity Shares (m) 54.7
M. Cap. (INR b)/(USD b) 33 / 1 The company is likely to have a stable quarter. We expect AUM
52-Week Range (INR) 701 / 541 growth of 26% YoY, driven by 25% disbursement growth. Loan
1,6,12 Rel Perf. (%) 4/-/- mix is likely to be largely stable.
Calculated margins are expected to expand ~200bp on a YoY basis
Financial Snapshot (INR b) to 8.6%. As a result, NII growth should come in at 67%.
Y/E Mar 2017 2018E 2019E 2020E With 45% YoY growth in opex, C/I ratio is likely to decline 400bp
NII 1,721.0 2.5 3.2 3.9 to 28.6%.
PPP 1,333.0 2.0 2.6 3.2 Asset quality is likely to remain stable. We expect provisions to be
PAT 646.0 1.0 1.3 1.6 sequentially stable at INR1.3b.
EPS (INR) 15.0 18.6 24.2 30.0 Net profit is likely to grow 97% YoY to INR294m.
BV/Sh (INR) 66.2 132.9 151.0 173.5
The stock trades at 4x FY19E and 3.5x FY20E BV. Maintain Buy.
RoA on AUM. % 2.1 2.7 2.8 2.8
RoE (%) 30.5 20.2 17.0 18.5
Valuations
P/E (x) 40.4 32.6 25.1 20.2
Key issues to watch for
P/BV (x) 9.2 4.6 4.0 3.5 Guidance on growth trends and loan mix.
Asset quality performance.
Management commentary on increasing competitive intensity
and margin trends.
Muthoot Finance
Bloomberg MUTH IN
CMP: INR417 TP: INR475 (+14%) Neutral
Equity Shares (m) 399.5
AUM is expected to grow 6% YoY to INR289b.
M. Cap. (INR b)/(USD b) 166 / 3
Margins should contract ~130bp YoY to 15.9% due to the high base
52-Week Range (INR) 526 / 360
in 4QFY17.
1,6,12 Rel Perf. (%) 9 / -18 / -2
We expect total income to decline 3% YoY to INR11.4b.
Asset quality is likely to be stable in 4QFY18, as collections should
Financial Snapshot (INR b)
be high.
Y/E March 2017 2018E 2019E 2020E
We estimate provisions of INR515m as against INR564m in 3QFY18.
NII 33.6 41.5 41.7 46.1
PAT is expected to grow 51% YoY to INR4.9b.
PPP 22.0 30.1 29.3 32.4
The stock trades at 1.8x FY19E and 1.6x FY20E BV. Maintain
PAT 11.8 17.6 17.8 19.9
Neutral.
EPS (INR) 29.5 44.0 44.7 49.8
BV/Sh.(INR) 163.1 196.5 230.3 268.0 Key issues to watch for
RoA on AUM (%) 4.6 6.3 5.9 6.0 Management commentary on business growth and steps taken to
RoE (%) 19.4 24.5 20.9 20.0 sustain AUM growth.
Div. Yld. (%) 1.4 2.1 2.1 2.4 Plan of branch expansion.
P/E (x) 14.1 9.5 9.3 8.4 Movement in yields and margins, with declining cost of funds.
P/BV (x) 2.6 2.1 1.8 1.6 Progress in gold auctions.
Healthcare
Company name Niche product approvals to offset regulatory impact on US
Alembic Pharma business; domestic business to recover from GST woes
Ajanta Pharma
Alkem Lab We expect our Pharma universe to continue reporting low-single-digit revenue
Aurobindo Pharma growth, as faster ANDAs approvals and regulatory issues pertaining to the USFDA
Biocon inspection hurt the US business. A few companies are expected to post a
Cadila Health significant decline in EBITDA during the quarter. Having said that, our pharma
Cipla universe is expected to report robust growth during the quarter, mainly due to a
Divis Labs
lower base of 4QFY17 (impacted by demonetization).
Dr Reddy’ s Labs
Cadila is expected to continue exhibiting strong growth in the US, led by gLialda
Fortis Health
launch and ramp-up in key products. Glenmark is expected to decline
Glenmark Pharma
GSK Pharma
significantly due to a high base of the year-ago period, which saw the launch of
IPCA Labs. gZetia FTF (launched in 3QFY17, with six months exclusivity). Sun Pharma and
Jubilant Life Lupin, too, are expected to disappoint due to a fall in the US business, led by
Lupin pricing pressure in the base business. Sanofi India, Granules, Ipca, Jubilant life
Sanofi India and Aurobindo are expected to post mid-double-digit growth.
Shilpa Medicare In 4QFY18, the domestic business is expected to report strong growth as the
Strides Shasun industry bounces back from GST woes and low base of 4QFY17 (impacted by
Sun Pharma demonetization). Although the US business is under pressure from increased
Torrent Pharma
pace of ANDA approvals and regulatory issues, we believe key product approvals
will help negate these issues.
We maintain our top picks – Sun Pharma, Granules and IPCA.
104 116
104
97
92
90 80
Dec-17
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Source: Bloomberg, MOSL
Exhibit 5: Comparative valuation
Sector / Companies CMP RECO EPS (INR) PE (x) EV/EBIDTA (x) ROE (%)
(INR) FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY20E
Healthcare
Alembic Pharma 542 Neutral 24.8 25.6 30.5 21.9 21.2 17.8 14.5 13.4 11.2 22.5 19.8 20.1
Alkem Lab 1,910 Buy 65.4 89.5 110.6 29.2 21.3 17.3 19.3 15.1 12.2 16.4 19.5 20.6
Ajanta Pharma 1,402 Buy 54.0 65.8 81.4 26.0 21.3 17.2 18.3 15.3 12.2 27.0 26.2 25.9
Aurobindo Pharma 593 Buy 43.8 48.7 53.6 13.6 12.2 11.1 8.8 8.1 6.9 24.2 21.7 19.6
Biocon 607 Neutral 7.6 10.9 19.8 79.7 55.7 30.7 38.1 28.2 17.9 8.9 11.6 18.4
Cadila Health 394 Buy 16.0 20.1 23.3 24.6 19.6 16.9 15.2 12.8 11.0 21.6 22.8 22.0
Cipla 571 Neutral 21.6 26.2 32.0 26.4 21.8 17.8 15.2 13.4 11.1 12.4 13.3 14.1
Divis Labs 1,107 Neutral 32.9 44.0 52.7 33.7 25.2 21.0 23.1 17.0 14.0 16.0 20.0 21.3
Dr Reddy’ s Labs 2,129 Neutral 67.1 114.1 146.1 31.7 18.7 14.6 14.7 9.7 7.5 9.0 13.9 15.6
Fortis Health 130 Buy 1.5 2.8 7.3 88.5 47.1 17.8 17.5 10.8 6.7 1.2 2.2 5.6
Glenmark Pharma 550 Neutral 30.6 32.9 41.1 18.0 16.7 13.4 11.5 11.3 9.4 16.4 15.3 16.2
Granules India 108 Buy 6.3 7.9 11.0 17.1 13.6 9.8 10.5 7.7 5.9 13.2 13.9 17.4
GSK Pharma 2,152 Neutral 38.3 42.6 48.5 56.2 50.5 44.4 34.8 33.5 28.9 19.7 27.2 30.9
IPCA Labs. 677 Buy 21.4 29.2 37.3 31.6 23.1 18.1 17.8 13.6 10.9 10.5 13.0 14.7
Jubilant Life 847 Buy 47.8 62.6 72.5 17.7 13.5 11.7 10.7 8.5 7.2 19.7 21.4 20.4
Laurus Labs 514 Buy 19.0 29.1 35.7 27.0 17.7 14.4 14.6 11.0 9.3 14.1 18.3 18.8
Lupin 789 Buy 31.0 40.2 54.1 25.4 19.6 14.6 12.2 10.6 8.2 10.1 12.1 14.6
Sanofi India 5,147 Buy 141.7 161.8 186.9 36.3 31.8 27.5 20.8 17.0 14.4 16.1 16.8 17.5
Sun Pharma 510 Buy 13.2 21.5 27.7 38.7 23.7 18.4 20.6 14.2 10.9 8.5 13.2 15.3
Shilpa Medicare 471 Buy 13.3 24.3 30.6 35.4 19.4 15.4 23.9 17.2 13.5 11.0 17.4 18.3
Strides Shasun 704 Buy 14.1 40.8 55.7 49.9 17.3 12.6 18.1 11.0 8.8 4.6 12.1 14.5
Torrent Pharma 1,288 Neutral 48.0 61.3 78.5 26.8 21.0 16.4 15.9 11.3 9.4 17.6 19.9 22.3
Sector Aggregate 28.9 21.5 17.1 16.2 12.8 10.2 12.3 14.7 16.0
Ajanta Pharma
Bloomberg AJP IN CMP: INR1,402 TP:INR1,840 (+31%) Buy
Equity Shares (m) 88.5
We expect Ajanta Pharma (AJP) to show 4.7% YoY growth in
M. Cap. (INR b)/(USD b) 124 / 2
revenues on a high base of past year. Except domestic
52-Week Range (INR) 1818 / 1106
1,6,12 Rel Perf. (%) 2 / 18 / -31
formulation segment, we expect a YoY reduction in revenue in all
segments.
With a pick-up in industry growth, we expect AJP to outperform
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E by growing at 15% YoY due to product launches and better
Sales 20.0 20.8 24.9 29.7 traction in the existing portfolio.
EBITDA 6.9 6.5 7.7 9.4 We expect a decline in Institutional segment of Africa business, as a
NP 5.1 4.8 5.8 7.2 considerable amount of allocated business was supplied in 9MFY18
EPS (INR) 57.3 54.0 65.8 81.4 and the company is yet to receive order to supply for CY2018.
EPS Gro. (%) 21.9 -5.8 21.9 23.6 Though Asia sales are expected to continue at a healthy quarterly
BV/Sh. (INR) 177.2 223.1 279.1 348.2 run-rate, there would be YoY and QoQ decline due to a high base.
RoE (%) 36.7 27.0 26.2 25.9 On overall basis, we expect EBITDA margin to come in at 28.3%
RoCE (%) 35.8 26.9 26.1 25.9 and PAT at INR1b for 4QFY18.
Valuations The stock trades at 21.3x FY19E EPS. We maintain Buy, with a
P/E (x) 24.4 26.0 21.3 17.2 target price of INR1,840 (25x 12M forward earnings).
P/BV (x) 7.9 6.3 5.0 4.0 Key issues to watch out
EV/EBITDA (x) 17.9 18.7 15.6 12.4 Quantum of institutional business to be allocated by Global
EV/Sales (x) 6.2 5.9 4.8 3.9 Fund for next three years.
D. Yield (%) 0.9 0.6 0.7 0.9 Traction from recently launched products in US market.
Alembic Pharma
Bloomberg ALPM IN CMP: INR542 TP:INR555 (+2%) Neutral
Equity Shares (m) 188.5
In 4QFY18, we expect Alembic Pharma (ALPM) to post healthy
M. Cap. (INR b)/(USD b) 102 / 2
growth in sales by ~11% YoY to INR8.2b. International business is
52-Week Range (INR) 645 / 470
1,6,12 Rel Perf. (%) 0 / 2 / -24
expected to grow ~14% YoY to INR3.1b. India business is expected
to post robust growth of 25.5% YoY to INR3.6b due to a low base
(4QFY17 was impacted by demonetization and NLEM-related
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
price control).
Sales 31.3 31.3 35.9 41.0
Reported EBITDA is likely to post growth of ~37%YoY to INR1.8b,
EBITDA 6.1 6.9 7.4 8.8
with EBITDA margin expanding 410bp YoY to 22.2%.
NP 4.0 4.7 4.8 5.7
We expect reported PAT to increase by 22% YoY to INR1.1b.
EPS (INR) 21.6 24.8 25.6 30.5
Given that the recent investments in oncology, derma and opthal
EPS Gro. (%) -43.2 15.0 3.1 19.1 filings are expected to fetch returns only from FY20 and beyond,
BV/Sh. (INR) 100.8 119.7 139.3 163.7 high R&D expense, depreciation and pricing pressure in the US
RoE (%) 23.0 22.5 19.8 20.1 will keep growth under check in the near term. Maintain Neutral
RoCE (%) 22.1 21.9 19.5 25.6 with a TP of INR555 @20x 1HFY20E EPS (v/s INR540 @20x
Valuations 1HFY20E EPS.
P/E (x) 25.1 21.8 21.2 17.8
P/BV (x) 5.4 4.5 3.9 3.3 Key issues to watch out
EV/EBITDA (x) 15.4 13.2 12.4 10.3 Contribution of chronic portfolio and growth strategy.
EV/Sales (x) 3.0 2.9 2.5 2.2 Performance of US operations amid market pressure.
D. Yield (%) 0.9 0.9 0.9 0.9 Outlook on future ANDA launches/filings.
Alkem Labs
Bloomberg ALKEM IN CMP: INR1,910 TP: INR2,500 (+31%) Buy
Equity Shares (m) 119.6
We expect Alkem to post revenue growth of 15.4% YoY to
M. Cap. (INR b)/(USD b) 228 / 4
INR14.4b. Domestic business is expected to post strong growth of
52-Week Range (INR) 2468 / 1578
1,6,12 Rel Perf. (%) -12 / -2 / -23
~39% YoY to INR12.4b due to lower base in 4QFY17, which was
impacted by demonetization and decline in the anti-infective
market. International business is expected to grow 7% YoY, of
Financial Snapshot (INR Billion)
which US business is expected to grow by 17% YoY to INR3.4b.
Y/E March 2017 2018E 2019E 2020E
Sales 58.5 63.5 73.6 84.5
EBITDA margin is expected to expand ~690bp YoY, as margins in
EBITDA 10.0 11.9 14.1 16.9
4QFY17 were impacted due to higher R&D cost, ~500 MR
NP 8.9 7.8 10.7 13.2
additions and muted domestic growth. EBITDA is expected to
EPS (INR) 74.6 65.4 89.5 110.6
increase significantly by 82% YoY to INR2.7b in 4QFY18.
EPS Gro. (%) 6.0 -12.4 36.9 23.6
PAT is expected to increase by ~31% YoY to INR1.8b.
BV/Sh. (INR) 373.7 424.4 493.7 579.4
We maintain Buy with a TP of INR2,500 @24x Dec 19E PER. We
RoE (%) 21.9 16.4 19.5 20.6
argue for a multiple re-rating, given the superior earnings growth
RoCE (%) 20.1 14.5 21.8 23.1
profile (>25% EPS CAGR over FY18-20E), improving return ratios
Valuations
(RoICs to improve to ~30% by FY20E from ~20% in FY18E), net
P/E (x) 25.6 29.2 21.3 17.3 cash balance sheet, and high exposure to the domestic business
P/BV (x) 5.1 4.5 3.9 3.3 (~90% of profit comes from the domestic business).
EV/EBITDA (x) 23.1 19.1 15.5 12.5 Key issues to watch out
Update on observations issued by US FDA at Daman and St.
Louis facility.
Outlook on future ANDA launches/filings.
Pick-up in chronic business.
Aurobindo Pharma
Bloomberg ARBP IN
CMP: INR593 TP:INR820 (+38%) Buy
Equity Shares (m) 585.9
We expect Aurobindo (ARBP) to post 16% YoY sales growth to
M. Cap. (INR b)/(USD b) 348 / 5
INR42.4b in 4QFY18.
52-Week Range (INR) 809 / 504
1,6,12 Rel Perf. (%) -3 / -22 / -24
We expect US business (~56% of formulation sales) to grow by ~22%
YoY to INR20.1b. Europe and RoW sales are expected to exhibit
growth of 8% YoY. API sales are estimated to grow by ~5% YoY.
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
EBITDA margin is likely to expand moderately by ~140bp to 25.6%
Sales 150.9 166.9 185.7 207.7 YoY (flat sequentially). Overall EBITDA is estimated to increase by
EBITDA 34.3 39.4 43.6 48.8 ~24% to INR10b. We expect adj. PAT at INR6b, compared to
NP 23.0 25.6 28.5 31.4 INR5.3b in the corresponding quarter last year. Moderate growth
EPS (INR) 39.3 43.8 48.7 53.6 in PAT as compared to EBITDA growth is attributed to higher tax
EPS Gro. (%) 13.5 11.4 11.2 10.1 rate at 27.2% and depreciation.
BV/Sh. (INR) 160.0 201.2 247.4 298.5 We continue believing that ARBP is well poised to outperform its
RoE (%) 27.6 24.2 21.7 19.6 peers in the current circumstances, led by its strong US pipeline
RoCE (%) 19.0 18.7 18.2 17.1 and diversified product mix (top-25 products account for ~35% of
Valuations sales). We maintain Buy with a target price of INR820 @ 16x
P/E (x) 15.1 13.5 12.2 11.1 1HFY20E PER.
P/BV (x) 3.7 2.9 2.4 2.0 Key issues to watch out
EV/EBITDA (x) 12.1 10.5 9.1 7.8 Debt reduction during the quarter.
EV/Sales (x) 2.8 2.5 2.1 1.8 Outlook on the US business (~35-40 launches expected over next
Dividend Yield (%) 0.4 0.3 0.4 0.4 12 months).
Update on observations at Unit-IV.
Growth outlook for FY19E.
Biocon
Bloomberg BIOS IN CMP: INR607 TP: INR600 (-1%) Neutral
Equity Shares (m) 600.0
Biocon is likely to post revenue growth of ~1 2% YoY to INR10.3b,
M. Cap. (INR b)/(USD b) 364 / 6
on the back of strong growth in Biologics segment by ~49% YoY,
52-Week Range (INR) 658 / 295
followed by 15% YoY growth in branded formulation segment,
1,6,12 Rel Perf. (%) -1 / 75 / 50
partially off-set by 8% YoY decline in small molecule segment.
EBITDA is expected to increase ~18% YoY to INR2.1b, with EBITDA
Financial Snapshot (INR Billion) margins at 20.8%.
Y/E MARCH 2017 2018E 2019E 2020E We expect PAT to decline to INR875m, primarily due to an
Sales 40.8 41.2 52.6 71.8 increase in depreciation due to commencement of Malaysian
EBITDA 11.4 9.4 12.9 20.1 facility and higher tax rate of 31% v/s 6.5% in 4QFY17.
NP 6.0 4.6 6.5 11.9 We have a Neutral rating on the stock with TP of INR600 @ 30x
EPS (INR) 10.2 7.6 10.9 19.8 FY20E PER.
EPS Gro. (%) 31.8 -25.3 43.1 81.5
BV/Sh. (INR) 80.6 86.0 93.7 107.7
RoE (%) 12.3 8.9 11.6 18.4
RoCE (%) 9.4 7.2 11.5 18.1
Valuations
P/E (x) 59.5 79.7 55.7 30.7 Key issues to watch out
P/BV (x) 7.5 7.1 6.5 5.6 Outlook on small molecules and branded formulation segment.
EV/EBITDA (x) 32.0 38.9 28.2 17.9 Update on BIOS plans to list biologics business separately.
Div. Yield (%) 0.4 0.3 0.4 0.8 Growth outlook for FY19E.
Cadila Healthcare
Bloomberg CDH IN
CMP: INR394 TP:INR555 (+41%) Buy
Equity Shares (m) 1023.7
M. Cap. (INR b)/(USD b) 403 / 6
Cadila Healthcare's (CDH) 4QFY18 revenue is likely to grow
52-Week Range (INR) 558 / 361
significantly by 24% YoY to INR30.7b, driven by strong growth in
the US formulations business (up ~44% YoY to INR14.2b) on the
1,6,12 Rel Perf. (%) -1 / -23 / -23
back of launch of gLialda and ramp-up of other key products.
Overall export formulations are expected to grow ~46% YoY to
Financial Snapshot (INR Billion)
INR18.3b, while domestic formulation is likely to grow 10% YoY to
Y/E MARCH 2017 2018E 2019E 2020E
INR9.3b.
Sales 94.3 117.6 131.8 150.7
We expect EBITDA to significantly increase by 57% YoY to INR7.3b
EBITDA 19.0 27.1 32.6 37.7 and margin to expand ~500bp. Adj. PAT is also likely to increase
NP 14.5 16.4 20.6 23.8 ~95% YoY to INR5.5b on the back of significant margin expansion.
EPS (INR) 14.2 16.0 20.1 23.3 We believe CDH has made investments in the right areas, and will
EPS Gro. (%) -7.9 12.7 25.5 15.9 start accruing benefits over next 2-3 years. We expect strong EPS
BV/Sh. (INR) 68.0 80.1 96.3 115.7 growth from FY17-19E (29% CAGR) on the back of Moraiya
RoE (%) 23.0 21.6 22.8 22.0 resolution and strong launch pipeline in US, with better return
RoCE (%) 15.2 13.8 15.6 16.6 ratios over next two years.
Valuations Strong launch momentum and limited-competition launches (like
P/E (x) 27.7 24.6 19.6 16.9 Lialda) should drive strong margin improvement (FY19E EBITDA
P/BV (x) 5.8 4.9 4.1 3.4 margin to be ~25%). Maintain Buy with a TP of INR555 @22x
EV/EBITDA (x) 22.9 15.8 12.8 11.0 1HFY20E PER.
Key issues to watch out
Outlook for FY19E.
Update on US business post increased competition in gLialda
and Tamiflu.
Quarterly Performance (INR Million)
Y/E March FY17 FY18E FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Revenues 22,871 23,531 23,111 24,782 21,973 32,340 32,596 30,715 94,295 117,624
YoY Change (%) -1.2 1.0 -4.8 1.2 -3.9 37.4 41.0 23.9 -1.0 24.7
EBITDA 5,239 5,160 4,043 4,636 2,773 8,571 8,412 7,297 19,036 27,053
Margins (%) 22.9 21.9 17.5 18.7 12.6 26.5 25.8 23.8 20.2 23.0
Depreciation 843 864 898 1,145 1,220 1,267 1,473 1,399 3,750 5,359
Interest 140 187 66 99 219 406 135 254 450 1,014
Other Income 153 236 166 731 210 225 411 183 1,286 1,029
PBQ before EO Income 4,409 4,345 3,245 4,123 1,544 7,123 7,215 5,828 16,122 21,710
EO Exp/(Inc) 2 0 0 0 0 0 0 0 0 0
PBQ after EO Income 4,407 4,345 3,245 4,123 1,544 7,123 7,215 5,828 16,122 21,710
Tax 966 1,068 504 19 293 2,123 1,786 791 1,289 4,993
Rate (%) 21.9 24.6 15.5 0.5 19.0 29.8 24.8 13.6 8.0 23.0
Min. Int/Adj on Consol -121 -99 -76 249 133 33 4 -82 47 88
Adj PAT 3,564 3,376 2,817 3,855 1,384 5,033 5,433 4,954 14,880 16,804
YoY Change (%) -13.0 -26.5 -27.8 -0.7 -61.2 49.1 92.9 28.5 3.7 12.9
Margins (%) 15.6 14.3 12.2 15.6 6.3 15.6 16.7 16.1 15.8 14.3
Cipla
Bloomberg CIPLA IN
CMP: INR571 TP: INR600 (+5%) Neutral
Equity Shares (m) 804.5
We expect Cipla’s revenues to grow 9% YoY to INR39b in 4QFY18.
M. Cap. (INR b)/(USD b) 459 / 7
52-Week Range (INR) 663 / 479
Export formulation business is expected to report muted growth of
1,6,12 Rel Perf. (%) 0 / -8 / -15
~4% YoY, while domestic business is expected to report robust
growth of ~22% YoY. Export API sales are expected to report decline
of ~12% YoY to INR1.4b.
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
EBITDA is expected to increase significantly by ~55% YoY with margin
Sales 146.3 154.2 174.8 197.5 expansion of ~600bp. This is primarily due to lower margin in 4QFY17
EBITDA 24.8 30.5 35.5 41.3 on back of decline in domestic business and higher R&D expense.
NP 12.8 17.3 21.0 25.7 We expect reported PAT to increase significantly by 113% YoY to
EPS (INR) 15.9 21.6 26.2 32.0 INR4.3b on back of margin expansion.
EPS Gro. (%) -15.5 35.7 21.3 22.3 Unlike other large cap peers, Cipla is well poised to deliver robust
BV/Sh. (INR) 155.7 173.9 197.0 225.9 growth in the US due to a lower base and a significant pick-up in
RoE (%) 10.2 12.4 13.3 14.1 the filing quality and rate (filed 32 ANDAs in FY17 and planning to
RoCE (%) 8.1 9.8 11.1 12.2 file 20 in FY18E). We maintain our Neutral rating on the stock with
Valuations a TP of INR600 @ 20x 1HFY20E PER.
P/E (x) 35.9 26.5 21.8 17.8
Key issues to watch out
P/BV (x) 3.7 3.3 2.9 2.5
Launch of combination inhaler in the UK market (USD450m
EV/EBITDA (x) 20.0 16.0 13.4 11.1
market size).
Div. Yield (%) 0.4 0.4 0.4 0.4
Growth outlook for FY19E.
Sustained strong growth in domestic formulations (38% of
sales).
Divi’s Laboratories
Bloomberg DIVI IN CMP: INR1,107 TP:INR1,100 (-1%) Neutral
Equity Shares (m) 265.5
Divis Laboratories (DIVI) is likely to register decline in revenues by
M. Cap. (INR b)/(USD b) 294 / 5
~4% YoY to INR10.2b.
52-Week Range (INR) 1142 / 533
Adjusted EBITDA is likely to decline ~5% YoY to INR3.4b, with
1,6,12 Rel Perf. (%) 11 / 23 / 64
margin contracting slightly by ~45bp.
PAT is expected to report muted growth of ~2% YoY to INR2.6b.
Financial Snapshot (INR Billion) US FDA, in November 2017 lifted the import alert at DIVI’s
Y/E MARCH 2017 2018E 2019E 2020E Vishakhapatnam-based Unit-2 facility.
Sales 41.0 37.7 44.2 50.8 Though resolution of import alert in record time is a significant
EBITDA 14.3 11.9 15.9 19.0 positive, we believe that the run-up in the stock already factors
NP 10.6 8.7 11.7 14.0 most of it. We maintain Neutral, with a target price of INR1,100
EPS (INR) 39.9 32.9 44.0 52.7 (23x 1HFY20E EPS).
EPS Gro. (%) -5.8 -17.7 33.9 19.7 The stock trades at 21x FY20E earnings.
BV/Sh. (INR) 201.8 208.0 232.2 261.2
RoE (%) 22.0 16.0 20.0 21.3
RoCE (%) 21.8 16.0 19.9 21.3
Valuations
P/E (x) 27.7 33.7 25.2 21.0
P/BV (x) 5.5 5.3 4.8 4.2 Key issues to watch out
EV/EBITDA (x) 20.4 24.9 18.0 14.8 Outlook for growth for FY19E.
Div. Yield (%) 0.9 1.1 1.5 1.8 Ramp-up of new facility.
Dr Reddy’s Labs
Bloomberg DRRD IN CMP: INR2,129 TP: INR2,575 (+21%) Neutral
Equity Shares (m) 170.5
Dr Reddy’s Lab is expected to report moderate growth of ~6% YoY
M. Cap. (INR b)/(USD b) 363 / 6
52-Week Range (INR) 2788 / 1902
in 4QFY18, with revenue at INR37.5b.
1,6,12 Rel Perf. (%) -2 / -15 / -34
US business is likely to grow ~6% YoY to INR16.2b on the back of
new launches, while Europe sales are expected to post decline of
~4% YoY. India business is expected to report robust growth of
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
~16% YoY to INR6.6b.
Sales 140.8 144.2 170.9 201.6 EBITDA is expected to grow by 30% YoY to INR7.6b and margin to
EBITDA 24.2 24.9 38.4 48.0 expand by ~380bp YoY to 20.2% due to lower base in 4QFY17
NP 12.0 11.4 19.5 24.9 (which had lower gross margin (due to pricing pressure) and
EPS (INR) 72.6 67.1 114.1 146.1 certain one-off charges).
EPS Gro. (%) -45.1 -7.6 70.0 28.0 PAT is expected to increase by ~20% YoY to INR3.7b, led by
BV/Sh. (INR) 740 768 871 997 margin expansion.
RoE (%) 9.7 9.0 13.9 15.6 We believe the stock will remain range bound until the time we
RoCE (%) 6.4 4.8 10.4 12.4 do not get more visibility about key launches in the US (including
Valuations Aloxi, Nuvaring, Soboxone, Copaxone 20 & 40mg). We maintain
P/E (x) 29.3 31.7 18.7 14.6 Neutral with a TP of INR2,575 @ 20x 1HFY20E PER.
P/BV (x) 2.9 2.8 2.4 2.1
EV/EBITDA (x) 15.4 15.0 9.5 7.2 Key issues to watch out
Dividend Yield (%) 0.5 0.5 0.8 1.0 Update on USFDA resolution of warning letters for Srikakulam,
Duvvada and Miryalaguda API plants.
FY19 outlook for both the generics and PSAI businesses.
Impact of pricing pressure in the US.
Fortis Healthcare
Bloomberg FORH IN CMP: INR130 TP:INR185 (+42%) Buy
Equity Shares (m) 518.0
We expect Fortis to deliver revenue growth of 9% to INR12.2b on
M. Cap. (INR b)/(USD b) 67 / 1
the back of steady growth in the core businesses (Hospitals &
52-Week Range (INR) 231 / 107
Diagnostics). EBITDA margin will continue to expand sequentially.
1,6,12 Rel Perf. (%) -17 / -17 / -43
We expect hospital EBITDA to grow more than 4x by FY19E (from
FY16 base) on back of lower base, coupled with strong high-teen
Financial Snapshot (INR Billion) growth in EBITDAC, relatively flattish BT cost (at normalized level)
Y/E MARCH 2017 2018E 2019E 2020E and FHTL transaction.
Sales 45.7 47.0 52.6 60.5 We expect EBITDA margin for the diagnostics business to improve
EBITDA 3.5 3.3 5.6 8.8 by ~300bp by FY19E on the back of deeper penetration in existing
NP 4.8 0.7 1.3 3.4 markets, rationalization of low-margin centers, growth in samples
EPS (INR) 10.3 1.5 2.8 7.3 tested and higher share from the O&M model.
EPS Gro. (%) -638.2 -85.8 87.8 164.5 The current deal proposition by Manipal for the hospital business
BV/Sh. (INR) 111.1 124.6 127.3 134.5 does not provide much upside to the stock. Manipal Hospital has
RoE (%) 10.0 1.2 2.2 5.6 vast experience in the hospital and healthcare business with a
RoCE (%) 3.4 -1.9 3.1 5.4 string financial track record, which will be beneficial for FORH in
Valuations the medium-to-long term. Having said that, the deal is unlikely to
P/E (x) 12.6 88.5 47.2 17.8 be approved by shareholders due to lower valuation given to the
P/BV (x) 1.2 1.0 1.0 1.0 hospital business. We value the hospital business at 18x FY19E
EV/EBITDA 21.1 22.0 12.9 8.0 EV/EBITDA and the diagnostics business at 20x FY19E EV/EBITDA
(x)
EV/Sales (x) 1.6 1.5 1.4 1.2 with TP of INR185.
Key issues to watch out
Update on deal announcement on merger with Manipal Hospitals.
PAT breakeven of hospitals business.
Granules India
Bloomberg GRAN IN
CMP: INR108 TP:INR175 (+62%) Buy
Equity Shares (m) 228.7
M. Cap. (INR b)/(USD b) 25 / 0
We expect Granules India (GRAN) to post healthy 14% YoY growth
52-Week Range (INR) 157 / 101 in 4QFY18 reported sales to INR4.14b.
1,6,12 Rel Perf. (%) -5 / -11 / -35 EBITDA is likely to decrease marginally by ~3% YoY to INR760m
due to high input cost. EBITDA margin is also expected to contract
Financial Snapshot (INR Billion) by ~330bp YoY to 18.3% due to increase in expense on back of
Y/E MAR 2017 2018E 2019E 2020E commissioning of new facility.
Sales 14.4 16.4 21.6 27.1 Depreciation is expected to increase due to new facility getting
EBITDA 3.0 3.0 4.2 5.5 operational. We expect reported PAT to decrease ~14% YoY to
NP 1.7 1.5 2.0 2.8 INR391m.
EPS (INR) 7.2 6.3 7.9 11.0 We believe the stock is poised for multiple re-rating on the back
EPS Gro. (%) 32.3 -12.4 25.2 38.7 of asset sweating in traditional business, entry in high-value US
BV/Sh. (INR) 39.5 54.6 59.9 67.0 business and commencement of API sales from Omnichem JV. We
RoE (%) 21.1 13.2 13.9 17.4 maintain our Buy rating with a TP of INR175 @18x 1HFY20E.
RoCE (%) 17.9 13.9 14.7 18.1
Valuations
P/E (x) 14.9 17.0 13.6 9.8 Key issues to watch out
P/BV (x) 2.7 2.0 1.8 1.6 New ANDA filings in complex category.
EV/EBITDA (x) 12.2 12.1 9.1 7.1 Update on free-cash generation and debt repayment schedule.
D. Yield (%) 2.5 2.3 1.8 1.5 Update on JV with Onmichem.
Glenmark Pharma
Bloomberg GNP IN
CMP: INR550 TP:INR550 (+0%) Neutral
Equity Shares (m) 282.3
M. Cap. (INR b)/(USD b) 155 / 2
We expect Glenmark Pharmaceuticals (GNP) to report ~8% YoY
52-Week Range (INR) 930 / 517 decline in overall revenues to INR22.2b. Decline in sales is
1,6,12 Rel Perf. (%) 3 / -14 / -47 primarily attributed to decline in the US business (-27.7% YoY)
due to Zetia FTF launch in 3QFY17 (6 months exclusivity ended in
Financial Snapshot (INR Billion) 1QFY18).
Y/E MAR 2017 2018E 2019E 2020E The India branded business is likely to post moderate growth of
Sales 89.7 89.5 97.6 109.6 5% YoY, while LatAm business is expected to decline by ~34% YoY;
EBITDA 18.2 15.6 16.2 19.2 RoW and Europe businesses are expected to grow 6.2% and 3%
NP 11.1 8.6 9.3 11.6 YoY, respectively.
EPS (INR) 39.3 30.6 32.9 41.1 EBITDA is likely to decrease 9% YoY to INR3.7b and margin to
EPS Gro. (%) 58.0 -22.2 7.7 24.7 contract marginally by 15bp to 16.8%.
BV/Sh. (INR) 159.2 186.1 215.4 252.8 Weak cash flow conversion and high net debt remain key
RoE (%) 24.7 16.4 15.3 16.2 concerns. Maintain Neutral with a TP of INR550 @ 15x 1HFY20E
RoCE (%) 19.1 14.8 16.6 18.1 EPS. Any big in-licensing deal in innovation business could act as a
Valuations catalyst.
P/E (x) 14.0 18.0 16.7 13.4
P/BV (x) 3.5 3.0 2.6 2.2
Key issues to watch out
EV/EBITDA (x) 10.6 11.9 11.3 9.4 New ANDA filings in complex category.
D. Yield (%) 0.5 0.5 0.5 0.5 Update on free-cash generation and debt repayment schedule.
Progress of NCE/NBE pipeline and potential out-licensing
prospects.
GSK Pharma
Bloomberg GLXO IN
CMP: INR2,152 TP:INR2,500 (+16%) Neutral
Equity Shares (m) 84.7
M. Cap. (INR b)/(USD b) 182 / 3
In 4QFY18, we expect GlaxoSmithKline Pharmaceuticals (GLXO) to
52-Week Range (INR) 2760 / 2040
report marginal decline of ~3% YoY in revenues to INR7.4b.
1,6,12 Rel Perf. (%) -8 / -19 / -33 EBITDA is expected to increase 26% YoY to INR1.5b, and margin to
expand by ~510bp to 20.4% (due to regulatory issues GLXO
Financial Snapshot (INR Billion)
margin in 4QFY17 came in at 15.3%).
Y/E MARCH 2017 2018E 2019E 2020E Increase in EBITDA margin will improve adj. PAT to INR960m.
Sales 29.3 28.7 32.1 36.0 We believe GLXO has strong parent support, superior brand
EBITDA 3.5 4.8 5.3 6.1 portfolio (competitive advantage), high payout ratio (>100%) and
NP 2.9 3.2 3.6 4.1 industry-leading return ratios (RoCE of ~30%). At CMP, GLXO
EPS (INR) 34.4 38.3 42.6 48.5 trades at 56x FY18E and 50x FY19E, a huge premium to the sector.
EPS Gro. (%) -22.2 11.5 11.2 13.7 We, thus, maintain our Neutral rating with a target price of
BV/Sh. (INR) 236.9 194.8 156.9 156.9 INR2,500 @ 45x FY19E PER.
RoE (%) 14.5 19.7 27.2 30.9
RoCE (%) 13.9 17.7 24.2 30.9
Valuations
P/E (x) 62.6 56.1 50.5 44.4
P/BV (x) 9.1 11.0 13.7 13.7 Key issues to watch out
EV/EBITDA (x) 50.1 36.0 33.5 28.9 New product introductions in FY19E.
D. Yield (%) 1.4 3.3 3.3 3.3 Market performance of products impacted by DPCO 2013.
Ipca Laboratories
Bloomberg IPCA IN CMP: INR677 TP:INR750 (+11%) Buy
Equity Shares (m) 126.2
We expect Ipca Laboratories (IPCA) to post revenue growth of
M. Cap. (INR b)/(USD b) 85 / 1
16% YoY to INR7.7b, mainly due to growth in domestic business
52-Week Range (INR) 695 / 400
1,6,12 Rel Perf. (%) 1 / 31 / -4
and API business by ~29% and ~22% respectively.
International generic business is expected to post healthy growth
of ~13% YoY to INR2.5b on the back of strong growth in generics
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
business by ~27% YoY, which will be partially off-set by decline in
Sales 32.1 32.1 35.9 41.7
branded business by ~5%.
EBITDA 4.4 4.9 6.5 7.9 EBITDA is likely to increase significantly by ~130% YoY to INR1.6b,
NP 2.0 2.7 3.7 4.7 with expansion of ~1000bp in EBITDA margin to 20.2%, primarily
EPS (INR) 16.1 21.4 29.2 37.3 due to low base.
EPS Gro. (%) 52.8 33.2 36.6 27.7 PAT is expected to increase significantly by ~99% YoY to INR883m,
BV/Sh. (INR) 194.6 212.7 237.6 269.3 primarily due to margin expansion.
RoE (%) 8.6 10.5 13.0 14.7 We expect PAT CAGR of >30% until FY20, led by steady revenue
RoCE (%) 7.5 9.3 11.4 12.9 growth (~14% till FY20E), and a significant improvement in
Valuations margins (~380bp over two years) on cost-rationalization efforts,
P/E (x) 42.1 31.6 23.2 18.1 significantly lower remediation costs, and a pick-up in the tender
P/BV (x) 3.5 3.2 2.8 2.5 and US businesses. We have a Buy rating with TP of INR750.
Key issues to watch out
Update on resolution of USFDA regulatory issues.
Outlook for institutional tender business.
Impact of emerging market currency weakness.
Outlook for FY19.
Quarterly Performance (INR Million)
Y/E March FY17 FY18E FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Revenues (Core) 8,422 8,720 7,398 6,658 7,130 8,643 8,592 7,718 32,106 32,083
YoY Change (%) 11.1 16.8 8.1 6.6 -15.3 -0.9 16.1 15.9 11.3 -0.1
EBITDA 1,285 1,280 1,104 677 215 1,490 1,612 1,559 4,448 4,877
Margins (%) 15.3 14.7 14.9 10.2 3.0 17.2 18.8 20.2 13.9 15.2
Depreciation 422 429 432 428 433 441 438 485 1,730 1,797
Interest 65 68 57 44 56 64 56 68 241 244
Other Income 49 62 59 52 62 110 110 119 226 400
PBT before EO Expense 847 845 675 257 -212 1,096 1,228 1,124 2,703 3,235
Extra-Ord Expense 81 -78 39 0 0 0 0 0 0 0
PBT after EO Expense 766 923 636 257 -212 1,096 1,228 1,124 2,703 3,235
Tax 290 374 222 -187 -10 130 172 242 675 534
Rate (%) 34.2 44.2 32.9 -72.7 4.6 11.9 14.0 21.5 25.0 16.5
Reported PAT 476 549 414 444 -202 966 1,056 883 2,028 2,702
Adj PAT 557 471 453 444 -202 966 1,056 883 2,028 2,702
YoY Change (%) 82.5 31.1 88.4 9.6 -136.4 104.9 133.0 98.8 62.8 33.2
Margins (%) 5.6 6.3 5.6 6.7 -2.8 11.2 12.3 11.4 6.3 8.4
Laurus Labs
Bloomberg LAURUS IN CMP: INR514 TP:INR613 (+20%) Buy
Equity Shares (m) 106.0
We expect 13.7% YoY growth in sales to INR5.4b for the quarter,
M. Cap. (INR b)/(USD b) 54 / 1
led by better traction in ARV/Oncology API, Synthesis and
52-Week Range (INR) 634 / 485
1,6,12 Rel Perf. (%)
ingredient business. We also expect revenue from US formulation
-2 / -5 / -13
to kick in from 4QFY18.
The YoY growth would be partly offset by declining Hep-C
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E business.
Sales 19.0 20.9 25.3 29.2 Lower share of higher-margin business is expected to result in
EBITDA 4.1 4.3 5.7 6.8 400bp YoY reduction in EBITDA margin.
NP 1.9 2.0 3.1 3.8 Lower margin and higher tax rate are expected to result in 29%
EPS (INR) 17.8 19.0 29.1 35.7 YoY reduction in PAT to INR528m for the quarter.
EPS Gro. (%) 43.0 7.0 52.7 22.8
The stock trades at 17.6x FY19E EPS. We maintain Buy, with a
BV/Sh. (INR) 125.8 144.5 173.0 208.0
RoE (%)
target price of INR613 (18x 12M forward earnings).
17.4 14.1 18.3 18.8
RoCE (%) 13.4 11.1 14.1 14.8
Valuations
P/E (x) 28.7 26.8 17.6 14.3
P/BV (x) 4.1 3.5 3.0 2.5
Key issues to watch out
EV/EBITDA 15.3 14.8 11.0 9.2
(x) Outlook on ANDA filings and pace of approval.
EV/Sales (x) 3.3 3.0 2.5 2.1
D. Yield (%) 0.1 0.1 0.1 0.1 Outlook on ARV API business and filings for formulation.
Lupin
Bloomberg LPC IN CMP: INR789 TP:INR940 (+19%) Buy
Equity Shares (m) 451.6
We expect Lupin's (LPC) 4QFY18 revenue to decline ~6% YoY to
M. Cap. (INR b)/(USD b) 356 / 5
IN39.8b, mainly due to a decline in the US business by ~26% YoY
52-Week Range (INR) 1465 / 727
to INR14b.
1,6,12 Rel Perf. (%) 0 / -29 / -57
India business is expected to exhibit robust growth of ~27% YoY
to INR11.1b, while Japan sales are expected to improve 17.7%
Financial Snapshot (INR Billion) YoY to INR5.4b in 4QFY18, aided by currency tailwinds.
Y/E MARCH 2017 2018E 2019E 2020E
EBITDA is estimated to decline ~32% YoY to INR7.5b, as margins
Sales 174.9 157.8 179.6 208.2 are expected to come down by ~710bp to 18.9%.
EBITDA 44.9 30.6 36.8 46.4 Reported PAT is likely to decline 45% YoY to IN3.3b due to
NP 25.6 14.0 18.2 24.4 decrease in EBITDA margin.
EPS (INR) 56.6 31.0 40.2 54.1 LPC has invested ~INR60b toward R&D over FY16-18E (much
EPS Gro. (%) 12.4 -45.2 29.5 34.6 higher than what it invested in a decade prior to that). GMP
BV/Sh. (INR) 298.9 318.6 348.3 391.9 compliance is key to monetize this investment. Although the
RoE (%) 20.9 10.1 12.1 14.6 stock faces near-term pressure, key approvals in the US and
RoCE (%) 13.3 6.8 8.4 10.4 resolution of the WL status (expected in 12 months) will help
Valuations create value in 12-18 months. We maintain Buy with a TP of
P/E (x) 13.9 25.4 19.6 14.6 INR940 @ 20x 1HFY20E PER.
P/BV (x) 2.6 2.5 2.3 2.0
EV/EBITDA (x)
Key issues to watch out
9.2 13.0 10.6 8.2
D. Yield (%) Outlook on US business for FY19E and ANDA launches.
1.1 1.1 1.1 1.1
Outlook on future ANDA launches and Gavis integration.
Update on warning letter for Goa and Indore facility.
Outlook on inorganic growth initiatives.
Sanofi India
Bloomberg SANL IN CMP: INR5,147 TP:INR5,600 (+9%) Buy
Equity Shares (m) 23.0
We expect Sanofi India's (SANL) revenue to grow ~16 % YoY in
M. Cap. (INR b)/(USD b) 118 / 2
1QCY18 to INR6.4b. High growth of brands like Lantus, Allegra,
52-Week Range (INR) 5995 / 3901
Amaryl M, Enterogermina, Avila, Vaxlgrip and Cardace, and new
1,6,12 Rel Perf. (%) 3 / 19 / -3
product launches should drive SANL’s revenue growth.
EBITDA is also likely to increase significantly by 36% YoY to
Financial Snapshot (INR Billion)
Y/E Dec 2016 2017E 2018E 2019E
INR1.4b during this quarter; expect margin expansion by ~330bp.
Sales 23.7 24.9 28.1 31.0
We expect PAT to increase 44% YoY to INR863m.
EBITDA 5.3 5.4 6.2 7.1 We have modeled 9% sales growth, 10% EBITDA growth and 13%
Net Profit 3.0 3.3 3.7 4.3 earnings growth over CY16-19E. We maintain Buy with a TP of
Adj. EPS 129.1 141.7 161.8 186.9 INR5,600 @ 30x CY19E.
(INR)
EPS Gr. (%) 24.9 9.8 14.2 15.5
BV/Sh. (INR) 754.5 881.8 962.4 1,068.1
RoE (%) 17.1 16.1 16.8 17.5
RoCE (%) 16.5 16.2 16.4 17.3 Key issues to watch out
Payout (%) 63.5 57.3 50.2 43.5 Amortization of goodwill and brands acquired from Universal
Valuations Medicare.
P/E (x) 39.9 36.3 31.8 27.5
Clarity on nature of reversal of recently withdrawn NPPA
P/BV (x) 6.8 5.8 5.3 4.8
guidelines.
EV/EBITDA 21.4 20.7 17.0 14.4
(x)
Div. Yield (%) 1.3 1.4 1.4 1.4
Shilpa Medicare
Bloomberg SLPA IN CMP: INR471 TP: INR686 (+46%) Buy
Equity Shares (m) 80.0
We expect 8% YoY decline in net sales of Shilpa Medicare (SLPA),
M. Cap. (INR b)/(USD b) 38 / 1
on lower development income.
52-Week Range (INR) 749 / 401
1,6,12 Rel Perf. (%)
We expect US formulation sales momentum to continue due to
10 / -25 / -41
better traction in approved products.
EBITDA margin is expected to decline from 26.2% in 4QFY17 to
Financial Snapshot (INR Billion)
19% in 4QFY18 due to lower dossier income.
Y/E March 2017 2018E 2019E 2020E
Sales 7.8 7.8 9.5 11.6
With lowering of sales and decreased EBITDA margin, we expect
EBITDA 1.8 1.7 2.3 2.9
PAT to decline by 37% YoY to INR263m for the quarter.
NP 1.1 1.1 1.9 2.5
The stock trades at 19.4x FY19E EPS. We maintain Buy, with a
EPS (INR) 14.0 13.3 24.3 30.6
target price of INR686 (25x 12M forward earnings).
EPS Gro. (%) 6.2 -5.0 82.4 25.9
BV/Sh. (INR) 114.4 127.0 152.9 181.9
RoE (%) 14.4 11.0 17.4 18.3
RoCE (%) 11.5 8.4 13.5 15.2
Valuations
Key issues to watch out
P/E (x) 33.6 35.4 19.4 15.4
Outlook on new ANDA approvals
P/BV (x) 4.1 3.7 3.1 2.6
Outlook on market share in approved products
EV/EBITDA (x) 22.5 24.0 17.4 13.6
EV/Sales (x) 5.0 5.1 4.1 3.4
Strides Shasun
Bloomberg STR IN CMP: INR704 TP:INR989(+40%) Buy
Equity Shares (m) 89.4
We expect sales of INR7.9b for 4QFY18. The YoY numbers are not
M. Cap. (INR b)/(USD b) 63 / 1
comparable, as 4QFY17 includes API and domestic formulation
52-Week Range (INR) 1148 / 641
1,6,12 Rel Perf. (%) 1 / -23 / -49
sales. API business, which was hived off to Solara, is shown as
discontinued operations. Domestic formulation business was sold
to Eris Life Sciences in November 2017.
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
We expect marginal improvement on a QoQ basis.
Sales 34.8 29.5 34.4 39.9
We expect EBITDA margin to rise by 100bp QoQ, largely due to
EBITDA 6.4 4.1 6.8 8.1 new launches in the US market.
NP 2.9 1.3 3.6 5.0 Accordingly, PAT is expected to rise by 49% QoQ to INR598m for
EPS (INR) 32.3 14.1 40.8 55.7 4QFY18.
EPS Gro. (%) 77.6 -56.2 188.8 36.7 The stock trades at 17.3x FY19E EPS. We maintain Buy, with a
BV/Sh. (INR) 303.1 315.4 356.2 411.9 target price of INR989 (SOTP basis).
RoE (%) 10.8 4.6 12.1 14.5
RoCE (%) 8.3 5.1 8.8 10.2
Valuations Key issues to watch out
P/E (x) 21.9 50.1 17.3 12.7
Pace of ANDA filings and outlook on niche approvals.
P/BV (x) 2.3 2.2 2.0 1.7
Outlook on margin improvement in Australia business.
EV/EBITDA (x) 15.1 22.2 13.0 10.4
EV/Sales (x) 2.8 3.1 2.6 2.1
D. Yield (%) 0.0 0.0 0.0 0.0
Sun Pharma
Bloomberg SUNP IN
CMP: INR510 TP:INR675(+32%) Buy
Equity Shares (m) 2399.3
Sun Pharmaceuticals (SUNP) is likely to register decline in
M. Cap. (INR b)/(USD b) 1224 / 19
52-Week Range (INR) 701 / 433
revenues by ~4% YoY to INR65.8b, primarily on the back of a
1,6,12 Rel Perf. (%) -3 / -4 / -38
decrease in US business by ~16% to INR21.4b.
India business is expected to grow ~6% YoY, while the Row and
API businesses are expected to grow 3% YoY and 7% YoY,
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
respectively.
Sales SUNP’s EBITDA is expected to increase ~17% YoY to INR14.4b,
302.6 259.9 302.4 351.5
EBITDA 87.8 52.6 76.0 95.3
with margin expansion of ~380p to 21.9% primarily due to low
NP 69.6 26.6 51.8 66.7 base in 4QFY17 on back of one time inventory write-off of
EPS (INR) 28.9 11.0 21.5 27.7 USD45m and weak US business revenues.
EPS Gro. (%) 48.0 -61.8 94.8 28.8 Although we expect increase in EBITDA, PAT is expected to
BV/Sh. (INR) 152.3 156.3 170.8 191.6 decline 30% YoY to INR8.5b due to lower other income coupled
RoE (%) 18.1 8.5 13.2 15.3 with higher tax rate.
RoCE (%) 19.0 7.7 13.6 16.2 We expect the stock to remain under pressure in the near term
Valuations due to challenges related to growth and margins. We maintain
P/E (x) 19.5 38.7 23.7 18.4 Buy rating with a TP of INR675, based on 24x FY20E.
P/BV (x) 3.3 3.3 3.0 2.7 Key issues to watch out
EV/EBITDA 13.1 21.3 14.2 10.9
(x) Update on resolution of USFDA warning letter and 483
D.Yield (%) 0.7 1.2 1.2 1.2
observations on Halol.
Outlook for FY19E.
Launch of Tildrakizumab and other key products.
Torrent Pharmaceuticals
Bloomberg TRP IN CMP: INR1,288 TP:INR1,400 (+9%) Neutral
Equity Shares (m) 169.2
We expect TRP to post ~26% YoY growth in 4QFY18 reported
M. Cap. (INR b)/(USD b) 233 / 3.6
52-Week Range (INR) 1572 / 1144
sales to INR17.4b. US business is expected to increase ~7% YoY,
1,6,12 Rel Perf. (%) 5 / 5 / -24
while India business is expected to witness 70% YoY growth on
the back of integration of Unichem’s domestic portfolio.
Reported EBITDA is likely to increase 37% YoY to INR4.1b, with
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
increase in EBITDA margin by ~200bp YoY.
Sales 58.6 60.2 77.2 87.7 Although EBITDA is expected to increase, we expect PAT to
EBITDA 13.8 13.9 19.7 22.8 decline by ~21% YoY to INR1.8b due to increase in interest
NP 9.3 8.1 10.4 13.3 expense by 118% to INR1.3b and higher tax rate at 23.8% v/s
EPS (INR) 55.2 48.0 61.3 78.5 15.6% in 4QFY17.
EPS Gro. (%) -7.7 -12.9 27.6 28.0 Due to high interest cost, the Unichem deal will take three years to
BV/Sh. (INR) 257.1 287.7 326.9 377.0 turn EPS-accretive (additional interest cost burden of IN2.5-2.7b).
RoE (%) 23.8 17.6 19.9 22.3 Although TRP remains one of the better plays on India’s growth
RoCE (%) 18.6 12.0 18.6 19.9 story (because of a chronic heavy portfolio and one of the best
Valuations margins), the lack of growth catalysts in the near term will keep the
P/E (x) 23.4 26.8 21.0 16.4 stock range bound. Our TP is INR1,400@20x 1HFY20E PER.
P/BV (x) 5.0 4.5 3.9 3.4
EV/EBITDA (x) 16.8 16.4 11.3 9.4
Key issues to watch out
D. Yield (%) 1.3 1.1 1.4 1.8 Contribution of Unichem portfolio and growth strategy.
Performance of Brazilian operations amid market pressure.
Outlook on future ANDA launches.
Infrastructure
Company name Road sector at an inflexion point
Ashoka Buildcon Awarding as well as construction activity at new high in FY18
IRB Infra Over the past few years, the Indian government has shown the resolve to tackle
KNR Constructions issues prevailing in the infrastructure sector (related to land acquisition,
Sadbhav Engineering environment/forest clearances, model concession agreement amendment, etc),
with signs of activity improvement already evident since FY17.
Activity in the road sector picked up significantly in FY18 and awarding as well as
construction activity reached new peaks, with awarding of 47km/day (up 5% YoY)
and construction of 27km/day (up 19% YoY). Awarding activity was equally
distributed between EPC projects (51%) and HAM projects (47%), and the balance
2% was awarded on BoT basis. We expect the momentum to continue in FY19 as
well, given that large part of the orders under Bharatmala Pariyojna (34,800km,
INR5.3t) is yet to be awarded. NHAI intends to award contracts of 3,000km in
1QFY19 (which could not be awarded in FY18 due to non-availability of land).
Exhibit 2: India road awarding reached a new peak in FY18 Exhibit 3: Roads completed also at all-time highs in FY18
with 47km/day awarding (27km/day)
47 27
Awarded km (per day) 45 Construction km (per day)
23
27 29 17
16
22 14
12 12
9
5
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY12 FY13 FY14 FY15 FY16 FY17 FY18
Source: MOSL, Company Source: MOSL, Company
Exhibit 4: Relative performance – three-month (%) Exhibit 5: Relative performance – one-year (%)
Sensex Index MOSL Infrastructure Index Sensex Index MOSL Infrastructure Index
109 130
103 120
97 110
91 100
85 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Jan-18
Feb-18
Mar-18
Sep-17
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Ashoka Buildcon
Bloomberg ASBL IN
CMP: INR265 TP: INR290 (+10%) Buy
Equity Shares (m) 187.1
M. Cap. (INR b)/(USD b) 50 / 1 Order inflow during the quarter was robust, with ACL bagging HAM
52-Week Range (INR) 281 / 172 project worth INR55b and ABL winning EPC projects worth
1,6,12 Rel Perf. (%) 18 / 38 / 24 INR14.8b in the Road sector.
We expect revenue growth of 20% YoY, led by overall pickup of the
Financial Snapshot (INR b) orders in hand.
Y/E March 2017 2018E 2019E 2020E We expect operating margin to expand 340bp to13.8% and
Net Sales 29.8 34.1 39.6 46.0 operating profit to improve 60% YoY to INR1b.
EBITDA 8.9 10.3 11.6 12.1
Net profit is expected to decline 5.3% YoY to INR619m, given an
Adj. PAT -0.1 0.4 1.3 1.5
increase in depreciation charges and higher tax rate on expiry of
Adj. EPS (INR) -0.5 2.1 7.0 8.3
80IA benefit. Maintain Buy.
EPS Gr (%) NM NM 238.0 18.1
BV/Sh (INR) 89.3 98.4 105.2 113.6
RoE (%) NM 2.2 6.9 7.5
RoCE (%) 9.5 9.8 10.3 10.0
Valuations
P/E (x) NM 128.1 37.9 32.1 Key issues to watch
P/BV (x) 3.0 2.7 2.5 2.3 Equity contribution arrangement from ABL for the recently-won
EV/EBITDA (x) 10.4 9.3 8.5 8.2 HAM projects.
Div. Yield (%) 0.8 0.8 0.8 0.8 Execution timelines for the recently-won HAM projects.
IRB
Bloomberg IRB IN CMP: INR242 TP: INR240 (-1%) Neutral
Equity Shares (m) 351.5
M. Cap. (INR b)/(USD b) 85 / 1 IRB is expected to register flattish revenue growth of 1% YoY to
52-Week Range (INR) 272 / 194 INR16.4b on account of transfer of BoT projects to InvIT.
1,6,12 Rel Perf. (%) 9 / 9 / -11 EBITDA is expected to register growth of 1.4% YoY to INR8.3b.
EBITDA margin is expected to improve 30bp YoY to 51%.
Financial Snapshot (INR b) PAT is expected to improve 31% YoY to INR2.5b led by higher other
Y/E March 2017 2018E 2019E 2020E income and lower tax rate for the quarter.
Net Sales 282.2 291.0 311.2 354.9
IRB won orders worth INR89b in the HAM and BoT segments.
EBITDA 8.3 14.2 15.5 22.5
PAT 4.9 10.8 8.6 12.7
EPS (INR) 1.3 2.9 2.3 3.5
EPS Gr. (%) NM 119.0 -19.9 -19.9
BV/Sh. INR 88.0 88.9 89.6 90.7
RoE (%) 1.5 3.3 2.6 3.8
RoCE (%) 0.7 2.5 1.7 3.0
Valuations
P/E (x) 67.9 31.0 38.7 26.3
Key issues to watch
P/BV (x) 1.0 1.0 1.0 1.0 Execution timelines for the recently-won HAM projects.
EV/EBITDA (x) 27.8 15.2 15.1 11.5 Impact on the EPC margins of the company once execution of
Div Yield (%) 0.9 1.9 1.5 2.3 lower-margin HAM projects starts.
* Consolidated
KNR
Bloomberg KNRC IN CMP: INR285 TP: INR375 (+32%) Buy
Equity Shares (m) 140.6
M. Cap. (INR b)/(USD b) 40 / 1 We expect revenue growth of 13.3% YoY to INR4.9b, driven by
52-Week Range (INR) 349 / 190 execution of key projects like Hubli Hospet, Madurai and
1,6,12 Rel Perf. (%) -4 / 32 / 33 Thiruvanthpuram.
Operating profit is expected to grow 36%, led by margin
Financial Snapshot (INR b) improvement of 490bp YoY to 19.8%.
Y/E March 2017 2018E 2019E 2020E Operating margin improvement is expected to be led by the
Net Sales 15.4 18.0 20.0 27.8 Madurai and Thirvanthpuram projects, which are in advanced
EBITDA 2.3 3.6 3.2 4.3 stages of completion.
NP 1.7 2.4 2.0 2.6
Net profit is expected to decline 14% YoY on account of higher tax
EPS (INR) 12.0 16.9 14.0 18.2
rate assumption for the quarter at 28% as against -9% in 4QFY17.
EPS Gr. (%) 4.3 41.2 -17.3 30.2
Maintain Buy.
BV/Sh (INR) 63.7 79.3 93.0 111.0
RoE (%) 20.7 23.6 16.2 17.8
RoCE (%) 16.8 19.0 15.0 17.4
Valuations
P/E (x) 23.8 16.9 20.4 15.7
Key issues to watch
Management commentary on order inflow for the year and ahead.
P/BV (x) 4.5 3.6 3.1 2.6
EV/EBITDA (x) 17.9 10.9 12.1 8.9
Sadbhav Eng
Bloomberg SADE IN CMP: INR396 TP: INR460 (+16%) Buy
Equity Shares (m) 171.5
M. Cap. (INR b)/(USD b) 68 / 1
Sadbhav Infrastructure has received orders worth INR41.2b in the
52-Week Range (INR) 439 / 262 HAM segment whereas Sadbhav Engineering has bagged another
1,6,12 Rel Perf. (%) 1 / 26 / 19 INR1b order in the EPC segment.
We expect revenue of INR12.4b (up 20.5% YoY), led by smooth
Financial Snapshot (INR b) execution of orders in hand.
Y/E March 2017 2018E 2019E 2020E EBITDA is expected to grow 23% YoY to INR1.4b. EBITDA margin is
Net Sales 33.2 38.2 46.1 55.8 expected to improve 30bp YoY to 10.9% on better revenue mix.
EBITDA 3.6 4.3 5.3 6.6 Adjusted PAT at INR880m is expected to register 29% growth YoY.
Adj. PAT 1.9 2.4 2.7 3.0
EPS(INR) 11.0 13.9 16.0 17.4
EPS Gr. (%) 42.3 27.1 14.9 8.6
BV/Sh. (INR) 96.8 109.3 123.9 139.9
RoE (%) 12.0 13.5 13.7 13.2
RoCE (%) 7.9 9.0 10.3 12.2
Valuations
P/E (x)
Key issues to watch
36.1 28.4 24.7 22.8
P/BV (x) Improvement in working capital cycle and overall quality of
4.1 3.6 3.2 2.8
EV/EBITDA (x) balance sheet.
23.3 17.6 14.1 11.4
Div Yield (%) 0.3 0.3 0.3 0.3
*Consolidated
Logistics
Company name EXIM originating rail volumes remain healthy
Allcargo Lead distance for EXIM cargo reduced
Concor
EXIM originating container rail volume grew 21% YoY in January-February 2018,
Gateway Distriparks
indicating strong volume growth for the quarter. Domestic container volumes declined
by 1% YoY in January-February 2018.
CCRI is likely to report better margins QoQ, led by strong volume growth. Margins for
GDPL are unlikely to improve meaningfully due to increasing competitive intensity in
the CFS segment.
CCRI should witness strong QoQ improvement in earnings, led by robust rail volumes
during 4QFY18. AGLL’s earnings are expected to increase QoQ, led by improvement in
MTO segment.
0.95
0.91
1.05
0.92
0.93
0.91
0.80
0.87
0.86
0.85
0.90
0.98
0.94
0.90
3.2
2.9
3.5
3.3
3.5
3.5
3.4
3.9
3.7
3.5
3.4
3.7
3.8
3.6
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Oct-17
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Oct-17
Source: Indian Rail, MOSL Source: Indian Rail, MOSL
Exhibit 3: EXIM lead distance declined 5% YoY in February Exhibit 4: Domestic lead distance declined 1% YoY in
2018 February 2018
EXIM average lead (kms) YoY (%) Domestic average lead (kms) YoY (%)
0
(5) (7) (4) (3) (5)
(7) (8) (6) (7) (7) (5) 0 1 2
(9)
(11) (4) (6) (4) (3) (3)
(6) (4) (4) (1) (1)
(7)
1,312
1,304
1,378
1,350
1,377
1,356
1,360
1,313
1,333
1,378
1,308
1,349
1,335
1,285
844
836
832
805
813
829
861
810
798
813
809
820
821
791
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Oct-17
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Jan-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Oct-17
Jun-17
Aug-15
Apr-16
Dec-15
Apr-17
Feb-16
Aug-16
Dec-16
Feb-17
Aug-17
Dec-17
Feb-18
Oct-15
Oct-16
Oct-17
Jul-16
Jul-17
Nov-15
Nov-16
Nov-17
May-16
May-17
Sep-15
Jan-16
Mar-16
Sep-16
Jan-17
Mar-17
Sep-17
Jan-18
Allcargo
Bloomberg AGLL IN CMP: INR152 TP: INR198 (+30%) Buy
Equity Shares (m) 245.7
We expect AGLL to report EBITDA of INR 994m (-6% YoY, +7%
M. Cap. (INR b)/(USD b) 37 / 1
52-Week Range (INR) 229 / 145 QoQ), led by improvement in MTO segment. We expect PAT of
1,6,12 Rel Perf. (%) -13 / -17 / -22 INR419m (-27% YoY, +20% QoQ) in 4QFY18.
We estimate MTO volumes at 147k TEU (+16% YoY, +2% QoQ) and
Financial snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E CFS volumes at 92k TEU (+20% YoY, +28% QoQ).
Sales 55.7 65.0 73.9 83.7
We estimate ~6% EBITDA CAGR and ~10% PAT CAGR over FY17-20,
EBITDA 4.6 4.0 4.9 5.5
NP 2.4 2.0 2.8 3.2 and expect return ratios to improve from ~13.7% in FY17 to ~14.4%
EPS (INR) 9.8 8.2 11.4 13.2
in FY20, driven by margin expansion and reduction in capex
EPS Growth (%) -1.2 -16.5 38.6 16.3
BV/Share (INR) 72.9 79.1 87.3 96.6 intensity in the business.
RoE (%) 13.7 10.8 13.7 14.4 The stock trades at a P/E of 13.4x (FY19E) and 11.5x (FY20E), and at
RoCE (%) 12.1 9.5 11.8 12.5
an EV/EBITDA of 7.2x (FY19E) and 5.8x (FY20E). Maintain Buy.
Valuations
P/E (x) 15.5 18.5 13.4 11.5
P/BV (x) 2.1 1.9 1.7 1.6 Key issues to watch for
EV/EBITDA (x) 8.8 9.6 7.2 5.8 (a) Volume data, and (b) set up of logistics park in Jhajjar.
Concor
Bloomberg CCRI IN CMP: INR1,260 TP: INR1,386(10%) Neutral
Equity Shares (m) 243.7
We expect CCRI to report net sales of INR15.5b (-1% YoY, +6%
M. Cap. (INR b)/(USD b) 307 / 5
QoQ), led by (a) volume growth of 13% YoY, and (b) 12% YoY
52-Week Range (INR) 1500 / 985
decrease in realizations.
1,6,12 Rel Perf. (%) -2 / -11 / 13
We expect EXIM volumes to improve 13% YoY and expect domestic
Financial snapshot (INR b) volumes to grow 10% YoY.
Y/E March 2017 2018E 2019E 2020E
We estimate EBITDA at INR3.3b (-33% YoY, +11% QoQ) and
Sales 56.1 58.9 67.8 79.2
adjusted PAT at INR2.1b (-50% YoY, +13% QoQ).
EBITDA 12.5 12.4 15.1 18.7
The stock trades at a P/E of 24.6x (FY19E) and 21.7x (FY20E), and at
NP 9.3 10.8 12.5 14.2
an EV/EBITDA of 19x (FY19E) and 15.2x (FY20E).
EPS (INR) 38.0 44.2 51.2 58.2
EPS Gr. (%) -2.6 16.3 15.9 13.5 CCRI remains a direct play on the upcoming dedicated freight
BV/Sh (INR) 363.0 386.5 413.1 443.3 corridor (DFC) project, which will multiply its asset turnover and
RoE (%) 10.8 11.8 12.8 13.6 significantly improve profitability. Maintain Neutral.
RoCE (%) 10.5 11.5 12.5 13.3
Payout (%) 57.7 48.1 48.1 48.1
Valuations Key issues to watch for
P/E (x) 33.2 28.5 24.6 21.7 EXIM and domestic volumes, and realizations.
P/BV (x) 3.5 3.3 3.1 2.8 Progress on MMLPs and DFC projects.
EV/EBITDA (x) 23.2 23.4 19.0 15.2
Div. Yield (%) 1.3 1.4 1.6 1.8
Gateway Distriparks
Bloomberg GDPL IN CMP: INR185 TP: INR231 (+25%) Buy
Equity Shares (m) 108.6
We expect GDPL to report net sales of INR3b (flat YoY, +6% QoQ),
M. Cap. (INR b)/(USD b) 20 / 0
52-Week Range (INR) 292 / 170 led by growth in CFS business.
1,6,12 Rel Perf. (%) -10 / -27 / -38 We estimate EBITDA at INR575m (+10% YoY, +1% QoQ) and EBITDA
Financial snapshot (INR b)
margin at 18.7%. We estimate adjusted PAT at INR204m (+6% YoY,
Y/E March 2017 2018E 2019E 2020E
Sales 11.6 11.7 13.4 15.3 +19% QoQ).
EBITDA 2.2 2.2 2.6 3.2 The stock trades at a P/E of 17.5x (FY19E) and 14.3x (FY20E), and at
NP 0.7 0.7 1.2 1.4
an EV/EBITDA of 7.8x (FY19E) and 6.3x (FY20E.
EPS (INR) 6.8 6.2 10.6 12.9
GDPL remains a direct play on the upcoming dedicated freight
EPS Gr. (%) -32.3 -18.1 90.3 16.8
BV/Sh (INR) 93.6 95.5 102.3 108.3 corridor project, which will multiply its asset turnover and
RoE (%) 7.3 6.6 10.7 12.3
significantly improve profitability. Maintain Buy.
RoCE (%) 10.0 9.1 12.4 14.6
Valuations
P/E (x) 27.2 29.7 17.5 14.3
P/BV (x) 2.0 1.9 1.8 1.7 Key issues to watch for
EV/EBITDA (x) 9.5 9.6 7.8 6.3 Volume growth, realization and per TEU profitability.
Div. Yield (%) 3.8 2.0 1.8 3.1
Media
Company name Broadcasters to continue outpacing overall sector growth
D B Corp Print and Radio to bounce back, led by revival in local ad spending
Dish TV India
HT Media Rebound by local advertisers to stimulate overall growth
Jagran Prakashan With the waning GST impact, 4QFY18 witnessed healthy ad spends from local
MBL advertisers following the recovery in spends by national advertisers in 3Q. We
ENIL expect most media companies (including print and radio) to post ad recovery from
Prime Focus 4QFY18, as ad spends across sectors gain momentum. Furthermore, the favorable
PVR base (demonetization impact in 4QFY17) should be supportive.
Sun TV
Zee Entertainment
Ad revenue for media sector to grow 9% YoY
We expect ad revenue for our Media universe to grow 9% YoY. Broadcasters are
likely to continue their previous quarter’s trend of double-digit growth mainly on
the back of increased ad spends by national advertisers, led by increased launches
across the FMCG and auto space (contributing 55-60% of total ad revenue). We
expect Zee to garner 16% YoY growth in ad revenue ex-sports and Sun TV to register
21% YoY ad revenue growth. Print and radio companies, mainly dependent on local
advertisers, have fragmented ad revenue across sectors.
Amongst print companies, we expect DB Corp to register 14% YoY ad revenue
growth, mainly driven by low base and revival in ad spends. Jagran, however, is
expected to report flat YoY ad revenue due to high base of ad spends attributed to
the UP elections in 4QFY17.
Within the radio pack, higher contribution from new stations coupled with revived
volumes in existing stations should drive growth. We expect 15% YoY ad revenue
growth for MBL, but a 2% YoY decline for ENIL. This is mainly due to the price hike
strategy of ENIL, which we believe continues to hurt volume growth at legacy
stations.
7 7
5
0
-2 -2 -3 -4 -3
ZEE SUN TV Jagran DB HT HMVL MBL ENIL ZEE SUN TV Dish TV Jagran DB Corp HT HMVL
Corp Media Media
ZEE’s ad revenue includes sports business for 4QFY17 ZEE’s subscription revenue includes sports business for 4QFY17
Source: Company, MOSL Source: Company, MOSL
8 19 8 3 11 1 3 15 14
-2
ZEE SUN TV Dish TV Jagran DB Corp HT Media HMVL MBL ENIL Prime
Focus
ZEE’s subscription revenue includes sports business for 4QFY17 Source: Company, MOSL
43.5 44.8 49.6 49.1 51.8 51.4 56.9 54.6 58.0 56.9 58.2 56.0 57.8 56.6 61.5 60.8
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18E
Source: Company, MOSL
78
56
35
16 14 23
2 11 4 4
-9 -4 -7 -10 -1
-21
5.5 5.5 7.6 5.5 5.6 7.4 8.7 9.7 8.8 8.2 9.0 7.7 7.9 10.2 9.4 7.6
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18E
PAT for ZEE excludes exceptional gain from sports business Source: Company, MOSL
Sensex Index MOSL Media Index Sensex Index MOSL Media Index
111 128
104 116
104
97
92
90 80
Dec-17
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
D B Corp
Bloomberg DBCL IN CMP: INR313 TP: INR420 (+34%) Buy
Equity Shares (m) 183.7
We expect print ad revenue to grow 14% YoY to INR3.5b, primarily
M. Cap. (INR b)/(USD b) 57 / 1
due to low base and revival in local ad spends.
52-Week Range (INR) 395 / 290
1,6,12 Rel Perf. (%)
Circulation revenue is likely to grow 7% YoY to INR1.3b, led by the
-4 / -24 / -29
circulation drive.
DBCL’s aggregate revenue is likely to grow 11% to INR5.7b, as print
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
ads, which account for 60-65% of overall revenue, are expected to
Net Sales 22.6 23.4 25.6 27.8
pick up during the quarter.
EBITDA 6.4 5.9 6.9 7.9
We expect EBITDA to reach INR1.1b (+6% YoY) and margin to dip
Adj. Net Profit 3.7 3.4 4.2 5.1
~100bp YoY to 20.7% on account of higher newsprint cost.
Adj. EPS (INR) 20.4 18.3 23.0 27.6
We estimate net profit at INR691m, up 8% YoY.
Adj. EPS Gr. (%) 28.3 -10.4 25.8 20.1 The stock trades at 13.6x FY19E and 11.3x FY20E EPS. Maintain
BV/Sh (INR) 86.7 100.2 118.3 141.1 Buy.
RoE (%) 25.1 19.6 21.0 21.3
RoCE (%) 23.7 18.9 20.5 20.8 Key things to watch for
Div. Payout (%) 48.7 26.3 20.9 17.4 Ad revenue (we expect 14% YoY growth).
Valuations EBITDA margin (we expect 20.7%).
P/E (x) 15.3 17.1 13.6 11.3
P/BV (x) 3.6 3.1 2.6 2.2
EV/EBITDA (x) 8.8 9.2 7.3 5.9
Div. Yield (%) 2.6 1.3 1.3 1.3
Dish TV India
Bloomberg DITV IN CMP: INR72 TP: INR101 (+39%) Buy
Equity Shares (m) 1065.9
We expect DITV’s overall revenue to grow 4% QoQ to INR7.7b.
M. Cap. (INR b)/(USD b) 77 / 1
Subscription revenue is likely to grow 2% QoQ to INR7b on the back
52-Week Range (INR) 110 / 64
1,6,12 Rel Perf. (%)
of net subscriber adds. We expect net subscriber additions of 0.3m
3 / -9 / -41
in 4QFY18.
The headline numbers, however, could vary depending on the
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
management’s call to merge Videocon D2H financials, as all merger
Net Sales 30.1 30.0 34.2 38.2
formalities have been completed in March 2018.
EBITDA 9.7 8.4 11.2 13.6 ARPU is likely to remain steady due to intense competition
Adj. NP 1.1 -0.4 1.7 3.6 offsetting the gains from increasing HD share. We expect ARPU to
Adj. EPS (INR) 1.0 -0.3 1.6 3.4 grow by a meager 1% QoQ to INR145.
Adj. EPS Gr.(%) -84.2 -133.6 -565.3 109.9 EBITDA is likely to grow 12% QoQ to INR2.3b and margin is
BV/Sh (INR) 4.6 4.0 5.6 9.0 expected to expand 230bp QoQ to 29.4% primarily on the back of
RoE (%) 25.1 -11.9 33.2 46.0 revenue, with cost remaining steady.
RoCE (%) 18.0 6.6 15.8 23.4 We expect DITV’s net loss to widen to INR81m.
Valuations The stock trades at EV/EBITDA of 7.4x FY19E and 5.6x FY20E.
P/E (x) 70.4 -209.6 45.0 21.5 Maintain Buy.
P/BV (x) 15.7 17.2 12.5 7.9
EV/EBITDA (x) 8.6 10.2 7.4 5.6 Key things to watch for
Quarterly net subscriber adds (we expect 0.3m).
ARPU (we expect 1% QoQ growth to INR145).
EBIDTA margin (we expect 29.4%).
Entertainment Network
Bloomberg ENIL IN CMP: INR699 TP: INR820 (+17%) Buy
Equity Shares (m) 47.7
We expect ENIL’s standalone revenue to decline 2% YoY to
M. Cap. (INR b)/(USD b) 33 / 1
INR1.6b, pulled down by muted growth at legacy stations, partly
52-Week Range (INR) 1008 / 664
1,6,12 Rel Perf. (%)
offset by higher contribution from new stations.
-1 / -19 / -26
ENIL’s 35 legacy stations are expected to see a 7% YoY drop to
INR1.4b. This is primarily due to the price hike strategy wherein the
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E ad inventory cap is likely to continue outweighing the yield
Net Sales 5.6 5.4 6.7 8.2 improvement.
EBITDA 1.3 1.2 1.7 2.6 Its 17 new stations (batch-1 of phase-3) are expected to contribute
Adj. NP 0.5 0.3 0.7 1.4 INR237m (15% of revenue).
Adj. EPS (INR) 11.4 7.2 15.3 28.7 Standalone EBITDA is likely to grow 2% YoY to INR359m and
Adj. EPS Gr. (%) -49.5 -37.2 113.8 86.9 margins are expected to expand 90bp YoY.
BV/Sh (INR) 179.3 185.9 200.0 227.5 PAT is expected to decline 2% YoY to INR135m.
RoE (%) 6.6 3.9 7.9 13.4 The stock trades at an EV/EBITDA of 18.7x FY19E and 12x FY20E.
RoCE (%) 4.9 3.2 6.7 11.8 Maintain Buy.
Valuation
Key things to watch for
P/E (x) 61.2 97.5 45.6 24.4
Growth in advertisement revenue in new and old stations.
P/BV (x) 3.9 3.8 3.5 3.1
EV/EBITDA (x) 27.3 29.0 18.7 12.0
HT Media
Bloomberg HTML IN CMP: INR86 TP: INR98 (+14%) Neutral
Equity Shares (m) 230.5
We expect consolidated revenue to grow by a meager 1% YoY to
M. Cap. (INR b)/(USD b) 20 / 0
INR5.9b.
52-Week Range (INR) 119 / 78
1,6,12 Rel Perf. (%)
Ad revenue is likely to decline 2% YoY to INR4b, primarily due to
-3 / -16 / -9
weak English ad revenue.
English ad revenue is expected to decline ~7% YoY to INR2.1b,
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
mainly impacted by digital medium. However, 5% YoY growth in
Net Sales 24.5 23.7 24.5 25.4 Hindi ad revenue to INR1.8b should partly offset the impact on
EBITDA 3.0 4.1 4.0 3.9 overall ad revenue.
Adj. NP 1.7 2.7 2.8 2.9 We expect circulation revenue to decline 4% YoY to INR0.7b.
Adj. EPS (INR) 7.4 11.8 12.1 12.7 EBITDA is likely to grow 24% to INR0.9b and margin is expected to
Adj. EPS Gr. (%) -1.8 59.3 2.6 4.9 increase 290bp YoY to 15.4%, primarily on the back of savings in
BV/Sh (INR) 96.8 108.2 119.8 131.9 discretionary cost.
RoE (%) 7.9 9.7 10.2 10.5 Net profit is likely to come in at INR0.4b (+62% YoY). The stock
RoCE (%) 9.7 11.5 10.6 10.1 trades at 7.1x FY19E and 6.8x FY20E EPS. Maintain Neutral.
Div. Payout (%) 6.9 4.3 4.2 4.0
Valuations
P/E (x) 11.7 7.3 7.1 6.8 Key things to watch for
P/BV (x) 0.9 0.8 0.7 0.7 English ad revenue (we expect ~7% YoY de-growth).
EV/EBITDA (x) 10.0 6.3 5.4 4.5 Hindi ad revenue (we expect 5% growth).
Div. Yield (%) 0.5 0.5 0.5 0.5 EBITDA margin (we expect 15.4%).
Jagran Prakashan
Bloomberg JAGP IN CMP: INR172 TP: INR215 (+25%) Buy
Equity Shares (m) 326.9
We expect advertising revenue to remain flat at INR3.3b on
M. Cap. (INR b)/(USD b) 56 / 1
account of high base in 4QFY17 (led by UP elections).
52-Week Range (INR) 209 / 156
1,6,12 Rel Perf. (%)
However, driven by an increase in the circulation copies, circulation
5 / -10 / -19
revenue is likely to grow 7% YoY to INR1.1b.
We estimate Radio revenue to grow 15% to INR0.8b and EBITDA to
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
grow 53% to INR0.3b.
Net Sales 22.8 23.3 26.0 28.6 Aggregate revenue is expected to grow 3% to INR5.8b.
EBITDA 6.4 5.9 7.1 8.3 Increase in newsprint cost is likely to impact EBITDA. We expect
Adj. Net Profit 3.5 3.1 4.1 5.0 EBITDA decline of 9% YoY to INR1.3b and EBITDA margin at 22.8%
Adj. EPS (INR) 10.7 10.1 13.1 16.0 (-280bp YoY). PAT is expected to fall 11% to INR0.7b.
Adj. EPS Gr. (%) -11.5 -5.3 30.5 21.5 The stock trades at 13.1x FY19E and 10.8x FY20E EPS. Maintain
BV/Sh (INR) 65.9 63.1 72.1 83.9 Buy.
RoE (%) 18.4 14.9 18.5 19.5
RoCE (%) 15.9 14.1 17.1 18.1
Div. Payout (%) 0.0 35.8 27.4 22.6
Valuations
Key things to watch for
P/E (x) 16.2 17.1 13.1 10.8
Ad revenue (we expect flat YoY growth).
P/BV (x) 2.6 2.7 2.4 2.0
EBITDA margin (we expect 22.8% margin).
EV/EBITDA (x) 7.9 8.1 6.3 5.0
Div. Yield (%) 0.0 1.7 1.7 1.7
Music Broadcast
Bloomberg RADIOCIT IN CMP: INR397 TP: INR469 (+18%) Buy
Equity Shares (m) 57.1
We expect revenue to grow 15% YoY to INR762m on the back of
M. Cap. (INR b)/(USD b) 23 / 0
waning GST impact (providing impetus to revival in ad spends
52-Week Range (INR) 458 / 333
1,6,12 Rel Perf. (%)
across sectors) and higher utilization at new stations.
3 / -2 / -2
EBITDA is expected to rise 53% YoY to INR254m; margin is likely
to expand 836bp YoY to 33.3%.
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
We expect PAT to grow 170% YoY to INR122m, led by higher
Sales 2.7 3.0 3.5 4.0
EBITDA.
EBITDA 0.9 1.0 1.3 1.6 The stock trades at EV/EBITDA of 15.6x FY19E and 11.7x FY20E.
Adj. NP 0.4 0.5 0.8 1.0 Maintain Buy.
Adj. EPS (INR) 6.4 8.3 13.5 17.8
Adj.EPS Gr (%) -26.1 29.9 62.3 31.4
BV/Sh. (INR) 96.1 104.4 118.0 135.8
RoE (%) 9.7 8.3 12.2 14.0
RoCE (%) 8.6 8.7 12.0 14.0
Valuations Key things to watch for
P/E (x) 61.7 47.5 29.3 22.3 Growth in utilization in new and old stations.
P/BV (x) 4.1 3.8 3.4 2.9 Yield improvement at legacy stations.
EV/EBITDA (x) 23.5 21.5 15.6 11.7
Prime Focus
Bloomberg PRIF IN CMP: INR90 TP: INR130 (+44%) Buy
Equity Shares (m) 298.9
We expect consolidated revenue to grow 14% YoY to INR7.5b,
M. Cap. (INR b)/(USD b) 27 / 0
primarily on the back of creative business.
52-Week Range (INR) 135 / 81
1,6,12 Rel Perf. (%)
Given the strong offering pipeline, we expect creative business to
-10 / -7 / -11
grow at 12% YoY to INR6b.
Further, the Tech business is likely to reach INR1.1b, growing at
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
24% YoY, driven by client additions and contract renewals.
Net Sales 21.5 24.2 27.7 31.9 We expect EBITDA to reach INR1.9b, up 7% YoY, and margin to dip
EBITDA 4.8 5.4 6.5 7.7 ~160bp to 25.8% due to higher operating cost.
Adj. Net Profit 0.4 0.7 1.7 2.6 We estimate net profit at INR633m, up 60% YoY.
Adj. EPS (INR) 1.2 2.5 5.8 7.9 The stock trades at an EV/EBITDA of 5x FY19E and 3.7x FY20E.
Adj.EPS Gr. (%) NM 100.6 137.5 36.4 Maintain Buy.
BV/Sh (INR) 18.6 23.8 37.9 46.7
RoE (%) 7.6 11.6 18.9 20.7
RoCE (%) 8.5 10.2 13.6 15.7
Valuations
P/E (x) 73.6 36.7 15.5 11.3 Key things to watch for
P/BV (x) 4.8 3.8 2.4 1.9 Consolidated revenue (we expect 14% YoY growth).
EV/EBITDA (x) 8.4 7.0 5.0 3.7 EBITDA margin (we expect 25.8%).
PVR
Bloomberg PVRL IN CMP: INR1,248 TP: INR1,760 (+41%) Buy
Equity Shares (m) 46.7
We expect revenue to grow 21% YoY to INR5,839m in 4QFY18 on
M. Cap. (INR b)/(USD b) 58 / 1
account of screen additions and strong content pipeline.
52-Week Range (INR) 1660 / 1145
1,6,12 Rel Perf. (%)
Margins are likely to expand ~360bp to 13.3%. We expect EBITDA
-2 / -3 / -25
to grow 66% to INR777m.
We expect PAT to reach INR58m in 4QFY18.
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E
The stock trades at 33.4x FY19E and 24.3x FY20E EPS. Maintain
Net Sales 21.2 23.4 27.5 32.9
Buy.
EBITDA 3.1 3.8 5.1 6.2
Adj. Net Profit 1.0 1.0 1.7 2.4
Adj. EPS (INR) 20.5 22.1 37.3 51.5
Adj. EPS Gr. (%) -3.8 7.8 68.7 37.9
BV/Sh (INR) 206.5 226.8 261.7 310.8
RoE (%) 10.4 10.2 15.3 18.0
RoCE (%) 9.5 9.3 12.4 14.8
Payout (%) 7.0 8.2 6.5 4.7
Valuations Key things to watch for
P/E (x) 60.8 56.4 33.4 24.3 Growth in sponsorship revenue.
P/BV (x) 6.0 5.5 4.8 4.0 Number of screen additions.
EV/EBITDA (x) 23.4 19.4 14.5 11.5
Div Yield (%) 0.2 0.2 0.3 0.3
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Sales 5,622 5,438 5,309 4,826 6,366 5,554 5,573 5,839 21,194 23,354
YoY Change (%) 15.7 14.6 6.1 18.4 13.2 2.1 5.0 21.0 14.6 10.2
Total Expenditure 4,557 4,634 4,509 4,358 5,246 4,649 4,569 5,062 18,058 19,547
EBITDA 1,065 804 800 467 1,120 905 1,003 777 3,136 3,807
Margins (%) 19.0 14.8 15.1 9.7 17.6 16.3 18.0 13.3 14.8 16.3
Depreciation 331 346 345 363 376 347 375 517 1,384 1,660
Interest 193 194 204 216 208 207 212 226 806 903
Other Income 165 175 111 171 164 42 32 56 623 311
PBT before EO expense 707 440 363 60 700 393 449 90 1,569 1,555
Extra-Ord expense 26 0 0 15 0 6 0 0 41 0
PBT 681 440 363 45 700 387 449 90 1,528 1,555
Tax 249 149 127 45 258 140 154 31 570.0 520.9
Rate (%) 36.6 33.8 35.1 99.8 36.8 36.1 34.2 34.8 37.3 33.5
Reported PAT 428 291 239 -0.5 445 252 289 58.4 958 1,034
Adj PAT 444 291 239 -0.5 445 255 289 58.4 984 1,034
YoY Change (%) -3.0 -8.7 -23.5 NM 0.1 -12.3 20.8 NM -8.0 5.0
Margins (%) 7.6 5.4 4.5 0.0 7.0 4.5 5.2 1.0 4.5 4.4
E: MOSL Estimates
Sun TV
Bloomberg SUNTV IN CMP: INR894 TP: INR1,225 (+37%) Buy
Equity Shares (m) 394.1
We expect Sun TV’s standalone revenue to grow 19% YoY to
M. Cap. (INR b)/(USD b) 352 / 5
INR6.9b.
52-Week Range (INR) 1097 / 652
1,6,12 Rel Perf. (%)
Advertising and broadcasting revenue is expected to witness 21%
-1 / 11 / 1
YoY jump to INR3.5b, on the back of (1) transition to commission
model, (2) waning GST impact, and (3) low base.
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
We expect subscription revenue to grow 19% YoY to INR3.3b
Net Sales 25.6 28.4 33.6 38.5 primarily led by fast pick-up in the digitization in Tamil Nadu
EBITDA 17.4 19.4 23.4 26.9 coupled with improving ARPU.
Adj. Net Profit 9.8 10.9 14.1 16.7 Sun TV’s standalone EBITDA is estimated to grow 27% YoY to INR5b
Adj. EPS (INR) 24.9 27.7 35.8 42.5 and margins to expand 450bp to 72.1%.
Adj. EPS Gr. (%) 14.1 11.6 29.1 18.7 PAT is expected to grow 23% YoY to INR2.9b.
BV/Sh (INR) 102.1 110.2 121.7 135.3 The stock trades at 25x FY19E and 21x FY20E EPS. Maintain Buy.
RoE (%) 26.0 26.1 30.9 33.1
RoCE (%) 26.0 26.1 30.9 33.1
Div. Payout (%) 46.5 70.8 67.7 67.9
Valuations
P/E (x) 36.0 32.2 25.0 21.0 Key things to watch for
P/BV (x) 8.8 8.1 7.3 6.6 Ad revenue growth (expect 21% YoY growth).
EV/EBITDA (x) 19.4 17.2 14.0 12.0 Subscription revenue growth (expect 19% YoY growth).
Div. Yield (%) 1.1 1.9 2.3 2.8
Zee Entertainment
Bloomberg Z IN
CMP: INR582 TP: INR705 (+21%) Buy
Equity Shares (m) 960.4
We expect advertising revenue to grow 15% YoY to INR9.7b. Ex-
M. Cap. (INR b)/(USD b) 559 / 9
52-Week Range (INR) 619 / 477
sports, ad revenue is expected to grow 16% YoY. Low base coupled
1,6,12 Rel Perf. (%) 6 / 5 / -2 with revived ad spending should bode well.
Subscription revenue is likely to decline 3% YoY to INR5.4b.
Financial Snapshot (INR Billion)
However, excluding sports, it is expected to grow 13% YoY.
Y/E MARCH 2017 2018E 2019E 2020E Total revenue is expected to grow 8% YoY to INR16.5b. Ex-sports,
Net Sales 64.3 66.1 76.5 87.7 revenue is likely to grow 16% YoY.
EBITDA 19.3 20.0 25.3 29.7 Yet, higher content cost coupled with the launch of ZEE5 is
Adj. NP 12.9 12.5 16.9 20.2 expected to pressurize EBITDA. We expected consolidated EBITDA
Adj. EPS (INR) 13.4 13.0 17.6 21.0 to witness 8% YoY decline to INR4.3b and margin to contract 450bp
Adj. EPS Gr. (%) 52.5 -2.9 35.4 19.3 YoY to 26.2%.
BV/Sh (INR) 69.3 80.2 94.2 111.6 PAT is expected to de-grow ~89% YoY to INR1.7b. However,
(INR)
RoE (%) 22.4 17.4 20.2 20.4 excluding the exceptional gain of INR12.2b from sale of sports
RoCE (%) 20.7 15.7 18.9 20.4 business in 4QFY17, on an adjusted basis, PAT is expected to
Div. Payout (%) 13.0 21.6 20.5 17.2 decline ~58% YoY.
Valuations The stock trades at 33x FY19E and 27.6x FY20E EPS. Maintain Buy.
P/E (x) 43.4 44.6 33.0 27.6
P/BV (x) 8.4 7.2 6.2 5.2 Key things to watch for
EV/EBITDA (x) 28.6 26.6 20.8 17.2 Ad revenue (expect 16% YoY growth ex-sports).
Div. Yield (%) 0.4 0.4 0.5 0.5 Subscription revenue (expect 13% YoY growth ex-sports).
Metals
Company name Ferrous companies to outperform on higher realization
Hindalco JSPL, SAIL and NMDC set to report strong earnings growth
Hindustan Zinc
Steel product prices increase sharply
Jindal Steel & Power
Steel product prices rose sharply in 4QFY18, driven by seasonally strong demand,
JSW Steel
higher exports, disruption at some of the domestic mills, and strong global prices
Nalco
amid Chinese winter shutdowns. Domestic long product prices increased ~21% QoQ
NMDC
(or ~INR6,700/t) and flat product prices were up ~13% QoQ (or INR5,000/t).
SAIL Domestic iron ore prices were also higher (up by ~28% QoQ or INR600/t, for NMDC’s
Tata Steel fines) due to strong demand and disruption in mining activity in Odisha. Base metal
Vedanta prices have increased modestly – aluminum LME is up ~3% QoQ to USD2,174/t, zinc
is up ~6% QoQ to USD3,419/t and lead is up ~2% QoQ to USD2,529/t. Alumina was
down ~13% QoQ at USD376/t.
Steel volumes for the four companies under our coverage universe are expected to
increase 1% QoQ/5% YoY, led by JSPL. Tata Steel’s volumes declined ~9% QoQ due
to shut-down. Aluminum volumes are expected to increase 3% QoQ on ramp-up at
Vedanta.
37,500
33,000
28,500
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Feb-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Nov-16
May-17
Nov-13
Nov-14
May-15
May-16
Aug-17
Feb-18
May-13
May-14
Aug-15
Aug-16
Feb-16
Feb-17
Aug-13
Aug-14
Feb-14
Feb-15
Jun-14
Jun-15
Apr-13
Jun-16
Jun-17
Aug-13
Apr-14
Dec-13
Apr-15
Feb-14
Aug-14
Dec-14
Apr-16
Feb-15
Aug-15
Dec-15
Apr-17
Feb-16
Aug-16
Dec-16
Oct-13
Feb-17
Aug-17
Dec-17
Oct-14
Feb-18
Oct-15
Oct-16
Oct-17
500
-500
-1,000
Jul-12
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
Nov-12
Nov-13
Nov-14
Nov-15
Nov-16
Nov-17
May-12
May-13
May-14
May-15
May-16
May-17
Jan-12
Mar-12
Sep-12
Jan-13
Mar-13
Sep-13
Jan-14
Mar-14
Sep-14
Jan-15
Mar-15
Sep-15
Jan-16
Mar-16
Sep-16
Jan-17
Mar-17
Sep-17
Jan-18
Source: MOSL, Company
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Source: MOSL, Company
1,381
Nalco
1,256
1,240
1,600
1,134
1,117
1,116
1,070
1,012
1,003
1,400 Hindalco
993
989
913
909
1,200
Revenue (INR b)
VEDL
1,000
800 NMDC
600 JSP
400 JSW Steel
200
0 SAIL
Tata Steel
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
EBITDA (INR b)
100
JSP
50
0 JSW Steel
-50 SAIL
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
Tata Steel
Exhibit 11: Global aluminum production trend Exhibit 12: China aluminum production trend
Production YoY Production YoY
3.0 48
5,400 22.0 2.8 42
YoY growth (%)
17.0 2.6 36
YoY growth (%)
'000 tons
4,800
m tons
12.0 2.4 30
7.0 2.2 24
4,200
2.0 2.0 18
3,600 -3.0 1.8 12
-8.0 1.6 6
3,000 -13.0 1.4 0
Jul-16
Jul-17
Apr-16
Apr-17
Jan-16
Jan-17
Jan-18
Oct-15
Oct-16
Oct-17
Jul-16
Jul-17
Apr-16
Apr-17
Jan-16
Jan-17
Jan-18
Oct-16
Oct-17
USD/t
2,000 2.0
m tons
1,850 1.8
1,700 1.5
1,550 1.3
1,400 1.0
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Source: MOSL, Bloomberg
Exhibit 15: Relative performance – three months (%) Exhibit 16: Relative performance – one year (%)
Sensex Index MOSL Metals Index Sensex Index MOSL Metals Index
110 130
105 120
100 110
95 100
90 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Hindalco
Bloomberg HNDL IN CMP:INR208 TP:INR340 (+64%) Buy
Equity Shares (m) 2227.2
Standalone: We expect standalone EBITDA to decline 15% QoQ to
M. Cap. (INR b)/(USD b) 463 / 7
INR11.2b on (a) lower copper Tc/Rcs, (b) impact of cost increase
52-Week Range (INR) 284 / 180
1,6,12 Rel Perf. (%) -12 / -20 / -4
and LME hedging dragging the aluminum segment and (c) higher
transfer price of alumina from Utkal. Copper EBITDA is likely to
Financial Snapshot (INR Billion)
decline 12% QoQ to INR3.5b, while aluminum EBITDA would
Y/E March 2017 2018E 2019E 2020E
decline by 16% QoQ to INR7.7b. Including Utkal aluminum,
Sales 1,001.8 1,173 1,156 1,169
EBITDA will increase by 7% QoQ to INR12.4b.
EBITDA 124.4 139.4 146.6 144.7
Aluminum volumes are expected to increase 2% QoQ to 333kt,
NP 19.1 42.7 57.7 59.9
while copper volumes are expected to decline 7% QoQ to 95kt.
Adj. EPS (INR) 8.6 19.2 25.9 26.9
EPS Gr(%) -28.5 123.8 35.1 3.8
Novelis: We expect Novelis to report adjusted EBITDA of
BV/Sh. (INR) 129.9 147.8 172.6 198.4 USD313m, growth of 7% YoY. Adjusted EBITDA/t is estimated at
RoE (%) 7.4 13.8 16.2 14.5 USD388 (v/s USD383 in 3QFY18). Volumes are expected to
RoCE (%) 7.3 8.7 9.7 9.7 increase by 3% YoY to 813kt.
Payout (%) 15.0 8.5 6.3 6.1
Valuations Key issues to watch for
P/E (x) 24.3 10.8 8.0 7.7 Lower margins in aluminum.
P/BV 1.6 1.4 1.2 1.0 Foreign exchange rate impact at Novelis.
EV/EBITDA (x) 7.5 6.1 5.5 5.2
Div. Yield (%) 0.5 0.7 0.7 0.7
Hindustan Zinc
Bloomberg HZ IN CMP:INR307 TP: INR342 (+11%) Neutral
Equity Shares (m) 4225.3
We expect HZL’s EBITDA to increase 5% QoQ (down 9% YoY) to
M. Cap. (INR b)/(USD b) 1309 / 20
INR34.1b, on higher zinc and silver volumes, despite marginally
52-Week Range (INR) 340 / 227
1,6,12 Rel Perf. (%) 0 / -7 / -5
lower realization.
LME zinc is up 6% QoQ to USD3,419/t, but due to hedges the
Financial Snapshot (INR Billion)
effective LME for HZL will be down ~2% QoQ. Lead is broadly flat
Y/E March 2017 2018E 2019E 2020E
Sales 173.0 218 262 277
QoQ at USD2,488/t.
EBITDA 97.4 120.7 152.8 163.2 Refined zinc sales are expected to increase 5% QoQ to 209kt.
NP 83.2 89.4 117.7 128.2 Lead is expected to decline 10% QoQ to 41kt. Silver volumes are
Adj. EPS (INR) 19.7 21.2 27.9 30.3 expected to increase 14% QoQ to 150t.
EPS Gr(%) 7.5 31.7 8.9 PAT is expected to increase 16% QoQ to INR25.7b on higher other
BV/Sh. (INR) 72.9 84.5 102.3 121.7
income.
RoE (%) 24.4 26.9 29.8 27.1
RoCE (%) 29.4 34.5 39.8 35.6
Payout (%) 179.3 45.4 36.0 36.0
Valuations Key issues to watch for
P/E (x) 14.6 13.6 10.3 9.5 Decline in global zinc prices.
P/BV (x) 12.0 11.4 8.7 8.1
Production issues.
EV/EBITDA (x) 0.0 9.0 6.6 5.6
Div. Yield (%) 10.2 2.8 2.9 3.2
Quarterly
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Zinc refined (kt) 120 148 211 217 190 193 200 209 696 792
Lead refined (kt) 23 32 36 47 34 40 45 41 138 160
Silver (tonnes) 88 107 117 135 110 146 132 150 447 538
Zinc LME (USD/t) 1,918 2,252 2,518 2,777 2,589 2,950 3,236 3,179 2,366 3,048
Net Sales 25,306 35,257 49,799 62,602 45,760 53,090 59,220 59,657 172,964 217,727
Change (YoY %) -30.3 -12.6 45.2 99.9 80.8 50.6 18.9 -4.7 21.6 25.9
EBITDA 11,309 20,767 27,834 37,480 23,840 30,240 32,440 34,136 97,390 120,656
Change (YoY %) -42.5 2.6 88.3 186.5 110.8 45.6 16.5 -8.9 43.7 23.9
As % of Net Sales 44.7 58.9 55.9 59.9 52.1 57.0 54.8 57.2 56.3 55.4
Finance cost 712 712 451 142 1,370 840 170 0 2,017 2,380
DD&A 3,644 4,317 4,589 5,321 3,600 3,940 4,810 5,105 17,871 17,455
Other Income 6,101 7,702 5,882 4,811 5,300 4,870 2,980 3,596 24,496 16,746
PBT (before EO item) 13,053 23,440 28,676 36,829 24,170 30,330 30,440 32,626 101,998 117,566
EO exp. (income) -5 0 0 0 0 -2,910 0 0 -5 -2,910
PBT (after EO item) 13,059 23,440 28,676 36,829 24,170 33,240 30,440 32,626 102,003 120,476
Total Tax 2,680 4,421 5,477 6,259 5,410 7,790 8,140 6,852 18,837 28,192
% Tax 20.5 18.9 19.1 17.0 22.4 23.4 26.7 21.0 18.5 23.4
Reported PAT 10,379 19,019 23,199 30,570 18,760 25,450 22,300 25,775 83,166 92,285
Adjusted PAT 10,374 19,019 23,199 30,570 18,760 22,540 22,300 25,775 83,161 89,375
Change (YoY %) -53.4 -11.4 28.1 42.2 80.8 18.5 -3.9 -15.7 -0.7 7.5
JSW Steel
Bloomberg JSTL IN CMP: INR302 TP: INR334 (+11%) Buy
Equity Shares (m) 2417.2
Consolidated EBITDA is expected to increase 13% QoQ / 37% YoY
M. Cap. (INR b)/(USD b) 731 / 11
to INR43.3b on higher steel prices.
52-Week Range (INR) 321 / 184
1,6,12 Rel Perf. (%) 1 / 15 / 48
Standalone steel sales would increase 3% QoQ to ~4.1mt.
Standalone EBITDA/t is expected at INR9,866 per ton, increasing
Financial Snapshot (INR Billion)
10% QoQ on higher realization, partly offset by increase in cost.
Y/E March 2017 2018E 2019E 2020E
Adjusted consolidated PAT is estimated to decline 6% QoQ to
Sales 556.0 695.2 762.0 787.3
INR17.2b on a normalized tax rate (was 5% in 3Q).
EBITDA 122.6 138.4 156.1 156.2
Adj. PAT 35.8 52.0 58.0 57.4
Adj. EPS (INR) 14.8 21.5 24.0 23.7
EPS Gr(%) 45.3 11.5 -1.0
BV/Sh. (INR) 93.7 112.5 135.2 157.6
RoE (%) 17.3 20.9 19.4 16.2
RoCE (%) 7.9 8.8 9.6 8.8
Payout (%) 18.4 6.5 5.8 10.8 Key issues to watch for
Valuation Steel price hikes and impact of coking coal.
P/E (x) 20.4 14.0 12.6 12.7 Domestic steel demand growth.
P/BV 3.2 2.7 2.2 1.9
EV/EBITDA (x) 10.2 9.0 7.9 7.8
Div. Yield (%) 0.7 0.4 0.4 0.7
Nalco
Bloomberg NACL IN CMP: INR86 TP: INR84 (-2%) Neutral
Equity Shares (m) 1932.9
We expect EBITDA to be flat QoQ at INR4.7b as higher volumes
M. Cap. (INR b)/(USD b) 132 / 2
and aluminum realization are offset by lower alumina realization
52-Week Range (INR) 98 / 61
1,6,12 Rel Perf. (%) 3 / -21 / -21
and higher cost.
Aluminum LME is up 3% QOQ to USD2,162/t. Alumina realization
Financial Snapshot (INR Billion)
is expected to decline 13% QoQ to USD368/t.
Y/E March 2017 2018E 2019E 2020E
Aluminum volumes are expected to increase by 2% QoQ to 112kt.
Sales 75.4 92.2 92.9 94.1
Alumina sales would increase by 38% QoQ to 353kt.
EBITDA 10.8 15.0 16.6 17.0
PAT is estimated to increase 4% QoQ to INR2.9b.
NP 7.2 -0.3 9.9 10.2
Adj. EPS (INR) 3.7 -0.2 5.1 5.3
EPS Gr(%) 37.9 -104.7 NM 2.6
BV/Sh. (INR) 52.8 50.6 53.7 56.9
RoE (%) 7.2 -0.3 9.8 9.5
RoCE (%) 7.9 11.9 12.9 12.6
Payout (%) 60.5 59.7 41.0 40.0
Valuations
P/E (x) 19.1 -408.7 13.8 13.5 Key issues to watch for
P/BV 1.3 1.4 1.3 1.2 Availability of coal for captive power plant.
EV/EBITDA (x) 9.5 7.3 6.7 6.5 LME price trend, utilization of smelter.
Div. Yield (%) 3.9 2.5 2.5 2.5
NMDC
Bloomberg NMDC IN CMP: INR118 TP: INR215 (+81%) Buy
Equity Shares (m) 3163.9
NMDC’s EBITDA is expected to increase 54% QoQ to INR20.4b due
M. Cap. (INR b)/(USD b) 376 / 6
to higher realization and volumes.
52-Week Range (INR) 163 / 103
1,6,12 Rel Perf. (%) -7 / -6 / -23
Iron ore sales volumes are expected to increase 24% QoQ to
10mt, as evacuation issues are resolved.
Financial Snapshot (INR Billion)
Domestic iron ore realization is expected to increase 15% QoQ to
Y/E March 2017 2018E 2019E 2020E
INR3,419/t on price hikes.
Sales 88.3 112.4 115.0 120.7
Adjusted PAT is expected to increase 52% QoQ to INR13.8b.
EBITDA 44.9 62.8 65.5 69.0
Adj. PAT 31.5 43.2 44.4 46.5
Adj. EPS (INR) 10.0 13.6 14.0 14.7
EPS Gr(%) 11.7 37.0 2.9 4.7
BV/Sh. (INR) 71.2 78.5 85.3 92.8
RoE (%) 13.5 18.2 17.2 16.5 Key issues to watch for
RoCE (%) 11.5 17.8 16.8 16.2 Increase in global iron ore prices.
Payout (%) 74.9 46.6 51.3 49.0 Stronger-than-expected iron ore demand.
Valuation
P/E (x) 11.9 8.7 8.5 8.1
P/BV 1.7 1.5 1.4 1.3
EV/EBITDA (x) 7.2 5.4 5.1 4.9
Div. Yield (%) 4.3 4.5 5.1 5.1
Rain Industries
Bloomberg RINDL IN CMP:INR384 TP: INR480 (+25%) Buy
Equity Shares (m) 336.4
We expect EBITDA to increase 13% QoQ to INR7.7b on higher
M. Cap. (INR b)/(USD b) 129 / 2
volumes.
52-Week Range (INR) 476 / 92
1,6,12 Rel Perf. (%) 8 / 115 / 235
Carbon business EBITDA per ton will increase 1% QoQ to
USD135/t.
Financial Snapshot (INR Billion)
Chemical business EBITDA per ton will increase from USD58/t
Y/E March 2016 2017E 2018E 2019E
QoQ to USD60/t.
Sales 93.2 113.9 133.9 146.1
Cement business EBITDA per ton will decline 13% QoQ to
EBITDA * 13.5 23.1 28.6 30.8
INR450/t.
NP 3.2 8.6 13.1 14.5
Adj. PAT will increase 9% QoQ to INR3.6b.
Adj. EPS (INR) 9.6 25.5 38.9 43.0
EPS Gr (%) 1.2 165.2 52.3 10.7
BV/Sh. (INR) 89.6 112.7 149.2 189.9 Key issues to watch for
RoE (%) 10.9 25.2 29.7 25.4 Environment measures in China.
RoCE (%) 12.7 21.3 26.2 26.4 Global aluminum production growth.
Payout (%) 15.6 9.4 6.2 5.6
Valuation
P/E (x) 45.5 17.2 11.3 10.2
P/BV 4.9 3.9 2.9 2.3
EV/EBITDA, x* 15.6 9.0 6.9 6.1
Div. Yield (%) 0.2 0.5 0.5 0.5
SAIL
Bloomberg SAIL IN CMP: INR74 TP: 71 (-3%) Sell
Equity Shares (m) 4130.4
SAIL’s EBITDA is expected to increase ~51% QoQ to INR21.7b.
M. Cap. (INR b)/(USD b) 309 / 5
Volumes would increase 1% QoQ to 3.8mt. EBITDA per ton would
52-Week Range (INR) 101 / 53
1,6,12 Rel Perf. (%) -5 / 34 / 7
increase by ~INR2000/t to INR3,278/t on higher steel prices and
operating leverage gains from higher volumes.
Financial Snapshot (INR Billion)
PAT will increase from INR659m in 3QFY18 to INR6.2b in 4QFY18.
Y/E March 2017 2018E 2019E 2020E
Sales 445.0 568.7 666.1 689.5
EBITDA 0.7 44.7 83.0 106.9
NP -26.3 -3.6 17.8 26.8
Adj. EPS (INR) -6.4 -0.9 4.3 6.5
EPS Gr(%) -37.1 -86.1 -589.8 50.2
BV/Sh. (INR) 89.7 87.8 91.6 97.6
RoE (%) -6.9 -1.0 4.8 6.9
RoCE (%) -2.9 2.2 6.1 8.7 Key issues to watch for
Payout (%) Commissioning of Bhilai capacity and steel prices.
Valuation
P/E (x) -11.6 -83.9 17.1 11.4
P/BV 0.8 0.8 0.8 0.8
EV/EBITDA (x) 1,067.0 17.3 9.6 7.1
Div. Yield (%) 0.0 0.0 0.0 0.0
Tata Steel
Bloomberg TATA IN CMP: INR579 TP: 778 (+34%) Neutral
Equity Shares (m) 1203.1
India: We expect Tata Steel’s standalone EBITDA to decline 2%
M. Cap. (INR b)/(USD b) 697 / 11
QoQ to INR45.3b on lower volumes even as margins are higher.
52-Week Range (INR) 747 / 404
1,6,12 Rel Perf. (%) -12 / -13 / 15
Sales volume is down 9% QoQ to 3mt due to shutdown at
Kalinganagar. EBITDA per ton is estimated to increase ~INR1,000
Financial Snapshot (INR Billion)
QoQ to INR15,087/t on higher realization.
Y/E March 2017 2018E 2019E 2020E
Europe: EU sales volumes would increase 10% QoQ to 2.7mt.
Sales 1,123 1,277 1,279 691
Margins are estimated to increase to USD92/t on healthy steel
EBITDA 170 216 228 164
spreads.
Adj. PAT 37 70 83 74
Consolidated EBITDA is expected to increase 9% QoQ to INR62.2b.
Adj. EPS (INR) 38.0 58.2 69.4 61.4
EPS Gr(%) 394.2 53.4 19.1 -11.5
Adjusted PAT is expected to decrease 4% QoQ to INR23.1b.
BV/Sh. (INR) 330 398 457 509
RoE (%) 15.7 16.0 16.2 12.7
RoCE (%) 9.4 11.9 11.7 9.7 Key issues to watch for
Payout (%) -27.0 21.4 13.1 17.4 Imports from China and global iron ore prices.
Valuation
P/E (x) 15.2 9.9 8.3 9.4
P/BV 1.8 1.5 1.3 1.1
EV/EBITDA (x) 7.7 6.0 5.5 6.6
Div. Yield (%) 1.4 1.4 1.4 1.4
Vedanta
Bloomberg VEDL IN CMP:INR284 TP: INR346 (+22%) Buy
Equity Shares (m) 3717.0
We expect VEDL’s EBITDA to increase 7% QoQ (down 1% YoY) to
M. Cap. (INR b)/(USD b) 1056 / 16
INR72b, driven by oil, aluminum and iron ore. Adjusted PAT is
52-Week Range (INR) 356 / 218
1,6,12 Rel Perf. (%) -10 / -17 / -7
estimated to increase 28% QoQ to INR28.4b on higher other
income and lower tax rate.
Financial Snapshot (INR Billion)
Aluminum: EBITDA is expected to increase by 16% QoQ to
Y/E March 2017 2018E 2019E 2020E
INR7.1b, driven by higher LME (up ~USD65/t) and volumes (up 4%
Sales 722.3 886 1,041 1,123
QoQ to 444kt), partly offset by higher costs.
EBITDA * 175.5 198.2 258.5 286.2
Zinc India: EBITDA is expected to increase 5% QoQ to INR34.1b on
NP 56.3 84.8 124.2 144.6
higher zinc and silver volumes.
Adj. EPS (INR) 15.1 22.8 33.4 38.9
EPS Gr (%) 50.7 46.4 16.4
Power: EBITDA is expected to decline 17% QoQ to INR4.9b off a
BV/Sh. (INR) 162.7 159.9 176.8 196.8 stronger base.
RoE (%) 9.7 14.1 19.8 20.8 Copper: EBITDA is expected to increase 7% QoQ to INR3.2b.
RoCE (%) 12.4 14.0 18.4 19.4 Oil & Gas: EBITDA is expected to increase 17% QoQ to INR15.8b
Payout (%) 154.2 111.5 37.5 37.4 on higher oil prices and volumes.
Valuation
P/E (x) 18.8 12.4 8.5 7.3 Key issues to watch for
P/BV 1.7 1.8 1.6 1.4 Progress on ramp-up of 1.25mtpa smelter.
EV/EBITDA, x* 8.2 7.5 5.5 4.7 Movement in base metal prices.
Div. Yield (%) 6.8 7.5 3.7 4.3
105 120
100 110
95 100
90 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Brent up 19% QoQ (23% YoY), GRM strong, light/heavy spread widens
Exhibit 5: Brent crude price up 24% YoY and 9% QoQ at Exhibit 6: Premium of Brent over WTI declined QoQ to
USD67/bbl USD4.1/bbl in 4QFY18
Brent Crude Price (USD/bbl) Brent less WTI (USD/bbl)
32
140
24
105
16
70
8
35 0
0 -8
1QFY05
4QFY05
3QFY06
2QFY07
1QFY08
4QFY08
3QFY09
2QFY10
1QFY11
4QFY11
3QFY12
2QFY13
1QFY14
4QFY14
3QFY15
2QFY16
1QFY17
4QFY17
3QFY18
1QFY05
4QFY05
3QFY06
2QFY07
1QFY08
4QFY08
3QFY09
2QFY10
1QFY11
4QFY11
3QFY12
2QFY13
1QFY14
4QFY14
3QFY15
2QFY16
1QFY17
4QFY17
3QFY18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Exhibit 7: Reuters Singapore GRM rose 9% YoY (-3% QoQ) to Exhibit 8: YoY GRM increase led by higher Diesel and
an average of USD7.0/bbl in 4QFY18 Jet/Kero cracks
Reuters Singapore GRM (USD/bbl) 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
10 20
8 10
6 0
4 -10
-20
2
-30
0
Gasoline
LPG
Fuel Oil
Diesel
Jet/Kero
Naphtha
1QFY05
4QFY05
3QFY06
2QFY07
1QFY08
4QFY08
3QFY09
2QFY10
1QFY11
4QFY11
3QFY12
2QFY13
1QFY14
4QFY14
3QFY15
2QFY16
1QFY17
4QFY17
3QFY18
Exhibit 11: Polymer spreads up QoQ (INR/kg): PE/PP/PVC Exhibit 12: POY spreads up 11% QoQ; PSF spreads up 6.3%
spreads up 12.5%/11.6%/11.1% QoQ QoQ (INR/kg)
PE PP PVC POY PSF
80 80
60 70
40 60
20 50
0
40
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
1QFY11
2QFY11
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Source: Bloomberg, Company, MOSL Source: Bloomberg, Company
Exhibit 13: Petrol-diesel price difference (INR/liter) Exhibit 14: Petrol/diesel gross margin trend (INR/liter)
35
Petrol Diesel
Petrol - Diesel price
difference (INR/ltr)
3.4
3.2
3.2
3.2
3.1
3.1
25
3.1
2.9
2.7
2.7
2.7
2.6
2.6
2.6
2.5
2.4
2.4
2.3
2.3
2.2
2.0
2.0
1.9
1.9
15
5
Jun-11
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Jun-17
Dec-10
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
Dec-17
Exhibit 15: With almost nil subsidy, model ONGC’s net Exhibit 16: Expect higher LNG volumes in 4QFY18 (mmscmd)
realization for 4QFY18 at USD68.1/bbl and stable production in RIL’s KG-D6
Net Realization Subsidy Burden Gross Realization RIL KG-D6 PLNG GAIL India GSPL
114 106 110
97 95 96 101 103 102 100
114
97
110
110
110
109
109
91 94 86 87 90
108
107
103
102
64 66 64
76
58 59 56 59
68
64 52
63
61
48
62
63
62
63
43 46 44 43 46
62
64
56
55
52
49 2 51
51
51
61
63
40
74
48
46
44 29 31 34 35
35
40
22 24 23 23 24 24 25 24 25 25 26 23 27
59 5
68
61
56
55
52
51
51
51
48
48
47
47
47
46
46
45
44
6 5 6
41
8 8
40
7 6
36
35
33
13 13 12 12 12 11 11 10 9
1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
FY13 FY14 FY15 FY16 FY17 FY18
1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
8.0
7.2
6.7
6.6
6.2
6.1
5.3
5.3
5.0
4.9
4.6
8.6
8.0
7.9
3.6
7.6
7.5
7.5
3.4
6.8
6.5
2.4
6.4
2.1
5.9
10.8
10.0
4.6
2.3
2.0
2.1
8.8
0.8
2.7
6.0
3.0
4.3
7.7
8.9
4.3
8.0
6.2
6.1
3.2
(2.0)
(7.7)
(1.0)
1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
Aegis Logistics
Bloomberg AGIS IN CMP: INR263 TP: INR303 (+15%) Buy
Equity Shares (m) 334.0
M. Cap. (INR b)/(USD b) 88 / 1
AGIS is an attractive play on India’s rising LPG consumption.
52-Week Range (INR) 300 / 170 Recently commissioned Haldia LPG terminal will drive the next leg
1,6,12 Rel Perf. (%) 7 / 7 / 22 of growth for the LPG segment.
Liquids segment is expected to remain a cash cow for the company
Financial snapshot (INR b) and will grow in line with capacity addition.
Y/E March 2017 2018E 2019E 2020E We estimate AGIS’ EBITDA at INR765m (+47% YoY, +7% QoQ), led
Sales 39 52 67 87 by ramp-up of Haldia and Pipavav LPG terminal in 4QFY18.
EBITDA 2 3 5 6 We estimate PAT at INR600m (+101% YoY, +12% QoQ) for 4QFY18.
Adj. PAT 1 2 3 4
AGIS trades at 21.5x FY20E EPS of INR12.3 and 14.2x FY20E
Adj. EPS (INR) 4 6 10 12
EV/EBITDA. Maintain Buy.
EPS Gr.% 6 74 52 28
BV/Sh.INR 18 23 30 40
RoE (%) 21.7 30.7 35.9 35.0
RoCE (%) 18.5 24.6 30.3 31.3
Payout (%) 22.4 22.4 22.4 22.4
Valuation
Key issues to watch for
P/E (x) 73.0 41.9 27.6 21.5
(a) Ramp-up of Pipavav and Haldia LPG terminal, (b) Capacity
P/BV (x) 14.6 11.5 8.7 6.6
EV/EBITDA (x) 43.5 32.3 18.4 14.2
addition in the liquids segment, (c) Clarity on the commissioning
Div. Yld (%) 0.3 0.5 0.7 0.9 of two new LPG terminals.
BPCL
Bloomberg BPCL IN
CMP: INR426 TP: INR554 (+30%) Buy
Equity Shares (m) 1966.9
M. Cap. (INR b)/(USD b) 838 / 13
We expect BPCL’s core earnings to improve YoY/QoQ, led by strong
52-Week Range (INR) 550 / 400 GRMs and better marketing margins in 4QFY18.
1,6,12 Rel Perf. (%) -2 / -17 / -11 We model nil subsidy-sharing for OMCs; subsidy in 4QFY18 would
be entirely borne by the government.
Financial snapshot (INR b) We peg BPCL’s refinery throughput at 7.5mmt for 4QFY18 v/s
Y/E March 2017 2018E 2019E 2020E 7.3mmt in 3QFY18 and 6.0mmt in 4QFY17.
Sales 2,013 2,368 2,616 2,738 We model GRM of USD5.3/bbl and total inventory gains of INR5.9b
EBITDA 135 132 134 150 for BPCL in 4QFY18.
Adj. PAT 95 79 81 91 We expect BPCL to report adjusted EBITDA of INR32.1b (+45% YoY,
Adj. EPS (INR) 48.3 40.0 41.2 46.5 flat QoQ) in 4QFY18.
EPS Gr.% 97.8 -2.8 -14.9 16.3 We estimate PAT at INR16.5b (-10% YoY, -23% QoQ) for 4QFY18.
BV/Sh.INR 156.7 175.8 204.5 236.7 BPCL trades at 9.2x FY20E EPS of INR46.5 and 1.8x FY20E BV
RoE (%) 32.4 24.1 21.6 21.1 (adjusted for investments), with ~5% dividend yield. Maintain Buy.
RoCE (%) 16.2 12.6 11.7 12.1
Payout (%) 52.4 52.2 30.4 30.7 Key issues to watch for
Valuation
(a) Inventory and forex change impact, (b) GRM, (c) Kochi refinery
P/E (x) 8.8 10.7 10.3 9.2 expansion and (d) update on Mozambique/Brazil E&P blocks.
P/BV (x) 2.7 2.4 2.1 1.8
EV/EBITDA (x) 8.4 8.9 8.8 7.9
Div. Yld (%) 5.1 4.2 2.5 2.9
GAIL
Bloomberg GAIL IN
CMP: INR329 TP: INR285 (-14%) Sell
Equity Shares (m) 2249.4
M. Cap. (INR b)/(USD b) 741 / 11
We expect GAIL to report adj. PAT of INR11.9b (+14% YoY and -5%
52-Week Range (INR) 389 / 260 QoQ). We model nil subsidy sharing for GAIL in 4QFY18 (v/s nil in
1,6,12 Rel Perf. (%) -1 / -5 / 2 4QFY17 and 3QFY18).
We expect marginal improvement in gas transmission led by higher
Financial snapshot (INR b) LNG import as well as domestic gas production.
Y/E March 2017 2018E 2019E 2020E We estimate EBITDA at INR21b in 4QFY18 v/s INR15b in 4QFY17 and
Sales 480.7 529.8 547.4 619.8 INR19.7b in 3QFY18.
EBITDA 63.2 80.5 85.7 91.7 Segmental EBIT (pre-subsidy) is expected to be INR19b (+27% YoY),
Adj. PAT 38.2 47.3 51.4 55.4 led by a turnaround in petchem division profitability and likely
Adj. EPS (INR) 17.0 21.0 22.9 24.6 higher gas transmission profitability.
EPS Gr. (%) 71.4 23.9 8.8 7.7 GAIL trades at 13.4x FY20E EPS of INR24.6. Maintain Sell.
BV/Sh.(INR) 169.6 182.8 197.1 212.6
RoE (%) 9.6 11.9 12.0 12.0 Key issues to watch for
RoCE (%) 8.7 10.2 10.3 10.3 (a) Petchem profitability, (b) profitability in the gas trading
Payout (%) 50.1 37.3 37.3 37.3 business, (c) progress of pipeline projects, (d) pending tariff
Valuations revisions for key pipelines, and (e) visibility on placement of US
P/E (x) 19.4 15.7 14.4 13.4
contracts.
P/BV (x) 1.9 1.8 1.7 1.5
EV/EBITDA (x) 8.3 8.9 8.4 7.8
Div. Yield (%) 2.0 2.0 2.2 2.3
Gujarat Gas
Bloomberg GUJGA IN CMP: INR844 TP: INR1,066 (+26%) Buy
Equity Shares (m) 137.7
M. Cap. (INR b)/(USD b) 116 / 2
GUJGA has seen pick up in industrial volumes in 4QFY18. We expect
52-Week Range (INR) 974 / 722 volume of 6.6mmscmd, and EBITDA/scm at INR3.6 led by price hike
1,6,12 Rel Perf. (%) -1 / -8 / 0 taken in Dec 2017 in industrial segment.
We expect 4QFY18 PNG industrial/commercial volumes at
Financial snapshot (INR b) 4.7mmscmd (+9% YoY, +4% QoQ), and PNG household volumes at
Y/E March 2017 2018E 2019E 2020E 0.5mmscmd (-4% YoY, +2% QoQ). We expect CNG volumes at
Sales 50.9 62.4 78.3 88.8 1.3mmscmd (+9% YoY, +4% QoQ).
EBITDA 7.4 8.9 11.0 12.8 We expect GUJGA to report EBITDA of INR2.1b (+46% YoY, +7%
PAT 2.2 3.0 4.8 6.1 QoQ) for 4QFY18.
EPS (INR) 16.1 21.6 34.7 44.3 We expect GUJGA to report PAT of INR713m (+115% YoY, +19%
EPS Gr. (%) 7.0 34.3 61.1 27.5 QoQ).
BV/Sh.(INR) 119.5 137.0 165.2 201.2 We model total volumes of 6.2/7.1/8.0mmscmd and EBITDA/scm of
RoE (%) 14.0 16.8 23.0 24.2 INR3.9/4.3/4.4 in FY18/FY19/FY20.
RoCE (%) 14.4 15.9 20.4 23.8 The stock trades at 19.1x FY20E EPS of INR44.3. Maintain Buy.
Payout (%) 18.7 18.7 18.7 18.7
Valuations Key issues to watch for
P/E (x) 52.6 39.1 24.3 19.1 PNG and CNG volumes
P/BV (x) 7.1 6.2 5.1 4.2 EBITDA/scm
EV/EBITDA (x) 18.6 15.6 12.2 10.2 Gas cost
Div. Yield (%) 0.3 0.4 0.6 0.8
HPCL
Bloomberg HPCL IN CMP: INR353 TP: INR536 (+52%) Buy
Equity Shares (m) 1525.5
M. Cap. (INR b)/(USD b) 539 / 8
We expect HPCL’s core earnings to decline YoY/QoQ, led by lower
52-Week Range (INR) 493 / 324 core GRMs in 4QFY18.
1,6,12 Rel Perf. (%) -4 / -24 / -9 We model nil subsidy-sharing for OMCs; subsidy in 4QFY18 would
be entirely borne by the government.
Financial snapshot (INR b) We peg HPCL’s refinery throughput at 4.6mmt for 4QFY18 v/s
Y/E MARCH 2017 2018E 2019E 2020E 4.6mmt in 4QFY17 and 4.5mmt in 3QFY18.
Sales 1,870 2,202 2,402 2,507 We model GRM of USD4.6/bbl and total inventory gains of INR5.5b
EBITDA 105.8 104.8 100.2 114.8 for HPCL in 4QFY18.
Adj. PAT 62.1 60.3 49.6 57.7 We expect HPCL to report adjusted EBITDA of INR22.4b (-21% YoY,
Adj. EPS (INR) 40.7 39.5 32.5 37.8 +33% QoQ) in 4QFY18.
EPS Gr. (%) 66.6 (2.9) (17.8) 16.5 We estimate PAT at INR14.2b (-22% YoY, -27% QoQ) for 4QFY18.
BV/Sh.(INR) 133.4 147.5 168.6 193.1 HPCL trades at 9.3x FY20E EPS of INR37.8 and 1.8x FY20E BV
RoE (%) 32.4 28.2 20.6 20.9
(adjusted for investments), with ~5% dividend yield. Maintain Buy.
RoCE (%) 18.8 15.1 10.8 11.1
Payout (%) 67.4 64.3 35.1 35.1
Key issues to watch for
Valuations
GRM
P/E (x) 8.7 8.9 10.9 9.3
Impact of forex and inventory change
P/BV (x) 2.6 2.4 2.1 1.8
EV/EBITDA (x) 6.7 7.4 8.1 7.3
Div. Yield (%) 6.5 6.2 2.8 3.2
Indraprastha Gas
Bloomberg IGL IN CMP: INR278 TP: INR416 (+49%) Buy
Equity Shares (m) 700.0
We expect IGL to report volumes of 5.46mmscmd, and assume
M. Cap. (INR b)/(USD b) 195 / 3
EBITDA/scm at INR5.6 for 4QFY18.
52-Week Range (INR) 344 / 194
1,6,12 Rel Perf. (%) -7 / -11 / 26
We expect 4QFY18 CNG volumes at 4.07mmscmd (+12% YoY, +5%
QoQ) and PNG volumes at 1.39mmscmd (+17% YoY, +1% QoQ).
We expect IGL to report EBITDA of INR2.8b (+14% YoY, +5% QoQ)
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
for 4QFY18.
Sales 38.1 45.5 51.5 57.7
We expect IGL to report PAT of INR1.7b (+29% YoY, +4% QoQ).
EBITDA 9.6 10.7 12.4 13.8 We model total volumes of 5.2/5.8/6.5mmscmd and EBITDA/SCM at
Adj. PAT 6.2 6.6 7.7 8.8 ~INR5.9/SCM in FY18/FY19/FY20.
Adj. EPS (INR) 8.8 9.4 11.1 12.5 The stock trades at 22.2x FY20E EPS of INR12.5. Maintain Buy.
EPS Gr. (%) 46.9 6.9 17.7 13.2
BV/Sh.(INR) 41.8 48.9 57.6 66.6
RoE (%) 21.0 20.7 20.8 20.2
RoCE (%) 19.8 19.6 19.8 19.4
Payout (%) 22.7 21.3 18.1 24.0
Valuation
P/E (x) 31.7 29.6 25.2 22.2 Key issues to watch for
P/BV (x) 6.7 5.7 4.8 4.2 Increase in volumes
EV/EBITDA (x) 19.6 17.5 14.7 12.8
EBITDA/SCM
Div. Yield (%) 0.7 0.7 0.7 1.1
IOC
Bloomberg IOCL IN CMP: INR174 TP: INR261 (+50%) Buy
Equity Shares (m) 9478.7
We expect IOCL’s core earnings to improve YoY, led by strong GRMs
M. Cap. (INR b)/(USD b) 1650 / 25
and healthy marketing margins in 4QFY18.
52-Week Range (INR) 231 / 165
1,6,12 Rel Perf. (%) -7 / -20 / -20
We model nil subsidy-sharing for OMCs; subsidy in 4QFY18 would
be entirely borne by the government.
We peg IOCL’s refinery throughput at 17.0mmt for 4QFY18 v/s
Financial snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
17.1mmt in 4QFY17 and 18.2mmt in 3QFY18 –Paradip refinery was
Sales
under shutdown in Feb-Mar 2018.
3,553 4,320 4,788 5,337
We model GRM of USD5.6/bbl and total inventory gains of INR14b
EBITDA 340 366 333 386
for IOCL in 4QFY18.
Adj. PAT 198 196 167 205
We expect IOCL to report adjusted EBITDA of INR75b (-10% YoY,
Adj. EPS (INR) 21 21 18 22
+8% QoQ) in 4QFY18.
EPS Gr. (%) 101 -1 -15 23
We estimate PAT at INR48b (+30% YoY, -39% QoQ) in 4QFY18.
BV/Sh.(INR) 108 116 128 142
IOCL trades at 8.0x FY20E EPS of INR22 and at 1.2x FY20E BV.
RoE (%) 21 18 14 16
Dividend yield is 6-7%. Maintain Buy.
RoCE (%) 15 13 11 13
Payout (%) 64.1 62.9 34.4 34.4 Key issues to watch for
Valuations
Utilization of Paradip refinery
P/E (x) 8.3 8.4 9.9 8.0 GRM
P/BV (x) 1.6 1.5 1.4 1.2 Capex plans
EV/EBITDA (x) 6.6 5.9 6.3 5.3 Forex/inventory changes
Div. Yield (%) 6.4 7.0 3.0 3.7
Mahanagar Gas
Bloomberg MAHGL IN CMP: INR1,012 TP: INR1,228 (+21%) Buy
Equity Shares (m) 89.3
We expect MGL to report volumes of 2.79mmscmd, and assume
M. Cap. (INR b)/(USD b) 90 / 1
EBITDA/scm at INR8.0 for 4QFY18.
52-Week Range (INR) 1345 / 875
1,6,12 Rel Perf. (%) -1 / -12 / 1
We expect 4QFY18 CNG volumes at 2.01mmscmd (+5% YoY, flat
QoQ) and PNG volumes at 0.77mmscmd (+11% YoY, +5% QoQ).
We expect MGL to report EBITDA of INR2.0b (+22% YoY, -1% QoQ)
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
for 4QFY18.
Sales 20.3 23.0 24.5 27.1
We expect MGL to report PAT of INR1.3b (+26% YoY, +1% QoQ).
EBITDA 6.4 8.1 7.8 7.9 We model total volumes of 2.70/2.86/3.10mmscmd and
Adj. PAT 3.9 5.0 4.8 4.9 EBITDA/SCM at INR8.2/7.5/7 in FY18/FY19/FY20.
Adj. EPS (INR) 44.0 55.9 53.9 54.6 The stock trades at 18.6x FY20E EPS of INR54.6. Maintain Buy.
EPS Gr. (%) 26.5 27.0 -3.6 1.2
BV/Sh.(INR) 188.4 210.5 231.7 253.3
RoE (%) 24.5 28.0 24.4 22.5
RoCE (%) 24.3 27.8 24.2 22.4
Payout (%) 60.5 60.5 60.5 60.5
Valuation
P/E (x) 23.0 18.1 18.8 18.6 Key issues to watch for
P/BV (x) 5.4 4.8 4.4 4.0 Increase in volumes
EV/EBITDA (x) 13.7 10.7 10.7 10.3
EBITDA/SCM
Div. Yield (%) 2.2 2.8 2.7 2.7
MRPL
Bloomberg MRPL IN CMP: INR112 TP: INR119 (+7%) Neutral
Equity Shares (m) 1752.7
Reuters Singapore’s GRM is up +9% YoY (-3% QoQ) at USD7.0/bbl.
M. Cap. (INR b)/(USD b) 196 / 3
52-Week Range (INR) 146 / 106
We model MRPL’s GRM at USD5.2/bbl (v/s USD6.8/bbl in 3QFY18
1,6,12 Rel Perf. (%) -3 / -18 / -8
and USD8.1/bbl in 4QFY17).
We expect refinery throughput at 4.1mmt v/s 4.5mmt in 3QFY18
and 4.2mmt in 4QFY17.
Financial snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
We expect MRPL to report EBITDA of INR7.5b (v/s INR17.5b in
Sales 432.1 475.1 518.8 532.4 3QFY18). We estimate adjusted PAT at INR3.5b (v/s INR9.7b in
EBITDA 47.1 39.9 39.2 40.2 3QFY18).
Adj. PAT 25.9 20.5 20.0 21.7 For MRPL, we model GRM of USD6.4/bbl in FY19/20. The stock
Adj. EPS (INR) 14.8 11.7 11.4 12.4 trades at 9x FY20E EPS of INR12.4 and EV of 4.4x FY19E EBITDA.
EPS Gr. (%) 95.1 (20.7) (2.5) 8.3 Maintain Neutral.
(20.7)
BV/Sh.(INR) 57.5 66.4 75.2 84.7
RoE (%) 31.4 18.9 16.1 15.5 Key issues to watch for
RoCE (%) 19.6 13.7 13.0 13.2 GRM
Payout (%) 34.7 23.4 23.4 23.4 Forex fluctuations
Valuation Inventory changes
P/E (x) 7.6 9.5 9.8 9.0
P/BV (x) 1.9 1.7 1.5 1.3
EV/EBITDA (x) 5.1 5.3 5.0 4.4
Div. Yield (%) 5.4 2.1 2.0 2.2
Oil India
Bloomberg OINL IN CMP: INR221 TP: INR260 (+18%) Buy
Equity Shares (m) 1202.3
We estimate gross and net realization at USD65.5/bbl, with no
M. Cap. (INR b)/(USD b) 266 / 4
subsidy sharing burden.
52-Week Range (INR) 259 / 172
1,6,12 Rel Perf. (%) -3 / -12 / -11
However, other expenditure in 3QFY18 was much lower. We
expect this to normalize in 4QFY18. We estimate EBITDA at
INR10.5b (+77% YoY and -4% QoQ).
Financial snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
We expect OINL to report adjusted PAT of INR6.0b (v/s INR7.1b in
Sales 93.6 105.2 113.9 115.8
3QFY18 and INR0.2b in 4QFY17).
EBITDA 29.6 40.3 45.8 46.5 Our Brent price assumption is USD57.4/bbl for FY18 and USD60/bbl
Adj. PAT 27.0 22.1 32.7 33.7 for FY19/20.
Adj. EPS (INR) 22.5 18.3 27.2 28.1 The stock trades at 7.9x FY20E EPS of INR28.1. Maintain Buy.
EPS Gr. (%) 7.2 -18.3 48.1 3.3
BV/Sh.(INR) 242.0 251.7 266.1 281.0 Key issues to watch for
RoE (%) 5.7 7.4 10.5 10.3 DD&A charges
RoCE (%) 6.4 5.8 7.9 7.7 Oil & gas production volumes
Payout (%) 96.5 46.9 46.9 46.9
Valuations
P/E (x) 17.2 12.1 8.1 7.9
P/BV (x) 0.9 0.9 0.8 0.8
EV/EBITDA (x) 9.7 7.2 6.0 5.6
Div. Yield (%) 4.5 3.2 5.0 5.0
ONGC
Bloomberg ONGC IN CMP: INR178 TP: INR222 (+25%) Buy
Equity Shares (m) 12833.3
We estimate gross and net realization at USD68.1/bbl, as we
M. Cap. (INR b)/(USD b) 2280 / 35
expect the entire subsidy to be borne by the government.
52-Week Range (INR) 213 / 155
1,6,12 Rel Perf. (%) -4 / -2 / -16
We estimate EBITDA at INR131b (v/s INR67b in 3QFY18 and
INR125b in 4QFY17), led by a rise in realization.
We expect ONGC to report adjusted PAT of INR57b in 4QFY18 (v/s
Financial snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
INR50b in 3QFY18 and INR43.4b in 4QFY17).
Sales 1,421 1,575 1,754 1,847
Our Brent price assumption is USD57.4/bbl for FY18 and
EBITDA 471 635 721 769 USD60/bbl for FY19/20.
Adj. PAT 211 216 279 302 The stock trades at 7.6x FY20E EPS of INR23.5, with implied
Adj. EPS (INR) 16.4 16.8 21.8 23.5 dividend yield of ~5%. Maintain Buy.
EPS Gr. (%) 20.8 2.3 29.6 8.2
BV/Sh.(INR) 172.4 178.2 185.9 194.1
RoE (%) 10.1 9.6 12.0 12.4
RoCE (%) 8.5 8.5 10.1 10.3
Payout (%) 52.5 64.9 64.9 64.9
Valuation Key issues to watch for
P/E (x) 10.8 10.6 8.2 7.5 DD&A charges
P/BV (x) 1.0 1.0 1.0 0.9 Oil & gas production volumes
EV/EBITDA (x) 5.4 4.0 3.5 3.3
Development plan for KG Basin
Div. Yield (%) 4.2 5.2 6.8 7.4
Petronet LNG
Bloomberg PLNG IN CMP: INR232 TP: INR317 (+37%) Buy
Equity Shares (m) 1500.0
We model Dahej LNG volumes at 199tbtu, with 105% utilization,
M. Cap. (INR b)/(USD b) 348 / 5
and Kochi LNG volumes at 8.8tbtu, with 14% utilization in 4QFY18.
52-Week Range (INR) 275 / 198
1,6,12 Rel Perf. (%) -2 / -6 / 1
We expect PLNG to report PAT of INR5.4b (+15% YoY, +3% QoQ)
and EBITDA of INR8.2b (+34% YoY, -3% QoQ) for 4QFY18.
PLNG’s long-term growth would depend on Dahej’s ramp-up and
Financial snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
Kochi terminal’s pipeline connectivity.
Sales 246.2 286.0 289.5 332.9
As against 15mmt capacity, PLNG has ~16mmt long-term take-or-
EBITDA 25.9 33.1 36.1 43.1 pay contracts.
Adj. PAT 17.1 21.0 24.0 28.3 The stock trades at 12.3x FY20E EPS of INR18.8. Maintain Buy.
Adj. EPS (INR) 11.4 14.0 16.0 18.8
EPS Gr. (%) 102.7 23.0 14.3 17.9 Key issues to watch for
BV/Sh.(INR) 54.0 64.0 75.5 89.1 Utilization at Dahej terminal
RoE (%) 23.2 23.7 22.9 22.9 Progress on Kochi-Mangalore pipeline
RoCE (%) 20.2 21.3 21.6 22.9 Spot volumes and marketing margin on spot volumes
Payout (%) 25.7 28.1 28.1 28.1
Valuation
P/E (x) 20.4 16.6 14.5 12.3
P/BV (x) 4.3 3.6 3.1 2.6
EV/EBITDA (x) 13.9 10.7 9.4 7.4
Div. Yield (%) 1.1 1.4 1.7 1.9
Reliance Industries
Bloomberg RIL IN CMP: INR899 TP: INR1,134 (+26%) Buy
Equity Shares (m) 5918.0
We expect RIL to report GRM of USD11.4/bbl v/s USD11.6/bbl in
M. Cap. (INR b)/(USD b) 5319 / 82
3QFY18 and USD11.5/bbl in 4QFY17. We model a premium of
52-Week Range (INR) 990 / 648
1,6,12 Rel Perf. (%) -3 / 7 / 20
USD4.4/bbl over benchmark GRM of USD7.0/bbl (up 9% YoY –but
down 3% QoQ).
Petchem segment is expected to do better due to healthy deltas
Financial snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E
and strong volume growth in the segment.
Net Sales 3,054 4,040 5,311 5,567 We expect RIL to report consolidated EBITDA of INR183b v/s
EBITDA 462 641 782 847 INR176b in 3QFY18 and INR122b in 4QFY17.
Net Profit 299 362 401 462 We expect RIL to report consolidated PAT of INR95b (up 18% YoY
Adj. EPS (INR) 50.5 61.1 67.7 78.0 and 1% QoQ).
EPS Gr. (%) 0.5 20.9 10.9 15.2 RIL trades at 11.5x FY20E adjusted EPS of INR78. Core segment
BV/Sh. (INR) 445.6 496.8 563.7 632.3 performance is expected to be strong going forward. Positive
RoE (%) 12.1 13.0 12.8 13.0 developments in the telecom business would drive growth further
RoCE (%) 7.2 8.1 8.1 8.7 for the company. Maintain Buy.
Payout (%) 12.5 14.8 13.2 0.0
Valuations Key issues to watch for
P/E (x) 17.8 14.7 13.3 11.5 GRM
P/BV (x) 2.0 1.8 1.6 1.4 Petchem margins
EV/EBITDA (x) 16.2 11.6 8.7 7.6
Progress on remaining core expansions
EV/Sales (x) 2.4 1.8 1.3 1.2
Update on telecom venture
Retail
Company name Double-digit sales growth likely again for sector players
Jubilant Foodworks EBITDA and PAT to grow significantly
PC Jeweller
Titan Company
All three companies under our coverage likely to report strong numbers
We expect our Retail Universe to report healthy revenue growth of 17.3% YoY in
4QFY18. EBITDA is expected to increase by 45.1% YoY and adj. PAT by 61.4% YoY.
For Titan (TTAN), despite a high base (43% sales growth in 4QFY17), the jewelry
segment sales are likely to come in healthy and in line with management
expectations. Sales in the watches segment are also recovering, according to
management commentary in the last earnings call. We forecast healthy sales and
EBITDA growth of 17.7% YoY, while PAT growth is likely to be 49.5% YoY in 4QFY18.
As the blended EBITDA margin in the base quarter was unusually low at 7.9%, we
expect higher PAT growth relative to sales growth. Lower tax rates YoY are also
likely to boost PAT.
PC Jeweler (PCJ) is expected to report another quarter of healthy sales (+20% YoY) in
the domestic jewelry business, despite a high base. Thus, despite a likely decline in
exports because of the impact on new indirect taxes in the Gulf region, overall sales
growth is likely to be ~18%. With faster growth in the domestic business (led by
healthy same-store sales growth), the EBITDA margin for PCJ is likely to expand
170bp YoY to 9.9% in 4QFY18. Consequently, EBITDA is expected to grow by an
impressive 38.9% YoY and adj. PAT by 49.2% YoY.
For Jubilant Foodworks (JUBI), we expect sales to increase 22.8% YoY, with same-
store sales (SSS) up 20% YoY. Base quarter 4QFY17 had witnessed a 7.5% decline in
SSS. Thus, a favourable base and initiatives undertaken by the company should
result in high SSS growth. With SSS growth well above cost increases, the margins
are expected to expand sharply by 740bp YoY, resulting in more than doubling of
EBITDA and quadrupling of PAT from that in the year-ago period, when PAT had
declined 46.3% YoY.
We prefer the jewelry plays given huge growth opportunity for organized players
We continue maintaining our Buy rating on both TTAN and PCJ. In FY17, TTAN and
PCJ accounted for only ~8% of the INR2t jewelry market. Regulations governing the
segment, including identity proofs for all transactions over INR 200,000, GST
implementation and crackdown on black money, have tilted trade decisively in favor
of organized players, among which TTAN and PCJ are the dominant players in terms
of scale and trust. Earnings CAGR is likely to be very impressive for both companies
at around 30% over FY17-20.
While we like JUBI’s business model with strong earnings growth potential on a
recovery, poor visibility of double-digit SSSG beyond the near term (which is aided
by a weak base), as well as expensive valuations of 59.3x FY19E EPS and 45.1x FY20E
EPS (despite 70% EPS CAGR assumption over FY17-20), makes us vary of turning
constructive.
Krishnan Sambamoorthy – Research Analyst (Krishnan.Sambamoorthy@MotilalOswal.com); +91 22 6129 1545
Vishal Punmiya – Research Analyst (Vishal.Punmiya@MotilalOswal.com); +91 22 6129 1547
April 2018 264
March 2018 Results Preview | Sector: Retail
Exhibit 2: Tanishq’s LTL sales grew 12% in 3QFY18 Exhibit 3: Tanishq’s jewelry grammage grew 6% in 3QFY18
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
Source: Company, MOSL Source: Company, MOSL
28,401
27,690
26,561
26,867
26,793
25,810
25,780
27,805
29,539
31,066
29,137
28,892
28,751
28,983
29,248
30,188
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Exhibit 5: JUBI’s SSS is expected to grow 20% in 4QFY18 Exhibit 6: Domino’s is expected to add 13 stores in 4QFY18
17.8
911
876
7.7
6.3
6.6
1.9
6.6
4.6
3.2
2.0
2.9
4.2
6.5
5.5
838
797
761
726
679
632
602
576
552
(2.6)
(3.4)
(2.4)
(5.3)
(3.2)
(3.3)
(7.5)
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
Exhibit 7: Relative performance – three months (%) Exhibit 8: Relative performance – one-year (%)
Sensex Index MOSL Retail Index Sensex Index MOSL Retail Index
240
113
210
106
180
99
150
92 120
85 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Mar-18
Sep-17
Jan-18
Feb-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Jubilant Foodworks
Bloomberg JUBI IN
CMP: INR2,330 TP: INR2,185 (-6%) Neutral
Equity Shares (m) 65.8
We expect JUBI’s revenue to grow by 22.8% YoY to INR7.5b in
M. Cap. (INR b)/(USD b) 153 / 2
4QFY18.
52-Week Range (INR) 2396 / 818
1,6,12 Rel Perf. (%) 18 / 59 / 100 SSSG is likely to be 20% for the quarter on a base of 7.5% decline.
We anticipate addition of 13 Domino’s stores this quarter.
Financial Snapshot (INR b)
Y/E March 2017 2018E 2019E 2020E Gross margin is likely to contract by 220bp to 74.7%.
Sales 25.8 29.5 34.2 40.0 We expect EBITDA margin to expand by 750bp YoY to 17.3%, and
EBITDA 2.4 4.5 5.5 6.6
EBITDA to grow by 115.5% YoY to INR1.3b.
Adj. PAT 0.6 2.0 2.6 3.4
Adj. EPS (INR) 10.6 30.3 39.3 51.6 We estimate adj. PAT to grow by 313.4% YoY to INR617m.
EPS Gr. (%) -28.0 186.2 29.6 31.3 The stock trades at 59.3x/45.1x FY19E/20E EPS of
BV/Sh.(INR) 122.1 134.8 132.1 123.7
INR39.3/INR51.6. Maintain Neutral.
RoE (%) 8.7 22.5 29.8 41.7
RoCE (%) 8.9 23.6 29.4 40.3
Payout (%) 23.6 36.3 89.0 96.8 Key issues to watch for:
Valuations Demand outlook for QSR and Pizza space, as well as
P/E (x) 219.9 76.8 59.3 45.1 competition.
P/BV (x) 19.1 17.3 17.6 18.8 Benefits of cost-saving efforts.
EV/EBITDA (x) 63.2 33.6 27.5 22.2 Performance of Dunkin Donuts and margin guidance.
Div. Yield (%) 0.1 0.5 1.5 2.1
PC Jeweller
Bloomberg PCJL IN
CMP: INR313 TP: INR520 (+66%) Buy
Equity Shares (m) 394.2
We expect PCJ’s revenue to grow by 15% YoY in 4QFY18 to
M. Cap. (INR b)/(USD b) 123 / 2
52-Week Range (INR) 601 / 195
INR24.8b, led by strong SSSG in the domestic business.
1,6,12 Rel Perf. (%) -4 / -17 / 38 Store additions are likely to be lower this quarter than earlier
expectations.
Financial Snapshot (INR b)
Gross margins are likely to expand 150bp YoY to 13.7%.
Y/E March FY17 FY18E FY19E FY20E
Sales 84.8 103.6 124.1 149.9 We expect EBITDA margin to expand by 170bp YoY to 9.9%, and
EBITDA 7.6 10.4 12.7 15.5 EBITDA to grow by 38.9% YoY to INR2.5b.
NP 4.2 6.1 7.7 9.8
EPS (Rs) 10.7 15.4 19.5 24.9 We estimate adj. PAT to grow by 49.2% to INR1.6b.
EPS Growth (%) 5.7 44.4 26.6 27.6
BV/Share (Rs) 85.0 98.0 113.9 134.0 The stock trades at 16x/12.6x FY19E/20E EPS of INR19.5/INR24.9.
RoE (%) 14.6 16.9 18.4 20.1 Maintain Buy.
RoCE (%) 16.9 17.8 18.8 20.2
Valuation
P/E (x) 29.3 20.3 16.0 12.6
Key issues to watch for:
P/BV (x) 3.7 3.2 2.7 2.3 Pace of shift from unorganized to organized.
EV/EBITDA (x) 15.6 11.6 9.3 7.5 Outlook and same-store sales growth guidance.
EV/Sales (x) 1.4 1.2 0.9 0.8
Titan Company
Bloomberg TTAN IN CMP: INR933 TP: INR1090 (+16%) Buy
Equity Shares (m) 887.8
We expect TTAN’s revenue to increase 17.7% YoY to INR40.3b.
M. Cap. (INR b)/(USD b) 828 / 13
52-Week Range (INR) 963 / 456 We factor in EBITDA growth of 33.4% YoY for 4QFY18, with
1,6,12 Rel Perf. (%) 17 / 50 / 91 underlying margin expansion of 100bp YoY to 9% off a low base in
4QFY17.
Financial Snapshot (INR b)
Adj. PAT is expected to grow by 49.5% YoY to INR3.0b.
Y/E March 2017 2018E 2019E 2020E
Sales 129.8 157.7 194.5 235.5 The stock trades at 58.6x/47.2x FY19E/20E EPS of
EBITDA 11.6 15.5 19.7 24.4 INR15.9/INR19.8. Maintain Buy.
Adj. PAT 7.0 11.1 14.1 17.5
Adj. EPS (INR) 9.0 12.5 15.9 19.8
EPS Gr. (%) 18.5 38.8 27.0 24.1
BV/Sh.(INR) 48.0 59.1 63.8 66.6
RoE (%) 20.6 23.4 25.9 30.3
RoCE (%) 21.0 24.0 26.5 31.0
Payout (%) 39.7 50.0 70.0 85.0
Valuation
P/E (x) 103.3 74.4 58.6 47.2
P/BV (x) 19.4 15.8 14.6 14.0
EV/EBITDA (x) 70.6 52.6 41.2 33.1
Key issues to watch for:
Div. Yield (%) 0.4 0.7 1.2 1.8
Pace of shift from unorganized to organized.
Update on Prevention of Money Laundering Act (PMLA)
regulations, specifically for the jewellery sector.
Quarterly Performance
Y/E March FY17 FY18 FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Sales 28,026 26,799 39,484 34,297 39,851 34,731 42,748 40,384 129,789 157,715
YoY Change (%) 4.3 1.0 16.2 43.4 42.2 29.6 8.3 17.7 16.6 21.5
Total Exp 25,157 24,157 35,998 31,576 36,202 30,750 38,524 36,753 118,234 142,230
EBITDA 2,869 2,643 3,486 2,721 3,649 3,981 4,224 3,631 11,555 15,485
EBITDA Growth % 43.8 44.4 24.0 30.3 27.2 50.6 21.2 33.4 32.4 34.0
Margins (%) 10.2 9.9 8.8 7.9 9.2 11.5 9.9 9.0 8.9 9.8
Depreciation 263 278 289 224 295 310 349 242 1,105 1,196
Interest 88 120 79 82 108 145 109 75 377 437
Other Income 134 107 166 273 283 446 213 308 705 1,250
PBT 2,652 2,351 3,283 2,687 3,529 3,972 3,979 3,622 10,777 15,101
Tax 468 660 952 658 1,038 1,189 1,159 589 2,760 3,975
Rate (%) 17.7 28.1 29.0 24.5 29.4 29.9 29.1 16.3 25.6 26.3
Adjusted PAT 2,184 1,691 2,331 2,029 2,491 2,783 2,820 3,033 8,017 11,127
YoY Change (%) 44.1 15.6 3.1 8.6 14.1 64.6 21.0 49.5 12.8 38.8
E: MOSL Estimates
Technology
Our recent IT sector update
Looking on expectantly
Gradual growth uptick, tier-2’s outperformance to sustain
Watch out for INFO’s guidance, TCS’ margin outlook and sector’s
commentary on deals, BFS
Guidance for FY19 will understandably supersede the performance of 4Q, and
all eyes will be on INFO come 13th April. We expect INFO to start the year by
guiding for 6-8% growth in constant currency (which will be higher in reported
dollar), and are currently pegging our estimate at the higher end of that band.
Traditional pain points of 1Q seasonality no longer hold for WPRO, and with
weaker areas such as Healthcare and Communications having seen their
bottom, there is a good reason to expect better 1Q guidance than earlier years.
However, there is a risk of offset from client-specific factors like the Energy
account in 3Q. We expect 1QFY19 guidance of 1-3% QoQ CC.
Apart from quantitative guidance, TCS’ commentary on BFS and margins will be
crucial, as softness in both is a downside risk to current valuations.
Exhibit 5: YoY traction seen improving for TCS, INFO and TECHM (Revenue YoY CC, %)
Revenue YoY CC (%)
1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
15.8
12.0
10.3
10.8
14.0
12.4
15.0
12.0
15.8
13.6
11.4
13.1
14.1
16.1
12.3
10.3
10.6
22.6
18.9
14.7
12.6
12.1
11.0
9.8
9.9
6.8
8.4
7.3
6.1
6.9
6.1
7.4
8.9
7.4
5.3
6.4
4.6
5.8
7.4
8.3
8.4
6.0
7.6
9.5
7.2
6.3
5.3
3.5
2.9
3.2
3.0
9.2
8.1
9.1
5.9
6.0
8.1
8.1
5.0
5.6
TCS INFO WPRO HCLT TECHM
Source: Company, MOSL
NITEC
TCS
MPHL
KPIT
CYL
INFO
MTCL
PSYS
TECHM
WPRO
LTI
HEXW
ZENT
HCLT
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18
Exhibit 7: YoY margin improvement seen in HCLT, WPRO and TECHM (EBITDA margin, %)
1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18
12
TCS Infosys HCL Tech Wipro Tech Mahindra
Source: Company, MOSL
Exhibit 8: Upward traction seen in all Tier-II vendors other than PSYS, HEXW and KPIT (revenue growth, YoY, USD, %)
Persistent Hexaware KPIT Tech. Mindtree Mphasis Cyient NIIT Tech Zensar LTI
Systems
Source: Company, MOSL
Exhibit 12: Relative performance—3m (%) Exhibit 13: Relative performance—1Yr (%)
Sensex Index MOSL Technology Index Sensex Index MOSL Technology Index
115 130
110 120
105 110
100 100
95 90
Dec-17
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Cyient
Bloomberg CYL IN CMP: INR680 TP: INR675 (-1%) Buy
Equity Shares (m) 113.0
We expect CYL’s USD revenue to grow 8.8% QoQ in 4QFY18.
M. Cap. (INR b)/(USD b) 77 / 1
In the core services business, CYL’s revenue is expected to
52-Week Range (INR) 698 / 459
1,6,12 Rel Perf. (%)
increase by 2.5% QoQ. Due to appreciation in EUR/USD and
9 / 28 / 34
AUD/USD, we expect a cross-currency tailwind of 150bp for CYL.
Rangsons is expected to see strong growth and achieve its 15%
Financial Snapshot (INR b)
Y/E June 2017 2018E 2019E 2020E
growth guidance for the year by clocking USD22m in revenue (up
Sales 36.1 39.2 45.5 51.2
81% QoQ) during the quarter.
EBITDA 4.9 5.5 6.0 6.7 Margins are expected to contract 90bp QoQ to 13.7% on higher
PAT 3.7 4.2 4.3 4.8 incremental revenue from Rangsons (lower-margin business).
EPS (INR) 30.6 37.0 38.1 42.9 PAT estimate for the quarter is INR1,078m (-0.7% QoQ), primarily
EPS Gr. (%) (0.2) 20.9 3.0 12.4 because of margin contraction and a higher ETR compared to the
BV/Sh. (INR) 188.7 207.9 227.8 250.0 previous quarter.
RoE (%) 16.2 17.8 16.7 17.1 The stock trades at 18x FY19E and 16x FY20E EPS. Maintain Buy.
RoCE (%) 15.9 17.1 16.2 16.6
Payout (%) 34.3 48.0 48.0 48.0
Valuation Key issues to watch for
P/E (x) 22.4 18.5 18.0 16.0 Update on trajectory of top customer.
P/BV (x) 3.6 3.3 3.0 2.7 Revenue outlook and visibility for FY19.
EV/EBITDA (x) 14.3 12.4 10.9 9.5 Health and performance expectations of top customers.
Div yld (%) 1.5 2.6 2.7 3.0
HCL Technologies
Bloomberg HCLT IN CMP: INR968 TP: INR950 (-2%) Neutral
Equity Shares (m) 1412.9
We expect HCLT’s USD revenue to grow 3.2% QoQ and 2% QoQ
M. Cap. (INR b)/(USD b) 1368 / 21
on a constant currency basis.
52-Week Range (INR) 1042 / 797
Growth during the quarter will be a function of a pick-up in IMS,
1,6,12 Rel Perf. (%) 5/4/0
some moderation in ERD and a seasonal drop in IP revenue.
With this, we expect HCLT to close the year with USD revenue
Financial Snapshot (INR b)
Y/E JUNE 2017 2018E 2019E 2020E
growth of 12.6%, which would translate into ~10.8% CC growth,
Sales
at the lower end of its 10.5-12.5% guidance.
467.2 505.9 567.6 618.1
EBITDA 103.1 114.6 130.1 139.6
EBIT margins are likely to expand by 20bp to 19.8% because of
PAT 84.6 89.0 92.4 100.1 lower amortization related to the IP partnerships.
EPS (INR) 59.8 63.4 66.3 71.6 With this, we expect 19.8% EBIT margin for FY18, within the 19.5-
EPS Gr. (%) 49.2 6.0 4.5 8.1 20.5% guidance range.
BV/Sh. (INR) 239.0 256.0 283.5 311.6 Adjusted PAT estimate for the quarter is INR23.5b (+7% QoQ),
RoE (%) 27.5 25.7 24.4 24.0 also aided by higher other income.
RoCE (%) 25.3 23.1 22.8 22.4 The stock trades at 14.8x FY19E and 13.7x FY20E EPS. Maintain
Payout (%) 40.1 20.5 48.3 50.3 Neutral.
Valuation
P/E (x) 16.4 15.4 14.8 13.7 Key issues to watch for
P/BV (x) 4.1 3.8 3.5 3.1 Traction in IMS and Engineering Services; organic growth
EV/EBITDA 12.1 11.3 9.7 9.9 outlook for FY19.
(x) Operating margin movement.
Div yld (%) 2.4 1.3 3.3 3.7
Traction in Digital and update on IP partnerships.
Hexaware Technologies
Bloomberg HEXW IN CMP: INR416 TP: INR340 (-18%) Neutral
Equity Shares (m) 301.8
We expect USD revenue to increase by 3.6% and CC revenue to
M. Cap. (INR b)/(USD b) 125 / 2
grow by 3%.
52-Week Range (INR) 420 / 200
Ramp-down in key customers is now behind, and we expect the
1,6,12 Rel Perf. (%) 23 / 51 / 82
company to start delivering towards its stated outlook for CY18,
which requires a CQGR of 3% through the year.
Financial Snapshot (INR b)
Y/E DEC 2016 2017E 2018E 2019E
We expect stability in EBITDA margins at 16% (+10bp QoQ).
Sales
Pressure from customer ramp-downs, wage hikes and transition
35.3 39.4 44.8 51.1
EBITDA 5.7 6.6 7.4 8.4
costs impacted margins in the two quarters before this.
PAT 4.2 5.0 5.6 6.3 Our PAT estimate for the quarter is INR1,316m, up 8.6% from the
EPS (INR) 13.7 16.6 18.7 21.0 previous quarter, on the back of revenue growth, stable margins
EPS Gr. (%) 5.8 21.2 12.7 12.5 and higher other income.
BV/Sh. (INR) 56.3 66.0 76.3 87.7 The stock trades at 22.1x CY18E and 19.7x CY19E earnings.
RoE (%) 26.5 26.9 26.1 25.6 Neutral.
RoCE (%) 24.2 24.6 25.3 25.3
Payout (%) 38.6 23.5 41.6 37.0
Valuation
P/E (x) 30.2 24.9 22.1 19.7 Key issues to watch for
P/BV (x) 7.3 6.3 5.4 4.7 Large deal pipeline and traction post the increased S&M spend.
EV/EBITDA (x) 20.4 17.7 15.9 13.6 Health of top customers.
Div yld (%) 1.3 1.0 1.9 1.9 Margin outlook now that the revenue pressures are behind.
Infosys
Bloomberg INFO IN CMP: INR1,140 TP: INR1,250 (+10%) Buy
Equity Shares (m) 2285.6
In 3QFY18, while INFO kept its annual guidance unchanged at 5.5-
M. Cap. (INR b)/(USD b) 2606 / 40
6.5%, it cited expectations of a better 4Q compared to 3Q.
52-Week Range (INR) 1220 / 862
In line with this, we expect CC revenue growth of 1.5% in 4QFY18
1,6,12 Rel Perf. (%) 0 / 20 / 1
versus 0.8% in the previous quarter.
We expect EBITDA margin to expand by 20bp QoQ to 24.5%.
Financial Snapshot (INR b)
Y/E MAR 2017 2018E 2019E 2020E
Execution on profitability has been above expectations over the
Sales 684.9 705.7 783.5 859.3 last few quarters, primarily driven by higher utilization. However,
EBITDA 186.1 190.1 207.2 223.6 we expect the improvement to slow down as this lever has
PAT 143.8 162.2 154.1 171.4 peaked out.
EPS (INR) 62.8 65.4 71.2 79.2 With this, we expect full-year EBIT margin at 24.3%, above the
EPS Gr. (%) 6.4 4.2 8.9 11.2 mid-point of the profitability guidance range of 23-25%.
BV/Sh. (INR) 302 278.3 323.5 359.2 Our PAT estimate is INR38.1b (+3% QoQ), adjusted for the
RoE (%) 22.0 24.6 23.2 23.2 USD225m exceptional reversal of income tax expense provision in
RoCE (%) 22.0 24.6 23.2 23.2 the previous quarter.
Payout (%) 40.9 45.0 47.7 47.9 The stock trades at 15.1x FY19E and 13.6x FY20E earnings. Buy.
Valuations
Key issues to watch for
P/E (x) 17.1 16.4 15.1 13.6
Update on internal stability of the company and strategy under
P/BV (x) 3.6 3.9 3.3 3.0
the new leadership.
EV/EBITDA (x) 11.1 11.0 9.3 8.4
Commentary around contribution of newly-launched services,
Div Yield (%) 2.4 3.0 3.2 3.5
and revenue scale and growth from products and solutions.
Commentary around macro, verticals, margins and pricing.
KPIT Technologies
Bloomberg KPIT IN CMP: INR223 TP: INR250 (+12%) Neutral
Equity Shares (m) 200.2
Post the seasonal weakness witnessed in 3Q, we expect growth to
M. Cap. (INR b)/(USD b) 45 / 1
bounce back for KPIT in 4QFY18. We are modeling CC revenue
52-Week Range (INR) 236 / 105
growth of 2% and USD revenue growth of 2.8% QoQ.
1,6,12 Rel Perf. (%) 5 / 76 / 59
This would lead to a 9.3% growth for KPIT in FY18, which is a stark
improvement compared to 3.1% delivered in the previous year.
Financial Snapshot (INR b)
Y/E MAR 2017 2018E 2019E 2020E
Like in the previous quarters, we expect growth to be driven by
Sales 33.2 36.3 39.6 43.2
the Automotive & Engineering.
EBITDA 3.5 3.8 4.2 4.5 Given intense profitability pressures faced by KPIT over the past
PAT 2.1 2.5 2.7 3.5 few quarters, and revival of organic revenue growth, we expect
EPS (INR) 11.9 12.5 13.5 17.5 80bp QoQ improvement in EBITDA margin in 4QFY18 to 11.6%.
EPS Gr. (%) -15.3 5.1 7.8 29.2 Our PAT estimate of INR730m (+18% QoQ), is a function of
BV/Sh. (INR) 79.2 89.9 103.4 120.8 sequential improvement in operating performance and higher
RoE (%) 14.3 14.9 14.0 15.6 other income.
RoCE (%) 15.9 16.1 16.5 18.7 KPIT trades at 16.5x FY19E and 12.8x FY20E earnings. Maintain
Payout (%) 16.8 16.0 14.8 11.5 Neutral.
Valuations
P/E (x) 18.7 17.8 16.5 12.8
P/BV (x) 2.8 2.5 2.2 1.8 Key issues to watch for
EV/EBITDA (x) 11.5 10.3 8.6 7.5
Growth in IES, Engineering Services and top client.
Div yld (%) 0.9 0.9 0.9 0.9
Update on the deal with Birlasoft.
Plan to recoup profitability.
L&T Infotech
Bloomberg LTI IN CMP: INR1,418 TP: INR1,400 (-1%) Buy
Equity Shares (m) 172.0
LTI witnessed exceptionally strong growth of 8.5% QoQ in the
M. Cap. (INR b)/(USD b) 244 / 4
previous quarter, although 2.2% of it was pass-through.
52-Week Range (INR) 1543 / 696
Continued momentum, led by ramp-up in recent deal wins is
1,6,12 Rel Perf. (%) 2 / 69 / 85
expected to drive 4% USD revenue growth and 3.5% CC growth in
4QFY18.
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
With strong execution throughout the year, LTI is expected to
Sales 65.0 72.7 85.7 97.6
close FY18 with 16.4% YoY growth.
EBITDA 12.3 12.3 15.2 17.8 We expect EBITDA margin to remain steady at 17.1%, as the
PAT 9.7 11.6 12.8 15.1 company reinvests any gains in developing capabilities and
EPS (INR) 55.5 66.3 73.3 86.3 augments its sales function.
EPS Gr. (%) 5.9 19.5 10.5 17.9 Our PAT estimate for the quarter is INR3.4b, which is higher
BV/Sh. (INR) 179.7 230.1 285.7 351.4 sequentially by 19.2%. We have adjusted our PAT estimate for the
RoE (%) 37.6 32.4 28.4 27.1 one-time USD10m hit that LTI would be taking in the quarter in
RoCE (%) 40.3 30.2 32.4 31.2 relation to an issue with one of its customers.
Payout (%) 29.7 20.0 20.0 20.0 The stock trades at 19.4x FY19E and 16.4x FY20E earnings. Buy.
Valuation
P/E (x) 25.6 21.4 19.4 16.4 Key issues to watch for
P/BV (x) 7.9 6.2 5.0 4.0
Deal wins and visibility on continuity of traction next year.
EV/EBITDA (x) 19.1 19.4 15.5 12.9
Outlook on top clients and their contribution to growth.
Div Yld (%) 1.2 0.9 1.0 1.2
Growth in Digital.
MindTree
Bloomberg MTCL IN CMP: INR801 TP: INR725 (-10%) Buy
Equity Shares (m) 167.7
MTCL has been seeing a recovery in its organic growth trajectory.
M. Cap. (INR b)/(USD b) 134 / 2
With this trend continuing, we expect revenue growth of 4% QoQ
52-Week Range (INR) 873 / 433
in 4QFY18 on a constant currency basis. Because of cross-
1,6,12 Rel Perf. (%) 1 / 62 / 65
currency tailwinds of 30bp, we expect USD revenue growth of
4.3%.
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
With organic momentum returning, and margin levers of
Sales 52.4 54.4 62.6 70.0 utilization, offshoring and pricing improvement remaining intact,
EBITDA 7.2 7.3 9.4 11.0 we expect EBITDA margin expansion of 80bp QoQ to 15.9%.
PAT 4.2 5.3 6.9 8.0 Our PAT estimate for the quarter is INR1.7b, which implies 17.7%
EPS (INR) 24.9 33.4 41.7 48.8 QoQ growth. The increase is led by improved operating
EPS Gr. (%) -30.6 34.2 24.8 17.0 performance and higher other income.
BV/Sh. (INR) 153.0 159.2 182.8 209.9 The stock trades at 19.2x FY19E and 16.4x FY20E earnings. Buy.
RoE (%) 16.8 20.3 24.4 24.9
RoCE (%) 20.1 20.7 26.3 27.7
Payout (%) 40.2 38.9 36.0 36.9 Key issues to watch for
Valuation Update on the health of top clients, and outlook for next year.
P/E (x) 32.2 24.0 19.2 16.4 Margin trajectory, going forward, given improvement in organic
P/BV (x) 5.2 5.0 4.4 3.8 growth and in acquired entities.
EV/EBITDA (x) 17.3 16.6 12.7 10.6
Deal wins during the quarter and growth in Digital.
Div Yld (%) 1.2 1.6 1.9 2.2
Mphasis
Bloomberg MPHL IN CMP: INR855 TP: INR800 (-6%) Neutral
Equity Shares (m) 210.2
The HP channel has seen six consecutive quarters of steady
M. Cap. (INR b)/(USD b) 180 / 3
performance. We expect this trend to continue in 4QFY18 as well.
52-Week Range (INR) 933 / 522
Additionally, growth would be supported by continued traction in
1,6,12 Rel Perf. (%) 2 / 32 / 38
Direct International and stability in Digital Risk.
We expect CC revenue growth of 2.9% QoQ and cross-currency
Financial Snapshot (INR b)
Y/E MAR 2017 2018E 2019E 2020E
tailwinds of 50bp, leading to USD revenue growth of 3.4% QoQ.
Sales 60.8 65.4 72.7 81.0 The company is on an improving trajectory on a YoY basis, as
EBITDA 9.7 10.5 11.7 13.1 growth would improve to 15.6% YoY in 4QFY18 from -0.7% YoY in
PAT 8.2 8.5 9.8 10.6 4QFY17.
EPS (INR) 38.9 44.0 50.8 54.9
We expect EBIT margin to expand by 50bp to the higher end of its
EPS Gr. (%) 12.9 13.0 15.6 8.0
BV/Sh. (INR) 292.4 257.6 282.0 306.9
guided band of 14-16%.
RoE (%) 13.2 15.3 18.8 18.6 Our PAT estimate is INR2.5b (+15.9% QoQ). Higher PAT is led by
RoCE (%) 12.4 14.5 18.0 18.3 improved operating performance and translation gains.
Payout (%) 43.7 50.1 43.3 45.6 The stock trades at 16.2x FY19E and 15x FY20E EPS. Neutral.
Valuations
P/E (x) 21.1 18.7 16.2 15.0 Key issues to watch for
P/BV (x) 2.8 3.2 2.9 2.7
Outlook for Digital Risk. given an interest rate cycle reversal.
EV/EBITDA(x) 15.0 13.5 11.8 10.3
Div yld (%) 2.1 2.7 2.7 3.0 Strategy changes, roadmap under the new leadership, and
outlook for FY19E
Top customer outlook and consequent impact on the Direct
International channel.
NIIT Technologies
Bloomberg NITEC IN CMP: INR883 TP: INR800 (-9%) Neutral
Equity Shares (m) 61.2
We expect 2.5% QoQ CC revenue growth for NITEC in 4QFY18.
M. Cap. (INR b)/(USD b) 54 / 1
Traction is expected to continue despite a negative impact of the
52-Week Range (INR) 1012 / 420
ramp-down of Morris to the tune of USD1.5m. Growth would be
1,6,12 Rel Perf. (%) 3 / 55 / 92
supported by Digital and ramp-up of new deal wins.
The company would have a tailwind of 70bp because of cross-
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E currency movements, leading to USD revenue growth of 3.2%
Sales 27.8 29.8 33.0 36.1 QoQ.
EBITDA 4.6 5.0 5.6 6.2 We expect EBITDA margin to expand by 80bp QoQ to 17.9%
PAT 2.6 2.8 3.3 3.8
because of a better mix of revenue and improved operational
EPS (INR) 38.0 44.8 53.1 61.6
EPS Gr. (%) -16.9 17.9 18.5 15.9
efficiencies.
BV/Sh. (INR) 286.5 280.8 314.7 328.2 Our PAT estimate is INR818m (+8% QoQ). While the operational
RoE (%) 13.7 16.2 17.8 19.2 performance supports decent growth in PAT, it would be further
RoCE (%) 15.7 15.8 17.5 18.3 boosted by other higher income.
Payout (%) 32.9 31.2 30.1 26.0
The stock trades at 16.6x FY19E and 14.3x FY20E earnings.
Valuations
P/E (x) 23.2 19.7 16.6 14.3 Neutral.
P/BV (x) 3.1 3.1 2.8 2.7
EV/EBITDA 9.8 10.1 8.6 7.7
Key issues to watch for
(x)
Div Yld (%) 1.4 1.6 1.8 1.8 Traction in Digital and the international business.
Progress on development of strategy under new leadership.
Deal wins and outlook for the year.
Persistent Systems
Bloomberg PSYS IN CMP: INR677 TP: INR900 (+33%) Buy
Equity Shares (m) 80.0
We expect 5% QoQ decline in revenue for PSYS in 4QFY18. It
M. Cap. (INR b)/(USD b) 54 / 1
recently guided for a decline to the tune of USD8m in its IP
52-Week Range (INR) 878 / 558
portfolio. This decline has been greater than the earlier expected
1,6,12 Rel Perf. (%) -17 / -3 / 3
impact of a seasonal decline in IBM IoT revenue.
The decline in IP revenue would also result in a corresponding hit
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E on profitability, because of which we are baking in a contraction
Sales 28.8 30.3 34.4 38.3 of 470bp in EBITDA margin to 12.7%.
EBITDA 4.7 4.5 5.7 6.6 Our PAT estimate for the quarter is INR704m, down 23.2% QoQ.
Adj. PAT 3.1 3.2 4.0 4.8 The PAT decline is caused by the sharp drop in both revenue and
Adj. EPS (INR) 37.7 40.0 50.3 60.2 profitability.
EPS Gr. (%) 1.4 6.1 25.9 19.6 The stock trades at 13.5x FY19E and 11.3x FY20E earnings. Buy.
BV/Sh.(INR) 244.5 254.1 264.8 267.8
RoE (%) 17.0 16.5 20.0 23.3 Key issues to watch for
RoCE (%) 16.7 16.0 15.7 19.3 Performance and outlook for top clients in ISV (ex-IBM).
Payout (%) 23.9 32.5 27.8 26.6 Commentary on traction with Enterprise customers and
Valuations potential of winning large deals in Digital.
P/E (x) 18.0 16.9 13.5 11.3 Outlook on sustainable profit margins in the near-to-medium
P/BV (x) 2.8 2.7 2.6 2.5 term.
EV/EBITDA (x) 9.6 9.6 7.6 6.5 Outlook on IP revenue after the hit in 4QFY18.
Div. Yield (%) 1.3 1.9 2.1 2.4
Tata Elxsi
Bloomberg TELX IN CMP: INR1,005 TP: INR1,236 (+23%) Buy
Equity Shares (m) 62.3
Growth on a YoY basis has been picking up for the last three
M. Cap. (INR b)/(USD b) 63 / 1
quarters, and has increased from 9.3% in 1QFY18 to 11.4% in
52-Week Range (INR) 1123 / 644
3QFY18.
1,6,12 Rel Perf. (%) -2 / 19 / 24
We expect this trend to continue, resulting in 14% YoY growth in
4QFY18 to INR3,717m.
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E EBITDA margin at 25% is expected to contract by 210bp QoQ, but
Sales 12.3 13.8 15.8 18.4 expand by 180bp YoY to 25%.
EBITDA 2.9 3.4 4.0 4.7 PAT at INR607m is expected to see an increase of 36.3% YoY.
Adj. PAT 1.8 2.3 2.7 3.2 The stock trades at 23x FY19E and 19.5x FY20E earnings. Buy.
Adj. EPS (INR) 28.1 36.8 43.6 51.5
EPS Gr. (%) 13.2 30.8 18.4 18.2
BV/Sh.(INR) 89.8 114.5 143.0 216.2
RoE (%) 37.1 36.0 33.8 28.7
RoCE (%) 37.1 36.0 33.8 43.3
Payout (%) 34.2 32.7 34.6 27.8
Valuations Key issues to watch for
P/E (x) 35.7 27.3 23.0 19.5 Addition of new customers and subsequent realization.
P/BV (x) 11.2 8.8 7.0 4.6 JLR’s contribution to revenue.
EV/EBITDA (x) 20.5 16.7 13.9 11.0 Outlook on growth and profitability for the next year.
Div. Yield (%) 0.8 1.0 1.2 1.8
TCS
Bloomberg TCS IN CMP: INR 2,908 TP: INR2,700 (-7%) Neutral
Equity Shares (m) 1970.4
Revenue growth for TCS is expected to pick up in 4QFY18 to 2.2%
M. Cap. (INR b)/(USD b) 5730 / 88
QoQ in CC terms from 1.3% in the previous quarter, led by ramp-
52-Week Range (INR) 3255 / 2255
up of recently-won deals.
1,6,12 Rel Perf. (%) -2 / 13 / 9
With cross-currency tailwinds of 110bp, we expect USD revenue
growth of 3.3% QoQ.
Financial Snapshot (INR b)
Y/E MAR 2017 2018E 2019E 2020E
Our EBIT margin estimate for 4Q stands at 25.5% (+30bp QoQ),
Sales 1,179.7 1,228.7 1,374.1 1,499.9
led by currency benefits. However, we expect margins to take a
EBITDA 323.1 325.0 360.3 390.5 hit 1QFY19 onwards, as lower margin deals start to hit
PAT 262.9 257.8 281.7 308.7 profitability, in addition to the usual headwinds of visa expenses
EPS (INR) 133.4 131.8 147.1 161.3 and wage hikes.
EPS Gr. (%) 8.3 -1.2 11.6 9.6 Our PAT estimate stands at INR68.6b (+5% QoQ), led by
BV/Sh. (INR) 448.3 418.3 482.1 550.5 sequential growth in operating parameters and higher other
RoE (%) 32.6 30.7 32.8 31.3 income.
RoCE (%) 32.4 26.8 25.3 25.3 The stock trades at 19.8x FY19E and 18x FY20E earnings. Neutral.
Payout (%) 35.2 109.3 47.0 47.9
Key issues to watch for
Valuation
Outlook on BFS and Retail.
P/E (x) 21.8 22.1 19.8 18.0
Traction in new Digital initiatives (automation/solutions).
P/BV (x) 6.5 7.0 6.0 5.3
EV/EBITDA Margin expectations for the next year, given multiple
16.3 16.1 14.3 12.9
(x)
Div. yield (%) 1.6 5.0 2.4 2.7
headwinds.
Tech Mahindra
Bloomberg TECHM IN CMP: INR617 TP: INR700 (+14%) Buy
Equity Shares (m) 984.7
We expect 3% QoQ growth in USD revenue in 4QFY18, led by
M. Cap. (INR b)/(USD b) 607 / 9
1.5% CC organic growth, and 150bp benefit from cross-currency
52-Week Range (INR) 652 / 358
movements.
1,6,12 Rel Perf. (%) 3 / 27 / 24
Organic growth is expected to be a function of flat revenue in LCC,
strength in Enterprise and some seasonal support from Comviva.
Financial Snapshot (INR b)
Y/E MARCH 2017 2018E 2019E 2020E
We expect EBITDA margin to expand by 100bp QoQ to 17.3%, led
Sales 291.4 307.3 346.5 386.7
by seasonal strength in Comviva, completion of rationalization in
EBITDA 41.8 46.9 56.9 63.6 LCC and better operational efficiencies.
Adj. PAT 28.4 35.4 37.6 43.8 Expect PAT to increase by 1.5% QoQ to INR9.6b, despite higher
Adj. EPS (INR) 32.0 39.8 42.3 49.3 margins, led by lower other income and higher ETR.
EPS Gr. (%) -8.8 24.4 6.5 16.4 The stock trades at 14.6x FY19E and 12.5x FY20E earnings. Buy.
BV/Sh.(INR) 187.9 197.9 228.9 264.6
RoE (%) 18.4 20.9 20.1 20.2
RoCE (%) 15.2 17.0 16.4 16.8
Payout (%) 29.1 30.2 23.6 24.4
Key issues to watch for
Valuation
Performance of the Telecom segment and expectations around
P/E (x) 19.3 15.5 14.6 12.5
top customer performance.
P/BV (x) 3.3 3.1 2.7 2.3
EV/EBITDA (x) 12.6 11.4 8.9 7.4
Comments on profitability, including LCC.
Div. Yield (%) 1.5 1.9 1.6 1.9
TCV of deal wins in the Enterprise segment.
Wipro
Bloomberg WPRO IN CMP: INR284 TP: INR300 (+6%) Neutral
Equity Shares (m) 4925.5
In the previous quarter, Wipro had guided for 1% to 3% QoQ CC
M. Cap. (INR b)/(USD b) 1398 / 22
growth for 4Q. The guidance embedded meaningful revenue
52-Week Range (INR) 335 / 242
impact from insolvency of a customer, whereby it also took
1,6,12 Rel Perf. (%) -1 / -6 / 0
~USD50m one-time provision on costs in the previous quarter.
We expect growth to be at the lower end of the guided range at
Financial Snapshot (INR b) 1.5%. A cross-currency tailwind of 100bp would lead to USD
Y/E MAR 2017 2018E 2019E 2020E revenue growth of 2.5% QoQ.
Sales 550.4 547.0 585.1 636.3 We expect EBIT margin in IT Services to remain steady at 17.3%
EBITDA 108.8 111.5 123.2 137.2 (+10bp QoQ) because of low organic growth at a time when
PAT 83.3 86.8 91.1 102.4 operational efficiencies have played out over the last few
EPS (INR) 16.9 17.9 18.8 21.1 quarters.
EPS Gr. (%) -6.3 5.9 5.0 12.4 Our PAT estimate is INR21.6b (+11.6% QoQ). However, adjusting
BV/Sh. (INR) 105.9 101.8 120.6 129.7 for the one-time provisioning in the previous quarter, 4Q PAT
RoE (%) 16.9 17.2 17.0 16.9 would decline 4.1% QoQ on account of lower other income and
RoCE (%) 13.6 13.6 14.8 15.5 higher ETR.
Payout (%) 5.8 0.0 0.0 47.3 The stock trades at 15.1x FY19E and 13.4x FY20E earnings.
Valuations Neutral.
P/E (x) 16.8 15.8 15.1 13.4
Key issues to watch for
P/BV (x) 2.7 2.8 2.4 2.2
Revenue growth guidance for 1QFY19.
EV/EBITDA (x) 10.8 11.5 9.7 8.5
Commentary on Healthcare and Communications verticals.
Div Yld (%) 0.3 0.0 0.0 3.5
Commentary on large deal wins and ramp-up schedule.
Zensar Technologies
Bloomberg ZENT IN CMP: INR 901 TP: INR1,100 (+22%) Buy
Equity Shares (m) 45.4
We expect revenue of USD127m, representing growth of 3.2%
M. Cap. (INR b)/(USD b) 41 / 1
QoQ. This would translate into 1.9% QoQ CC growth, a cross-
52-Week Range (INR) 1000 / 730
currency tailwind of 30bp for ZENT.
1,6,12 Rel Perf. (%) 3 / 14 / -14
Growth would be a function of strength in Digital, recovery in the
Financial Snapshot (INR b) US and portfolio rationalization.
Y/E MAR 2017 2018E 2019E 2020E We expect EBITDA margin to expand by 20bp QoQ to 13.5%. This
Sales 30.6 31.1 36.1 40.6
would mark the return of ZENT’s profitability to levels seen before
EBITDA 3.8 3.8 4.8 5.9
the margin shocker in 4QFY17, where EBITDA margin had touched
PAT 2.3 2.3 2.8 3.7
EPS (INR) 52.1 51.9 63.1 82.6
a low of 7.9%.
EPS Gr. (%) -24.1 -0.3 21.6 30.9 Our PAT estimate is INR688m, up 19.8% QoQ on account of
BV/Sh. (INR) 325.9 363.9 414.1 477.5 translation gains.
RoE (%) 17.2 15.0 16.2 18.5
The stock trades at 14.3x FY19E and 10.9x FY20E earnings. Buy.
RoCE (%) 23.2 18.8 22.1 24.1
Payout (%) 23.0 22.8 17.6 19.9
Valuations
P/E (x) 17.3 17.4 14.3 10.9
P/BV (x) 2.8 2.5 2.2 1.9 Key issues to watch for
EV/EBITDA (x) 9.7 9.7 7.3 5.6 Traction in Digital, large deals and other new initiatives.
Div Yld (%) 1.3 1.3 1.2 1.8 Margin outlook, given restructuring of IMS business.
Progress on revival of revenue growth post US turnaround.
Telecom
Company name Another dismal quarter…
Bharti Airtel …primarily led by continued ARPU downtrading
Bharti Infratel
Idea Cellular There appears to be no solace for the Telecom sector. 4QFY18 consolidated EBITDA is likely
Tata Communications to decline 8% QoQ for Bharti and 15% QoQ for Idea. RJio’s EBITDA should improve 12% on
10% revenue growth. Bharti Infratel’s EBITDA should decline 2% QoQ, hit by tenancies.
TCOM should see 1% EBITDA growth.
ARPU continues its downward spiral: 4QFY18 saw fresh round of undercutting
by telcos, with lower price plans focusing on market share gains v/s profitability
to gain the 15% revenue market share still lying with smaller operators. We
expect ARPU downtrading of 7-8% for Bharti/Idea and 5% for RJio.
Cut in international IUC from INR0.53/minute to INR0.30/minute (applicable
from February 2018) is likely to impact the EBITDA of the incumbents, Bharti
and Idea, by 1-1.5%.
JioPhone impact: In January 2018, RJio re-launched its Jiophone at a new price
point of INR49 (in addition to INR150 earlier), targeting the low ARPU
subscribers. Further, our channel checks indicate that RJio is expected to add
6m-8m monthly Jiophone subscribers, thus eating into the feature phone
market of incumbents.
Bharti’s India wireless EBITDA is expected to witness a steep 17% QoQ (and 39%
YoY) decline to INR29b. Idea’s consolidated EBITDA too is expected to fall 15% QoQ
(and 51% YoY) to INR10.4b. Bharti’s consolidated EBITDA is likely to fall 8% QoQ
(and 12% YoY) to INR68.9b.
Bharti’s India wireless EBITDA margin is likely to shrink ~440bp QoQ (and 870bp YoY)
to 28.2%, while Idea’s consolidated EBITDA margin is expected to contract 220bp
QoQ (9pp) to 16.6%. Bharti’s other segments like Africa, passive infrastructure and
enterprise may remain subdued, leading to consolidated EBITDA margin contraction
of 240bp QoQ (-150bp YoY) to 34.4%.
Our view: We expect ARPU to continue to remain under pressure for the next 3-4
quarters until the larger players take away share from the smaller players. As all
three big players (Bharti, Vodafone-Idea and RJio) reach a position of similar market
share and financial & network capabilities, ARPU recovery should set in, driving
EBITDA and FCF growth.
1200 29 28
1150 21 21 23
14
1100 7 9 7 6 4 6 6
4 5
1050 1 -1 0 -1 -3
-3 -5 -5
1000
-16 -15
950
900
Jul-16
Jul-17
Jun-16
Jun-17
Nov-16
Nov-17
Apr-16
May-16
Apr-17
May-17
Aug-16
Dec-16
Aug-17
Dec-17
Mar-17
Jan-18
Jan-16
Feb-16
Mar-16
Sep-16
Jan-17
Feb-17
Sep-17
Oct-16
Oct-17
Source: TRAI, MOSL
Exhibit 3: Player-wise QoQ wireless traffic trend (b min) Exhibit 4: Player-wise QoQ wireless traffic growth trend (%)
Bharti (India) Idea Vodafone - India
Bharti (India) Idea Vodafone - India
13.1
16
11.3
512
10.8
10.7
495
10.3
437
422
12
9.1
8.4
381
7.3
330
315
313
308
283
15.5
5.4
8
255
251
231
3.6
210
3.5
199
196
3.1
2.2
1.7
4 0.7
0
-0.5
1QFY17 -1.3
2QFY17 -1.9
-2.0
-4
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18E
FY17 FY18
Exhibit 5: Player-wise QoQ data traffic trend (b Mb) Exhibit 6: Player-wise QoQ wireless traffic growth trend (%)
Bharti (India) Idea Vodafone - India Bharti (India) Idea Vodafone - India
1312
1106
99.1
83.8
73.5
784
710
61.4
571
567
47.8
472
439
384
30.2
24.3
253
22.7
238
225
178
172
16.7
158
15.4
129
127
13.2
110
109
107
105
101
109.8
93
9.8
12.7
31.0
65.9
41.1
18.6
6.5
1.3
7.7
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18E
-3.5
FY17 FY18
Exhibit 7: Player-wise QoQ ARPU trend (INR) Exhibit 8: Player-wise QoQ wireless traffic growth trend (%)
Bharti (India) Idea Vodafone - India
Bharti (India) Idea Vodafone - India
176
171
0.9
0.8
158
154
196
142
141
132
188
172
114
114
158
-13.1
145
123
-0.4
-0.5
-1.1
-15.2
-2.0
-3.1
-4.0
-4.4
-6.3
-6.6
-13.0
-7.0
-7.5
-7.7
-8.3
-8.4
-8.4
180
173
156
142
141
130
113
104
-9.2
-9.4
-9.9
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4QE
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
4QFY18E
FY17 FY18
Agg. India wireless revenue Agg. India wireless revenue growth (QoQ, %)
8 7
600 6 5 4
500 1 2 2
-1 -1 0
400 -3
300 -6
-10 -9
200
100
0
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
2QFY18
3QFY18
Source: TRAI, MOSL
Exhibit 10: Relative Performance-3m (%) Exhibit 11: Relative Performance-1 Yr (%)
Sensex Index MOSL Telecom Index Sensex Index MOSL Telecom Index
108
143
100
131
92
119
84
107
76 95
Dec-17
Jan-18
Feb-18
Mar-18
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Bharti Airtel
Bloomberg BHARTI IN CMP: INR402 TP: INR581 (+45%) Buy
Equity Shares (m) 3997.3 We expect consolidated revenue to decline 1.4% QoQ (and 9%
M. Cap. (INR b)/(USD b) 1606 / 25 YoY) to INR200.4b. Given the continued ARPU downtrading on
52-Week Range (INR) 565 / 333 account of the renewed competition from RJIo, we expect India
1,6,12 Rel Perf. (%) -4 / -2 / 6 wireless revenue to decline 4.4% QoQ (and 21% YoY) to
INR102.8b. Africa revenue is expected to remain flat QoQ at
Financial Snapshot (INR Billion) INR51.5b.
Y/E March 2017 2018E 2019E 2020E Consolidated EBITDA margin is likely to contract 240bp QoQ to
Net Sales 954.7 841.0 853.1 957.4 34.4%, led by 440bp contraction in India wireless margin to
EBITDA 353.3 300.4 302.1 356.2 28.2%, partly offset by 20bp expansion in Africa EBITDA margin to
Adj. NP 44.4 14.4 7.3 22.0 35.4%.
Adj EPS(INR) 11.1 3.6 1.8 5.5 Consolidated net profit is expected to fall 46% QoQ (and 56% YoY)
Adj EPS Gr.(%) -9.5 -67.5 -49.3 200.6 to INR1.6b.
BV/Sh (INR) 168.8 170.5 171.1 175.4 We expect India wireless ARPU to decline 7% QoQ (and 28% YoY)
RoE (%) 6.6 2.1 1.1 3.2 to INR114.
RoCE (%) 5.3 3.8 3.2 4.3 Bharti trades at an EV/EBITDA of 8.9x FY19E and 7.3x FY20E.
Div. payout (%) 12.7 40.8 65.7 21.9 Maintain Buy.
Valuations
Key monitorables
P/E (x) 36.1 111.1 219.3 73.0
Consolidated revenue (expect 1.4% decline QoQ).
P/BV (x) 2.4 2.4 2.3 2.3
India wireless revenue (expected to decline 4.4% QoQ).
EV/EBITDA (x) 7.4 8.9 8.9 7.3
Consolidated EBITDA margin (expected at 34.4%; -240bp QoQ).
Div. Yld (%) 0.2 0.2 0.2 0.2
India wireless EBITDA margin (expected at 28.2%; -440bp QoQ).
Bharti Infratel
Bloomberg BHIN IN CMP: INR338 TP: INR380 (+12%) Neutral
Equity Shares (m) 1896.7
We expect consolidated revenue to decline 2% QoQ (but grow 2%
M. Cap. (INR b)/(USD b) 641 / 10
YoY) to INR36b.
52-Week Range (INR) 482 / 319
1,6,12 Rel Perf. (%)
Consolidation in the sector is likely to continue pressurizing
1 / -23 / -9
tenancies. We expect 2% QoQ decline in tenancies leading to 2%
QoQ decline in consolidated rental revenue to INR22.1b. We
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
expect energy and other reimbursements to remain flat QoQ at
Net Sales 134.2 144.3 147.9 159.4
INR13.9b.
EBITDA 59.0 63.6 61.7 66.5 We expect consolidated EBITDA too to decline 2% QoQ to
Adj. NP 27.5 25.6 28.2 31.1 INR15.7b. Though rental EBITDA margin is expected to drop 90bp
AdjEPS INR 14.9 13.8 15.3 16.8 QoQ to 65.5%, 190bp expansion in energy EBITDA margin to 8.8%
Gr. (%) 25.3 -6.9 10.4 10.0 would enable consolidated EBITDA margin of 43.6%.
BV/Sh (INR) 83.7 80.2 78.0 77.4 We expect PAT to rise 14% QoQ to INR6.7b.
RoE (%) 16.2 16.9 19.3 21.6 Bharti Infratel trades at EV/EBITDA of 9x FY19E and 8.4x FY20E.
RoCE (%) 13.2 14.6 14.6 16.5 Maintain Neutral.
Payout (%) 125.0 125.8 114.0 103.6
Valuations Key monitorables
P/E (x) 22.8 24.4 22.1 20.1 Consolidated net co-location deletions (we expect ~3,720 QoQ
P/BV (x) 4.0 4.2 4.3 4.4 tenancy deletions in 4QFY18).
EV/EBITDA (x) 9.6 8.8 9.0 8.4 Consolidated revenue per sharing operator (expected to remain
Div. Yld (%) 4.7 4.4 4.4 4.3 flat QoQ).
Idea Cellular
Bloomberg IDEA IN CMP: INR77 TP: INR91 (+17%) Buy
Equity Shares (m) 3600.5
We expect consolidated revenue to decline 4.2% QoQ (and 23.2%
M. Cap. (INR b)/(USD b) 279 / 4
52-Week Range (INR)
YoY) to INR62.4b.
118 / 72
1,6,12 Rel Perf. (%) -5 / -4 / -20 We expect ARPU to decline 8% QoQ (and 27% YoY) to INR104,
impacted by downward revision in price plans (by RJio).
Financial Snapshot (INR Million)
EBITDA margin is expected to contract ~220bp QoQ/9.5pp YoY to
Y/E March 2017 2018E 2019E 2020E
16.6% due to plunge in revenue.
Net Sales 355.8 284.3 258.8 292.6
EBITDA 102.8 56.8 49.9 72.3 We expect Idea’s net loss to widen to INR15.8b v/s INR12.8b in
Adj. NP -4.0 -47.4 -56.1 -45.8 3QFY18.
AdjEPS (INR) -1.1 -10.9 -12.9 -10.5 Idea trades at an EV/EBITDA of 17.2x FY19E and 11.9x FY20E.
Adj.EPSGr(%) -116.2 880.5 18.5 -18.3 Maintain Buy.
BV/Sh(INR) 68.6 61.4 48.5 46.7
RoE (%) -1.7 -18.4 -23.4 -24.2
RoCE (%) 1.6 -2.4 -3.2 -2.0
Key monitorables
Payout (%) 0.0 0.0 0.0 0.0
Consolidated revenue (expect 4.2% decline QoQ).
Valuations
Blended ARPU (we expect INR104, 8% QoQ fall).
P/E (x) -69.9 -7.1 -6.0 -7.4
EBITDA margin (we expect 220bp contraction QoQ).
P/BV (x) 1.1 1.3 1.6 1.7
EV/EBITDA(x) 7.4 14.3 17.2 11.9
Div. Yield (%) 0.0 0.0 0.0 0.0
Tata Communications
Bloomberg TCOM IN CMP: INR652 TP: INR750 (+15%) Buy
Equity Shares (m) 285.0
Tata Communications’ revenue is expected grow 1% QoQ (decline
M. Cap. (INR b)/(USD b) 186 / 3
3% YoY) to INR41.6b on steady data revenues, offsetting the
52-Week Range (INR) 773 / 570
1,6,12 Rel Perf. (%) 4 / -12 / -22
impact of muted voice revenue.
Data revenue is likely to grow 2% QoQ (6% YoY) to INR29.5b
Financial Snapshot (INR Million) whereas voice revenue is expected to decline 2% QoQ (and 20%
Y/E March 2017 2018E 2019E 2020E YoY) to INR12.1b.
Net Sales 176.2 168.0 174.8 190.5
Core EBITDA is expected to grow 1% QoQ to INR6.2b on the back
EBITDA 24.1 23.6 27.9 33.9
of data EBITDA, and Core EBITDA margin should remain flat at
Adj. NP 2.8 0.6 3.1 6.5
AdjEPS (INR) 10.0 2.2 11.0 22.8
14.9%. Data EBITDA is expected to grow 3% QoQ to INR5.5b.
Adj.EPSGr. (%) 192.1 -77.4 388.0 108.3 The stock trades at an EV/EBITDA of 9.8x FY19E and 7.5x FY20E.
BV/Sh(INR) 55.9 48.8 59.8 82.6 Maintain Buy.
RoE (%) 46.1 4.3 20.2 32.1
RoCE (%) 9.9 -39.1 5.3 8.3
Valuations
P/E (x) 65.6 289.9 59.4 28.5 Key monitorables
P/BV (x) 11.7 13.4 10.9 7.9 Data revenue performance (we expect 2% QoQ growth).
EV/EBITDA(x) 11.4 11.7 9.8 7.5 Data EBITDA margin (we expect flat EBITDA margin of 18.7%).
Div. Yield (%) 0.7 0.7 0.7 0.7
Utilities
Company name Coal India and Power Grid to outperform
CESC Coal India to benefit from price hike
Coal India
JSW Energy Within our Utilities Universe, we expect Coal India to outperform, led by the price
NHPC hike benefit. We estimate its EBITDA (ex-OBR) to increase 22% QoQ/39% YoY to
NTPC INR67.5b on the price hike benefit. Dispatches have increased 5% YoY/QoQ to
Power Grid Corp. 159mt. We expect higher growth (~7% YoY) in FSA volumes, while e-auction
Tata Power volumes are expected to be broadly flat. FSA realizations are estimated to decline
3% YoY, while e-auction realization is estimated to be broadly flat QoQ. We expect
PAT to increase 89% YoY/71% QoQ to INR51.4b.
Power Grid’s PAT is expected to increase by ~19% YoY to INR23.9b, led by growth in
regulated equity. We estimate capitalization of INR84.9b, taking full-year
capitalization to ~INR280b. NTPC’s adj. PAT is expected to increase by ~3% YoY to
INR27.4b due to under-recoveries at some of its plants. Regulated equity is expected
to increase by ~15% YoY to INR507b. Commercial capacity is unchanged QoQ.
1.6GW of capacity was commissioned during the quarter.
ST prices seasonally higher: Short-term (ST) prices on IEX were down 2% QoQ to
INR3.5/kWh. IEX day-ahead volumes were up 12% YoY to 10.6bu in 4QFY18.
102 114
98 106
94 98
90 90
Jul-17
Jun-17
Nov-17
Apr-17
May-17
Aug-17
Dec-17
Mar-17
Sep-17
Jan-18
Feb-18
Mar-18
Oct-17
Dec-17
Jan-18
Feb-18
Mar-18
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
CESC
Bloomberg CESC IN
CMP: INR1005 TP: INR1,391 (+38%) Buy
Equity Shares (m) 133.2
We expect CESC’s standalone PAT to increase 2.8% YoY to
M. Cap. (INR b)/(USD b) 134 / 2
INR3.03b, driven by savings in transmission and distribution losses,
52-Week Range (INR) 1189 / 812
1,6,12 Rel Perf. (%) 2 / -5 / 6
partly offset by delay in approval of tariff for FY18.
Regulated equity is estimated to grow by 6.7% YoY/1.3% QoQ to
Financial Snapshot (INR Million) INR40.1b.
Y/E MARCH FY17 FY18E FY19E FY20E Spencer EBITDA should improve with a better performance after
Sales 139.0 146.5 156.3 164.6 initial GST hiccups, and transitory impact due to regulatory issues
EBITDA 31.6 36.2 37.7 39.1 in certain states in 3Q. The company expects to turn PAT positive
NP 6.9 11.5 12.7 13.7 in 4QFY18. Buy.
EPS (INR) 51.9 86.5 95.2 103.1
EPS Gr. (%) 14.7 66.8 10.0 8.4
BV/Sh. (INR ) 797.4 871.9 955.1 1,046.2
RoE (%) 6.5 10.4 10.4 10.3
RoCE (%) 7.3 8.3 8.5 8.5
Payout (%) 19.3 11.6 10.5 9.7
VALUATION
P/E (x) 19.2 11.5 10.5 9.7 Key issues to watch for
P/BV (x) 1.3 1.1 1.0 1.0 Performance of Spencer.
EV/EBITDA (x) 8.8 7.5 7.1 6.6 Progress on demerger.
Div. Yield (%) 1.0 1.0 1.0 1.0
Coal India
Bloomberg COAL IN
CMP: INR278 TP: INR397 (+43%) Buy
Equity Shares (m) 6207.4
We expect Coal India’s EBITDA (ex-OBR) to increase ~22% QoQ to
M. Cap. (INR b)/(USD b) 1728 / 27
INR67.6b on price hike benefit and higher volumes.
52-Week Range (INR) 317 / 234
-9 / -3 / -17
Dispatches are up 5% YoY to 159.1mt. FSA volumes are estimated
1,6,12 Rel Perf. (%)
to increase 6.8% YoY to 124mt on strong power sector demand.
Financial Snapshot (INR Million) E-auction volumes would be flat YoY at ~28mt.
Y/E MARCH 2017 2018E 2019E 2020E FSA realization is estimated to decline 3% YoY to INR1,338/ton on
Net Sales 782.2 840.3 941.6 1,002.9 grade slippage impact, after factoring for the price hike.
EBITDA 149.1 171.8 251.9 292.8 E-auction realization is estimated to be flat QoQ at INR1,974/t.
NP 92.7 110.4 163.9 190.9 PAT is estimated to increase ~71% QoQ to INR51.4b. Buy.
Adj.EPS (INR) 14.9 17.8 26.4 30.8
EPS Gr. (%) -34.0 19.2 48.4 16.5
BV/Sh. (INR) 39.5 37.5 40.1 43.2
RoE (%) 37.8 47.4 65.8 71.2
RoCE (%) 32.2 46.0 67.3 73.0
Payout (%) 163.0 111.3 90.0 90.0
Valuation
P/E (x) 18.4 15.4 10.4 8.9 Key issues to watch for
P/BV (x) 6.9 7.3 6.8 6.3 E-auction volumes and realization.
EV/EBITDA 8.8 8.0 5.6 4.9 Global coal prices.
(x)
Div. Yield (%) 7.3 6.0 7.2 8.4
JSW Energy
Bloomberg JSW IN
CMP: INR79 TP: INR53 (-33%) Sell
Equity Shares (m) 1640.1
We estimate JSW Energy’s EBITDA to decline 11% YoY to INR5.2b
M. Cap. (INR b)/(USD b) 130 / 2
on lower generation at Hydro and merchant power plants.
52-Week Range (INR) 98 / 60
0 / -1 / 12
Vijaynagar PLF is estimated at 45% v/s 77% in the previous year.
1,6,12 Rel Perf. (%)
Imported coal prices are estimated to be broadly flat QoQ at
Financial Snapshot (INR Million) USD84/t. Sell.
Y/E MARCH 2017 2018E 2019E 2020E
Sales 826.3 815.4 845.6 918.0
EBITDA 33.2 28.6 29.0 31.3
NP 6.3 6.2 5.9 6.5
EPS (INR) 3.8 3.8 3.6 4.0
EPS Gr. (%) -51.5 -0.9 -5.6 10.5
BV/Sh. (INR ) 63.2 64.6 65.8 67.3
RoE (%) 6.3 5.9 5.5 6.0
RoCE (%) 8.6 7.8 7.5 7.5
Payout (%) 52.1 52.6 55.7 50.4
VALUATION
P/E (x) 21.0 21.2 22.5 20.3 Key issues to watch for
P/BV (x) 1.3 1.2 1.2 1.2 International coal prices.
EV/EBITDA (x) 8.5 9.6 9.4 9.1 Short-term power market prices.
Div. Yield (%) 2.5 2.5 2.5 2.5
NHPC
Bloomberg NHPC IN
CMP: INR29 TP: INR36 (+26%) Buy
Equity Shares (m) 10259.3
We expect PAT to increase 2% YoY to INR1.7b.
M. Cap. (INR b)/(USD b) 298 / 5
52-Week Range (INR) 35 / 26
6 / -2 / -21
Other income is expected to decline from INR5.7b in 3Q to INR1.3b
1,6,12 Rel Perf. (%)
in 4Q as the base is stronger due to dividend from subsidiaries and
Financial Snapshot (INR Million) late payment surcharge. Buy.
Y/E MARCH 2017 2018E 2019E 2020E
Sales 86.2 90.6 106.2 117.3
EBITDA 48.4 51.7 66.4 74.8
NP 30.3 25.1 30.7 32.8
EPS (INR) 3.0 2.4 3.0 3.2
EPS Gr. (%) 25.6 -17.2 22.2 7.0
BV/Sh. (INR ) 28.3 28.6 29.4 30.3
RoE (%) 10.0 8.6 10.3 10.7
RoCE (%) 7.0 6.4 7.8 9.1
Payout (%) 98.9 88.3 72.3 71.3
Valuation
P/E (x) 9.9 11.7 9.5 8.9 Key issues to watch for
P/BV (x) 1.0 1.0 1.0 0.9 Commissioning of on-going projects.
Div. Yield (%) 8.4 6.3 6.3 6.7
NTPC
Bloomberg NTPC IN
CMP: INR170 TP: INR214 (+26%) Buy
Equity Shares (m) 8245.5
We expect adjusted PAT to increase ~3% YoY to INR27.4b, as
M. Cap. (INR b)/(USD b) 1398 / 21
growth in regulated equity is offset by under-recovery on account
52-Week Range (INR) 188 / 153
6 / -5 / -9
of lower DC at a few plants.
1,6,12 Rel Perf. (%)
Installed capacity is unchanged QoQ. It commissioned ~1.6GW in
Financial Snapshot (INR Million) standalone and 600MW in JV in the quarter.
Y/E MARCH 2017 2018E 2019E 2020E Regulated equity is expected to increase by 15% YoY to INR507b.
Net Sales 817.2 838.9 943.0 1,029.8 Buy.
EBITDA 218.3 227.8 289.1 329.3
NP 101.9 107.1 125.1 136.8
Adj.EPS (INR) 12.4 13.0 15.2 16.6
EPS Gr. (%) 5.1 5.0 16.9 9.3
BV/Sh. (INR) 118.7 126.4 135.6 145.0
RoE (%) 10.9 10.6 11.6 11.8
RoCE (%) 6.6 6.5 7.2 7.7
Payout (%) 38.7 34.7 33.0 36.2
Valuation
P/E (x) 13.5 12.8 11.0 10.0 Key issues to watch for
P/BV (x) 1.4 1.3 1.2 1.1 PLF for coal-based projects and generation loss.
EV/EBITDA (x) 11.3 11.5 9.4 8.2 Core RoE and incentives.
Div. Yield (%) 2.7 3.0 3.6 3.9 Impact of shift in GCV determination.
Tata Power
Bloomberg TPWR IN
CMP: INR83 TP: INR74 (-11%) Sell
Equity Shares (m) 2705.0
We expect Tata Power’s adj. PAT to increase ~15% QoQ (up 51%
M. Cap. (INR b)/(USD b) 228 / 4
YoY) to INR4.5b, driven by an increase in coal prices, offset by
52-Week Range (INR) 102 / 76
2 / 3 / -17
higher losses at Mundra.
1,6,12 Rel Perf. (%)
We expect fuel cost under-recovery at Mundra of INR0.8/kWh,
Financial Snapshot (INR Million) driven by higher coal prices.
Y/E MARCH 2017 2018E 2019E 2020E We estimate PAT of coal companies to increase by ~43% YoY to
Sales 279.0 312.9 324.7 341.8 INR3.6b, driven by higher realization. Sell.
EBITDA 58.5 64.6 69.3 71.9
NP 14.0 12.9 19.6 21.3
EPS (INR) 5.2 4.8 7.3 7.9
EPS Gr. (%) 83.8 -7.5 51.9 8.6
BV/Sh. (INR ) 43.5 46.3 53.8 58.6
RoE (%) 11.9 10.6 14.5 14.0
RoCE (%) 6.8 5.5 6.3 6.4
Payout (%) 0.0 27.2 17.9 16.5
Valuation
P/E (x) 16.1 17.4 11.4 10.5 Key issues to watch for
P/BV (x) 1.9 1.8 1.5 1.4 Cost control at Mundra.
Div. Yield (%) 0.0 1.6 1.6 1.6 Performance at Delhi.
Arvind
Bloomberg ARVND IN CMP: INR403 TP: INR402 Neutral
Equity Shares (m) 258.2
We expect revenue to grow 14.8% YoY to INR28,296m in 4QFY18.
M. Cap. (INR b)/(USD b) 104 / 2
52-Week Range (INR) 478 / 354 EBIDTA margin is likely to contract 60bp YoY to 8.8%. EBIDTA is
1,6,12 Rel Perf. (%) -1 / 4 / -13 likely to grow by 7.4% YoY to INR2476m.
Avenue Supermarts
Bloomberg DMART IN
CMP: INR1364 TP: INR920 (-33%) Sell
Equity Shares (m) 624.1
M. Cap. (INR b)/(USD b) 851 / 13 We expect revenue to grow 125% YoY to INR 38,8830m in 4QFY18.
52-Week Range (INR) 1393 / 628 EBIDTA margin is likely to expand 130bp YoY to 8%. EBIDTA is likely
1,6,12 Rel Perf. (%) 6 / 18 / 104
to grow by 50% YoY to INR3,110m.
Financial Snapshot (INR Billion) We estimate PAT to grow 82% YoY to INR1,756m from INR967m.
Y/E MARCH 2017 2018E 2019E 2020E Sell.
Net Sales 119.0 150.9 190.5 242.6
EBITDA 9.8 13.5 18.1 23.8
Adj. Net Profit 4.8 7.8 10.8 14.4
Adj. EPS (INR) 7.7 12.6 17.2 23.0
Adj. EPS Gr. (%) 34.5 63.6 37.4 33.4
BV/Sh (INR) 61.6 70.3 82.4 98.5 Key things to watch for
RoE (%) 17.9 19.0 22.6 25.4
Store additions during the quarter.
RoCE (%) 14.2 16.1 21.4 25.4
Like-to-like store sales growth.
Div. Payout (%) 0.0 30.0 30.0 30.0
Valuations
P/E (x) 154.1 94.2 68.6 51.4
P/BV (x) 19.2 16.8 14.3 12.0
EV/EBITDA (x) 67.2 48.8 36.5 27.7
Div. Yield (%) 0.0 0.4 0.5 0.6
BSE
Bloomberg BSE IN CMP: INR788 TP: INR1,070 (+36%) Buy
Equity Shares (m) 54.8
We expect revenue to decline by 7.8% YoY to INR1,500m,
M. Cap. (INR b)/(USD b) 43 / 1
52-Week Range (INR) 1178 / 726 primarily because of the absence of income from depository
1,6,12 Rel Perf. (%) 0 / -26 / -31 services, adjusted for which there would be growth.
We estimate EBITDA margin of 36.3%, up 1,820bp YoY and 340bp
Financial Snapshot (INR Billion)
QoQ. Stability in costs, combined with an increase in revenue
Y/E March 2017 2018E 2019E 2020E
from sources other than depository, is expected to drive margins
Net Sales 5.2 4.7 5.1 5.5
EBITDA 1.0 1.1 1.3 1.5
higher.
PAT 2.4 2.4 2.6 2.9 PAT at INR783m is expected to grow at 30.2% YoY. Buy.
EPS (INR) 41.0 42.6 47.6 52.9
EPS Gr (%) 68.4 4.0 11.6 11.2
BV / Sh (INR) 495 492 618 628 Key things to watch for
P/E (x) 22.7 7.2 19.5 17.6 Volume movement and market share dynamics post pricing
P / BV (x) 1.9 1.9 1.5 1.5 strategy change
RoE (%) 8.3 8.7 7.7 8.4 Performance in non-equity segments
RoCE (%) 13.7 11.2 10.0 10.6 Update on operations in and prospects of INX
Castrol (India)
Bloomberg CSTRL IN CMP: INR205 TP: INR247 (+21%) Buy
Equity Shares (m) 989.1
We expect revenue to grow 3% YoY (-7% QoQ) to INR9.1b, led by
M. Cap. (INR b)/(USD b) 203 / 3
227 / 172 volumes at 51.2m liters (+2% YoY, -3% QoQ) and realization at
52-Week Range (INR)
1,6,12 Rel Perf. (%) 4 / 9 / -17 INR177/liter (+1% YoY, -1% QoQ).
We expect CSTRL to report EBITDA of INR2.6b (-2% YoY, -16%
Financial Snapshot (INR b)
QoQ). EBITDA margin would be 28.6%, lower than 29.8% in
Y/E Dec 2016 2017 2018E 2019E
1QCY17.
Sales 33.6 35.8 36.8 37.6
EBITDA 9.9 10.3 10.0 9.7 We estimate net profit at INR1.7b (-3% YoY, -12% QoQ).
PAT 6.7 6.9 6.7 7.0
The stock trades at 28.9x CY19E EPS of INR7.1. Maintain Buy.
EPS (INR) 6.8 7.0 6.8 7.1
EPS Gr. (%) 5.8 2.9 -2.8 4.0
BV/Sh.(INR) 9.9 10.3 11.0 11.7
RoE (%) 86.3 69.1 63.8 62.3 Key issues to watch for
RoCE (%) 86.4 69.2 63.9 62.4 (a) Volume growth.
Payout (%) 97.4 81.5 90.0 90.0 (b) Operating margin expansion.
Valuations
(c) Launch of new products.
P/E (x) 30.0 29.2 30.0 28.9
(d) Competitive pressure from other players.
P/BV (x) 20.7 19.9 18.7 17.4
EV/EBITDA (x) 19.5 18.8 18.8 19.1
Div. Yield (%) 2.7 2.3 2.5 2.6
Delta Corp
Bloomberg DELTA IN CMP: INR276 TP: INR332 (+20%) Buy
Equity Shares (m) 267.1
We expect revenue to grow 42% YoY to INR1,535m, driven by
M. Cap. (INR b)/(USD b) 74 / 1
52-Week Range (INR) 401 / 139 traction in Goa casinos and ramp-up of online business.
1,6,12 Rel Perf. (%) -20 / 35 / 18 EBITDA margin is likely to expand 1,390bp to 45.7%, and EBITDA is
expected to grow 104% YoY to INR702m on a low base.
Financial Snapshot (INR Billion)
Y/E MARCH 2017 2018E 2019E 2020E Net profit is likely to increase 287% YoY to INR440m.
Net Sales 4.5 5.9 7.7 9.7
We maintain our target price at INR332/share. Buy.
EBITDA 1.6 2.5 3.2 4.4
Adj. Net Profit 0.7 1.5 2.0 2.8
Adj. EPS (INR) 3.1 5.7 7.4 10.4
Adj. EPS Gr. (%) 125.5 87.7 25.7 39.7
BV/Sh (INR) 39.7 59.4 65.4 74.1
Key things to watch for
RoE (%) 8.1 12.2 11.9 14.9 Company strategy w.r.t increase in annual license fee.
RoCE (%) 8.7 11.7 11.9 22.2 Goa - move from offshore to onshore - policy to be announced
Div. Payout (%) 13.2 25.0 21.0 16.2 by Goa government.
Valuations Daman - grant of casino license
P/E (x) 81.9 43.6 33.6 24.1 Sikkim -commencement of new airport.
P/BV (x) 6.3 4.2 3.8 3.4
EV/EBITDA (x) 53.0 32.2 26.0 18.8
Div. Yield (%) 0.1 0.5 0.5 0.6
PBT 292 397 147 181 350 624 669 667 1,020 2,324
Tax 85 91 40 64 127 194 225 227 280 779
Rate (%) 29.2 22.9 27.2 35.4 36.1 31.1 33.6 34.0 27.4 33.5
Minority Interest & P/L of Asso. Cos. 4 -16 6 3 1 -2 -3 0 2 2
Reported PAT 202 322 101 114 223 433 447 440 738 1,543
Adj PAT 170 323 105 114 211 433 447 440 707 1,531
YoY Change (%) 2,539.9 494.1 -9.4 -29.3 24.4 33.8 327.8 286.4 126.5 116.5
Margins (%) 15.6 24.1 10.1 10.5 16.4 29.8 27.6 28.7 15.6 26.0
E: MOSL Estimates
Info Edge
Bloomberg INFOE IN CMP: INR1220 TP: INR1550 (27%) Buy
Equity Shares (m) 126.4
We expect standalone revenue to grow 11.1% YoY to INR2.3b.
M. Cap. (INR b)/(USD b) 156 / 2
Recruitment segment (~75% of business) is estimated to grow
1863 1458 / 800
1,6,12 Rel Perf. (%) -3 / 9 / 39
13% YoY to INR1.8b.
We estimate real estate portal 99acres.com’s revenue at
INR302m (10% YoY) and that of matrimonial portal
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E
Jeevansathi.com at INR178m (up 25% YoY).
Sales 8.0 9.1 10.4 12.1
99acres.com should see better growth as demonetization now
EBITDA 2.3 3.1 3.7 4.7 gets captured in the base and RERA-led uncertainty has been
NP 2.0 2.6 3.2 4.1 waning.
EPS (Rs) 15.7 23.4 26.3 33.4 Our EBITDA margins estimate for the quarter stands at 33%
EPS Gr. (%) 38.2 49.0 12.5 27.1 compared to 34.7% in the previous quarter, and 30.3% in 4QFY17.
BV/Share 162.7 177.6 196.7 222.9 Consequently, we expect PAT of INR675m, up 105.3% YoY. Buy.
RoE (%) 10.2 13.7 14.0 15.9
RoCE (%) 10.2 13.7 14.0 15.9
Key things to watch for
Valuations
Situation around the RERA-led uncertainty and consequent
P/E (x) 77.6 52.1 46.3 36.4
impact on 99acres.com.
P/BV (x) 7.5 6.8 6.2 5.5
EV/EBITDA (x) 56.5 42.9 35.6 27.0
Traction in the recruitment business from segments other than IT.
EV/Sales (x) 16.0 14.9 12.7 10.5
Commentary around monetization in Zomato.com.
InterGlobe Aviation
Bloomberg INDIGO IN CMP: INR1,368 TP: INR1,400 (+2%) Neutral
Equity Shares (m) 383.9
We expect INDIGO to report revenue of INR60b in 4QFY18 (+24%
M. Cap. (INR b)/(USD b) 525 / 8
1377 / 1005 YoY, -3% QoQ) and EBITDAR of INR14.8b (+11% YoY, -24% QoQ).
52-Week Range (INR)
1,6,12 Rel Perf. (%) 5 / 20 / 19 We model ticket yield at INR3.51 (+2.3% YoY, -5% QoQ) and RPK
at 14.7b (+20% YoY). Any deviation in yield would have a
Financial Snapshot (INR Billion)
meaningful impact on our estimates.
Y/E March 2017 2018E 2019E 2020E
Sales 185.8 232.0 292.8 352.0 We model ATF at INR61.7/liter (+11.5% YoY, +9.4% QoQ) for
EBITDA 21.4 33.3 34.8 46.7 4QFY18 and expect INDIGO to report net profit of INR3.7b.
NP 16.6 24.8 28.8 38.4
We model ASK at 76b/92b in FY19/FY20 v/s 54b in FY17, and RPK
EPS (INR) 43.2 64.7 75.0 100.0
at 68b/81b in FY19/FY20 v/s 46.3b in FY17, driven by an increase
EPS Gr. (%) -16.6 49.6 15.9 33.4
in fleet size.
BV/Sh (INR) 98.5 175.2 187.7 204.4
RoE (%) 51.0 47.3 41.3 51.0 The stock trades at 13.7x FY20E EPS of INR100 and at an EV of
RoCE (%) 31.4 36.7 45.0 57.7 8.1x FY20E adjusted EBITDAR. Maintain Neutral.
Payout (%) 89.1 83.3 83.3 83.3
Valuations
Key issues to watch for
P/E (x) 31.6 21.1 18.2 13.7
Induction of new aircraft in the fleet.
P/BV (x) 13.9 7.8 7.3 6.7
Fuel costs and their impact on yields.
Adj.EV/EBITDAR(x) 13.7 10.3 9.6 8.1
Div. Yield (%) 2.3 3.3 3.8 5.1
Kaveri Seed
Bloomberg KSCL IN CMP: INR498 TP: INR664 (+33%) Buy
Equity Shares (m) 69.1
We expect revenue to grow 10% YoY to INR443m in 4QFY18. We
M. Cap. (INR b)/(USD b) 34 / 1
52-Week Range (INR) 708 / 433 expect growth to be driven by continuous focus on non-cotton
1,6,12 Rel Perf. (%) 3 / -10 / -22 business.
We expect EBITDA margin of -3.3% v/s -67.4% in 4QFY17 and
Financial Snapshot (INR Billion)
EBITDA of INR-15m v/s INR-272m in 4QFY17.
Y/E March 2017 2018E 2019E 2020E
Sales 7.0 7.8 8.9 10.2 We expect adjusted PAT of INR-26m in 4QFY18 as against INR-
EBITDA 1.4 2.3 2.7 3.2 306m in the year-ago period. Buy.
NP 1.3 2.3 2.7 3.1
EPS (INR) 19.1 34.2 40.6 47.4
EPS Gr. (%) -21.4 79.5 18.5 17.0
BV/Sh (INR) 146.8 139.4 159.5 186.6
RoE (%) 13.6 23.4 27.1 27.4
RoCE (%) 16.0 24.7 28.7 29.0
Payout (%) 32.2 52.6 50.3 43.0
Key things to watch for
Valuations
Outlook of monsoon and corn acreage in rabi season.
P/E (x) 26.1 14.6 12.3 10.5
P/BV (x) 3.4 3.6 3.1 2.7
Market share movement in major markets of Gujarat and
EV/EBITDA (x) 23.6 14.1 11.7 9.7 Maharashtra.
Div Yield (%) 0.6 2.9 3.3 3.3
Quarterly Performance
Y/E March FY17 FY18E FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Net Sales 4,940 678 679 403 5,906 696 706 443 7,050 7,780
YoY Change (%) -8.4 2.2 -2.7 -1.9 19.6 2.7 4.1 10.0 -1.6 10.4
Total Expenditure 3,357 644 644 675 3,837 549 609 458 5,654 5,469
EBITDA 1,583 34 34 -272 2,069 147 97 -15 1,395 2,311
Margins (%) 32.0 5.0 5.0 -67.4 35.0 21.2 13.8 -3.3 19.8 29.7
Depreciation 78 72 69 66 63 61 57 60 302 254
Interest 0 0 0 0 2 1 0 0 2 5
Other Income 54 170 101 18 43 164 16 48 344 280
PBT before EO expense 1,559 132 66 -320 2,046 250 56 -27 1,435 2,332
PBT 1,559 132 -527 -912 2,046 250 56 -27 843 2,332
Tax 15 60 30 -40 22 41 1 -1 70 70
Rate (%) 1.0 45.6 -5.7 4.4 1.1 16.5 2.6 4.2 8.3 3.0
Minority Interest & P/L of Asso. Cos. 0 0 0 0 0 0 0 0
Reported PAT 1,544 72 -557 -872 2,024 209 54 -26 773 2,262
Adj PAT 1,544 72 69 -306 2,024 209 54 -26 1,316 2,262
YoY Change (%) -29.6 NM -40.9 NM 31.1 191.7 -21.9 -91.5 -55.1 71.8
Margins (%) 31.3 10.6 10.2 -75.9 34.3 30.0 7.7 -5.8 18.7 29.1
E: MOSL Estimates
Manpasand Beverages
Bloomberg MANB IN CMP: INR375 TP: INR467 (+25%) Buy
Equity Shares (m) 114.4
We expect revenue to grow 43% YoY to INR 3,910m in 4QFY18,
M. Cap. (INR b)/(USD b) 43 / 1
52-Week Range (INR) 512 / 336 based on healthy growth in Mango Sip and Fruits Up, and increased
1,6,12 Rel Perf. (%) -2 / -26 / -6 traction in recently launched Jeera Sip and Siznal. Additionally,
sales through Parle-tie up will contribute to ~5% of revenues.
Financial Snapshot (INR Billion)
EBIDTA margin is likely to expand 137bp to 20.3% and EBIDTA is
Y/E MARCH 2017 2018E 2019E 2020E
Net Sales
likely to grow by 53.3% YoY to INR794m.
7.2 9.6 14.2 18.6
EBITDA 1.4 1.8 2.8 3.6 We estimate PAT to grow 39% YoY to INR436m from INR313m.
Adj. Net Profit 0.7 1.0 1.6 2.1 Buy.
Adj. EPS (INR) 6.3 8.8 13.9 18.7
Adj. EPS Gr. (%) 43.8 38.2 58.4 34.6
BV/Sh (INR) 100.8 107.4 117.9 132.0
RoE (%) 7.3 7.2 12.3 15.0 Key things to watch for
RoCE (%) 8.4 8.4 14.3 17.3 Progress on performance of tie-ups.
Div. Payout (%) 12.3 24.6 24.6 24.6 Performance of new product launches.
Valuations Update on commissioning of new plants.
P/E (x) 58.6 42.4 26.8 19.9
P/BV (x) 3.7 3.5 3.2 2.8
EV/EBITDA (x) 28.8 22.4 14.8 11.1
Div. Yield (%) 0.2 0.5 0.7 1.0
MCX
Bloomberg MCX IN CMP: INR734 TP: INR1,050 (+43%) Buy
Equity Shares (m) 51.0
Total volumes at MCX traded during the quarter stood at INR15t,
M. Cap. (INR b)/(USD b) 37 / 1
52-Week Range (INR) 1258 / 665 up 17.3% QoQ and 20.9% YoY.
1,6,12 Rel Perf. (%) -3 / -37 / -50 Volumes at MCX have seen a strong pick-up after four quarters of
YoY decline post demonetization.
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E That drives our revenue expectation of INR694m, which is an
Sales 2.6 2.6 3.1 3.6 increase of 13.8% YoY.
EBITDA 0.8 0.7 1.3 1.6
Consequently, EBITDA margins are expected to expand by
NP 1.3 1.1 1.6 1.9
1,590bp YoY to 29%.
EPS (INR) 24.8 21.3 32.0 36.9
EPS Gr. (%) 6.2 -14.3 50.5 15.4 We expect PAT to increase by 57% YoY to INR343m. Buy.
BV/Sh.(INR) 266.4 259.4 275.7 329.2
RoE (%) 10.2 8.1 12.0 12.2
RoCE (%) 10.0 7.8 11.6 11.9
Key things to watch for
Payout (%) 70.7 113.7 75.5 65.5
Expectations of volume revival.
Valuations
Pace of reforms under SEBI.
P/E (x) 29.1 34.0 22.6 19.6
P/BV (x) 2.7 2.8 2.6 2.2
Strategy around new opportunities.
EV/EBITDA (x) 30.5 35.3 20.1 15.9
Dividend yield 2.5 3.3 3.3 3.3
Quarterly Performance
FY17 FY18E FY17 FY18E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales 676 652 686 626 592 673 610 694 2,641 2,568
Q-o-Q Gr. (%) 18.7 7.8 5.1 -8.7 -5.5 13.6 -9.4 13.8 12.4 -2.8
Staff Costs 143 144 198 160 178 178 169 169 644 693
Other expenses 265 257 296 335 282 288 306 284 1,116 1,158
Depreciation 49 42 45 49 48 48 35 40 186 171
EBIT 219 209 148 82 84 158 101 201 695 546
Margins (%) 32.4 32.1 21.5 13.1 14.2 23.6 16.5 29.0 26.3 21.3
Other Income 308 302 312 243 277 243 156 257 1,164 931
PBT bef. Exceptional items 527 511 459 325 361 401 256 458 1,857 1,478
Tax 152 134 119 106 98 110 68 114 512 391
Rate (%) 28.9 26.3 26.0 32.6 27.2 27.3 26.7 25.0 27.5 26.5
PAT 375 376 339 219 263 292 188 343 1,346 1,087
Q-o-Q Gr. (%) 30.3 0.5 -9.9 -35.5 20.0 11.0 -35.6 82.9 221.7 -17.0
EPS (INR) 6.5 7.4 6.7 4.3 5.1 5.7 3.7 6.7 26.4 21.3
Total volumes (INR t) 16.0 16.4 13.9 12.4 12.0 14.1 12.8 15.0 58.7 53.9
Q-o-Q Gr. (%) 7.3 2.3 -15.2 -10.3 -3.4 17.0 -8.8 17.3
Y-o-Y Gr. (%) 17.7 10.3 6.4 -16.5 -24.8 -14.0 -7.6 20.9 4.1 -8.1
E: MOSL Estimates
Navneet Education
Bloomberg NELI IN CMP: INR148 TP: INR194 (+31%) Buy
Equity Shares (m) 233.6
We expect revenue to grow 47% YoY to INR3,074m in 4QFY18,
M. Cap. (INR b)/(USD b) 35 / 1
52-Week Range (INR) 194 / 128 EBIDTA margin is likely to expand 460bp YoY to 17.9% and EBIDTA
1,6,12 Rel Perf. (%) 12 / -14 / -23 is likely to grow by 97% YoY to INR550m.
Oberoi Realty
Bloomberg OBER IN CMP: INR509 TP: INR612 (+20%) Buy
Equity Shares (m) 339.5
We expect sales volumes to decline 2% YoY to 132,500sf in the
M. Cap. (INR b)/(USD b) 173 / 3
52-Week Range (INR) 577 / 339 quarter, primarily on account of decreased traction in Mulund
1,6,12 Rel Perf. (%) 2 / 16 / 26 (Eternia and Enigma) and 360 West projects.
In case of annuity portfolio, the primary driver would be increased
Financial Snapshot (INR Billion)
occupancy to 55% from 30% YoY in respect of its Commerz II
Y/E MARCH 2017 2018E 2019E 2020E
project.
Sales 11.1 12.3 39.8 36.3
EBITDA 5.7 6.6 21.8 20.0 We estimate sales of INR3,139m, up 8% YoY.
Net Profit 3.8 4.2 16.9 15.8
We expect EBITDA margin to expand by 180bp YoY to 54.1%.
EPS (INR) 11.2 12.5 49.8 46.5
EPS Gr. (%) -13.1 11.7 300.0 -6.7 We estimate net profit of INR1,073m, up 5% YoY.
BV/Sh (INR) 168.6 178.8 219.7 257.8
We maintain our target price at INR612.
RoE (%) 6.8 7.2 25.0 19.5
RoCE (%) 6.1 6.0 18.2 15.3
Valuations
P/E (x) 44.2 39.6 9.9 10.6 Key things to watch for
P/BV (x) 2.9 2.8 2.2 1.9 Launch plan for monetizing Thane land parcel.
EV/EBITDA (x) 30.3 27.6 8.0 8.4 Action plan to increase sales momentum for its Mulund Projects
EV/ Sales (x) 15.5 14.8 4.4 4.6 (Eternia and Enigma).
Quess Corp
Bloomberg QUESS IN CMP: INR1006 TP: INR1300 (+29%) Buy
Equity Shares (m) 146.5
We expect revenue of INR18.2b for Quess in 4QFY18, signifying
M. Cap. (INR b)/(USD b) 147 / 2
52-Week Range (INR) 1199 / 688 growth of 47% YoY.
1,6,12 Rel Perf. (%) 1 / 16 / 30 Inorganic additions that would add to YoY growth in the quarter
include Monster, TBSS, Greenpiece and Vedang Cellular.
Financial Snapshot (INR Billion)
Excluding these, growth is expected to be 28% YoY.
INR million FY17 FY18E FY19E FY20E
Sales 43.1 61.0 81.3 96.9 Additionally, incremental revenue from the smart city
EBITDA 2.4 3.5 5.3 6.6 implementation is expected to add 5pp more to growth.
NP 1.3 3.2 5.0 6.3
EBITDA margins at 5.9% are expected to be higher by 20bp YoY
EPS (Rs) 9.9 22.8 34.1 43.1
because of margin-accretive acquisitions.
EPS Growth (%) 40.4 130.7 49.6 26.6
BV/Share (Rs) 73.8 180.1 224.8 280.5 Our PAT estimate is INR901m, up 144% YoY. Buy.
P/E (x) 102.8 44.6 29.8 23.5
P/BV (x) 13.7 5.6 4.5 3.6 Key things to watch for
EV/EBITDA (x) 56.0 40.4 27.7 21.6 Integration of recently acquired entities.
EV/Sales (x) 3.1 2.3 1.8 1.5 Restructuring of operations in the Industrials segment.
RoE (%) 21.0 22.3 21.7 22.0 Organic growth momentum, and traction in the general staffing
RoCE (%) 13.8 19.0 19.5 20.4 business post GST.
PI Industries
Bloomberg PI IN CMP: INR903 TP: INR1061 (+18%) Buy
Equity Shares (m) 136.6
We expect revenue to grow 5.6% YoY to INR6,392m, aided by
M. Cap. (INR b)/(USD b) 123 / 2
52-Week Range (INR) 1035 / 674 growth of 7% in agri-input business and 5% in CSM business.
1,6,12 Rel Perf. (%) 4 / 15 / -3 We estimate 110bp margin contraction to 24.3%, and expect
EBITDA to remain flat at INR1,553m.
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E We estimate adjusted PAT at INR1,156m, as against INR1,352m in
Sales 22.8 23.2 26.5 30.4 4QFY17. Buy.
EBITDA 5.5 5.6 6.9 8.0
NP 4.6 4.1 5.2 6.1
EPS (INR) 33.4 29.9 38.1 44.2
EPS Gr. (%) 46.4 -10.5 27.3 16.2
BV/Sh. (INR) 118.3 141.4 171.6 207.9
RoE (%) 32.8 23.0 24.3 23.3 Key things to watch for
RoCE (%) 31.0 22.6 24.3 29.5 CSM growth and order book.
Valuations New launches and tie-ups.
P/E (x) 27.0 30.2 23.7 20.4
P/BV (x) 7.6 6.4 5.3 4.3
EV/EBITDA (x) 21.0 20.1 15.9 13.3
EV/Sales (x) 5.1 4.8 4.2 3.5
S H Kelkar
Bloomberg SHKL IN CMP: INR260 TP: INR318 (+22%) Buy
Equity Shares (m) 144.6
We expect revenue to grow 14% YoY to INR3,075m in 4QFY18, led
M. Cap. (INR b)/(USD b) 38 / 1
52-Week Range (INR) 333 / 237 by a rebound in FMCG demand and available cross-selling
1,6,12 Rel Perf. (%) -8 / -4 / -25 opportunities post CFF acquisition.
EBIDTA margin is likely to expand 480bp YoY to 18.5%, and EBIDTA
Financial Snapshot (INR Billion)
is likely to grow by 54% YoY to INR569m.
Y/E MARCH 2017 2018E 2019E 2020E
Net Sales 10.6 10.6 12.3 14.1 We estimate adj. PAT to grow 30% YoY to INR357m from INR274m.
EBITDA 1.7 1.9 2.3 2.9 Buy.
Adj. Net Profit 1.0 1.1 1.4 1.8
Adj. EPS (INR) 7.2 7.9 9.7 12.2
Adj. EPS Gr. (%) 43.5 9.1 22.4 26.6
BV/Sh (INR) 56.1 61.4 68.3 77.0
RoE (%) 13.7 13.4 14.9 16.9 Key things to watch for
RoCE (%) 19.0 19.8 21.8 24.8 Supply side issues with disruptions in Germany, US, China.
Div. Payout (%) 28.9 28.9 28.9 28.9 CFF acquisition – cross-selling opportunities.
Valuations Complete shift of ingredients from Netherlands to
P/E (x) 37.9 34.8 28.4 22.5 manufacturing plants in India.
P/BV (x) 4.9 4.5 4.0 3.6
EV/EBITDA (x) 24.0 20.5 17.3 13.6
Div. Yield (%) 0.6 0.6 0.8 1.1
SRF
Bloomberg SRF IN CMP: INR2,008 TP: INR2,351 (+17%) Buy
Equity Shares (m) 57.4
Execution of deferred order book is expected to deliver revenue
M. Cap. (INR b)/(USD b) 115 / 2
52-Week Range (INR) 2045 / 1420 growth of 8.5% YoY to INR14.3b.
1,6,12 Rel Perf. (%) 8 / 22 / 9 We expect packaging film business to deliver growth of over 18%,
followed by growth of 6% in the chemicals & polymers business.
Financial Snapshot (INR Billion)
Y/E March 2017 2018E 2019E 2020E We expect EBITDA margin to remain flattish at 16.1%, with
Sales 48.2 55.0 64.8 74.4 growth of 7% in EBITDA to INR2,316m. Adjusted PAT is expected
EBITDA 9.7 9.5 12.0 14.5 to decline 11.2% YoY to INR1,018m. Buy.
NP 4.9 4.4 6.1 8.1
EPS (INR) 85.9 77.4 105.0 138.3
EPS Gr. (%) 12.8 -9.9 35.6 31.7
BV/Sh. (INR) 544.6 602.1 683.9 798.9
RoE (%) 16.6 13.3 16.3 18.7
RoCE (%)
Key things to watch for
17.7 16.7 20.7 25.2
Valuations Outlook on specialty chemicals.
P/E (x) Margins in Technical Textiles and Packaging segments.
23.4 25.9 19.1 14.5
P/BV (x) 3.7 3.3 2.9 2.5
EV/EBITDA (x) 13.8 14.4 11.2 8.9
EV/Sales (x) 2.8 2.5 2.1 1.7
TeamLease Services
Bloomberg TEAM IN CMP: INR2312 TP: INR2700 (+17%) Buy
Equity Shares (m) 17.1
We expect revenue growth of 26.5% YoY to INR10.3b. This marks
M. Cap. (INR b)/(USD b) 40 / 1
52-Week Range (INR) 2537 / 982 a significant pick-up from 12.7% YoY growth seen in the previous
1,6,12 Rel Perf. (%) 16 / 35 / 120 quarter.
We note that in the previous quarter, volume addition was back-
Financial Snapshot (INR Billion)
ended, which will get fully realized in 4Q, resulting in strong
Y/E March 2017 2018E 2019E 2020E
growth.
Sales 30.4 36.8 46.6 57.5
EBITDA 0.4 0.7 0.9 1.3 EBITDA margin is expected to be 1.9%, flat QoQ and up 10bp YoY.
NP 0.7 0.7 1.0 1.5
Our PAT expectation of INR217m (-43.5% YoY) factors in a zero
EPS (Rs) 38.8 43.3 59.6 88.1
EPS Growth (%) 167.6 11.6 37.5 47.9
tax rate owing to benefits from Section 80JJJAA of the Income Tax
BV/Share (Rs) 222.9 266.2 325.8 413.9 Act. However, the decline is because the company realized
P/E (x) 60.5 54.2 39.4 26.6 exceptionally high benefits in 4QFY17 (ETR of -104%). Buy.
P/BV (x) 10.5 8.8 7.2 5.7
Key issues to watch for
EV/EBITDA (x) 86.4 57.8 40.1 27.3
Expectations around a GST-led pick-up in the general staffing
EV/Sales (x) 1.3 1.0 0.8 0.6
business.
RoE (%) 19.2 17.7 20.1 23.8
Momentum in the IT staffing business.
RoCE (%) 19.0 17.7 19.9 23.6
Penetration of other HR services in existing customers and new
accounts.
UPL
Bloomberg UPLL IN CMP: INR764 TP: INR945 (+24%) Buy
Equity Shares (m) 505.0
We expect revenue to grow 10.4% YoY to INR58.9b in 4QFY18,
M. Cap. (INR b)/(USD b) 386 / 6
52-Week Range (INR) 902 / 675 driven by robust growth of 15% in ROW market, followed by 12%
1,6,12 Rel Perf. (%) 9 / -10 / -8 growth in North America.
We expect Latin America to post moderate growth of 6.5%, with
Financial Snapshot (INR Billion)
India and Europe business growing at 10% each.
Y/E March 2017 2018E 2019E 2020E
Sales 163.1 175.8 196.1 222.3 We expect EBITDA margin to expand 70bp YoY to 21.8% and
EBITDA 32.2 35.8 40.7 47.0 EBITDA to increase 14% YoY to INR12,854m.
NP 19.9 21.7 23.8 28.1
We expect adjusted PAT to de-grow 15.3% to INR7,145m on
EPS (Rs) 39.5 43.0 47.2 55.6
EPS Gr. (%) 81.5 8.9 9.7 17.9
account of higher tax rate of 25% in 4QFY18 v/s 7.2% in 4QFY17.
BV/Share 146.5 180.7 218.2 262.4 Buy.
RoE (%) 30.0 26.3 23.6 23.1
Key things to watch for
RoCE (%) 22.4 19.3 18.9 19.3
Acreages and growth in Brazil.
Valuations
P/E (x) 19.4 17.8 16.2 13.7
New launches and share of branded products.
P/BV (x) 5.2 4.2 3.5 2.9
EV/EBITDA (x) 13.0 11.5 10.0 8.4
EV/Sales (x) 2.6 2.4 2.1 1.8
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of
which are available on www.motilaloswal.com. MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited
(BSE), Multi Commodity Exchange of India Limited(MCX) and National Commodity & Derivatives Exchange Limited(NCDEX) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National
Securities Depository Limited (NSDL) and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products and Insurance Regulatory & Development Authority of India (IRDA) as Corporate Agent for insurance products
.Details of associate entities of Motilal Oswal Securities Limited are available on the website at http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
MOSL, it’s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at
the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act
as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.;
however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there
might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have
received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a) managed or co-managed public offering of securities from subject company of this research report,
b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in
this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result,
the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part
or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report
is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied,
is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to
buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by
virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the
specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement Companies where there is interest
Analyst ownership of the stock No
A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or
its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have
expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject
MOSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong)
Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to “Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only
available to professional investor and will be engaged only with professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from
registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered
investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption
under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional
Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional
investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule
15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S.,
MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of
this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject
to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal
Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the
Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced
in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial
instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in
this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of
independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including
those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy,
completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the
views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval.
MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform
investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this
into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and
the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or
published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall
be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees
to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL
or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm
Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id: na@motilaloswal.com, Contact No.:022-38281085.
Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MCX/NCDEX); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser:
INA000007100.IRDA Corporate Agent-CA0541. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS
(Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers
Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products
3 April 2018 4